FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Berteli, TS
   Borges, ED
   Da Luz, CM
   Ferreira, CR
   Navarro, PA
   Vireque, AA
AF Berteli, Thalita S.
   Borges, Eduardo D.
   Da Luz, Caroline M.
   Ferreira, Christina R.
   Navarro, Paula A.
   Vireque, Alessandra A.
TI RELATIONSHIP BETWEEN THE DURATION OF EQUILIBRATION STEP OF THE
   VITRIFICATION AND CHANGES ON ABUNDANCE AND COMPOSITION OF OOCYTE
   MEMBRANE LIPIDS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 76th Scientific Congress of the
   American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2020
CL ELECTR NETWORK
SP Amer Soc Reprod Med
C1 [Berteli, Thalita S.; Borges, Eduardo D.; Da Luz, Caroline M.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Ferreira, Christina R.] Purdue Univ, Metabolite Profiling Facil, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.
   [Vireque, Alessandra A.] Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, Ribeirao Preto, SP, Brazil.
RI Ferreira, Christina R/F-4744-2012
OI Ferreira, Christina R/0000-0003-3988-6454
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES [001, A 88887.371487/201900]; Foundation to Support
   Teaching, Research, and Assistance (FAEPA) at Clinical Hospital, Faculty
   of Medicine of Ribeirao Preto, University of Sao Paulo; Invitra Assisted
   Reproductive Technologies LTDA; Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [305173/2019-7]
FX Coordination for the Improvement of Higher Education Personnel (CAPES),
   Finance Code: 001 (process n. A 88887.371487/201900); Foundation to
   Support Teaching, Research, and Assistance (FAEPA) at Clinical Hospital,
   Faculty of Medicine of Ribeirao Preto, University of Sao Paulo; Invitra
   Assisted Reproductive Technologies LTDA. Brazilian National Council for
   Scientific and Technological Development (CNPq), (process n.
   305173/2019-7), Trial registration number: CEUA-FMRP/USP-107/2017.
CR de Lima CB, 2018, J MASS SPECTROM, V53, P1247, DOI 10.1002/jms.4301
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2020
VL 114
IS 3
SU S
MA P-952
BP E531
EP E531
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA OC7RP
UT WOS:000579355301480
DA 2020-12-17
ER

PT J
AU Berteli, TS
   Borges, ED
   Luz, CM
   Ferreira, CR
   Vireque, AA
   Navarro, PA
AF Berteli, Thalita S.
   Borges, Eduardo D.
   Luz, Caroline M.
   Ferreira, Christina R.
   Vireque, Alessandra A.
   Navarro, Paula A.
TI IMPACT OF OVARIAN STIMULATION AND IN VITRO FERTILIZATION ON LIPID
   PROFILE OF MICE BLASTOCYSTS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 76th Scientific Congress of the
   American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2020
CL ELECTR NETWORK
SP Amer Soc Reprod Med
C1 [Berteli, Thalita S.; Borges, Eduardo D.; Luz, Caroline M.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Ferreira, Christina R.] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA.
   [Vireque, Alessandra A.] Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, Ribeirao Preto, SP, Brazil.
RI Ferreira, Christina R/F-4744-2012
OI Ferreira, Christina R/0000-0003-3988-6454
FU Coordenacao de Aperfeicoamento de Pessoal de Nvel Superior (CAPES)CAPES
   [A 88887.371487/2019-00]; Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia do Hospital das Clnicas da FMRP -USP (FAEPA); Invitra
   Assisted Reproductive Technologies LTDA
FX Coordenacao de Aperfeicoamento de Pessoal de Nvel Superior (CAPES)
   -process no. A 88887.371487/2019-00; Fundacao de Apoio ao Ensino,
   Pesquisa e Assistencia do Hospital das Clnicas da FMRP -USP (FAEPA);
   Invitra Assisted Reproductive Technologies LTDA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2020
VL 114
IS 3
SU S
MA P-43
BP E125
EP E125
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA OC7RP
UT WOS:000579355300308
DA 2020-12-17
ER

PT J
AU Berteli, TS
   Borges, ED
   Luz, CM
   Ferreira, CR
   Vireque, AA
   Navarro, PA
AF Berteli, Thalita S.
   Borges, Eduardo D.
   Luz, Caroline M.
   Ferreira, Christina R.
   Vireque, Alessandra A.
   Navarro, Paula A.
TI IMPACT OF OOCYTE VITRIFICATION AND SUPPLEMENTATION OF THE VITRIFICATION
   MEDIA WITH ANTIOXIDANTS AND FATTY ACIDS ON LIPID PROFILE OF MICE
   BLASTOCYSTS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 76th Scientific Congress of the
   American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2020
CL ELECTR NETWORK
SP Amer Soc Reprod Med
C1 [Berteli, Thalita S.; Borges, Eduardo D.; Luz, Caroline M.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Ferreira, Christina R.] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA.
   [Vireque, Alessandra A.] Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, Ribeirao Preto, SP, Brazil.
RI Ferreira, Christina R/F-4744-2012
OI Ferreira, Christina R/0000-0003-3988-6454
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [A 88887.371487/2019-00]; Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia do Hospital das Clinicas da FMRP - USP (FAEPA); Invitra
   Assisted Reproductive Technologies LTDA
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) -
   process n. A 88887.371487/2019-00; Fundacao de Apoio ao Ensino, Pesquisa
   e Assistencia do Hospital das Clinicas da FMRP - USP (FAEPA); Invitra
   Assisted Reproductive Technologies LTDA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2020
VL 114
IS 3
SU S
MA P-187
BP E182
EP E183
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA OC7RP
UT WOS:000579355300450
DA 2020-12-17
ER

PT J
AU Berteli, TS
   Wang, F
   Navarro, PA
   Kohlrausch, FB
   Keefe, DL
AF Berteli, Thalita S.
   Wang, Fang
   Navarro, Paula A.
   Kohlrausch, Fabiana B.
   Keefe, David L.
TI LINE 1 COPY NUMBER DECREASES AND TELOMERE LENGTH INCREASES WITH AGING IN
   SPERM CELLS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 76th Scientific Congress of the
   American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2020
CL ELECTR NETWORK
SP Amer Soc Reprod Med
C1 [Berteli, Thalita S.; Wang, Fang; Kohlrausch, Fabiana B.] NYU, Langone Med Ctr, New York, NY USA.
   [Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Keefe, David L.] NYU, Grossman Sch Med, New York, NY USA.
FU Coordination for the Improvement of Higher Education Personnel (CAPES),
   BrazilCAPES [001, 88887.371487/2019-00]; Brazilian National Council for
   Scientific and Technological Development (CNPq, Brazil)National Council
   for Scientific and Technological Development (CNPq) [204747/2018-0];
   Stanley H. Kaplan Fund of the NYU Grossman School of Medicine
FX Coordination for the Improvement of Higher Education Personnel (CAPES,
   Finance Code: 001, Brazil; Grant number 88887.371487/2019-00 to TSB),
   Brazilian National Council for Scientific and Technological Development
   (CNPq, Brazil; Grant number 204747/2018-0 to FBK) and the Stanley H.
   Kaplan Fund of the NYU Grossman School of Medicine (to DLK).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2020
VL 114
IS 3
SU S
MA P-991
BP E546
EP E547
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA OC7RP
UT WOS:000579355301519
DA 2020-12-17
ER

PT J
AU Berteli, TS
   Borges, ED
   Luz, CM
   Ferreira, CR
   Navarro, PA
   Vireque, AA
AF Berteli, Thalita S.
   Borges, Eduardo D.
   Luz, Caroline M.
   Ferreira, Christina R.
   Navarro, Paula A.
   Vireque, Alessandra A.
TI DISTURBANCE IN OOCYTE MEMBRANE LIPIDS DURING EQUILIBRATION STEP OF THE
   VITRIFICATION PROTOCOL.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 76th Scientific Congress of the
   American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2020
CL ELECTR NETWORK
SP Amer Soc Reprod Med
C1 [Berteli, Thalita S.; Borges, Eduardo D.; Luz, Caroline M.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Ferreira, Christina R.] Purdue Univ, Metabolite Profiling Facil, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.
   [Vireque, Alessandra A.] Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, Ribeirao Preto, SP, Brazil.
RI Ferreira, Christina R/F-4744-2012
OI Ferreira, Christina R/0000-0003-3988-6454
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [A 88887.371487/2019-00]; Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia do Hospital das Clinicas da FMRP - USP (FAEPA); Invitra
   Assisted Reproductive Technologies LTDA
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) -
   process n. A 88887.371487/2019-00; Fundacao de Apoio ao Ensino, Pesquisa
   e Assistencia do Hospital das Clinicas da FMRP - USP (FAEPA); Invitra
   Assisted Reproductive Technologies LTDA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2020
VL 114
IS 3
SU S
MA P-186
BP E182
EP E182
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA OC7RP
UT WOS:000579355300449
DA 2020-12-17
ER

PT J
AU Robinson, LG
   Pimentel, R
   Wang, F
   Kramer, YG
   Gonullu, DC
   Agarwal, S
   Navarro, PA
   McCulloh, D
   Keefe, DL
AF Robinson, LeRoy G., Jr.
   Pimentel, Ricardo
   Wang, Fang
   Kramer, Yael G.
   Gonullu, Damla C.
   Agarwal, Suneet
   Navarro, Paula A.
   McCulloh, David
   Keefe, David L.
TI Impaired reproductive function and fertility preservation in a woman
   with a dyskeratosis congenita
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article
DE Female reproductive aging; Telomeres; Oocytes; Dyskeratosis congenita
ID TELOMERE LENGTH; FAILURE; OOCYTE
AB Purpose To determine the impact of accelerated telomere shortening on the fertility parameters and treatment outcomes of a woman with dyskeratosis congenita (DKC). Methods A case study of the clinical data, blood, discarded oocytes, and arrested embryos of a woman with DKC and donated cryopreserved embryos from unaffected patients. Mean telomere length in blood cells was analyzed by flow cytometry-fluorescence in situ hybridization (flow-FISH) and qPCR. The load of short telomeres in blood cells was measured by universal single telomere length analysis (Universal STELA). The mean telomere length in embryos was analyzed by single-cell amplification of telomere repeats (SCATR) PCR. Results Comparison of clinical parameters revealed that the DKC patient had reduced anti-Mullerian hormone (0.3 vs 4.1 +/- 5.7 ng/ML), reduced oocytes retrieved (7 vs 18.5 +/- 9.5), reduced fertilization rate, and reduced euploidy rate relative to unaffected patients. Additionally, mean telomere length in DKC embryos were shorter than unaffected embryos. However, hormone treatment led to increased leukocyte telomere length, while the load of short telomeres was also shown to decrease during the course of treatment. Conclusions We demonstrate for the first time the direct detrimental impacts of short telomeres on female fertility. We further demonstrate positive effects of hormone treatments for people with telomere disorders.
C1 [Robinson, LeRoy G., Jr.; Pimentel, Ricardo; Wang, Fang; Gonullu, Damla C.; Keefe, David L.] NYU, Dept Obstet & Gynecol, Langone Hlth, 550 First Ave,NBV-9N1A, New York, NY 10016 USA.
   [Kramer, Yael G.; McCulloh, David; Keefe, David L.] NYU, Langone Fertil Ctr, New York, NY 10016 USA.
   [Agarwal, Suneet] Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.
   [Navarro, Paula A.] Univ Sao Paulo, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
RP Keefe, DL (corresponding author), NYU, Dept Obstet & Gynecol, Langone Hlth, 550 First Ave,NBV-9N1A, New York, NY 10016 USA.; Keefe, DL (corresponding author), NYU, Langone Fertil Ctr, New York, NY 10016 USA.
EM david.keefe@nyucm.org
RI Navarro, Paula/G-2744-2012
OI Robinson, LeRoy/0000-0002-1584-456X; Gonullu, Damla/0000-0001-7134-0078
CR Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792
   Baker TG., 1970, REPROD MAMMALS, P1
   Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084
   Bendix L, 2010, AGING CELL, V9, P383, DOI 10.1111/j.1474-9726.2010.00568.x
   Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036
   Britt-Compton B, 2009, FEBS LETT, V583, P3076, DOI 10.1016/j.febslet.2009.08.029
   Butler MG, 1998, CANCER GENET CYTOGEN, V105, P138, DOI 10.1016/S0165-4608(98)00029-6
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450
   Kalmbach KH, 2013, FERTIL STERIL, V99, P23, DOI 10.1016/j.fertnstert.2012.11.039
   Keefe DL, 2007, CELL MOL LIFE SCI, V64, P139, DOI 10.1007/s00018-006-6466-z
   Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036
   Liu L, 2004, BIOL REPROD, V71, P1724, DOI 10.1095/biolreprod.104.028985
   Liu L, 2004, P NATL ACAD SCI USA, V101, P6496, DOI 10.1073/pnas.0400755101
   Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664
   NAVOT D, 1991, LANCET, V337, P1375, DOI 10.1016/0140-6736(91)93060-M
   PLACHOT M, 1988, HUM REPROD, V3, P627, DOI 10.1093/oxfordjournals.humrep.a136758
   Shay JW, 2004, NAT GENET, V36, P437, DOI 10.1038/ng0504-437
   Sklavos MM, 2015, J CLIN ENDOCR METAB, V100, pE197, DOI 10.1210/jc.2014-2838
   Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319
   Treff NR, 2011, PLOS GENET, V7
   Wang F, 2013, P NATL ACAD SCI USA, V110, pE1906, DOI 10.1073/pnas.1306639110
   Wright DL, 2001, MOL HUM REPROD, V7, P947, DOI 10.1093/molehr/7.10.947
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD MAY
PY 2020
VL 37
IS 5
BP 1221
EP 1225
DI 10.1007/s10815-020-01758-x
EA MAY 2020
PG 5
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA LX9QG
UT WOS:000532647500002
PM 32405899
DA 2020-12-17
ER

PT J
AU Saez, NF
   Jimenez, IG
   Domenech, MB
   Sanchez, FM
   Martinez, IE
   Navarro, PA
AF Fuertes Saez, N.
   Gimenez Jimenez, I.
   Batista Domenech, M.
   Montero Sanchez, F.
   Elia Martinez, I.
   Argente Navarro, P.
TI Motor deficit in the puerperium. Is neuroaxial analgesia the most
   frequent cause?
SO REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION
LA Spanish
DT Article
DE Motor deficit; Hip osteopenia; Puerperium; Neuroaxial anesthesia
ID TRANSIENT OSTEOPOROSIS; HIP
AB Motor deficits of lower limbs during pregnancy and the puerperium are relatively frequent. They are usually attributed to complications which are associated with neuroaxial techniques performed by the anesthesiologist. But there are other possible causes, such as transient osteoporosis of the hips. Transient osteoporosis of pregnancy is a rare and self-limited pathology of unknown etiology. The most severe complication that can occur are pathological fractures, mainly in the load joints. This pathology usually occurs in the third trimester of pregnancy and is showed up with pain and functional impotence of the lower limb affected.
   We present the case of a 35-year-old woman, 40+3 weeks of pregnancy who starts labour. Normally functioning epidural catheter is placed and finally cesarean section is decided because failure to progress; 48 h later the patient begins with functional impotence and pain in the lower left limb. MRI is performed, epidural hematoma is ruled out and osteopenia of the hips is proved. The patient is diagnosed with transient osteoporosis of pregnancy. (C) 2019 Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor. Published by Elsevier Espana, S.L.U. All rights reserved.
C1 [Fuertes Saez, N.; Gimenez Jimenez, I.; Batista Domenech, M.; Montero Sanchez, F.; Argente Navarro, P.] Hosp Univ & Politecn La Fe, Serv Anestesiol & Reanimac, Valencia, Spain.
   [Elia Martinez, I.] Hosp Univ & Politecn La Fe, Serv Radiol, Valencia, Spain.
RP Saez, NF (corresponding author), Hosp Univ & Politecn La Fe, Serv Anestesiol & Reanimac, Valencia, Spain.
EM Neusfuer@gmail.com
CR Izu CB, 2014, REUMATOL CLIN, V10, P58, DOI 10.1016/j.reuma.2013.01.009
   Cano-Marquina AJ, 2012, SEMIN FUND ESP REUMA, V13, P65, DOI [10.1016/j.semreu.2011.12.001., DOI 10.1016/J.SEMREU.2011.12.001]
   Cohen I, 2007, J TRAUMA, V62, P1281, DOI 10.1097/01.ta.0000198206.60286.2f
   Lombana VE, 2013, J OBSTET ANAESTH CRI, V3, P108
   Neal JM, 2015, REGION ANESTH PAIN M, V40, P401, DOI 10.1097/AAP.0000000000000286
   Sweeney AT, 2000, J CLIN DENSITOM, V3, P291, DOI 10.1385/JCD:3:3:291
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0034-9356
EI 2340-3284
J9 REV ESP ANEST REANIM
JI Rev. Esp. Anestesiol. Reanim.
PD APR
PY 2020
VL 67
IS 4
BP 215
EP 218
DI 10.1016/j.redar.2019.10.006
PG 4
WC Anesthesiology
SC Anesthesiology
GA KZ6QT
UT WOS:000523385100007
PM 31785785
DA 2020-12-17
ER

PT J
AU Teixeira, DM
   Miyague, AH
   Barbosa, MAP
   Navarro, PA
   Raine-Fenning, N
   Nastri, CO
   Martins, WP
AF Teixeira, Danielle M.
   Miyague, Andre H.
   Barbosa, Mariana A. P.
   Navarro, Paula A.
   Raine-Fenning, Nick
   Nastri, Carolina O.
   Martins, Wellington P.
TI Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection
   for assisted reproduction
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE *Infertility, Male; *Pregnancy Rate; *Sperm Retrieval; Abortion,
   Spontaneous [epidemiology]; Live Birth [*epidemiology];
   Micromanipulation [methods]; Organelle Shape; Randomized Controlled
   Trials as Topic; Sperm Injections; Intracytoplasmic [*methods]; Female;
   Humans; Male; Pregnancy
ID INTRACYTOPLASMIC INJECTION; PREGNANCY RATES; MORPHOLOGY; EMBRYOS
AB Background
   Subfertility is a condition found in up to 15% of couples of reproductive age. Gamete micromanipulation, such as intracytoplasmic sperm injection (ICSI), is very useful for treating couples with compromised sperm parameters. An alternative method of sperm selection has been described; the spermatozoa are selected under high magnification (over 6000x) and used for ICSI. This technique, named intracytoplasmic morphologically selected sperm injection (IMSI), has a theoretical potential to improve reproductive outcomes among couples undergoing assisted reproduction techniques (ART). However, our previous version of this Cochrane Review was unable to find evidence that supported this possible beneficial effect. This is an update of Teixeira 2013.
   Objectives
   To identify, appraise, and summarise the available evidence regarding efficacy and safety of IMSI compared to ICSI in couples undergoing ART.
   Search methods
   We searched for randomised controlled trials (RCTs) in these electronic databases: the Cochrane Gynaecology and Fertility Group Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, LILACS, and in these trial registers: ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform. We also handsearched the reference lists of included studies and similar reviews. We performed the last electronic search on 18 November 2019.
   Selection criteria
   We only considered RCTs that compared ICSI and IMSI; we did not include quasi-randomised trials. We considered studies that permitted the inclusion of the same participant more than once (cross-over or per cycle trials) only if data regarding the first treatment of each participant were available.
   Data collection and analysis
   Two review authors independently performed study selection, data extraction, and assessment of the risk of bias and quality of the evidence; we solved disagreements by consulting a third review author. We corresponded with study investigators to resolve any queries, as required.
   Main results
   The updated search retrieved 535 records; we included 13 parallel-designed RCTs comparing IMSI and ICSI (four studies were added since the previous version), comprising 2775 couples (IMSI = 1256; ICSI = 1519). We are uncertain if IMSI improves live birth rates (risk ratio (RR) 1.11, 95% confidence interval (CI) 0.89 to 1.39; 5 studies, 929 couples; I-2 = 1%), miscarriage rates per couple (RR 1.07, 95% CI 0.78 to 1.48; 10 studies, 2297 couples; I-2 = 0%, very-low quality evidence), and miscarriage rate per pregnancy (RR 0.90, 95% CI 0.68 to 1.20; 10 studies, 783 couples; I-2 = 0%, very-low quality evidence). We are uncertain if IMSI improves clinical pregnancy rates (RR 1.23, 95% CI 1.11 to 1.37; 13 studies, 2775 couples; I-2 = 47%, very-low quality evidence). None of the included studies reported congenital abnormalities. We judged the evidence for all outcomes to be of very low-quality. We downgraded the quality of the evidence due to limitations of the included studies (risk of bias), inconsistency of results, and a strong indication of publication bias.
   Authors' conclusions
   The current evidence from randomised controlled trials does not support or refute the clinical use of intracytoplasmic sperm injection (intracytoplasmic morphologically selected sperm injection (IMSI). We are very uncertain of the chances of having a live birth and of the risk of having a miscarriage. We found very low-quality evidence that IMSI may increase chances of a clinical pregnancy, which means that we are still very uncertain about any real difference.
   We did not find any trials reporting on the risk of congenital abnormalities. Well-designed and sufficiently powered trials are still required.
C1 [Teixeira, Danielle M.] Univ Fed Parana, Dept Obstet & Gynecol, Curitiba, Parana, Brazil.
   [Miyague, Andre H.] Hosp Univ Evangel Curitiba, Dept Obstet & Gynecol, Curitiba, Parana, Brazil.
   [Barbosa, Mariana A. P.; Navarro, Paula A.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Raine-Fenning, Nick] Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham, England.
   [Nastri, Carolina O.; Martins, Wellington P.] SEMEAR Fertilidade, Reprod Med, Av Aurea Apparecida Braghetto Machado 220, BR-14021460 Ribeirao Preto, SP, Brazil.
RP Martins, WP (corresponding author), SEMEAR Fertilidade, Reprod Med, Av Aurea Apparecida Braghetto Machado 220, BR-14021460 Ribeirao Preto, SP, Brazil.
EM wpmartins@gmail.com
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607
CR Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0007-2
   Antinori M, 2008, REPROD BIOMED ONLINE, V16, P835, DOI 10.1016/S1472-6483(10)60150-2
   Antinori S, 2008, HUMAN REPROD S1, V23, pi165
   Apryshko VP, 2010, REPROD BIOMED ONL S3, V20, pS25
   Balaban B, 2011, REPROD BIOMED ONLINE, V22, P472, DOI 10.1016/j.rbmo.2010.11.003
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016
   Bartoov B, 2002, J ANDROL, V23, P1
   Berkovitz A, 2006, REPROD BIOMED ONLINE, V12, P634, DOI 10.1016/S1472-6483(10)61191-1
   Berkovitz A, 2005, HUM REPROD, V20, P185, DOI 10.1093/humrep/deh545
   Cassuto NG, 2011, FERTIL STERIL, V96, pS85, DOI 10.1016/j.fertnstert.2011.07.329
   Check JH, 2013, CLIN EXP OBSTET GYN, V40, P15
   Braga DPDF, 2011, UROLOGY, V78, P786, DOI 10.1016/j.urology.2011.06.018
   De Vos A, 2013, HUM REPROD, V28, P617, DOI 10.1093/humrep/des435
   Duran-Retamal M, 2020, ACTA OBSTET GYN SCAN, V99, P24, DOI 10.1111/aogs.13703
   Figueira RCS, 2010, J REPRODUKTIONSMEDIZ, V7, P250
   Figueira RDS, 2011, FERTIL STERIL, V95, P990, DOI 10.1016/j.fertnstert.2010.11.018
   Gatimel N, 2016, J ASSIST REPROD GEN, V33, P349, DOI 10.1007/s10815-015-0645-5
   Ghazali S, 2017, HUM REPROD, V32, P249
   Gleicher N, 2019, Hum Reprod Open, V2019, phoz017, DOI 10.1093/hropen/hoz017
   Hazout A, 2006, REPROD BIOMED ONLINE, V12, P19, DOI 10.1016/S1472-6483(10)60975-3
   He Fan, 2018, Zhonghua Nan Ke Xue, V24, P254
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Iaconelli A, 2011, HUM REPROD, V26, pI71, DOI 10.1093/humrep/26.s1.48
   Karabulut S, 2019, ZYGOTE, V27, P299, DOI 10.1017/S0967199419000297
   Kim JW, 2014, FERTIL STERIL, V102, pE349, DOI 10.1016/j.fertnstert.2014.07.1178
   Knez K, 2012, REPROD BIOMED ONLINE, V25, P168, DOI 10.1016/j.rbmo.2012.03.011
   Knez K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-123
   La Sala GB, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0279-9
   La Sala GB, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0096-y
   Leandri RD, 2013, ANDROLOGY-US, V1, P692, DOI 10.1111/j.2047-2927.2013.00104.x
   Lefebvre C, 2011, COCHRANE HDB SYSTEMA
   Mahmoud K, 2011, HUM REPROD, V26, pI181
   Mangoli E, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13340
   Marci R, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-16
   Mauri AL, 2010, EUR J OBSTET GYN R B, V150, P42, DOI 10.1016/j.ejogrb.2010.01.004
   McMaster University (developed by Evidence Prime), GRADEPRO GDT
   Oliveira JBA, 2010, FERTIL STERIL, V94, pS55, DOI 10.1016/j.fertnstert.2010.07.214
   Oliveira JBA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-99
   PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F
   Scarselli F, 2014, HUM REPROD, V29, P286
   Setti AS, 2013, EUR J OBSTET GYN R B, V171, P286, DOI 10.1016/j.ejogrb.2013.09.006
   Setti AS, 2012, FERTIL STERIL, V98, pS80, DOI 10.1016/j.fertnstert.2012.07.288
   Setti AS, 2012, REPROD BIOMED ONLINE, V24, P420, DOI 10.1016/j.rbmo.2012.01.007
   Setti AS, 2011, FERTIL STERIL, V95, P2711, DOI 10.1016/j.fertnstert.2011.03.003
   Setti AS, 2010, REPROD BIOMED ONLINE, V21, P450, DOI 10.1016/j.rbmo.2010.05.017
   Setti AS, 2012, REPROD BIOMED ONLINE, DOI [10.1016/j.rbmo.2012.10.020, DOI 10.1016/J.RBMO.2012.10.020]
   Teixeira DM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010167.pub2
   Wilding M, 2011, J ASSIST REPROD GEN, V28, P253, DOI 10.1007/s10815-010-9505-5
NR 49
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2020
IS 2
AR CD010167
DI 10.1002/14651858.CD010167.pub3
PG 47
WC Medicine, General & Internal
SC General & Internal Medicine
GA KQ8MZ
UT WOS:000517176800014
PM 32083321
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Meola, J
   Placa, JR
   Peronni, KC
   Rocha , CV
   Silva, WA
   Ferriani, RA
   Navarro, PA
AF Da Broi, M. G.
   Meola, J.
   Placa, J. R.
   Peronni, K. C.
   Rocha Jr, C., V
   Silva Jr, W. A.
   Ferriani, R. A.
   Navarro, P. A.
TI Is the profile of transcripts altered in the eutopic endometrium of
   infertile women with endometriosis during the implantation window?
SO HUMAN REPRODUCTION
LA English
DT Article
DE endometriosis; female infertility; eutopic endometrium; transcriptome;
   miRNA; implantation window
ID GENE-EXPRESSION; PROGESTERONE-RECEPTOR; STROMAL CELLS; ABNORMALITIES;
   CLASSIFICATION; RECEPTIVITY; MICROARRAY; BIOMARKERS; FAILURE; HOXA10
AB STUDY QUESTION: Compared to healthy women, is the profile of transcripts altered in the eutopic endometrium of infertile women with endometriosis during the implantation window (IW)?
   SUMMARY ANSWER: The eutopic endometrium of infertile women with endometriosis seems to be transcriptionally similar to the endometrium of infertile and fertile controls (FC) during the IW.
   WHAT IS KNOWN ALREADY: Endometriosis is a disease related to infertility; nevertheless, little is known regarding the ethiopathogenic mechanisms underlying this association. Some studies evaluating the eutopic endometrium of endometriosis patients suggest there is an endometrial factor involved in the disease-related infertility. However, no study to date has evaluated the endometrial transcriptome (mRNA and miRNA) by next generation sequencing (NGS), comparing patients with endometriosis as the exclusive infertility factor (END) to infertile controls (IC; male and/or tubal factor) and FC.
   STUDY DESIGN, SIZE, DURATION: From November 2011 to November 2015 we performed a case-control study, where 17 endometrial samples (six END, six IC, five FC) were collected during the IW.
   PARTICIPANTS/MATERIALS, SETTING, METHODS: All endometrial samples had the RNA extracted. Two libraries were prepared for each one (mRNA and miRNA), which were sequenced, respectively, at HISEQ 2500 (RNA-Seq) and MiSeq System (miRNA-Seq), Illumina. The normalization and differential expression were conducted in statistical R environment using DESeq2 package. qPCR was used for data validation, which were analyzed by Kruskal-Wallis test and Dunn posttest (P <0.05).
   MAIN RESULTS AND THE ROLE OF CHANCE: RNA-Seq revealed no differentially expressed genes (DEG) among END, IC and FC groups. miRNA-Seq revealed three differentially expressed miRNAs (has-27a-5p, has-miR-150-5p, has-miR-504-5p) in END group compared to FC group. However, none of the miRNAs identified in the sequencing was validated by qPCR.
   LIMITATIONS, REASONS FOR CAUTION: The main limitation of this study was the small sample size evaluated as a result of the restrictive eligibility criteria adopted, limiting the generalization of the results obtained here. On the other hand, strict eligibility criteria, which eliminated factors potentially related to impaired endometrial receptivity, were required to increase the study's internal validity.
   WIDER IMPLICATIONS OF THE FINDINGS: This study brings new perspectives on the mechanisms involved in endometriosis-related infertility. The present findings suggest the eutopic endometrium of infertile women with endometriosis, without considering the disease's stage, is transcriptionally similar to controls during the IW, possibly not affecting receptivity. Further studies are needed to evaluate endometrial alterations related to endometriosis' stages.
C1 [Da Broi, M. G.; Meola, J.; Rocha Jr, C., V; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Div Human Reprod, Dept Gynecol & Obstet, Ribeirao Preto Med Sch, Ave Bandeirantes 900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Placa, J. R.; Silva Jr, W. A.] NAP USP, Ctr Integrat Syst Biol CISBi, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Peronni, K. C.; Silva Jr, W. A.] Univ Sao Paulo, Ctr Med Genom, HCFMRP, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Silva Jr, W. A.] Univ Sao Paulo, Dept Genet, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Ferriani, R. A.; Navarro, P. A.] Natl Council Sci & Technol Dev CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
RP Da Broi, MG (corresponding author), Univ Sao Paulo, Div Human Reprod, Dept Gynecol & Obstet, Ribeirao Preto Med Sch, Ave Bandeirantes 900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM michi.dabroi@gmail.com
RI Navarro, Paula/G-2744-2012; Da Broi, Michele G/E-7753-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU Sao Paulo Research Foundation (FAPESP-Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) [2011/17614-6]; National Council for Scientific and
   Technological Development (CNPq-Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico)National Council for Scientific and
   Technological Development (CNPq); National Council for Scientific and
   Technological Development (INCT-National Institutes of Hormones and
   Woman's Health) [471943/2012-6, 309397/2016-2]; National Council for
   Scientific and Technological DevelopmentNational Council for Scientific
   and Technological Development (CNPq) [140137/2015-7]
FX Sao Paulo Research Foundation (FAPESP-Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo; fellowship 2011/17614-6 to M.G.B); National Council
   for Scientific and Technological Development (CNPq-Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico; INCT-National Institutes of
   Hormones and Woman's Health, grant 471943/2012-6, 309397/2016-2 to
   P.A.N.; fellowship 140137/2015-7 to M.G.B.).
CR Absenger Y, 2004, MOL HUM REPROD, V10, P399, DOI 10.1093/molehr/gah053
   Altmae S, 2014, HUM REPROD UPDATE, V20, P12, DOI 10.1093/humupd/dmt048
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bedaiwy MA, 2015, REPROD SCI, V22, P1153, DOI 10.1177/1933719115585145
   Broi Michele G Da, 2017, JBRA Assist Reprod, V21, P196, DOI 10.5935/1518-0557.20170038
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cho S, 2009, AM J REPROD IMMUNOL, V61, P286, DOI 10.1111/j.1600-0897.2009.00692.x
   Cohen J, 1988, STAT POWER ANAL BEHA
   Daftary GS, 2002, MOL ENDOCRINOL, V16, P571, DOI 10.1210/me.16.3.571
   Diaz-Gimeno P, 2014, INT J DEV BIOL, V58, P127, DOI 10.1387/ijdb.130340pd
   Fassbender A, 2012, HUM REPROD, V27, P2020, DOI 10.1093/humrep/des127
   Focarelli R, 2018, REPROD SCI, V25, P579, DOI 10.1177/1933719117718276
   Fraser IS, 2007, FERTIL STERIL, V87, P466, DOI 10.1016/j.fertnstert.2007.01.023
   Garcia-Velasco JA, 2015, REPROD BIOMED ONLINE, V31, P647, DOI 10.1016/j.rbmo.2015.07.014
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Giudice LC, 2002, ANN NY ACAD SCI, V955, P252, DOI 10.1111/j.1749-6632.2002.tb02786.x
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Gupta S, 2006, REPROD BIOMED ONLINE, V13, P349, DOI 10.1016/S1472-6483(10)61439-3
   Herndon CN, 2016, REPROD SCI, V23, P1289, DOI 10.1177/1933719116650758
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Hu SG, 2014, J CLIN ENDOCR METAB, V99, pE2744, DOI 10.1210/jc.2014-2155
   Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kresowik JDK, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.116590
   Laudanski P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/760698
   Laudanski P, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-78
   LESSEY BA, 1994, J CLIN ENDOCR METAB, V79, P643, DOI 10.1210/jc.79.2.643
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041
   May KE, 2011, HUM REPROD UPDATE, V17, P637, DOI 10.1093/humupd/dmr013
   Minici F, 2008, HUM REPROD, V23, P530, DOI 10.1093/humrep/dem399
   Munro SK, 2010, MOL HUM REPROD, V16, P297, DOI 10.1093/molehr/gaq010
   Noyes R W, 1975, Am J Obstet Gynecol, V122, P262
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS156
   Robin X, 2009, EXPERT REV PROTEOMIC, V6, P675, DOI 10.1586/EPR.09.83
   Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115
   Shaer A, 2014, CELL MOL BIOL LETT, V19, P483, DOI 10.2478/s11658-014-0207-3
   Sharma Alok, 2012, J Hum Reprod Sci, V5, P2, DOI 10.4103/0974-1208.97777
   Sherwin JRA, 2008, HUM REPROD, V23, P1063, DOI 10.1093/humrep/den078
   Shi XY, 2014, INT J MOL MED, V33, P59, DOI 10.3892/ijmm.2013.1536
   Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461
   Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076
   Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328
   Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034
   Tiberi F, 2010, FERTIL STERIL, V94, P2558, DOI 10.1016/j.fertnstert.2010.03.006
   Wang MM, 2018, REPROD SCI, V25, P654, DOI 10.1177/1933719117734320
   Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121
   Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304
   Yang PY, 2019, REPROD SCI, V26, P900, DOI 10.1177/1933719118799199
   Yang RQ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027826
   Zhao LY, 2017, BIOMED REP, V6, P654, DOI 10.3892/br.2017.902
   Zhou M, 2016, HUM REPROD, V31, P2598, DOI 10.1093/humrep/dew223
NR 58
TC 3
Z9 3
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD DEC
PY 2019
VL 34
IS 12
BP 2381
EP 2390
DI 10.1093/humrep/dez225
PG 10
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA KB9KT
UT WOS:000506806500008
PM 31796963
DA 2020-12-17
ER

PT J
AU Rocha, CV
   Da Broi, MG
   Miranda-Furtado, CL
   Navarro, PA
   Ferriani, RA
   Meola, J
AF Rocha-Junior, Carlos Valerio
   Da Broi, Michele Gomes
   Miranda-Furtado, Cristiana Libardi
   Navarro, Paula Andrea
   Ferriani, Rui Alberto
   Meola, Juliana
TI Progesterone Receptor B (PGR-B) Is Partially Methylated in Eutopic
   Endometrium From Infertile Women With Endometriosis
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE endometriosis; infertility; endometrial receptivity; progesterone
   receptor; methylation
ID MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; DNA METHYLATION; REDUCED
   EXPRESSION; IMPLANTATION; RESISTANCE; RECEPTIVITY; PERITONEAL;
   BIOMARKERS; ESTROGEN
AB Endometriosis is frequently related to infertility and little is known about the mechanisms underlying this association. Some studies point to an endometrial factor involved in this condition, which could compromise embryo implantation. Progesterone plays crucial role in endometrial receptivity by acting through progesterone receptor (PGR) isoforms PR-A and PR-B whose expression is epigenetically regulated by DNA methylation, in a specific promoter region for each isoform. Epigenetic changes in PGR-A and PGR-B may be related to progesterone resistance of endometriosis-related infertility. In order to better understand the mechanisms involved in endometrial receptivity, this case-control study aimed to compare the methylation pattern of PGR-A and PGR-B in eutopic endometrium from infertile women with and without endometriosis during the secretory phase. Endometrial biopsies from 19 patients (10 infertile women with endometriosis and 9 infertile controls) with regular cycles were performed during the secretory phase and were dated according to Noyes' criteria. The percentage of DNA methylation at PGR-A and PGR-B was carried out by high-resolution melting assay. The PGR-A gene showed 0% of DNA methylation (unmethylated) in both control and endometriosis groups. However, PGR-B gene showed a partially methylated pattern in majority of the patients (n = 7), with methylation percentage corresponding to 50%, while in the control group the percentage of methylation was 20% (hypomethylated; P = .04). The increased percentage of methylation at PGR-B may be related to reduced gene expression, which could compromise the endometrial receptivity in patients with endometriosis.
C1 [Rocha-Junior, Carlos Valerio; Da Broi, Michele Gomes; Miranda-Furtado, Cristiana Libardi; Navarro, Paula Andrea; Ferriani, Rui Alberto; Meola, Juliana] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Navarro, Paula Andrea; Ferriani, Rui Alberto; Meola, Juliana] CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
   [Miranda-Furtado, Cristiana Libardi] Univ Fed Ceara, Drug Res & Dev Ctr, Fortaleza, Ceara, Brazil.
RP Rocha, CV (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM carlos.rocha.bio@hotmail.com
RI Lovato, Juliana Meola/E-3440-2012; Da Broi, Michele G/E-7753-2012;
   Navarro, Paula/G-2744-2012; Furtado, Cristiana Libardi
   Miranda/Z-6059-2019
OI Lovato, Juliana Meola/0000-0003-2514-4011; Da Broi, Michele
   G/0000-0003-4256-0228; Furtado, Cristiana Libardi
   Miranda/0000-0002-8711-8225; Navarro, Paula Andrea/0000-0003-2368-4188
CR Aghajanova L, 2009, BIOL REPROD, V80, P105, DOI 10.1095/biolreprod.108.070300
   Aghajanova L, 2008, SEMIN CELL DEV BIOL, V19, P204, DOI 10.1016/j.semcdb.2007.10.008
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   Alizadeh Zohreh, 2011, Iranian Biomedical Journal, V15, P66
   Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897
   Bedaiwy MA, 2015, REPROD SCI, V22, P1153, DOI 10.1177/1933719115585145
   Bulun SE, 2010, SEMIN REPROD MED, V28, P3, DOI 10.1055/s-0029-1242987
   Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cho S, 2009, AM J REPROD IMMUNOL, V61, P286, DOI 10.1111/j.1600-0897.2009.00692.x
   Cohen J, 1988, STAT POWER ANAL BEHA
   Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8
   Fraser IS, 2007, FERTIL STERIL, V87, P466, DOI 10.1016/j.fertnstert.2007.01.023
   Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502
   Gupta S, 2006, REPROD BIOMED ONLINE, V13, P349, DOI 10.1016/S1472-6483(10)61439-3
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Igarashi TM, 2005, FERTIL STERIL, V84, P67, DOI 10.1016/j.fertnstert.2005.01.113
   Jackson KS, 2007, REPROD SCI, V14, P137, DOI 10.1177/1933719106298409
   Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043
   Koukoura O, 2016, MOL MED REP, V13, P2939, DOI 10.3892/mmr.2016.4925
   Lee B, 2009, BIOL REPROD, V80, P79, DOI 10.1095/biolreprod.108.070391
   LESSEY BA, 1994, J CLIN ENDOCR METAB, V79, P643, DOI 10.1210/jc.79.2.643
   LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835
   Lessey BA, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-S1-S9
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   Matsuzaki S, 2006, FERTIL STERIL, V85, P308, DOI 10.1016/j.fertnstert.2005.08.017
   Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275
   Moberg C, 2015, ARCH GYNECOL OBSTET, V292, P429, DOI 10.1007/s00404-015-3626-0
   Moberg C, 2015, HUM FERTIL, V18, P30, DOI 10.3109/14647273.2014.922705
   Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112
   Noyes R W, 1975, Am J Obstet Gynecol, V122, P262
   Osteen KG, 2005, FERTIL STERIL, V83, P529, DOI 10.1016/j.fertnstert.2004.11.026
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS156
   Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037
   Shen FR, 2015, ARCH GYNECOL OBSTET, V291, P439, DOI 10.1007/s00404-014-3419-x
   Surrey ES, 2007, J ASSIST REPROD GEN, V24, P553, DOI 10.1007/s10815-007-9164-3
   Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328
   TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256
   VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244
   Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121
   Wolfler MM, 2016, ANN ANAT, V206, P1, DOI 10.1016/j.aanat.2016.03.004
   Wu Y, 2006, EPIGENETICS-US, V1, P106, DOI 10.4161/epi.1.2.2766
   Young SL, 2013, REPROD BIOMED ONLINE, V27, P497, DOI 10.1016/j.rbmo.2013.06.010
   Yu X, 2016, CLIN EXP OBSTET GYN, V43, P75
NR 46
TC 5
Z9 5
U1 2
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD DEC
PY 2019
VL 26
IS 12
BP 1568
EP 1574
DI 10.1177/1933719119828078
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA JV6MM
UT WOS:000502477200003
PM 30782101
DA 2020-12-17
ER

PT J
AU Ferreira, EM
   Giorgi, VSI
   Rodrigues, JK
   de Andrade, AZ
   Jordao, AA
   Navarro, PA
AF Ferreira, Elisa Melo
   Innocenti Giorgi, Vanessa Silvestre
   Rodrigues, Jhenifer Kliemchen
   de Andrade, Aline Zyman
   Jordao Junior, Alceu Afonso
   Navarro, Paula Andrea
TI Systemic oxidative stress as a possible mechanism underlying the
   pathogenesis of mild endometriosis-related infertility
SO REPRODUCTIVE BIOMEDICINE ONLINE
LA English
DT Article
DE Endometriosis; Infertility; Live births; Oxidative stress; Serum markers
ID VITAMIN-E; FOLLICULAR-FLUID; DNA-DAMAGE; WOMEN; MARKERS; SERUM;
   SUPPLEMENTATION; MELATONIN; OUTCOMES
AB Research question: Does systemic oxidative stress occur during the early follicular phase of the menstrual cycle in infertile women with minimal (stage I) or mild (stage II) endometriosis? Are serum oxidative stress markers during the early follicular phase of the menstrual cycle good predictors of successful gestation in these women who undergo ovarian stimulation for intracytoplasmic sperm injection (ICSI)?
   Materials and methods: A pilot study (prospective case-control study) was conducted in a University Hospital. Serum samples were obtained during the early follicular phase of the natural cycle preceding ovarian stimulation for ICSI of infertile women (with and without stage I and II endometriosis, the latter having male factor infertility). Total hydroperoxides (FOX1), malondialdehyde, advanced oxidation protein products, reduced glutathione, superoxide dismutase, total antioxidant capacity (TAC), 8-hydroxy-2'-deoxyguanosine (8OHdG) and vitamin E were analysed in serum from 35 women with stage I or II endometriosis and 60 control women. The accuracy of oxidative stress markers for predicting clinical pregnancy and live births was determined by receiver operator characteristic curves.
   Results: Women with stage I and II endometriosis showed lower serum 8OHdG concentrations (16.02 ng/ml) compared with the control group (22.08 ng/ml). The best predictor for clinical pregnancy and live births was TAC, whereas FOX1 was the best predictor of clinical pregnancy in the control group.
   Conclusions: Infertile women with stage I and II endometriosis present systemic oxidative stress during the early follicular phase of the menstrual cycle. Some oxidative stress markers were good predictors of clinical pregnancy and live births after ICSI. Serum TAC was predictive of clinical pregnancy and live births after ICSI in women with stage I or II endometriosis.
C1 [Ferreira, Elisa Melo; Innocenti Giorgi, Vanessa Silvestre; Rodrigues, Jhenifer Kliemchen; de Andrade, Aline Zyman; Navarro, Paula Andrea] Univ Sao Paulo, Fac Med RibeiraoPreto, Dept Obstet & Gynecol, Human Reprod Div, BR-14048900 Ribeirao Preto, SP, Brazil.
   [Jordao Junior, Alceu Afonso] Univ Sao Paulo, Fac Med Ribeirao Preto, Nutr & Metab Lab, BR-14048900 Ribeirao Preto, SP, Brazil.
   [Navarro, Paula Andrea] CNPq, Natl Inst Hormones & Womens Hlth, Porto Alegre, RS, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med RibeiraoPreto, Dept Obstet & Gynecol, Human Reprod Div, BR-14048900 Ribeirao Preto, SP, Brazil.; Navarro, PA (corresponding author), CNPq, Natl Inst Hormones & Womens Hlth, Porto Alegre, RS, Brazil.
EM pnavarro@fmrp.usp.br
RI Navarro, Paula/G-2744-2012
OI Ferreira, Evandro/0000-0002-1057-5508; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU National Council for Scientific and Technological Development
   (CNPq-ConselhoNacional de DesenvolvimentoCientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [474858/2009-0, 309056/2009-8, 503867/2010-1];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/58197-6]
FX The authors thank the staff of the Human Reproduction Laboratory,
   University Hospital, Department of Gynecology and Obstetrics, Faculty of
   Medicine of Ribeirao Preto, University of Sao Paulo (FMRP-USP),
   especially Professor Rui Alberto Ferriani, for his invaluable assistance
   and support. They are also indebted to the Nutrition and Metabolism
   Laboratory, FMRPUSP, especially Paula Payao Ovidio and Virginia Leira
   Lipoli Bertini for technical support. This study received financial
   support from the National Council for Scientific and Technological
   Development (CNPq-ConselhoNacional de DesenvolvimentoCientifico e
   Tecnologico; 474858/2009-0; 309056/2009-8; 503867/2010-1) and FAPESP
   (2008/58197-6).
CR Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   ARNAUD J, 1991, J CHROMATOGR-BIOMED, V572, P103, DOI 10.1016/0378-4347(91)80476-S
   Balaban B, 2011, HUM REPROD, V26, pI24
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Berube S, 1998, FERTIL STERIL, V69, P1034, DOI 10.1016/S0015-0282(98)00081-8
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cohen J, 1988, STAT POWER ANAL BEHA
   Costa Carolina M. da, 2006, J. Bras. Patol. Med. Lab., V42, P345, DOI 10.1590/S1676-24442006000500006
   Da Broi MG, 2018, MOL REPROD DEV, V85, P128, DOI 10.1002/mrd.22943
   Da Broi MG, 2016, CELL TISSUE RES, V366, P231, DOI 10.1007/s00441-016-2428-4
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Fassbender A, 2013, FERTIL STERIL, V99, P1135, DOI 10.1016/j.fertnstert.2013.01.097
   Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43
   Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Hamdan M, 2015, OBSTET GYNECOL, V125, P79, DOI 10.1097/AOG.0000000000000592
   HU ML, 1994, METHOD ENZYMOL, V233, P380
   Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x
   Mier-Cabrera J, 2008, INT J GYNECOL OBSTET, V100, P252, DOI 10.1016/j.ijgo.2007.08.018
   Nwose EU, 2008, MED HYPOTHESES, V70, P1002, DOI 10.1016/j.mehy.2007.07.048
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Rad SS, 2015, INT J REPROD BIOMED, V13, P439
   Santulli P, 2015, HUM REPROD, V30, P49, DOI 10.1093/humrep/deu290
   Sim J, 2012, J CLIN EPIDEMIOL, V65, P301, DOI 10.1016/j.jclinepi.2011.07.011
   Stern JE, 2013, J ASSIST REPROD GEN, V30, P1445, DOI 10.1007/s10815-013-0092-0
   Tanabe M, 2015, J REPROD DEVELOP, V61, P35, DOI 10.1262/jrd.2014-105
   Tatemoto H, 2004, BIOL REPROD, V71, P1150, DOI 10.1095/biolreprod.104.029264
   Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
NR 33
TC 2
Z9 3
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1472-6483
EI 1472-6491
J9 REPROD BIOMED ONLINE
JI Reprod. Biomed. Online
PD NOV
PY 2019
VL 39
IS 5
BP 785
EP 794
DI 10.1016/j.rbmo.2019.06.011
PG 10
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA JM4ZQ
UT WOS:000496224700009
PM 31540845
DA 2020-12-17
ER

PT J
AU Saez, NF
   Alepuz, FE
   Navarro, PA
AF Fuertes Saez, Neus
   Escriba Alepuz, Francisco
   Argente Navarro, Pilar
TI Selective bronchial block with Uniblocker (TM) in paediatric pulmonary
   sequestration
SO TRENDS IN ANAESTHESIA AND CRITICAL CARE
LA English
DT Article
DE Pulmonary sequestration; Bronchial blocker; Uniblocker (TM);
   Fibrobronchoscope; Thoracoscopy; Pediatric lung isolation
ID LUNG VENTILATION
AB Technological advances and improvements in surgical equipment have made possible minimally invasive surgical methods, which offer multiple advantages for patients [1]. We can find among them Video-Assisted Thoracoscopic Surgery (VATS). The indications for VATS in children have increased exponentially [2]. It requires the collaboration of the anesthesiologist, who adapts the anesthetic management to achieve correct one lung ventilation. It allows an adequate surgical field exposure [1], and it prevents hypoxemia. How we can achieve a correct lung isolation technique is one of the hypotheses that the anesthesiologist has to consider, basically in cases involving infants and children, because some techniques we would use in adults are not available. In this case, we use a Uniblocker (TM) 5 Frames (Fr) bronchial blocker. In the pediatric population, the problem is that bronchial blockers have very small or no working channels. This makes it difficult to aspirate the lung to collapse it. We want to show how to achieve complete lung collapse in a pediatric patient with Uniblocker (TM) 5 Fr which has no working channel. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fuertes Saez, Neus; Escriba Alepuz, Francisco; Argente Navarro, Pilar] Hosp La Fe, Dept Anesthesiol & Intens Care, Valencia, Spain.
RP Saez, NF (corresponding author), Hosp Univ & Politecn La Fe, Dept Anesthesiol & Intens Care, Fernando Abril Martorell 106, Valencia 46026, Spain.
EM neusfuer@gmail.com
CR Cutler J., 2010, MED MANAGEMENT THORA, P87
   Fabila TS, 2013, INDIAN J ANAESTH, V57, P339, DOI 10.4103/0019-5049.118539
   Fitzgerald J, PAEDIAT ANAESTH
   Hammer GB, 1999, ANESTH ANALG, V89, P1426, DOI 10.1097/00000539-199912000-00019
   Letal M, 2017, BJA EDUC, V17, P57, DOI 10.1093/bjaed/mkw047
   Marasigan B.L., 2013, BENUMOF HAGBERGS AIR, P549
   Paranjpe JS, 2017, MED J DY PATIL U, V10, P190
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2210-8440
EI 2210-8467
J9 TRENDS ANAESTH CRIT
JI Trends Anaesth. Crit. Care
PD OCT
PY 2019
VL 28
BP 39
EP 42
DI 10.1016/j.tacc.2019.08.004
PG 4
WC Anesthesiology
SC Anesthesiology
GA JD1TV
UT WOS:000489759300008
DA 2020-12-17
ER

PT J
AU Chamani, IJ
   Wang, F
   Luo, D
   Navarro, PA
   Cortes, VL
   Keefe, DL
AF Chamani, Isaac J.
   Wang, Fang
   Luo, Danxia
   Navarro, Paula Andrea
   Cortes, Vanessa Lynn
   Keefe, David L.
TI INHIBITION OF LINE-1 TRANSPOSITION BLOCKS TELOMERE ELONGATION AND
   DOWNREGULATES TOTIPOTENCY GENES DURING MOUSE EMBRYO DEVELOPMENT.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 75th Scientific Congress of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 12-16, 2019
CL Philadelphia, PA
SP Amer Soc Reprod Med
C1 [Chamani, Isaac J.] NYU, Sch Med, New York, NY USA.
   [Wang, Fang; Luo, Danxia; Navarro, Paula Andrea; Cortes, Vanessa Lynn; Keefe, David L.] NYU, Dept Obstet & Gynecol, Sch Med, New York, NY 10016 USA.
CR Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2019
VL 112
IS 3
SU S
MA P-45
BP E126
EP E126
DI 10.1016/j.fertnstert.2019.07.448
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA JA4SG
UT WOS:000487821301071
DA 2020-12-17
ER

PT J
AU Navarro, PA
AF Navarro, Paula Andrea
TI Infertility Associated to Endometriosis: Clarifying Some Important
   Controversies
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
ID WOMEN
C1 [Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM drapaulanavarro@gmail.com
RI Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   Berube S, 1998, FERTIL STERIL, V69, P1034, DOI 10.1016/S0015-0282(98)00081-8
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Canis M, 1997, FERTIL STERIL, V67, P817
   Neto MAC, 2016, REV BRAS GINECOL OBS, V38, P218, DOI 10.1055/s-0036-1584126
   D'Hooghe TM, 2003, SEMIN REPROD MED, V21, P243
   Da Broi MG, 2018, J ASSIST REPROD GEN, V35, P735, DOI 10.1007/s10815-018-1143-3
   Da Broi MG, 2019, J BRAS REPROD ASSIST, V23, P273, DOI 10.5935/1518-0557.20190029
   Da Broi MG, 2016, CELL TISSUE RES, V364, P1, DOI 10.1007/s00441-015-2339-9
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Hamdan M, 2015, OBSTET GYNECOL, V125, P79, DOI 10.1097/AOG.0000000000000592
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   Sensky T E, 1980, Int J Gynaecol Obstet, V17, P573
NR 15
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD SEP
PY 2019
VL 41
IS 9
BP 523
EP 524
DI 10.1055/s-0039-1697638
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IZ7BL
UT WOS:000487239800001
PM 31546274
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Pimentel, RN
   Navarro, PA
   Wang, F
   Robinson, LG
   Cammer, M
   Liang, FX
   Kramer, Y
   Keefe, DL
AF Pimentel, Ricardo N.
   Navarro, Paula A.
   Wang, Fang
   Robinson, LeRoy G., Jr.
   Cammer, Michael
   Liang, Fengxia
   Kramer, Yael
   Keefe, David Lawrence
TI Amyloid-like substance in mice and human oocytes and embryos
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article
DE Amyloid; Oocyte quality; Reproductive aging; female fertility
ID ZYGOTIC GENE ACTIVATION; TRANSCRIPTIONAL ACTIVITY; PRIMORDIAL FOLLICLES;
   FUNCTIONAL AMYLOIDS; FOLLICULAR-FLUID; MOUSE; CELL; EXPRESSION; GOVERNS;
   STATE
AB Purpose To identify and characterize amyloid-like substance (ALS) in human and mouse oocytes and preimplantation embryos. Methods An experimental prospective pilot study. A total of 252 mouse oocytes and preimplantation embryos and 50 immature and in vitro matured human oocytes and parthenogenetic human embryos, from 11 consenting fertility patients, ages 18-45. Fluorescence intensity from immunofluorescent staining and data from confocal microscopy were quantified. Data were compared by one-way analysis of variance, with the least square-MEANS post-test, Pearson correlation coefficients (r), and bivariate analyses (t tests). ALS morphology was verified using transmission electron microscopy. Results Immunostaining for ALS appears throughout the zona pellucida, as well as in the cytoplasm and nucleus of mouse and human oocytes, polar bodies, and parthenogenetic embryos, and mouse preimplantation embryos. In mouse, 2-cell embryos exhibited the highest level of ALS (69000187.4 +/- 6733098.07). Electron microscopy confirmed the presence of ALS. In humans, fresh germinal vesicle stage oocytes exhibited the highest level of ALS (4164.74088 +/- 1573.46) followed by metaphase I and II stages (p = 0.008). There was a significant negative association between levels of ALS and patient body mass index, number of days of ovarian stimulation, dose of gonadotropin used, time between retrieval and fixation, and time after the hCG trigger. Significantly higher levels of ALS were found in patients with AMH between 1 and 3 ng/ml compared to < 1 ng/ml. Conclusion We demonstrate for the first time the presence, distribution, and change in ALS throughout some stages of mouse and human oocyte maturation and embryonic development. We also determine associations between ALS in human oocytes with clinical characteristics.
C1 [Pimentel, Ricardo N.] NYU, Dept Obstet & Gynecol, Sch Med, 550 Fitst Ave,NBV 9N1, New York, NY USA.
   [Pimentel, Ricardo N.; Navarro, Paula A.] Univ Sao Paulo, Dept Obstet & Gynecol, Human Reprod Div, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Wang, Fang; Robinson, LeRoy G., Jr.; Kramer, Yael; Keefe, David Lawrence] NYU, Dept Obstet & Gynecol, Langone Med Ctr, New York, NY 10003 USA.
   [Cammer, Michael; Liang, Fengxia] NYU, Sch Med, DART Microscopy Lab, New York, NY USA.
RP Keefe, DL (corresponding author), NYU, Dept Obstet & Gynecol, Langone Med Ctr, New York, NY 10003 USA.
EM david.keefe@nyumc.org
RI Navarro, Paula/G-2744-2012
OI Robinson, LeRoy/0000-0002-1584-456X; Navarro, Paula
   Andrea/0000-0003-2368-4188; Cammer, Michael/0000-0003-4930-1739
FU FAPESP, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/219070]; Stanley H. Kaplan Endowment Fund
FX Support from FAPESP, Brazil (Process 2015/219070) (PN) and the Stanley
   H. Kaplan Endowment Fund.
CR Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483
   Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X
   Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83
   Amer Soc Reprod Med Collaboration, 2008, FERTIL STERIL, V90, pS1, DOI 10.1016/j.fertnstert.2008.08.122
   Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466
   Battaglia DE, 1996, HUM REPROD, V11, P2217
   Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060
   Boke E, 2017, CELL CYCLE, V16, P153, DOI 10.1080/15384101.2016.1241605
   Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051
   Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034
   Bui HT, 2011, REPRODUCTION, V141, P67, DOI 10.1530/REP-10-0109
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5
   Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011
   Duan FH, 2014, J ASSIST REPROD GEN, V31, P1611, DOI 10.1007/s10815-014-0345-6
   Egge N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129907
   Ferreira EM, 2009, EUR J OBSTET GYN R B, V145, P76, DOI 10.1016/j.ejogrb.2009.03.016
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Guyonnet B, 2014, MOL CELL BIOL, V34, P2624, DOI 10.1128/MCB.00073-14
   Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065
   Hornstein MD, 2016, REPROD SCI, V23, P1630, DOI 10.1177/1933719116667227
   Jin F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001147
   KEEFE DL, 1995, FERTIL STERIL, V64, P577, DOI 10.1016/S0015-0282(16)57796-6
   Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810
   Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103
   LATHAM KE, 1991, DEVELOPMENT, V112, P921
   Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019
   Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487
   Liu L, 2004, BIOL REPROD, V71, P1724, DOI 10.1095/biolreprod.104.028985
   LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951
   Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713
   Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155
   Mann MRW, 2002, GENOME BIOL, V3
   Mehar A, 2013, EUR TRANSP
   Nothias JY, 1996, EMBO J, V15, P5715, DOI 10.1002/j.1460-2075.1996.tb00955.x
   Park DS, 1997, J NEUROSCI, V17, P8975
   Parodi J, 2012, MOL CELLS, V34, P349, DOI 10.1007/s10059-012-2247-8
   Pastore LM, 2018, J ASSIST REPROD GEN, V35, P17, DOI 10.1007/s10815-017-1058-4
   Pinzer BR, 2012, NEUROIMAGE, V61, P1336, DOI 10.1016/j.neuroimage.2012.03.029
   POLANI PE, 1991, HUM GENET, V88, P64, DOI 10.1007/BF00204931
   Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416
   Scheffer JB, 2017, INT J FERTIL STERIL, V11, P40
   SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806
   Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323
   Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108
   Sun XH, 2015, CELL CYCLE, V14, P721, DOI 10.1080/15384101.2014.995496
   Sutovsky P, 2000, INT REV CYTOL, V195, P1
   Takahashi T, 2013, J OBSTET GYNAECOL RE, V39, P1431, DOI 10.1111/jog.12111
   Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707
   Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0
   Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822
   Urieli-Shoval S, 2013, J CLIN ENDOCR METAB, V98, P4970, DOI 10.1210/jc.2012-1801
   Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394
   Xu XH, 2013, STEM CELL RES, V10, P213, DOI 10.1016/j.scr.2012.11.005
   Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260
   Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538
   Zhang H, 2015, HUM REPROD UPDATE, V21, P779, DOI 10.1093/humupd/dmv037
NR 58
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD SEP
PY 2019
VL 36
IS 9
BP 1877
EP 1890
DI 10.1007/s10815-019-01530-w
PG 14
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA IW9MB
UT WOS:000485316600015
PM 31332596
OA Green Published
DA 2020-12-17
ER

PT J
AU Borges, ED
   Vireque, AA
   Berteli, TS
   Ferreira, CR
   Silva, AS
   Navarro, PA
AF Borges, E. D.
   Vireque, A. A.
   Berteli, T. S.
   Ferreira, C. R.
   Silva, A. S.
   Navarro, P. A.
TI An update on the aspects of Zika virus infection on male reproductive
   system
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Review
DE Zika virus; Male reproductive tract; Assisted reproduction; Semen;
   Metabolomics
ID MALE SEXUAL TRANSMISSION; GUILLAIN-BARRE-SYNDROME; WHOLE-BLOOD;
   EXPOSURE; RESPONSES; MODEL; SEMEN; LEADS
AB Zika virus (ZIKV) is mainly transmitted through Aedes mosquito bites, but sexual and post-transfusion transmissions have been reported. During acute infection, ZIKV is detectable in most organs and body fluids including human semen. Although it is not currently epidemic, there is a concern that the virus can still reemerge since the male genital tract might harbor persistent reservoirs that could facilitate viral transmission over extended periods, raising concerns among public health and assisted reproductive technologies(ART) experts and professionals. So far, the consensus is that ZIKV infection in the testes or epididymis might affect sperm development and, consequently, male fertility. Still, diagnostic tests have not yet been adapted to resource-restricted countries. This manuscript provides an updated overview of the cellular and molecular mechanisms of ZIKV infection and reviews data on ZIKV persistence in semen and associated risks to the male reproductive system described in human and animal models studies. We provide an updated summary of the impact of the recent ZIKV outbreak on human-ART, weighing on current recommendations and diagnostic approaches, both available and prospective, with special emphasis on mass spectrometry-based biomarker discovery. In the light of the identified gaps in our accumulated knowledge on the subject, we highlight the importance for couples seeking ART to follow the constantly revised guidelines and the need of specific ZIKV diagnosis tools for semen screening to contain ZIKV virus spread and make ART safer.
C1 [Borges, E. D.; Berteli, T. S.; Navarro, P. A.] Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Borges, E. D.; Vireque, A. A.] Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
   [Ferreira, C. R.] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA.
   [Silva, A. S.] Univ Sao Paulo, Dept Social Med, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Navarro, P. A.] CNPq, Natl Inst Hormones & Womans Hlth, Brasilia, DF, Brazil.
RP Borges, ED (corresponding author), Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.; Borges, ED (corresponding author), Invitra Assisted Reprod Technol LTD, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
EM eduardoborgesd@gmail.com
RI Ferreira, Christina R/F-4744-2012; Borges, Eduardo/Y-5712-2019; Navarro,
   Paula/G-2744-2012; Silva, Anderson Soares/H-6934-2012
OI Ferreira, Christina R/0000-0003-3988-6454; Borges,
   Eduardo/0000-0002-0131-1121; Silva, Anderson Soares/0000-0002-0824-2616;
   Navarro, Paula Andrea/0000-0003-2368-4188
FU Purdue University Women's Global Health Institute (WGHI); Indiana
   Clinical and Translational Sciences Institute (CTSI) through Mildred
   Elizabeth Edmundson Research (MEER) award [PDT 728 2017]
FX Financial support from the Purdue University Women's Global Health
   Institute (WGHI) and Indiana Clinical and Translational Sciences
   Institute (CTSI) through Mildred Elizabeth Edmundson Research (MEER)
   award PDT 728 2017 is acknowledged.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Araujo Filho E, 2017, JBRA ASSIST REPROD, V21, P276
   Ball D, 2016, GUIDELINES AM SOC RE
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   BFS. British Fertility Society, 2016, ZIK VIR FERT TREATM
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bujan L, 2016, BMJ-BRIT MED J, V352, pi1062
   da Silva LRC, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020051
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cassuto NG, 2018, J GYNECOL OBSTET HUM, V47, P211, DOI 10.1016/j.jogoh.2018.02.004
   CDC, 2016, ZIK TRAV INF
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Clancy CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33528-2
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Cordeiro CN, 2017, CURR OPIN OBSTET GYN, V29, P175, DOI 10.1097/GCO.0000000000000366
   Cordeiro Fernanda B, 2017, Rapid Commun Mass Spectrom, V31, P1462, DOI 10.1002/rcm.7927
   Crutchfield CA, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-015-9102-9
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Ferreira CR, 2016, ANALYST, V141, P5252, DOI 10.1039/c6an01618a
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kielian M, 2002, FUSION BIOL MEMBRANE, P409
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mariani BD, 2017, patent, Patent No. [US20180142310A1, 20180142310]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pando-Robles V, 2017, VECTOR-BORNE ZOONOT, V17, P361, DOI 10.1089/vbz.2016.2040
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Sikka V, J GLOBAL INFECT DIS, P3
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01972-17, 10.1128/JCM.01972-17]
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization (WHO), 2016, PREV SEX TRANSM ZIK
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yarrington Christina D, 2019, Fertil Res Pract, V5, P1, DOI 10.1186/s40738-018-0053-5
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 90
TC 5
Z9 5
U1 1
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD JUL
PY 2019
VL 36
IS 7
BP 1339
EP 1349
DI 10.1007/s10815-019-01493-y
PG 11
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA IK4EU
UT WOS:000476540700005
PM 31147867
OA Green Published
DA 2020-12-17
ER

PT J
AU Lima, MLS
   Romao, GS
   Bettiol, H
   Barbieri, MA
   Ferriani, RA
   Navarro, PA
AF Lima, Maria L. S.
   Romao, Gustavo S.
   Bettiol, Heloisa
   Barbieri, Marco Antonio
   Ferriani, Rui A.
   Navarro, Paula A.
TI Association of birth weight with functional ovarian reserve during
   menacme estimated by serum concentration of anti-Mullerian hormone
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FOLLICLE-STIMULATING-HORMONE; ADOLESCENT GIRLS; FETAL-GROWTH; WOMEN;
   PHASE; SIZE; AGE
AB To investigate the relationship of birth weight (BW) of females born at full term with functional ovarian reserve (FOR) during menacme, based on serum level of anti-Mullerian hormone (AMH), among women who were 34-35 years old. This prospective birth cohort study assessed all women who were born in Ribeirao Preto City, State of Sao Paulo (Brazil) between June 1, 1978 and May 31, 1979. The primary endpoint was serum AMH, a marker of FOR, and its correlation with the BW of females classified as small for gestational age (SGA), appropriate for gestational age (AGA), and large for gestational (LGA). We included 274 women in this study, 19 were SGA, 238 were AGA, and 17 were LGA. The average of AMH concentration was not significantly different (p=0.11) among women in the SGA group (2.14 ng/mL), AGA group (2.13 ng/mL), and LGA group (2.57 ng/mL). An analysis of variance indicated that the three groups also had no significant differences in the percentage of women who had adequate AMH levels (1 ng/mL; p = 0.11). There were no significant differences in the serum concentrations of AMH among 34 and 35 year-old women who were born at full term and classified as SGA, AGA, and LGA. Our sample size allowed detection of major differences between these groups (effect size of 0.8). Association of birth weight of females born at full term with functional ovarian reserve during menacme estimated by serum concentration of anti-Mullerian hormone.
C1 [Lima, Maria L. S.; Romao, Gustavo S.; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto FMRP, Dept Gynecol, Ribeirao Preto, Brazil.
   [Bettiol, Heloisa; Barbieri, Marco Antonio] Univ Sao Paulo, Ribeirao Preto FMRP, Dept Pediat, Ribeirao Preto, Brazil.
RP Lima, MLS (corresponding author), Univ Sao Paulo, Ribeirao Preto FMRP, Dept Gynecol, Ribeirao Preto, Brazil.
EM marialuciadslima@gmail.com
RI Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
FU Foundation for the Support of Research in the State of Sao Paulo
   (FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/16118-0]
FX This study received financial support from the Foundation for the
   Support of Research in the State of Sao Paulo (FAPESP, Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo), Grant 2013/16118-0.
CR Arbo E, 2007, HUM REPROD, V22, P3192, DOI 10.1093/humrep/dem258
   BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9
   BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0
   Bernal AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015558
   Chan KA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124149
   Chandra Anjani, 2005, Vital Health Stat 23, P1
   Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004
   Chiofalo B, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6073167
   Cohen J, 1988, STAT POWER ANAL BEHA
   De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x
   Di Paola R, 2018, ARCH GYNECOL OBSTET, V298, P1029, DOI 10.1007/s00404-018-4906-2
   Figueras F, 2017, BEST PRACT RES CL OB, V38, P48, DOI 10.1016/j.bpobgyn.2016.10.006
   Gleicher N, 2010, FERTIL STERIL, V94, P2824, DOI 10.1016/j.fertnstert.2010.04.067
   Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s
   Hart R, 2010, FERTIL STERIL, V94, P1118, DOI 10.1016/j.fertnstert.2009.11.002
   Hourvitz A, 2009, REPROD BIOMED ONLINE, V19, P599, DOI 10.1016/j.rbmo.2009.04.002
   Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P3391, DOI 10.1210/jc.87.7.3391
   Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P1986, DOI 10.1210/jc.87.5.1986
   Ibanez L, 2003, HUM REPROD, V18, P1565, DOI 10.1093/humrep/deg351
   Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042
   Kerkhof GF, 2010, EUR J ENDOCRINOL, V163, P937, DOI 10.1530/EJE-10-0528
   Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162
   Pastore LM, 2018, J ASSIST REPROD GEN, V35, P17, DOI 10.1007/s10815-017-1058-4
   Pelosi E, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127381
   Pfeifer S, 2015, FERTIL STERIL, V103, pE44, DOI 10.1016/j.fertnstert.2015.03.019
   Silber SJ, 2017, FERTIL STERIL, V107, P1232, DOI 10.1016/j.fertnstert.2017.03.014
   Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567
   Steiner AZ, 2008, MENOPAUSE, V15, P940, DOI 10.1097/gme.0b013e31816429e5
   Stern JE, 2013, J ASSIST REPROD GEN, V30, P1445, DOI 10.1007/s10815-013-0092-0
   Su HI, 2014, FERTIL STERIL, V101, P1766, DOI 10.1016/j.fertnstert.2014.02.046
   Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X
   Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281
   van Rooij Ilse A J, 2004, Menopause, V11, P601, DOI 10.1097/01.GME.0000123642.76105.6E
   WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624
NR 34
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 30
PY 2019
VL 9
AR 8071
DI 10.1038/s41598-019-44016-6
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA2UT
UT WOS:000469418100017
PM 31147558
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Ferriani, RA
   Navarro, PA
AF Da Broi, Michele Gomes
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Ethiopathogenic mechanisms of endometriosis-related infertility
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Review
DE endometriosis; infertility; etiopathogenesis
ID IN-VITRO FERTILIZATION; LEUKEMIA INHIBITORY FACTOR; OXIDATIVE STRESS
   MARKERS; TUMOR-NECROSIS-FACTOR; PERITONEAL-FLUID; FOLLICULAR-FLUID;
   CUMULUS CELLS; OVARIAN RESERVE; GENE-EXPRESSION; GRANULOSA-CELLS
AB Endometriosis is a highly prevalent disease among women of reproductive age and is frequently associated to infertility. However, the mechanisms underlying endometriosis-related infertility are still not completely known. Several studies have been conducted in order to elucidate this question. Besides anatomical changes that may impair gametes and embryo transport along the tubes; a smaller ovarian reserve due to advanced endometriosis and endometriomas; and a dysregulated hypothalamicpituitary-ovarian axis, there are pieces of evidence suggesting that the peritoneal ectopic endometrial foci may induce a local inflammatory response, with the recruitment of macrophages, cytokine release, and reactive oxygen species generation, leading to a pro-oxidant peritoneal microenvironment. These alterations may be systemically reflected and also affect the follicular microenvironment. A harmful follicular fluid may disrupt cumulus cells functions and, consequently, compromise oocyte competence. There is also evidence suggesting that the peritoneal fluid of women with endometriosis may alter sperm function. Reduced endometrial receptivity is also pointed as a possible mechanism involved in endometriosis-related infertility, which needs further investigation.
C1 [Da Broi, Michele Gomes; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, Ribeirao Preto, SP, Brazil.
   [Ferriani, Rui Alberto; Navarro, Paula Andrea] CNPq, Natl Inst Hormones & Womans Hlth, Brasilia, DF, Brazil.
RP Da Broi, MG (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, SP, Brazil.
EM michi.dabroi@gmail.com
RI Da Broi, Michele G/E-7753-2012; Navarro, Paula/G-2744-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Aeby TC, 1996, AM J OBSTET GYNECOL, V174, P1779, DOI 10.1016/S0002-9378(96)70210-7
   Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Aghajanova L, 2003, FERTIL STERIL, V79, P808, DOI 10.1016/S0015-0282(02)04830-6
   Ahn SH, 2015, J IMMUNOL, V195, P2591, DOI 10.4049/jimmunol.1501138
   Ahn SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795976
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647
   ARUMUGAM K, 1994, HUM REPROD, V9, P1153, DOI 10.1093/oxfordjournals.humrep.a138649
   Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065
   Bersinger NA, 2006, AM J OBSTET GYNECOL, V195, P103, DOI 10.1016/j.ajog.2005.12.010
   Broi Michele G Da, 2017, JBRA Assist Reprod, V21, P196, DOI 10.5935/1518-0557.20170038
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   Cahill DJ, 2003, AM J REPROD IMMUNOL, V49, P66, DOI 10.1034/j.1600-0897.2003.01156.x
   Cahill DJ, 1997, J ASSIST REPROD GEN, V14, P554, DOI 10.1023/A:1022568331845
   Cahill DJ, 2000, HUM REPROD UPDATE, V6, P56, DOI 10.1093/humupd/6.1.56
   Catenacci M, 2008, Minerva Ginecol, V60, P209
   Cheong YC, 2002, HUM REPROD, V17, P69, DOI 10.1093/humrep/17.1.69
   Choi YS, 2015, REPRODUCTION, V149, P155, DOI 10.1530/REP-14-0438
   Cordeiro FB, 2015, J ASSIST REPROD GEN, V32, P1817, DOI 10.1007/s10815-015-0592-1
   Cranney R, 2017, ACTA OBSTET GYN SCAN, V96, P633, DOI 10.1111/aogs.13114
   Cunha JS, 2003, J ASSIST REPROD GEN, V20, P117, DOI 10.1023/A:1022625106489
   Cunha JSL, 2001, HORM METAB RES, V33, P216, DOI 10.1055/s-2001-14945
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2017, REPROD SCI, V24, P1469, DOI 10.1177/1933719117691142
   Da Broi MG, 2016, CELL TISSUE RES, V366, P231, DOI 10.1007/s00441-016-2428-4
   Da Broi MG, 2016, CELL TISSUE RES, V364, P1, DOI 10.1007/s00441-015-2339-9
   de Andrade AZ, 2010, REV BRAS GINECOL OBS, V32, P279, DOI 10.1590/S0100-72032010000600005
   Diaz-Fontdevila M, 2009, FERTIL STERIL, V91, P2061, DOI 10.1016/j.fertnstert.2008.05.073
   Donabela F, 2011, FERTIL STERIL, V96, pS236, DOI 10.1016/j.fertnstert.2011.07.909
   Donabela FC, 2015, REPROD SCI, V22, P1452, DOI 10.1177/1933719115585146
   DOODY MC, 1988, FERTIL STERIL, V49, P47
   Downs SM, 1999, BIOL REPROD, V60, P1446, DOI 10.1095/biolreprod60.6.1446
   Du YB, 2013, ARCH GYNECOL OBSTET, V287, P123, DOI 10.1007/s00404-012-2567-0
   EISERMANN J, 1988, FERTIL STERIL, V50, P573
   FitzHarris G, 2007, DEVELOPMENT, V134, P4283, DOI 10.1242/dev.005272
   Garcia-Velasco JA, 2015, REPROD BIOMED ONLINE, V31, P647, DOI 10.1016/j.rbmo.2015.07.014
   Jianini BTGM, 2017, REPROD SCI, V24, P1304, DOI 10.1177/1933719116687658
   Giorgi VSI, 2016, REPROD SCI, V23, P342, DOI 10.1177/1933719115602772
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Giudice LC, 2002, ANN NY ACAD SCI, V955, P252, DOI 10.1111/j.1749-6632.2002.tb02786.x
   Goodman LR, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.029
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Gupta S, 2006, REPROD BIOMED ONLINE, V13, P349, DOI 10.1016/S1472-6483(10)61439-3
   Hamamah S, 2006, REPROD BIOMED ONLINE, V13, P807, DOI 10.1016/S1472-6483(10)61028-0
   Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048
   Haouzi D, 2009, CURR MED CHEM, V16, P1905, DOI 10.2174/092986709788186075
   Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2
   Hock DL, 2001, J REPROD MED, V46, P7
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Hosseini E, 2016, J ASSIST REPROD GEN, V33, P1105, DOI 10.1007/s10815-016-0727-z
   Hsu AL, 2015, FERTIL STERIL, V103, P347, DOI 10.1016/j.fertnstert.2014.11.002
   Huang B, 2014, INT J CLIN EXP PATHO, V7, P2273
   Jorgensen H, 2017, FERTIL STERIL, V107, P1191, DOI 10.1016/j.fertnstert.2017.03.013
   Kashi AM, 2017, INT J GYNECOL OBSTET, V136, P200, DOI 10.1002/ijgo.12046
   KEENAN JA, 1995, AM J REPROD IMMUNOL, V34, P381, DOI 10.1111/j.1600-0897.1995.tb00968.x
   Kianpour M, 2013, INT J FERTIL STERIL, V7, P96
   Lamaita RM, 2012, J OBSTET GYNAECOL RE, V38, P810, DOI 10.1111/j.1447-0756.2011.01805.x
   Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7
   Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Liu Y, 2000, J Tongji Med Univ, V20, P163
   Lo Turco EG, 2013, MOL REPROD DEV, V80, P441, DOI 10.1002/mrd.22180
   Lolicato F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.120634
   Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043
   Mansour G, 2009, FERTIL STERIL, V92, P61, DOI 10.1016/j.fertnstert.2008.05.048
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   Margari KM, 2013, EUR J OBSTET GYN R B, V169, P103, DOI 10.1016/j.ejogrb.2013.02.010
   Miller JE, 2017, ONCOTARGET, V8, P7138, DOI 10.18632/oncotarget.12577
   Monniaux D, 2016, THERIOGENOLOGY, V86, P41, DOI 10.1016/j.theriogenology.2016.04.017
   Nasiri N, 2017, CELL J, V18, P582
   Nikas G, 1999, HUM REPROD, V14, P99, DOI 10.1093/humrep/14.suppl_2.99
   Nikas G, 2003, ANN NY ACAD SCI, V997, P120, DOI 10.1196/annals.1290.042
   Nikas G, 1997, ANN NY ACAD SCI, V816, P129, DOI 10.1111/j.1749-6632.1997.tb52136.x
   Oral E, 1996, FERTIL STERIL, V66, P787, DOI 10.1016/S0015-0282(16)58637-3
   Ordi J, 2003, J ASSIST REPROD GEN, V20, P465, DOI 10.1023/B:JARG.0000006709.61216.6f
   Carvalho LFP, 2012, REV ASSOC MED BRAS, V58, P607, DOI 10.1590/S0104-42302012000500020
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Reeve L, 2005, HUM REPROD, V20, P448, DOI 10.1093/humrep/deh606
   Revel A, 2012, FERTIL STERIL, V97, P1028, DOI 10.1016/j.fertnstert.2012.03.039
   Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011
   Said TM, 2005, FERTIL STERIL, V83, P1665, DOI 10.1016/j.fertnstert.2004.11.068
   SAITO T, 1994, BIOL REPROD, V50, P266, DOI 10.1095/biolreprod50.2.266
   Sanchez AM, 2014, HUM REPROD UPDATE, V20, P217, DOI 10.1093/humupd/dmt053
   Santulli P, 2015, HUM REPROD, V30, P49, DOI 10.1093/humrep/deu290
   SCHENKEN RS, 1984, FERTIL STERIL, V41, P122
   Seyhan A, 2015, SEMIN REPROD MED, V33, P422, DOI 10.1055/s-0035-1567820
   Shaeib F, 2016, REPROD SCI, V23, P498, DOI 10.1177/1933719115607993
   Shanti A, 1999, FERTIL STERIL, V71, P1115, DOI 10.1016/S0015-0282(99)00145-4
   Sikora J, 2012, AM J REPROD IMMUNOL, V68, P138, DOI 10.1111/j.1600-0897.2012.01147.x
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Singh AK, 2016, J ASSIST REPROD GEN, V33, P1363, DOI 10.1007/s10815-016-0782-5
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Tamanini C, 2004, REPROD DOMEST ANIM, V39, P206, DOI 10.1111/j.1439-0531.2004.00505.x
   Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102
   Toya M, 2000, FERTIL STERIL, V73, P344, DOI 10.1016/S0015-0282(99)00507-5
   TUMMON IS, 1988, FERTIL STERIL, V50, P716
   Uncu G, 2013, HUM REPROD, V28, P2140, DOI 10.1093/humrep/det123
   Wang XM, 2018, EUR REV MED PHARMACO, V22, P2513, DOI 10.26355/eurrev_201805_14899
   Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121
   Wu GX, 2017, J ASSIST REPROD GEN, V34, P357, DOI 10.1007/s10815-016-0865-3
   Xu BF, 2012, FERTIL STERIL, V98, P389, DOI 10.1016/j.fertnstert.2012.04.032
   Yoshino O, 2003, AM J REPROD IMMUNOL, V50, P60, DOI 10.1034/j.1600-0897.2003.00037.x
   Young SL, 2013, REPROD BIOMED ONLINE, V27, P497, DOI 10.1016/j.rbmo.2013.06.010
NR 106
TC 4
Z9 4
U1 1
U2 4
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD APR-JUN
PY 2019
VL 23
IS 3
BP 273
EP 280
DI 10.5935/1518-0557.20190029
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IZ3IR
UT WOS:000486978900014
PM 31091056
OA Green Published
DA 2020-12-17
ER

PT J
AU Lopez, JLT
   Cadahia, DP
   Noalles, MJA
   Cortes, TS
   Navarro, PA
AF Lopez, J. Lopez-Torres
   Piedracoba Cadahia, D.
   Alcantara Noalles, M. J.
   Simo Cortes, T.
   Argente Navarro, P.
TI Perioperative factors that contribute to postoperative pain and/or
   nausea and vomiting in ambulatory laparoscopic surgery
SO REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION
LA Spanish
DT Article
DE Laparoscopic surgery; Ambulatory surgery; Postoperative pain;
   Postoperative nausea and vomiting; Cholecystectomy; Gynaecological
   laparoscopic surgery
ID RANDOMIZED CLINICAL-TRIAL; CHOLECYSTECTOMY; MANAGEMENT
AB Introduction: Both postoperative pain and postoperative nausea and vomiting are major factors that determine the time and quality of recovery in laparoscopic surgery.
   Objective: To determine the perioperative factors that contribute to the appearance of postoperative pain and postoperative nausea and vomiting in outpatient laparoscopic surgery.
   Material and methods: A prospective study was conducted on a cohort of 297 patients undergoing laparoscopic ambulatory surgery. A record was made of preoperative factors (usual medication, anaesthetic risk, etc.), intraoperative (surgical and anaesthetic times, drugs, CO2 pressure, etc.), and postoperative factors (major and minor complications, recovery times, etc.). As dependent variables, the postoperative symptoms considered were, nausea, vomiting, and/or postoperative pain.
   Results: Considering as a combined variable the occurrence of nausea, vomiting or moderate/severe pain (4 or more points on a visual analogue scale), one or more of these symptoms occurred in 58.7% of the patients (95% CI: 52.8-64.4). Using a logistic regression, the variables associated with the appearance of symptoms were: female gender (OR: 3.4), waiting time over 45 minutes prior to surgery (OR: 4.9) and no anti-emetic prophylaxis (OR: 12.2).
   Conclusions: In patients undergoing ambulatory laparoscopic surgery, one in 4 had postoperative nausea and vomiting, and approximately half of moderate-intensity pain before discharge. Considering the overall the occurrence of pain and/or postoperative nausea and vomiting, these symptoms affect more than half of the patients being operated on, and are more frequent in women and in those who have to wait to access the operating room. (C) 2018 Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor. Published by Elsevier Espana, S.L.U. All rights reserved.
C1 [Lopez, J. Lopez-Torres] Complejo Hosp Univ Albacete, Serv Anestesiol & Reanimac, Albacete, Spain.
   [Piedracoba Cadahia, D.; Alcantara Noalles, M. J.; Simo Cortes, T.; Argente Navarro, P.] Hosp La Fe, Serv Anestesiol & Reanimac, Valencia, Spain.
RP Lopez, JLT (corresponding author), Complejo Hosp Univ Albacete, Serv Anestesiol & Reanimac, Albacete, Spain.
EM jaime.lopeztorres.lopez@gmail.com
CR Acosta-Villegas F, 2010, CIR ESPAN, V88, P369, DOI 10.1016/j.ciresp.2010.07.009
   Ahn Y, 2011, HPB, V13, P677, DOI 10.1111/j.1477-2574.2011.00371.x
   Ammori Basil J, 2003, J Hepatobiliary Pancreat Surg, V10, P303, DOI 10.1007/s00534-002-0807-6
   [Anonymous], 2016, JSLS, V20, P1
   Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022
   Bandey S, 2016, J CLIN DIAGN RES, V10, pUC5, DOI 10.7860/JCDR/2016/21021.8274
   Barthelsson C, 2008, J EVAL CLIN PRACT, V14, P577, DOI 10.1111/j.1365-2753.2007.00920.x
   Bhakta Pradipta, 2016, Acta Anaesthesiol Taiwan, V54, P108, DOI 10.1016/j.aat.2016.10.002
   Bogani G, 2015, EUR J OBSTET GYN R B, V195, P1, DOI 10.1016/j.ejogrb.2015.09.036
   Brescia A, 2013, SURG-J R COLL SURG E, V14, P14
   Cassinotti E, 2008, INT J SURG, V6, P93
   D'souza N, 2011, INT J GYNECOL OBSTET, V113, P124, DOI 10.1016/j.ijgo.2010.11.022
   El-Dawlatly AA, 2009, BRIT J ANAESTH, V102, P763, DOI 10.1093/bja/aep067
   Gan TJ, 2006, ANESTH ANALG, V102, P1884, DOI 10.1213/01.ANE.0000219597.16143.4D
   Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3
   Gurusamy KS, 2014, COCHRANE DB SYST REV, V28
   Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006930.pub2
   Kadam Vasanth Rao, 2016, J Anaesthesiol Clin Pharmacol, V32, P80, DOI 10.4103/0970-9185.168195
   Keir A, 2013, INT J SURG, V11, P792, DOI 10.1016/j.ijsu.2013.05.039
   Khanna A, 2013, BRIT J SURG, V100, P1290, DOI 10.1002/bjs.9202
   Koc M, 2005, ANZ J SURG, V75, P693, DOI 10.1111/j.1445-2197.2005.03496.x
   Le Tina P, 2010, Anesthesiol Clin, V28, P225, DOI 10.1016/j.anclin.2010.02.003
   Perez MAL, 2013, CIR ESPAN, V91, P424, DOI 10.1016/j.ciresp.2012.10.010
   Piirainen A, 2015, DRUGS R&D, V15, P319, DOI 10.1007/s40268-015-0107-7
   Sanchez-Ledesma MJ, 2002, ANESTH ANALG, V95, P1590, DOI 10.1097/00000539-200212000-00022
   Tang HR, 2015, DIGEST LIVER DIS, V47, P556, DOI 10.1016/j.dld.2015.04.007
   Tharanon C, 2016, INT J WOMENS HEALTH, V8, P373, DOI 10.2147/IJWH.S109568
NR 27
TC 0
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0034-9356
EI 2340-3284
J9 REV ESP ANEST REANIM
JI Rev. Esp. Anestesiol. Reanim.
PD APR
PY 2019
VL 66
IS 4
BP 189
EP 198
DI 10.1016/j.redar.2018.11.007
PG 10
WC Anesthesiology
SC Anesthesiology
GA HQ8DC
UT WOS:000462653100003
PM 30665796
DA 2020-12-17
ER

PT J
AU Palacio, A
   Quintiliano, D
   Lira, I
   Navarro, P
   Orellana, V
   Reyes, A
   Henriquez, D
AF Palacio, Ana
   Quintiliano, Daiana
   Lira, Isidora
   Navarro, Paula
   Orellana, Valentina
   Reyes, Alejandra
   Henriquez, Daniela
TI Changes in body composition in patients following bariatric surgery:
   gastric bypass and sleeve gastrectomy
SO NUTRICION HOSPITALARIA
LA Spanish
DT Article
DE Body composition; Roux-en-Y gastric bypass; Sleeve gastrectomy; Muscle
   mass; Bioimpedance
ID FAT-FREE MASS; ENERGY-EXPENDITURE; WEIGHT-LOSS; OBESITY; PRESERVATION;
   PREDICTION; IMPACT
AB Introduction: among the surgical techniques that promote greater weight loss are Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). These procedures generate changes in muscle mass (MM) and fat mass (FM).
   Objective: the aim of this study was to determine changes in body composition in patients undergoing RYGB and SG in a period of one-year after surgery.
   Methods: a cross-sectional retrospective study was conducted in three clinical centers of bariatric surgery in the Metropolitan Region, Chile. Information on MM and FM was obtained through bioimpedance analysis of 96 women and 32 men, operated between 2013 and 2017.
   Results: RYGB operated subjects presented higher MM content preoperatively and at the end of the first year compared to SG. In the first six months, the loss for MM, FM and % total fat (% FM) was similar in both techniques. Men with RYGB present greater loss of MM and FM in the first trimester post-surgery than those who submitted to SG (p = 0.0453). Subjects submitted to RYGB presented higher weight and body mass index (BMI) in the preoperative (p = 0.0109); the BMI at the end was similar in both surgical techniques (p = 0.6936). The lost kilos of MM were greater in the subjects submitted to RYGB (p = 0.0042), however, the % loss of MM exceeds the recommended (up to 22%) in both techniques.
   Conclusion: the nutritional approach is necessary to increase protein intake pre- and post-surgery as well as physical activity in order to preserve this compartment.
C1 [Palacio, Ana; Quintiliano, Daiana; Lira, Isidora; Navarro, Paula; Orellana, Valentina; Henriquez, Daniela] Univ Desarrollo, Fac Med, Escuela Nutr & Dietet, Ave La Plaza 680, Santiago 7550000, Chile.
   [Palacio, Ana] Univ Catolica Chile, Ctr Tratamiento Obesidad, Santiago, Chile.
   [Reyes, Alejandra] Clin Tabancura, Ctr Integral Nutr Obesidad, Santiago, Chile.
RP Palacio, A (corresponding author), Univ Desarrollo, Fac Med, Escuela Nutr & Dietet, Ave La Plaza 680, Santiago 7550000, Chile.
EM anapalacio@udd.cl
CR Albaugh V, 2018, F1000RES, V617, P1
   Andolfi C, 2018, J LAPAROENDOSC ADV A, P1
   Angrisani L, 2017, OBES SURG, V27, P1633, DOI 10.1007/s11695-017-2675-9
   Attila Csendes J., 2015, REV CHIL CIR, V67, P61
   Belfiore A, 2015, OBES SURG, V25, P2344, DOI 10.1007/s11695-015-1700-0
   Candelaria Martinez M, 2016, MEX J EATING DIS, V7, P32, DOI [10.1016/j.rmta.2016.02.002, DOI 10.1016/J.RMTA.2016.02.002]
   Coen PM, 2016, DIABETES OBES METAB, V18, P16, DOI 10.1111/dom.12545
   Crisp AH, 2018, OBES SURG, V28, P1665, DOI 10.1007/s11695-017-3074-y
   CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963
   Dagan SS, 2017, SURG OBES RELAT DIS, V13, P101, DOI 10.1016/j.soard.2016.05.026
   Faria SL, 2012, OBES SURG, V22, P1257, DOI 10.1007/s11695-012-0651-y
   Faria SL, 2009, OBES SURG, V19, P856, DOI 10.1007/s11695-009-9842-6
   Friedrich AE, 2013, OBES SURG, V23, P1957, DOI 10.1007/s11695-013-1036-6
   Fruhbeck G, 2004, NEW ENGL J MED, V350, P308, DOI 10.1056/NEJM200401153500323
   Gomez-Arbelaez D, 2017, J CLIN ENDOCR METAB, V102, P488, DOI 10.1210/jc.2016-2385
   Guidi Barbara, 2018, J ENDOCRINOL INVEST, P1
   Heindel JJ, 2018, ANN REV PHARM TOXICO, V59
   Hunt HR, 2009, BEHAV MODIF, V33, P795, DOI 10.1177/0145445509348055
   Maimoun L, 2016, BONE, V90, P23, DOI 10.1016/j.bone.2015.11.020
   Mechanick JI, 2013, OBESITY, V21, pS1, DOI 10.1002/oby.20461
   Ministerio de Salud (MINSAL), 2017, ENC NAC SAL 2016 201
   Muller M J, 2002, Obes Rev, V3, P113, DOI 10.1046/j.1467-789X.2002.00057.x
   Muñoz Rodrigo, 2016, Rev Chil Cir, V68, P411, DOI 10.1016/j.rchic.2016.05.007
   Oria HE, 1997, OBES SURG, V7, P521
   Otto M, 2016, OBES SURG, V26, P479, DOI 10.1007/s11695-015-1792-6
   Sans A, 2017, OBES SURG, V27, P2940, DOI 10.1007/s11695-017-2720-8
   Schiavo L, 2017, SURG OBES RELAT DIS, V13, P1692, DOI 10.1016/j.soard.2017.06.007
   Steele T, 2015, OBES REV, V16, P248, DOI 10.1111/obr.12247
   WEBSTER JD, 1984, HUM NUTR-CLIN NUTR, V38C, P299
   Wells J, 2015, AM SURGEON, V81, P812
NR 30
TC 2
Z9 2
U1 0
U2 1
PU ARAN EDICIONES, S L
PI MADRID
PA C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN
SN 0212-1611
EI 1699-5198
J9 NUTR HOSP
JI Nutr. Hosp.
PD MAR-APR
PY 2019
VL 36
IS 2
BP 334
EP 339
DI 10.20960/nh.2255
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HT9YU
UT WOS:000464929400016
PM 30868905
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Bedoschi, GM
   Navarro, PA
   Oktay, KH
AF Bedoschi, Giuliano M.
   Navarro, Paula A.
   Oktay, Kutluk H.
TI Novel insights into the pathophysiology of chemotherapy-induced damage
   to the ovary
SO PANMINERVA MEDICA
LA English
DT Review
DE Drug therapy; Ovarian diseases; Amenorrhea
ID ANTI-MULLERIAN HORMONE; PROTECTS MOUSE OOCYTES; PREMENOPAUSAL WOMEN;
   CANCER-TREATMENT; BREAST-CANCER; MLLERIAN HORMONE; YOUNG-WOMEN; DNA
   BREAKS; RESERVE; MECHANISMS
AB Cancer is the second leading cause of death in the USA and is considered a public health issue worldwide. Early diagnosis and advancement of treatment modalities contributed to declining mortality rates. Consequently, survival rates increased, leading to a greater interest in maintaining the quality of life after cancer treatment. Overall survival and disease-free survival rates are improved with the use of adjuvant chemotherapy. However, chemotherapy treatment might cause short and long-term side effects for cancer survivors. A special concern of young women diagnosed with cancer is their reproductive potential after chemotherapy. Chemotherapy drugs act by distinct mechanisms in the ovaries. DNA damage of primordial follicle oocytes, leading to chemotherapy-induced apoptosis, was recognized as the principal mechanism responsible for the irreversible decline of the ovarian reserve. The oocyte first attempts to repair DNA damage via the DNA damage repair pathway mediated by ataxia-telangiectasia mutated. Elimination through apoptosis occurs in cells in which DNA damage could not be repaired. In this review, the clinical impact and the major mechanisms of ovarian damage from chemotherapy treatment will be briefly described.
C1 [Bedoschi, Giuliano M.; Oktay, Kutluk H.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.
   [Bedoschi, Giuliano M.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Oktay, KH (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.
EM info@fertilitypreservation.org
RI Bedoschi, Giuliano/E-2225-2013; Navarro, Paula/G-2744-2012
OI Bedoschi, Giuliano/0000-0003-3104-1297; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Anckaert E, 2012, HUM REPROD, V27, P1829, DOI 10.1093/humrep/des101
   Anders C, 2008, CANCER INVEST, V26, P286, DOI 10.1080/07357900701829777
   Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201
   Anderson RA, 2011, J CLIN ENDOCR METAB, V96, P1336, DOI 10.1210/jc.2010-2582
   Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492
   Bedoschi G, 2016, FUTURE ONCOL, V12, P2333, DOI 10.2217/fon-2016-0176
   Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718
   Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034
   Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004
   Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034
   BYRNE J, 1992, AM J OBSTET GYNECOL, V166, P788, DOI 10.1016/0002-9378(92)91335-8
   Carter J, 2005, GYNECOL ONCOL, V97, P90, DOI 10.1016/j.ygyno.2004.12.019
   Cook CL, 2000, FERTIL STERIL, V73, P859, DOI 10.1016/S0015-0282(99)00639-1
   Curtin SC, 2013, NCHS DATA BRIEF, V136, P1
   de Moor JS, 2013, CANCER EPIDEM BIOMAR, V22, P561, DOI 10.1158/1055-9965.EPI-12-1356
   de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4
   Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062
   Dillon KE, 2013, FERTIL STERIL, V99, P477, DOI 10.1016/j.fertnstert.2012.09.039
   Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601
   Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042
   Fanchin R, 2003, HUM REPROD, V18, P328, DOI 10.1093/humrep/deg043
   Fornier MM, 2002, SAN ANT BREAST CANC
   Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033
   Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839
   HORTOBAGYI G N, 1986, NCI (National Cancer Institute) Monographs, P105
   Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402
   Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017
   Kerr JB, 2012, NAT MED, V18, P1170, DOI 10.1038/nm.2889
   Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877
   Kujjo LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009204
   Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872
   Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P1933, DOI 10.1002/cncr.26403
   Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054
   Meirow D, 2007, HUM REPROD, V22, P1626, DOI 10.1093/humrep/dem027
   Meirow D, 2001, HUM REPROD, V16, P632, DOI 10.1093/humrep/16.4.632
   Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127
   Oktay K, 2018, J CLIN ONCOL, V36, P1994, DOI 10.1200/JCO.2018.78.1914
   Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042
   Oktem O, 2007, CANCER-AM CANCER SOC, V110, P2222, DOI 10.1002/cncr.23071
   Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299
   Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969
   Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311
   Reh A, 2008, FERTIL STERIL, V90, P1635, DOI 10.1016/j.fertnstert.2007.09.048
   Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395
   Rossi V, 2017, CELL DEATH DIFFER, V24, P72, DOI 10.1038/cdd.2016.97
   Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908
   Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011
   Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442
   Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814
   Soleimani R, 2011, AGING-US, V3, P782, DOI 10.18632/aging.100363
   Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337
   Titus S, 2015, SEMIN REPROD MED, V33, P384, DOI 10.1055/s-0035-1567824
   Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925
   van den Berg MMJ, 2012, BBA-MOL BASIS DIS, V1822, P1951, DOI 10.1016/j.bbadis.2012.07.001
   van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065
   Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772
   Winship AL, 2018, HUM REPROD UPDATE
   Xu Jiaquan, 2016, NCHS Data Brief, P1
   Yu B, 2010, CANCER-AM CANCER SOC, V116, P2099, DOI 10.1002/cncr.25037
NR 59
TC 7
Z9 7
U1 0
U2 10
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0031-0808
EI 1827-1898
J9 PANMINERVA MED
JI Panminerva Medica
PD MAR
PY 2019
VL 61
IS 1
BP 68
EP 75
DI 10.23736/S0031-0808.18.03494-8
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA HI7VE
UT WOS:000456663500009
PM 29962184
DA 2020-12-17
ER

PT J
AU Umeoka, EH
   Eiras, MC
   Viana, IG
   Giorgi, VS
   Bueno, A
   Damasceno, DC
   Garcia-Cairasco, N
   Navarro, PA
AF Umeoka, Eduardo H.
   Eiras, Matheus C.
   Viana, Iara G.
   Giorgi, Vanessa S.
   Bueno, Aline
   Damasceno, Debora C.
   Garcia-Cairasco, Norberto
   Navarro, Paula A.
TI Maternal reproductive performance and fetal development of the Wistar
   Audiogenic Rat (WAR) strain
SO SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Wistar Audiogenic Rat (WAR); embryos; epilepsy; audiogenic seizures;
   reproductive performance; fetal development
ID INFERIOR COLLICULUS; NEUROETHOLOGICAL EVALUATION; SEIZURES; EPILEPSY;
   EPILEPTOGENESIS; MICROINJECTION; BICUCULLINE; ILAE
AB Wistar Audiogenic Rat (WAR) strain is an animal model for epilepsy studies, the chronic multifactorial disease that affects millions of people worldwide. The animals of this strain are genetically predisposed to sound-induced seizures, called audiogenic seizures, and have been used for many years in studies to understand the mechanisms involved in the epilepsies and their neuropsychiatric comorbidities, as well as the screening of potential anti-convulsant agents. Nevertheless, little is known about the reproductive characteristics of these animals. The main goal of this study was to characterize the female reproductive performance and the fetal growth of WARs in comparison to the Wistar rats, obtaining important information for physiology and behavioral studies, as well as for the preservation of the strain. The results indicated few differences between WAR and Wistar regarding the female reproductive performance. There was no significant difference in the number of pregnant females by mating, number of live births per female, number of cells per blastocyst, and several characteristics related to reproductive performance, such as pre- and post-implantation losses. However, significant differences were observed in birth weight and weight gain until weaning, with WAR animals presenting a body weight below Wistar at birth and reduced body weight gain during the lactation period. In addition, the WAR females showed lower body weight on the day 20 of pregnancy and a larger number of corpora lutea, when compared with those of Wistar animals. Thus, we conclude that although Wistar and WAR strains have few differences in their reproductive performance, which might impact future physiological life challenges or others experimentally induced procedures, it still is a very viable strain regarding reproduction.
C1 [Umeoka, Eduardo H.; Viana, Iara G.; Giorgi, Vanessa S.; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Umeoka, Eduardo H.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Neurosci & Behav Sci Dept, Ribeirao Preto, SP, Brazil.
   [Umeoka, Eduardo H.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, Ribeirao Preto, SP, Brazil.
   [Eiras, Matheus C.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Genet, Ribeirao Preto, SP, Brazil.
   [Bueno, Aline; Damasceno, Debora C.] Univ Estadual Paulista UNESP, Botucatu Med Sch, Gynecol Obstet & Mastol Postgrad Course, Botucatu, SP, Brazil.
RP Umeoka, EH (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Gynecol & Obstet, Av Bandeirantes 3900,HCFMRP USP 9 Andar, BR-14049900 Ribeirao Preto, SP, Brazil.
EM eduardoumeoka@gmail.com
RI Damasceno, Debora C/C-7234-2012; Navarro, Paula/G-2744-2012
OI Damasceno, Debora C/0000-0002-7003-9643; Umeoka,
   Eduardo/0000-0003-3609-585X; Navarro, Paula Andrea/0000-0003-2368-4188
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2007/50261-4, 2015/18773-1]; PNPD-CAPESCAPES; CAPESCAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq);
   HCFMRP-FAEPA; USP
FX This work was financially support by FAPESP (grant numbers 2007/50261-4,
   2015/18773-1), PNPD-CAPES, CAPES, CNPq, HCFMRP-FAEPA and USP. NGC holds
   a CNPq Researcher Fellowship.
CR Ambeskovica M, 2017, NEUROSCI BIOBEHAV RE
   Barker DJP, 1994, MOTHERS BABIES DIS L
   Cao-Lei L, 2017, NEUROSCI BIOBEHAV R, DOI [10.1016/j.neubiorev.2017.05.016, DOI 10.1016/J.NEUBIOREV.2017.05.016]
   Damasceno DC, 2008, ANOMALIAS CONGENITAS
   DAMASCENO DÉBORA CRISTINA, 2002, Rev. Assoc. Med. Bras., V48, P312, DOI 10.1590/S0104-42302002000400036
   Doretto MC, 2003, BEHAV GENET, V33, P33, DOI 10.1023/A:1021099432759
   Doretto MC, 1998, NEUROREPORT, V9, P2415, DOI 10.1097/00001756-199807130-00048
   ENGEL J, 1995, EPILEPSIA, V36, pS23
   FAINGOLD CL, 1994, BRAIN RES, V640, P40, DOI 10.1016/0006-8993(94)91855-4
   FAINGOLD CL, 1987, METAB BRAIN DIS, V2, P81, DOI 10.1007/BF00999720
   Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550
   Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x
   Galvis-Alonso OY, 2004, NEUROSCIENCE, V125, P787, DOI 10.1016/j.neuroscience.2004.01.042
   Garcia-Cairasco N, 2002, HEARING RES, V168, P208, DOI 10.1016/S0378-5955(02)00371-4
   Garcia-Cairasco N, 2017, EPILEPSY BEHAV, V71, P250, DOI 10.1016/j.yebeh.2017.04.001
   GARCIACAIRASCO N, 1993, BEHAV BRAIN RES, V58, P57, DOI 10.1016/0166-4328(93)90090-D
   GarciaCairasco N, 1996, PHARMACOL BIOCHEM BE, V53, P503, DOI 10.1016/0091-3057(95)02040-3
   Lee Y, 2018, NEUROBIOL DIS, V111, P80, DOI 10.1016/j.nbd.2017.12.014
   Lopez-Lopez D, 2017, EPILEPSY BEHAV, V71, P226, DOI 10.1016/j.yebeh.2015.12.020
   Moraes MFD, 2000, EPILEPSY RES, V39, P251
   NIGGESCHULZE A, 1994, LAB ANIM-UK, V28, P55, DOI 10.1258/002367794781065717
   PAMPFER S, 1990, DIABETES, V39, P471, DOI 10.2337/diabetes.39.4.471
   Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023
   Ribeiro-Santos R, 2000, P 1 LAT EP C SANT CH, P292
   Romcy-Pereira RN, 2003, NEUROSCIENCE, V119, P533, DOI 10.1016/S0306-4522(03)00191-X
   Santos TMM, 2015, CELL STRESS CHAPERON, V20, P595, DOI 10.1007/s12192-015-0581-4
   Tejada J, 2013, EPILEPSY BEHAV, V26, P212, DOI 10.1016/j.yebeh.2012.09.029
   TERRA VC, 1994, BEHAV BRAIN RES, V62, P29, DOI 10.1016/0166-4328(94)90035-3
   TERRA VC, 1992, BEHAV BRAIN RES, V52, P19, DOI 10.1016/S0166-4328(05)80321-3
   Thouas G. A., 2001, Reprod Biomed Online, V3, P25
   Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x
   TSUTSUI J, 1992, BEHAV BRAIN RES, V52, P7, DOI 10.1016/S0166-4328(05)80320-1
   Umeoka EHL, 2011, BRAIN RES, V1381, P141, DOI 10.1016/j.brainres.2011.01.042
   WILLOTT JF, 1980, EXP NEUROL, V70, P288, DOI 10.1016/0014-4886(80)90028-X
NR 34
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1939-6368
EI 1939-6376
J9 SYST BIOL REPROD MED
JI Syst. Biol. Reprod. Med.
PD JAN 2
PY 2019
VL 65
IS 1
BP 87
EP 94
DI 10.1080/19396368.2018.1483443
PG 8
WC Andrology; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA HJ8HA
UT WOS:000457437300013
PM 29927665
DA 2020-12-17
ER

PT J
AU Salomao, PB
   Navarro, PA
   Romao, APMS
   Lerri, MR
   Lara, LAD
AF Salomao, Priscilla Bianchini
   Navarro, Paula Andrea
   Mariano Salata Romao, Adriana Peterson
   Lerri, Maria Rita
   da Silva Lara, Lucia Alves
TI Sexual Function of Women with Infertility
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE Marital Infertility; sexuality; female sexual dysfunction; anxiety;
   depression; assisted reproduction
ID RISK-FACTORS; PREVALENCE; DYSFUNCTION; MEN; QUALITY; SEEKING; COUPLES;
   SAMPLE; HEALTH
AB Objective To assess the sexual function, anxiety, and depression of infertile women relative to a control group.
   Methods Infertile women (infertile group, IG) of reproductive age were invited to participate in this controlled study. A control group (CG) of women was recruited from the general population of the same city. Sexual function was assessed by the Female Sexual Function Index (FSFI), and anxiety and depression were measured by the Hospital Anxiety and Depression Scale (HADS).
   Results A total of 280 women participated in the present study, 140 in the IG and 140 in the CG. The analysis of the FSFI scores showed that 47 women (33.57%) in the IG and 49 women (35%) in the CG had sexual dysfunction (FSFI <= 26.55; p = 0.90). Women with anxiety or depression had a greater risk of sexual dysfunction, and sexual dysfunction increased the risk of anxiety and depression. Married women had a lower risk of depression than single women who were living with their partners.
   Conclusion Infertile women had no increased risk of sexual dysfunction relative to controls. Anxiety and depression increased the risk of sexual dysfunction in the studied population.
C1 [Salomao, Priscilla Bianchini; Navarro, Paula Andrea; Mariano Salata Romao, Adriana Peterson; Lerri, Maria Rita; da Silva Lara, Lucia Alves] Univ Sao Paulo Ribeirao Preto, Sch Med, Av Bandeirantes 3900, BR-14040900 Ribeirao Preto, SP, Brazil.
RP Salomao, PB (corresponding author), Univ Sao Paulo Ribeirao Preto, Sch Med, Av Bandeirantes 3900, BR-14040900 Ribeirao Preto, SP, Brazil.
EM pri_salomao@hotmail.com
RI Navarro, Paula/G-2744-2012; Lara, Lucia A/F-6873-2013; Lerri, Maria
   Rita/C-8337-2014
OI Lerri, Maria Rita/0000-0001-8597-2615; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Abdo CHN, 2004, INT J IMPOT RES, V16, P160, DOI 10.1038/sj.ijir.3901198
   Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046
   Carvalheira AA, 2010, J SEX MED, V7, P1454, DOI 10.1111/j.1743-6109.2009.01693.x
   Coeffin-Driol C, 2004, Gynecol Obstet Fertil, V32, P624, DOI 10.1016/j.gyobfe.2004.06.004
   Mendonca CR, 2014, REV BRAS GINECOL OBS, V36, P484, DOI 10.1590/SO100-720320140004952
   Domar A, 2012, HUM REPROD, V27, P1073, DOI 10.1093/humrep/des016
   Ferraresi SR, 2013, RECENT PATENTS ENDOC, V7, P198, DOI 10.2174/18722148113079990009
   Galhardo A, 2011, HUM REPROD, V26, P2408, DOI 10.1093/humrep/der209
   Grontvedt TV, 2015, SCAND J PSYCHOL, V56, P516, DOI 10.1111/sjop.12215
   Hentschel H, 2008, J SEX MARITAL THER, V34, P107, DOI 10.1080/00926230701636171
   Herrmann D, 2011, J ASSIST REPROD GEN, V28, P1111, DOI 10.1007/s10815-011-9637-2
   Hosmer D.W., 2000, APPL LOGISTIC REGRES
   Iris A, 2013, ARCH GYNECOL OBSTET, V287, P809, DOI 10.1007/s00404-012-2633-7
   Jamali Safieh, 2014, Iran J Reprod Med, V12, P189
   Jiann BP, 2009, J SEX MED, V6, P3364, DOI 10.1111/j.1743-6109.2009.01494.x
   Kassa M, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0033-8
   Keskin U, 2011, FERTIL STERIL, V96, P1213, DOI 10.1016/j.fertnstert.2011.08.007
   Klemetti R, 2010, ACTA OBSTET GYN SCAN, V89, P677, DOI 10.3109/00016341003623746
   Latorre G FS, 2015, REV INSPIRAR MOV SAU, V7, P23
   Mirblouk F, 2016, INT J REPROD BIOMED, V14, P117
   Nappi R E, 2007, Minerva Ginecol, V59, P287
   Pacagnella RD, 2009, CAD SAUDE PUBLICA, V25, P2333
   Pakpour AH, 2012, ARCH GYNECOL OBSTET, V286, P1589, DOI 10.1007/s00404-012-2489-x
   Palha AP, 2011, ADV PSYCHOSOM MED, V31, P164, DOI 10.1159/000328922
   Prado DS, 2010, REV BRAS GINECOL OBS, V32, P139, DOI 10.1590/S0100-72032010000300007
   PURIFOY FE, 1992, ARCH SEX BEHAV, V21, P369, DOI 10.1007/BF01542026
   Revonta M, 2010, SEX REPROD HEALTHC, V1, P91, DOI 10.1016/j.srhc.2010.06.002
   Wischmann T, 2014, GEBURTSH FRAUENHEILK, V74, P759, DOI 10.1055/s-0034-1368461
   Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 30
TC 3
Z9 3
U1 1
U2 4
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD DEC
PY 2018
VL 40
IS 12
BP 771
EP 778
DI 10.1055/s-0038-1673699
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HD4HI
UT WOS:000452487800007
PM 30381810
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Rosello, IA
   Garcia, ER
   Jimenez, IG
   Navarro, PA
AF Albero Rosello, I.
   Romero Garcia, E.
   Gimenez Jimenez, I.
   Argente Navarro, P.
TI Duodopa nasoduodenal tube at intrabronchial position
SO REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION
LA Spanish
DT Editorial Material
C1 [Albero Rosello, I.; Romero Garcia, E.; Gimenez Jimenez, I.; Argente Navarro, P.] Hosp Univ & Politecn La Fe, Serv Anestesiol Reanimac & Terapeut Dolor, Valencia, Spain.
RP Rosello, IA (corresponding author), Hosp Univ & Politecn La Fe, Serv Anestesiol Reanimac & Terapeut Dolor, Valencia, Spain.
EM nachoalbero@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0034-9356
EI 2340-3284
J9 REV ESP ANEST REANIM
JI Rev. Esp. Anestesiol. Reanim.
PD OCT
PY 2018
VL 65
IS 8
BP 480
EP 481
DI 10.1016/j.redar.2017.12.011
PG 2
WC Anesthesiology
SC Anesthesiology
GA GX0QV
UT WOS:000447417100013
PM 29426624
DA 2020-12-17
ER

PT J
AU Borges, ED
   Vireque, AA
   Berteli, TS
   de Lima, CB
   Sobreira, TJ
   Ferreira, CR
   Navarro, PA
AF Borges, E. D.
   Vireque, A. A.
   Berteli, T. S.
   de Lima, C. B.
   Sobreira, T. J.
   Ferreira, C. R.
   Navarro, P. A.
TI LIPIDOMICS OF SPERM CELLS OF FERTILE AND SUB-FERTILE MEN BY
   MRM-PROFILING
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 74th Annual Meeting of the American-Society-for-Reproductive-Medicine
   (ASRM)
CY OCT 06-10, 2018
CL Denver, CO
SP Amer Soc Reprod Med
C1 [Borges, E. D.; Berteli, T. S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, Ribeirao Preto, Brazil.
   [Vireque, A. A.] Invitra Assisted Reprod Tecnol, Ribeirao Preto, Brazil.
   [de Lima, C. B.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Sobreira, T. J.; Ferreira, C. R.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.
   [Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Obstet & Gynecol, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; Ferreira, Christina R/F-4744-2012; Borges,
   Eduardo/Y-5712-2019
OI Ferreira, Christina R/0000-0003-3988-6454; Borges,
   Eduardo/0000-0002-0131-1121
FU Fundacao CAPESCAPES; Invitra Tecnologia da Reproducao Assistida LTDA
FX The study was funded by Fundacao CAPES and Invitra Tecnologia da
   Reproducao Assistida LTDA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2018
VL 110
IS 4
SU S
MA P-487
BP E303
EP E304
DI 10.1016/j.fertnstert.2018.07.853
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GY6PS
UT WOS:000448713601176
OA Bronze
DA 2020-12-17
ER

PT J
AU Giorgi, VS
   Ferriani, RA
   Navarro, P
AF Giorgi, V. S.
   Ferriani, R. A.
   Navarro, P.
TI THE ROLE OF L-CARNITINE AND OMEGA-3 FATTY ACIDS IN PREVENT MEIOTIC
   DAMAGES TO BOVINE OOCYTES MATURED IN VITRO WITH FOLLICULAR FLUID FROM
   WOMEM WITH DIFFERENT STAGES OF ENDOMETRIOSIS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 74th Annual Meeting of the American-Society-for-Reproductive-Medicine
   (ASRM)
CY OCT 06-10, 2018
CL Denver, CO
SP Amer Soc Reprod Med
C1 [Giorgi, V. S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Ribeirao Preto, Brazil.
   [Ferriani, R. A.] Univ Sao Paulo, Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Navarro, P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Obstet & Gynecol, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES
FX Supported by: Coordination for the Improvement of Higher Education
   Personnel (CAPES).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2018
VL 110
IS 4
SU S
MA P-728
BP E396
EP E397
DI 10.1016/j.fertnstert.2018.07.1108
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GY6PS
UT WOS:000448713601414
OA Bronze
DA 2020-12-17
ER

PT J
AU Palhares, MB
   Martins, WP
   Romao, GS
   Ferriani, RA
   Navarro, PA
AF Palhares Jr, Maurilio B.
   Martins, Wellington P.
   Romao, Gustavo S.
   Ferriani, Rui A.
   Navarro, Paula A.
TI Combining Age, Antral Follicle Count, Anti-Mullerian Hormone, and
   Follicle-Stimulating Hormone Is More Accurate Than Individual Markers in
   Predicting Poor Ovarian Response
SO JOURNAL OF REPRODUCTIVE MEDICINE
LA English
DT Article
DE assisted reproductive techniques; in vitro fertilization; poor ovarian
   response; anti-Mullerian hormone; antral follicle count; follicle
   stimulating hormone
ID IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; LIVE BIRTH;
   ANTIMULLERIAN HORMONE; CYCLE CANCELLATION; EMBRYO-TRANSFER;
   METAANALYSIS; RESERVE; HYPERSTIMULATION; ENDOMETRIOMA
AB OBJECTIVE: To compare the predictive accuracy of a formula combining age, anti-Mullerian hormone (AMH), antral follicle count (AFC), and follicle-stimulating hormone (FSH) with those individual markers in predicting poor ovarian response (POR) in young, nonobese women undergoing their first IVF cycle.
   STUDY DESIGN: Women aged < 40 y, FSH < 10 IU/L, BMI < 30 kg/m(2) undergoing first IVF cycle. POR was defined as <= 3 oocytes retrieved or cycle cancellation. The predictive accuracy of each marker alone and the formula combining the 4 markers were determined by area under the receiver operating characteristic curve (AU-ROC). Additionally, we examined the cutoff values and false-positive rates (FPRs) for predicting POR at detection rates of 50% and 80%.
   RESULTS: Of the 141 women we evaluated, 45 had POR. The AU-ROC of the combined parameters (0.82) was significantly higher than that for the individual parameters: age=0.67, AFC=0.74, AMH=0.75, and FSH=0.61. For a detection rate of 50%, the formula had FPR=10%, while the individual markers had FPR=13-24%; for a detection rate of 80%, the formula had FPR=27%, while the individual markers had FPR=42-72%.
   CONCLUSION: Combining age, AMH, AFC, and FSH is significantly more accurate than those individual markers for the prediction of POR.
C1 Univ Sao Paulo FMRP USP, Dept Obstet & Gynecol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   Univ Ribeirao Preto UNAERP, Med Course, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), HCRP, Av Bandeirantes,3900-8 Andar,Campus Univ, BR-14048900 Ribeirao Preto, SP, Brazil.
EM wpmartins@gmail.com
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX Supported by Brazilian official centers CNPq and FAPESP. These
   institutions had no influence on the study design, interpretation of
   data, or the decision to publish the results.
CR Balaban B, 2011, HUM REPROD, V26, pI24
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Melo MAB, 2009, FERTIL STERIL, V91, P148, DOI 10.1016/j.fertnstert.2007.11.042
   Biljan MM, 2000, HUM REPROD, V15, P2140, DOI 10.1093/humrep/15.10.2140
   Broekmans FJM, 2010, FERTIL STERIL, V94, P1044, DOI 10.1016/j.fertnstert.2009.04.040
   Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034
   Neto MAC, 2015, ULTRASOUND OBST GYN, V46, P501, DOI 10.1002/uog.14884
   De Sutter P, 2003, FERTIL STERIL, V79, P1294, DOI 10.1016/S0015-0282(03)00264-4
   Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092
   Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019
   Figueiredo JBP, 2013, ARCH GYNECOL OBSTET, V287, P779, DOI 10.1007/s00404-012-2672-0
   Frazier LM, 2004, FERTIL STERIL, V82, P834, DOI 10.1016/j.fertnstert.2004.02.144
   Gonzalez-Comadran M, 2012, REPROD BIOMED ONLINE, V25, P450, DOI 10.1016/j.rbmo.2012.07.011
   Hendriks DJ, 2008, REPROD BIOMED ONLINE, V17, P727, DOI 10.1016/S1472-6483(10)60323-9
   Jayaprakasan K, 2010, FERTIL STERIL, V94, P1775, DOI 10.1016/j.fertnstert.2009.10.022
   Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042
   Kim Chung-Hoon, 2014, Dev Reprod, V18, P145, DOI 10.12717/DR.2014.18.3.145
   La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037
   Lima ML, 2015, ULTRASOUND OBST GYN, V46, P239, DOI 10.1002/uog.14763
   Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017
   Martins WP, 2014, ULTRASOUND OBST GYN, V44, P131, DOI 10.1002/uog.13402
   Martins WP, 2014, ULTRASOUND OBST GYN, V43, P25, DOI 10.1002/uog.12566
   McIlveen M, 2007, HUM REPROD, V22, P778, DOI 10.1093/humrep/del435
   Moolenaar LM, 2013, REPROD BIOMED ONLINE, V27, P362, DOI 10.1016/j.rbmo.2013.07.004
   Mutlu MF, 2013, J ASSIST REPROD GEN, V30, P657, DOI 10.1007/s10815-013-9975-3
   Nastri CO, 2015, ULTRASOUND OBST GYN, V45, P377, DOI 10.1002/uog.14684
   Nelson SM, 2015, FERTIL STERIL, V103, P923, DOI 10.1016/j.fertnstert.2014.12.114
   Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051
   Oliveira JBA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-94
   Penarrubia J, 2005, HUM REPROD, V20, P622, DOI 10.1093/humrep/deh674
   Riddle DL, 1999, PHYS THER, V79, P939, DOI 10.1093/ptj/79.10.939
   Simoni M, 2002, HUM REPROD UPDATE, V8, P413, DOI 10.1093/humupd/8.5.413
   Stern JE, 2013, J ASSIST REPROD GEN, V30, P1445, DOI 10.1007/s10815-013-0092-0
   Teixeira DM, 2014, HUM REPROD UPDATE, V20, P614, DOI 10.1093/humupd/dmu013
   Tutuncu Levent, 2012, Ginekol Pol, V83, P111
   Vrontikis A, 2010, J ASSIST REPROD GEN, V27, P383, DOI 10.1007/s10815-010-9421-8
NR 36
TC 0
Z9 0
U1 0
U2 3
PU SCI PRINTERS & PUBL INC
PI ST LOUIS
PA PO DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA
SN 0024-7758
EI 1943-3565
J9 J REPROD MED
JI J. Reprod. Med.
PD SEP-OCT
PY 2018
VL 63
IS 9-10
BP 461
EP 466
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GX3EO
UT WOS:000447604600010
DA 2020-12-17
ER

PT J
AU Viana, I
   Vireque, A
   Navarro, P
AF Viana, I.
   Vireque, A.
   Navarro, P.
TI Lipid and antioxidant supplements improve cryotolerance and embryonic
   quality of Metaphase II mouse oocytes undergoing vitrification
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 34th Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUN 01-04, 2018
CL Barcelona, SPAIN
SP European Soc Human Reprod & Embryol
C1 [Viana, I.; Navarro, P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ginecol & Obstet, Ribeirao Preto, Brazil.
   [Viana, I.] Semear Fertilidade, Ribeirao Preto, Brazil.
   [Vireque, A.] Invitra Assisted Reprod Technol LTDA, Pesquisa & Desenvolvimento, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; Vireque, Alessandra/G-2208-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2018
VL 33
SU 1
MA P-224
BP 244
EP 244
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GM8WX
UT WOS:000438519901117
DA 2020-12-17
ER

PT J
AU Malvezzi, H
   Da Broi, MG
   Meola, J
   Rosa-e-Silva, JC
   Ferriani, RA
   Navarro, PA
AF Malvezzi, Helena
   Da Broi, Michele Gomes
   Meola, Juliana
   Rosa-e-Silva, Julio Cesar
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Peritoneal fluid of women with endometriosis reduces SOD1 in bovine
   oocytes in vitro maturation
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Endometriosis; Peritoneal fluid; Antioxidant; Superoxide dismutase
ID OXIDATIVE STRESS; INFERTILE WOMEN; FOLLICULAR-FLUID; MINIMAL/MILD
   ENDOMETRIOSIS; GENE-EXPRESSION; CELLS; DAMAGE; FERTILIZATION;
   PATHOGENESIS; SPINDLE
AB Studies have demonstrated oxidative stress in peritoneal fluid (PF) from women with endometriosis and the importance of enzymatic antioxidant machinery to avoid oocyte oxidative damage. Considering that PF constantly surrounds the ovaries and has direct contact with the oocyte at ovulation, we wonder if PF from women with endometriosis may affect antioxidant enzyme gene expression. Thus, the present study aims to evaluate the PF impact from infertile women with minimal and mild endometriosis and from fertile control women without endometriosis on SOD1, CAT, GSR gene's expression in experimental bovine oocytes matured in vitro. Samples of PF were obtained from women who underwent videolaparoscopy-7 infertile with EI/II and 7 fertile without endometriosis. Immature bovine oocytes underwent in vitro maturation in the absence of PF and in the presence of three concentrations (1, 5 and 10%) of PF from fertile and from infertile women with EI/II. After 22 to 24 h of IVM, oocytes were denuded and stored for analysis of SOD1, CAT and GSR by real-time polymerase chain reaction. Oocyte SOD1 expression was significantly lower in the 10% endometriosis group (0.67 +/- 0.32) when compared with no-peritoneal fluid (1.05 +/- 0.24, p < 0.008) and 10% control groups (1.06 +/- 0.22, p < 0.006). These findings raise the possibility of a deleterious influence of PF from women with EI/II on the oocyte, not only after ovulation but also during the maturation process, which could contribute to worsening oocyte quality, being one of the mechanisms related to infertility in patients with endometriosis.
C1 [Malvezzi, Helena; Da Broi, Michele Gomes; Meola, Juliana; Rosa-e-Silva, Julio Cesar; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Ferriani, Rui Alberto; Navarro, Paula Andrea] CNPq, Natl Inst Hormones & Womens Hlth, Porto Alegre, RS, Brazil.
RP Malvezzi, H (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM helenamalvezzi@gmail.com; michi.dabroi@gmail.com; jumeola@yahoo.com.br;
   juliocrs@usp.br; raferria@fmrp.usp.br; pnavarro@fmrp.usp.br
RI Lovato, Juliana Meola/E-3440-2012; Da Broi, Michele G/E-7753-2012;
   Navarro, Paula/G-2744-2012; Malvezzi, Helena/Z-1100-2019
OI Lovato, Juliana Meola/0000-0003-2514-4011; Da Broi, Michele
   G/0000-0003-4256-0228; Malvezzi, Helena/0000-0002-5504-6116; Navarro,
   Paula Andrea/0000-0003-2368-4188
FU National Council for Scientific and Technological Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq), Brazil.
CR Acien P, 2013, ISRN OBSTET GYNECOL, V2013, P12, DOI DOI 10.1155/2013/242149
   Adona PR, 2004, ZYGOTE, V12, P197, DOI 10.1017/S0967199404002771
   Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Albertini David F, 2003, Reprod Biomed Online, V6, P410
   Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1
   Alizadeh M, 2015, CASP J INTERN MED, V6, P25
   Andrade Aline Zyman de, 2010, Rev. Bras. Ginecol. Obstet., V32, P279, DOI 10.1590/S0100-72032010000600005
   Barckmann B, 2013, BBA-GENE REGUL MECH, V1829, P714, DOI 10.1016/j.bbagrm.2012.12.011
   Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333
   Braza-Boils A, 2015, HUM REPROD, V30, P2292, DOI 10.1093/humrep/dev204
   Bricou A, 2008, EUR J OBSTET GYN R B, V138, P127, DOI 10.1016/j.ejogrb.2008.01.014
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Bungum HF, 2016, J REPROD IMMUNOL, V114, P6, DOI 10.1016/j.jri.2016.01.003
   Canis M, 1997, FERTIL STERIL, V67, P817
   Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2016, CELL TISSUE RES, V366, P231, DOI 10.1007/s00441-016-2428-4
   Da Broi MG, 2016, CELL TISSUE RES, V364, P1, DOI 10.1007/s00441-015-2339-9
   Ding GL, 2010, FERTIL STERIL, V93, P2538, DOI 10.1016/j.fertnstert.2009.11.011
   Donabela FC, 2015, REPROD SCI, V22, P1452, DOI 10.1177/1933719115585146
   Donnez J, 2016, FERTIL STERIL, V106, P1011, DOI 10.1016/j.fertnstert.2016.07.1075
   Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457
   Ferreira EM, 2009, EUR J OBSTET GYN R B, V145, P76, DOI 10.1016/j.ejogrb.2009.03.016
   Fuldeore M, 2015, FERTIL STERIL, V103, P163, DOI 10.1016/j.fertnstert.2014.10.011
   Jianini BTGM, 2017, REPROD SCI, V24, P1304, DOI 10.1177/1933719116687658
   Giorgi VSI, 2016, REPROD SCI, V23, P342, DOI 10.1177/1933719115602772
   Gomes FM, 2008, EUR J OBSTET GYN R B, V138, P60, DOI 10.1016/j.ejogrb.2007.12.008
   Gomez-Torres MJ, 2002, HUM REPROD, V17, P777, DOI 10.1093/humrep/17.3.777
   Harlev A, 2015, EXPERT OPIN THER TAR, V19, P1447, DOI 10.1517/14728222.2015.1077226
   Hashimoto S, 2002, BIOL REPROD, V66, P1696, DOI 10.1095/biolreprod66.6.1696
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Leonardi M, 2016, FERTIL STERIL, V106, P386, DOI 10.1016/j.fertnstert.2016.03.047
   Lonergan P, 2016, ANNU REV ANIM BIOSCI, V4, P255, DOI 10.1146/annurev-animal-022114-110822
   Ma CH, 2010, FERTIL STERIL, V93, P920, DOI 10.1016/j.fertnstert.2009.01.131
   Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Moussa M, 2015, ANIM REPROD SCI, V155, P11, DOI 10.1016/j.anireprosci.2015.01.011
   Nandi S, 2017, THERIOGENOLOGY, V104, P80, DOI 10.1016/j.theriogenology.2017.07.024
   Nasiri N, 2017, CELL J, V18, P582
   Navarro PA, 2014, REPROD E CLIMATERIO, V29, P112
   Nesbitt-Hawes EM, 2015, REPROD SURG ASSIST C, V86, P29
   Carvalho LFP, 2012, ARCH GYNECOL OBSTET, V286, P1033, DOI 10.1007/s00404-012-2439-7
   Polak G, 2013, EUR J OBSTET GYN R B, V168, P187, DOI 10.1016/j.ejogrb.2012.12.043
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Stochino-Loi E, 2017, FERTIL STERIL, V107, P707, DOI [10.1016/j.fertnstert.2016.12.013, 10.1016/.fertnstert.2016.12.013]
   Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8
   Wang X, 2002, FERTIL STERIL, V78, P1272, DOI 10.1016/S0015-0282(02)04236-X
   Wingfield M, 2000, MINIMAL MILD ENDOME, V2, P21
   Young VJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16859
   Young VJ, 2013, HUM REPROD UPDATE, V19, P558, DOI 10.1093/humupd/dmt024
   Yuan Y, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099952
NR 56
TC 5
Z9 6
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD JUN
PY 2018
VL 372
IS 3
BP 621
EP 628
DI 10.1007/s00441-018-2805-2
PG 8
WC Cell Biology
SC Cell Biology
GA GF6WN
UT WOS:000432109000013
PM 29464366
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Giorgi, VSI
   Wang, F
   Keefe, DL
   Albertini, D
   Navarro, PA
AF Da Broi, M. G.
   Giorgi, V. S. I.
   Wang, F.
   Keefe, D. L.
   Albertini, D.
   Navarro, P. A.
TI Influence of follicular fluid and cumulus cells on oocyte quality:
   clinical implications
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Review
DE Oocyte; Follicular fluid; Cumulus cells; Developmental competence
ID IN-VITRO-FERTILIZATION; POLYCYSTIC-OVARY-SYNDROME; BONE MORPHOGENETIC
   PROTEIN-15; PERIFOLLICULAR BLOOD-FLOW; PREIMPLANTATION EMBRYO QUALITY;
   HYALURONIC-ACID SYNTHESIS; ENDOTHELIAL GROWTH-FACTOR; BOVINE
   GRANULOSA-CELLS; KIT-LIGAND EXPRESSION; NECROSIS-FACTOR-ALPHA
AB An equilibrium needs to be established by the cellular and acellular components of the ovarian follicle if developmental competence is to be acquired by the oocyte. Both cumulus cells (CCs) and follicular fluid (FF) are critical determinants for oocyte quality. Understanding how CCs and FF influence oocyte quality in the presence of deleterious systemic or pelvic conditions may impact clinical decisions in the course of managing infertility. Given that the functional integrities of FF and CCs are susceptible to concurrent pathological conditions, it is important to understand how pathophysiological factors influence natural fertility and the outcomes of pregnancy arising from the use of assisted reproduction technologies (ARTs). Accordingly, this review discusses the roles of CCs and FF in ensuring oocyte competence and present new insights on pathological conditions that may interfere with oocyte quality by altering the intrafollicular environment.
C1 [Da Broi, M. G.; Giorgi, V. S. I.; Navarro, P. A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Div Human Reprod, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Wang, F.; Keefe, D. L.] NYU, Dept Obstet & Gynecol, Lab Reprod Med, Sch Med, 180 Varick St, New York, NY 10014 USA.
   [Keefe, D. L.] NYU, Dept Obstet & Gynecol, Langone Med Ctr, New York, NY 10016 USA.
   [Albertini, D.] Ctr Human Reprod, New York, NY USA.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Div Human Reprod, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM david.keefe@nyumc.org; dalbertini@thechr.com; pnavarro@fmrp.usp.br
RI Navarro, Paula/G-2744-2012; Da Broi, Michele G/E-7753-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU Foundation for Research Support of the State of Sao Paulo (FAPESP,
   Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2015/21907-0]
FX This work was supported in part by a scholarship the Foundation for
   Research Support of the State of Sao Paulo (FAPESP, grant number
   2015/21907-0, Brazil) to PAN.
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088
   Akiyama I, 2014, REPROD SCI, V21, P477, DOI 10.1177/1933719113503411
   Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647
   Altun T, 2011, J ASSIST REPROD GEN, V28, P245, DOI 10.1007/s10815-010-9502-8
   Ambekar AS, 2013, J PROTEOMICS, V87, P68, DOI 10.1016/j.jprot.2013.05.017
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barcelos IDES, 2015, REPROD BIOMED ONLINE, V30, P532, DOI 10.1016/j.rbmo.2015.01.012
   Beckers NGM, 2002, FERTIL STERIL, V78, P291, DOI 10.1016/S0015-0282(02)03227-2
   Bedaiwy MA, 2012, GYNECOL ENDOCRINOL, V28, P51, DOI 10.3109/09513590.2011.579652
   Bellver J, 2006, REPROD BIOMED ONLINE, V12, P562, DOI 10.1016/S1472-6483(10)61181-9
   Berisha B, 2000, J ENDOCRINOL, V167, P371, DOI 10.1677/joe.0.1670371
   Boots CE, 2016, HUM REPROD, V31, P2090, DOI 10.1093/humrep/dew181
   Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200
   Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568
   Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004
   Bromfield JJ, 2015, J ANIM SCI, V93, P2021, DOI 10.2527/jas.2014-8496
   Bromfield JJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106914
   Bromfield JJ, 2011, ENDOCRINOLOGY, V152, P5029, DOI 10.1210/en.2011-1124
   BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F
   Buratini J, 2011, REPROD FERT DEVELOP, V23, P32, DOI 10.1071/RD10224
   Busnelli A, 2015, HUM REPROD, V30, P315, DOI 10.1093/humrep/deu319
   Butzow TL, 2000, J CLIN ENDOCR METAB, V85, P3271, DOI 10.1210/jc.85.9.3271
   Cano F, 1997, J ASSIST REPROD GEN, V14, P254, DOI 10.1007/BF02765826
   Carneiro LC, 2016, REPROD BIOL, V16, P1, DOI 10.1016/j.repbio.2015.12.002
   Cetica P, 2002, REPRODUCTION, V124, P675, DOI 10.1530/reprod/124.5.675
   Chang HM, 2014, MOL HUM REPROD, V20, P373, DOI 10.1093/molehr/gau001
   Chattopadhayay R, 2010, GYNECOL OBSTET INVES, V69, P197, DOI 10.1159/000270900
   Cheng EH, 2013, HUM REPROD, V28, P929, DOI 10.1093/humrep/det004
   Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067
   Colton SA, 2003, BIOL REPROD, V69, P761, DOI 10.1095/biolreprod.102.013649
   Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011
   Coulam CB, 1999, HUM REPROD, V14, P1979, DOI 10.1093/humrep/14.8.1979
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2016, CELL TISSUE RES, V366, P231, DOI 10.1007/s00441-016-2428-4
   da Silveira JC, 2015, REPROD SCI, V22, P1474, DOI 10.1177/1933719115574344
   de Andrade AZ, 2010, REV BRAS GINECOL OBS, V32, P279, DOI 10.1590/S0100-72032010000600005
   de Boer EJ, 2002, FERTIL STERIL, V77, P978, DOI 10.1016/S0015-0282(02)02972-2
   Deady LD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004989
   Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224
   Diez-Fraile A, 2014, HUM FERTIL, V17, P90, DOI 10.3109/14647273.2014.897006
   Donabela FC, 2015, REPROD SCI, V22, P1452, DOI 10.1177/1933719115585146
   Donnez J, 2016, FERTIL STERIL, V106, P1011, DOI 10.1016/j.fertnstert.2016.07.1075
   Downs SM, 1998, BIOL REPROD, V58, P1084, DOI 10.1095/biolreprod58.4.1084
   Downs SM, 1999, BIOL REPROD, V60, P1446, DOI 10.1095/biolreprod60.6.1446
   Dumesic DA, 2008, SEMIN REPROD MED, V26, P53, DOI 10.1055/s-2007-992925
   Dumesic DA, 2015, FERTIL STERIL, V103, P303, DOI 10.1016/j.fertnstert.2014.11.015
   EDWARDS RG, 1974, J REPROD FERTIL, V37, P189, DOI 10.1530/jrf.0.0370189
   Eichenlaub-Ritter U, 2011, MITOCHONDRION, V11, P783, DOI 10.1016/j.mito.2010.08.011
   Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018
   EMONARD H, 1990, CELL MOL BIOL, V36, P131
   Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829
   EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175
   Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092
   FitzHarris G, 2007, DEVELOPMENT, V134, P4283, DOI 10.1242/dev.005272
   Foong SC, 2006, J CLIN ENDOCR METAB, V91, P2327, DOI 10.1210/jc.2005-2142
   Franks S, 2000, MOL CELL ENDOCRINOL, V163, P49, DOI 10.1016/S0303-7207(99)00239-7
   Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43
   Gaafar TM, 2014, IMMUNOL INVEST, V43, P572, DOI 10.3109/08820139.2014.901974
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Ge L, 2008, FERTIL STERIL, V90, P2376, DOI 10.1016/j.fertnstert.2007.10.054
   Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040
   Giorgi VSI, 2016, REPROD SCI, V23, P342, DOI 10.1177/1933719115602772
   Gittens JEI, 2005, J CELL SCI, V118, P113, DOI 10.1242/jcs.01587
   Gode F, 2011, FERTIL STERIL, V95, P2274, DOI 10.1016/j.fertnstert.2011.03.045
   Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121
   Gueripel X, 2006, BIOL REPROD, V75, P836, DOI 10.1095/biolreprod.106.055574
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Halis G, 2004, ANN NY ACAD SCI, V1034, P300, DOI 10.1196/annals.1335.032
   Hashimoto S, 2000, MOL REPROD DEV, V56, P520, DOI 10.1002/1098-2795(200008)56:4&lt;520::AID-MRD10&gt;3.0.CO;2-0
   Hennet ML, 2012, INT J DEV BIOL, V56, P819, DOI 10.1387/ijdb.120133cc
   Herath S, 2007, REPRODUCTION, V134, P683, DOI 10.1530/REP-07-0229
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   Huang X, 2016, REPRODUCTION, V151, P643, DOI 10.1530/REP-16-0071
   Huang X, 2016, J ASSIST REPROD GEN, V33, P111, DOI 10.1007/s10815-015-0630-z
   Huang X, 2013, REPRODUCTION, V145, P597, DOI 10.1530/REP-13-0005
   Huey S, 1999, FERTIL STERIL, V72, P707, DOI 10.1016/S0015-0282(99)00327-1
   HURWITZ A, 1991, ENDOCRINOLOGY, V129, P3427, DOI 10.1210/endo-129-6-3427
   Ibrahim LA, 2016, REPRODUCTION, V152, P261, DOI 10.1530/REP-15-0573
   Jablonka-Shariff A, 1998, ENDOCRINOLOGY, V139, P2944, DOI 10.1210/en.139.6.2944
   Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437
   Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154
   Karagouni E, 1998, FERTIL STERIL, V70, P553, DOI 10.1016/S0015-0282(98)00243-X
   Keay SD, 1998, FERTIL STERIL, V70, P214, DOI 10.1016/S0015-0282(98)00145-9
   Kedem A, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0113-3
   Keefe D, 2015, FERTIL STERIL, V103, P317, DOI 10.1016/j.fertnstert.2014.12.115
   Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/Y10-009, 10.1139/y10-009]
   Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613
   Kwon H, 2010, FERTIL STERIL, V94, P2417, DOI 10.1016/j.fertnstert.2010.03.053
   Lawson R, 2003, HUM REPROD, V18, P527, DOI 10.1093/humrep/deg101
   Lee KS, 2001, J ASSIST REPROD GEN, V18, P490, DOI 10.1023/A:1016649026353
   Lee KS, 2000, J ASSIST REPROD GEN, V17, P222, DOI 10.1023/A:1009495913119
   Lee MS, 2010, J ASSIST REPROD GEN, V27, P629, DOI 10.1007/s10815-010-9459-7
   Liu NN, 2012, ENDOCRINE, V42, P708, DOI 10.1007/s12020-012-9706-z
   Liu SY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0605-y
   Liu ZT, 2016, GYNECOL ENDOCRINOL, V32, P557, DOI 10.3109/09513590.2016.1138463
   Lolicato F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.120634
   Luke B, 2011, HUM REPROD, V26, P245, DOI 10.1093/humrep/deq306
   Machtinger R, 2012, HUM REPROD, V27, P3198, DOI 10.1093/humrep/des308
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Moreno JM, 2015, FERTIL STERIL, V104, P1037, DOI 10.1016/j.fertnstert.2015.07.001
   Moreno-Moya JM, 2014, FERTIL STERIL, V101, P1516, DOI 10.1016/j.fertnstert.2013.10.042
   Marquard KL, 2011, FERTIL STERIL, V95, P2146, DOI 10.1016/j.fertnstert.2010.10.026
   Mauro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095910
   McConnell NA, 2002, ENDOCRINOLOGY, V143, P2905, DOI 10.1210/en.143.8.2905
   McNatty KP, 2005, REPRODUCTION, V129, P481, DOI 10.1530/rep.1.00517
   McReynolds S, 2012, FERTIL STERIL, V98, P1574, DOI 10.1016/j.fertnstert.2012.08.012
   Meldrum DR, 2016, FERTIL STERIL, V105, P548, DOI 10.1016/j.fertnstert.2016.01.013
   Mitsube K, 2013, FERTIL STERIL, V99, P903, DOI 10.1016/j.fertnstert.2012.11.017
   Miyoshi T, 2012, MOL CELL ENDOCRINOL, V358, P18, DOI 10.1016/j.mce.2012.02.011
   Molinari E, 2016, MOL HUM REPROD, V22, P566, DOI 10.1093/molehr/gaw038
   MOLLOY D, 1987, FERTIL STERIL, V47, P450
   Monniaux D, 2016, THERIOGENOLOGY, V86, P41, DOI 10.1016/j.theriogenology.2016.04.017
   Monteleone P, 2008, J ASSIST REPROD GEN, V25, P183, DOI 10.1007/s10815-008-9218-1
   Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200
   MURDOCH WJ, 1983, BIOL REPROD, V28, P1001, DOI 10.1095/biolreprod28.4.1001
   Murphy AA, 1998, J CLIN ENDOCR METAB, V83, P2110, DOI 10.1210/jc.83.6.2110
   Nargund G, 1996, HUM REPROD, V11, P2512
   Nargund G, 1996, HUM REPROD, V11, P109
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Neuer A, 1997, HUM REPROD, V12, P925
   Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899
   Pacella L, 2012, FERTIL STERIL, V98, P986, DOI 10.1016/j.fertnstert.2012.06.025
   Paczkowski M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108548
   Palini S, 2014, REPROD BIOMED ONLINE, V29, P65, DOI 10.1016/j.rbmo.2014.03.010
   Pancarci SM, 2012, ANIM REPROD SCI, V130, P9, DOI 10.1016/j.anireprosci.2011.12.013
   Pellicer A, 1998, FERTIL STERIL, V70, P425, DOI 10.1016/S0015-0282(98)00204-0
   Phy JL, 2004, J CLIN ENDOCR METAB, V89, P3561, DOI 10.1210/jc.2003-031888
   Carvalho LFP, 2012, ARCH GYNECOL OBSTET, V286, P1033, DOI 10.1007/s00404-012-2439-7
   Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665
   Pinto CRF, 2003, THERIOGENOLOGY, V60, P819, DOI 10.1016/S0093-691X(03)00096-7
   Polzikov M, 2012, J ASSIST REPROD GEN, V29, P1141, DOI 10.1007/s10815-012-9827-6
   Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Prescott J, 2016, HUM REPROD, V31, P1475, DOI 10.1093/humrep/dew085
   Price JC, 2013, ENDOCRINOLOGY, V154, P3377, DOI 10.1210/en.2013-1102
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Pruksananonda Kamthorn, 2016, Clin Exp Reprod Med, V43, P82, DOI 10.5653/cerm.2016.43.2.82
   Purcell SH, 2011, J ASSIST REPROD GEN, V28, P517, DOI 10.1007/s10815-011-9592-y
   Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495
   Robker RL, 2011, J REPROD IMMUNOL, V88, P142, DOI 10.1016/j.jri.2011.01.008
   Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648
   Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941
   Russell DL, 2016, THERIOGENOLOGY, V86, P62, DOI 10.1016/j.theriogenology.2016.04.019
   SAITO T, 1994, BIOL REPROD, V50, P266, DOI 10.1095/biolreprod50.2.266
   SALUSTRI A, 1990, J BIOL CHEM, V265, P19517
   SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G
   SEIBEL MM, 1989, J CLIN ENDOCR METAB, V68, P1073, DOI 10.1210/jcem-68-6-1073
   Shaeib F, 2016, REPROD SCI, V23, P498, DOI 10.1177/1933719115607993
   Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007
   Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108
   Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Singh AK, 2016, J ASSIST REPROD GEN, V33, P1363, DOI 10.1007/s10815-016-0782-5
   Siu MKY, 2013, ADV EXP MED BIOL, V763, P186
   Skowronski MT, 2009, J HISTOCHEM CYTOCHEM, V57, P61, DOI 10.1369/jhc.2008.952499
   Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068
   Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008
   Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020
   Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882
   Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Szmidt NAK, 2016, HUM FERTIL, V19, P212, DOI 10.1080/14647273.2016.1221149
   Takeo S, 2017, REPROD FERT DEVELOP, V29, P759, DOI 10.1071/RD15228
   Tamanini C, 2004, REPROD DOMEST ANIM, V39, P206, DOI 10.1111/j.1439-0531.2004.00505.x
   Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102
   Tarin JJ, 1996, MOL HUM REPROD, V2, P895, DOI 10.1093/molehr/2.12.895
   Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805
   Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41
   Thomas FH, 2005, ENDOCRINOLOGY, V146, P941, DOI 10.1210/en.2004-0826
   Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19
   Uri-Belapolsky S, 2017, MOL REPROD DEV, V84, P460, DOI 10.1002/mrd.22799
   Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154
   Von Wald T, 2010, FERTIL STERIL, V93, P2354, DOI 10.1016/j.fertnstert.2008.12.129
   von Wolff M, 2014, HUM REPROD, V29, P1049, DOI 10.1093/humrep/deu044
   Vujisic S, 2006, HUM REPROD, V21, P2650, DOI 10.1093/humrep/del217
   Vural F, 2016, J ASSIST REPROD GEN, V33, P1355, DOI 10.1007/s10815-016-0780-7
   Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015901
   Wdowiak A, 2015, GYNECOL OBSTET FERTI, V43, P515, DOI 10.1016/j.gyobfe.2015.06.004
   Wigglesworth K, 2013, P NATL ACAD SCI USA, V110, pE3723, DOI 10.1073/pnas.1314829110
   Williams CJ, 2000, ENDOTEXT
   Winterhager E, 2015, HUM REPROD UPDATE, V21, P340, DOI 10.1093/humupd/dmv007
   Wissing ML, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0110-6
   Wu LL, 2015, DEVELOPMENT, V142, P681, DOI 10.1242/dev.114850
   Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551
   Wu YT, 2007, HUM REPROD, V22, P1526, DOI 10.1093/humrep/dem029
   Yang R, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0203-8
   Yang WJ, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0099-8
   Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103
   Zhang DD, 2015, J ASSIST REPROD GEN, V32, P1069, DOI 10.1007/s10815-015-0483-5
   Zhang GM, 2013, THERIOGENOLOGY, V80, P328, DOI 10.1016/j.theriogenology.2013.04.019
   Zhao HC, 2015, FREE RADICAL BIO MED, V86, P295, DOI 10.1016/j.freeradbiomed.2015.05.013
NR 192
TC 35
Z9 35
U1 1
U2 11
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD MAY
PY 2018
VL 35
IS 5
BP 735
EP 751
DI 10.1007/s10815-018-1143-3
PG 17
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA GI1SX
UT WOS:000434152000002
PM 29497954
OA Green Published
DA 2020-12-17
ER

PT J
AU Alepuz, FJE
   Garcia, JA
   Sastriques, JVC
   Alcala, E
   Navarro, PA
AF Escriba Alepuz, Francisco J.
   Alonso Garcia, Javier
   Cuchillo Sastriques, J. Vicente
   Alcala, Emilio
   Argente Navarro, Pilar
TI Emergency Ventilation of Infant Subglottic Stenosis Through Small-Gauge
   Lumen Using the Ventrain: A Case Report
SO A & A PRACTICE
LA English
DT Article
ID TRANSTRACHEAL JET VENTILATION; UPPER AIRWAY; MANAGEMENT; CATHETER;
   MODEL; PIGS
AB Postintubation subglottic stenosis is one of the most common causes of stridor in newborns and babies after prolonged mechanical ventilation. Management of this pathology is complex and requires highly trained personnel because it is associated with a high rate of airway-related mortality. This article presents the rescue of a difficult airway in a pediatric patient with subglottic stenosis with a new device available on the market, the Ventrain, offering certain advantages over those available until now.
C1 [Escriba Alepuz, Francisco J.; Alonso Garcia, Javier; Cuchillo Sastriques, J. Vicente; Alcala, Emilio; Argente Navarro, Pilar] La Fe Univ Hosp & Polytech, Anesthesiol & Reanimat Serv, Valencia, Spain.
RP Alepuz, FJE (corresponding author), Hosp Univ & Politecn La Fe, Avinguda Fernando Abril Martorell 106, Valencia 46026, Spain.
EM escriba1982@gmail.com
CR Berry M, 2014, BRIT J ANAESTH, V113, P1039, DOI 10.1093/bja/aeu188
   de Wolf MWP, 2017, CAN J ANESTH, V64, P37, DOI 10.1007/s12630-016-0760-5
   Dugganh LV, 2016, BRIT J ANAESTH, V117, P28, DOI 10.1093/bja/aew192
   Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371
   Hamaekers AEW, 2012, BRIT J ANAESTH, V108, P1017, DOI 10.1093/bja/aes033
   Hamaekers AEW, 2009, ANAESTHESIA, V64, P1353, DOI 10.1111/j.1365-2044.2009.06083.x
   Hamaekers AE, 2015, ANESTH ANALG, V120, P890, DOI 10.1213/ANE.0000000000000584
   Jagannathani N, 2016, BRIT J ANAESTH, V117, P3, DOI 10.1093/bja/aew054
   Monnier P, 2011, PEDIATRIC AIRWAY SURGERY: MANAGEMENT OF LARYNGOTRACHEAL STENOSIS IN INFANTS AND CHILDREN, P183, DOI 10.1007/978-3-642-13535-4_14
   Noppens RR, 2015, BRIT J ANAESTH, V115, P168, DOI 10.1093/bja/aev253
   Paxian M, 2015, BRIT J ANAESTH, V115, P308, DOI 10.1093/bja/aev200
   Rodriguez H, 2013, ACTA OTORRINOLAR ESP, V64, P339, DOI [10.1016/j.otoeng.2013.10.005, 10.1016/j.otorri.2013.03.006]
   Ross-Anderson DJ, 2011, BRIT J ANAESTH, V106, P140, DOI 10.1093/bja/aeq278
   Willemsen MGA, 2014, BRIT J ANAESTH, V112, P946, DOI 10.1093/bja/aeu125
NR 14
TC 10
Z9 10
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2325-7237
J9 A A PRACT
JI A A Pract.
PD MAR 15
PY 2018
VL 10
IS 6
BP 136
EP 138
DI 10.1213/XAA.0000000000000657
PG 3
WC Anesthesiology
SC Anesthesiology
GA FZ3PT
UT WOS:000427502600003
PM 29068802
OA Green Published
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Jordao, AA
   Ferriani, RA
   Navarro, PA
AF Da Broi, Michele G.
   Jordao-, Alceu A., Jr.
   Ferriani, Rui A.
   Navarro, Paula A.
TI Oocyte oxidative DNA damage may be involved in minimal/mild
   endometriosis-related infertility
SO MOLECULAR REPRODUCTION AND DEVELOPMENT
LA English
DT Article
DE 8-hydroxy-2-deoxyguanosine; early endometriosis; follicular fluid;
   oxidative stress
ID FOLLICULAR-FLUID; MILD ENDOMETRIOSIS; VITAMIN-E; ASSISTED REPRODUCTION;
   STRESS MARKERS; WOMEN; SERUM; GLUTATHIONE; IMPACT;
   8-HYDROXY-2'-DEOXYGUANOSINE
AB Early endometriosis is associated with infertility, and oxidative stress may play a role in the pathogenesis of disease-related infertility. This prospective case-control study aimed to compare the presence of oxidative stress markers in the follicular microenvironment and systemic circulation of infertile women with minimal/mild endometriosis (EI/II) versus individuals undergoing controlled ovarian stimulation for intracytoplasmic sperm injection (ICSI). Seventy-one blood samples (27 from infertile women with EI/II and 44 controls with tubal and/or male infertility factor) and 51 follicular fluid samples (19 EI/II and 32 controls) were obtained on the day of oocyte retrieval. Total hydroperoxides (FOX1), reduced glutathione, vitamin E, Superoxide dismutase, total antioxidant capacity, malondialdehyde, advanced oxidation protein products, and 8-hydroxy-2-deoxyguanosine (8OHdG) concentrations were measured in both fluids. Women with EI/II showed higher FOX1 (8.48 +/- 1.72 vs. 7.69 +/- 1.71mol/g protein) and lower total antioxidant capacity (0.38 +/- 0.18 vs. 0.46 +/- 0.15mEq Trolox/L) concentrations in serum, and higher 8OHdG concentrations (24.21 +/- 8.56 vs. 17.22 +/- 5.6ng/ml) in follicular fluid compared with controls. These data implicate both systemic and follicular oxidative stress may in infertile women with EI/II undergoing controlled ovarian stimulation for ICSI. Furthermore, the elevated 8OHdG concentrations in follicular fluid of women with EI/II may be related to compromised oocyte quality.
C1 [Da Broi, Michele G.; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, Sao Paulo, Brazil.
   [Jordao-, Alceu A., Jr.] Univ Sao Paulo, Ribeirao Preto Sch Med, Nutr & Metab Lab, Sao Paulo, Brazil.
   [Ferriani, Rui A.; Navarro, Paula A.] CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
RP Da Broi, MG (corresponding author), Ave Bandeirantes, BR-14049900 Sao Paulo, Brazil.
EM michi.dabroi@gmail.com
RI Navarro, Paula/G-2744-2012; Da Broi, Michele G/E-7753-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188; /0000-0003-1288-0802
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq) [309056/2009-8, 474858/2009-0, 503867/2010-1]; Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo-FAPESP (Brazil)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56373-1, 2008/58197-6,
   2014/15866-6]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   (Brazil), Grant numbers: 309056/2009-8, 474858/2009-0, 503867/2010-1;
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Brazil),
   Grant numbers: 2008/56373-1, 2008/58197-6, 2014/15866-6
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   ARNAUD J, 1991, J CHROMATOGR-BIOMED, V572, P103, DOI 10.1016/0378-4347(91)80476-S
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Bordin L, 2010, FERTIL STERIL, V94, P1616, DOI 10.1016/j.fertnstert.2009.10.038
   Canis M, 1997, FERTIL STERIL, V67, P817
   Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067
   Choi YS, 2015, REPRODUCTION, V149, P155, DOI 10.1530/REP-14-0438
   Costa CM, 2006, J BRAS PATOL MED LAB, V42, P5
   D'Hooghe TM, 2003, SEMIN REPROD MED, V21, P243
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2016, CELL TISSUE RES, V366, P231, DOI 10.1007/s00441-016-2428-4
   de Andrade AZ, 2010, REV BRAS GINECOL OBS, V32, P279, DOI 10.1590/S0100-72032010000600005
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686
   Giorgi VSI, 2016, REPROD SCI, V23, P342, DOI 10.1177/1933719115602772
   Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Gupta S, 2006, REPROD BIOMED ONLINE, V13, P349, DOI 10.1016/S1472-6483(10)61439-3
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   HU ML, 1994, METHOD ENZYMOL, V233, P380
   Jana SK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/329058
   Jarkovska K, 2010, J PROTEOME RES, V9, P1289, DOI 10.1021/pr900802u
   Lambrinoudaki IV, 2009, FERTIL STERIL, V91, P46, DOI 10.1016/j.fertnstert.2007.11.021
   Levay PE, 1997, J ASSIST REPROD GEN, V14, P212, DOI 10.1007/BF02766112
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   MEISTER A, 1983, BIOCHEM SOC T, V11, P793, DOI 10.1042/bst0110793
   Mier-Cabrera J, 2008, INT J GYNECOL OBSTET, V100, P252, DOI 10.1016/j.ijgo.2007.08.018
   Nwose EU, 2008, MED HYPOTHESES, V70, P1002, DOI 10.1016/j.mehy.2007.07.048
   Parazzini F, 1999, HUM REPROD, V14, P1332
   Pellicer A, 1995, HUM REPROD, V10, P91, DOI 10.1093/humrep/10.suppl_2.91
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011
   Seino T, 2002, FERTIL STERIL, V77, P1184, DOI 10.1016/S0015-0282(02)03103-5
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Sova H, 2012, ANTICANCER RES, V32, P3037
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X
   Tatemoto H, 2004, BIOL REPROD, V71, P1150, DOI 10.1095/biolreprod.104.029264
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
NR 44
TC 11
Z9 13
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1040-452X
EI 1098-2795
J9 MOL REPROD DEV
JI Mol. Reprod. Dev.
PD FEB
PY 2018
VL 85
IS 2
BP 128
EP 136
DI 10.1002/mrd.22943
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Developmental Biology;
   Reproductive Biology
SC Biochemistry & Molecular Biology; Cell Biology; Developmental Biology;
   Reproductive Biology
GA FW9EQ
UT WOS:000425638900005
PM 29247565
DA 2020-12-17
ER

PT J
AU Sicchieri, F
   Silva, AB
   Silva, ACJDRE
   Navarro, PADS
   Ferriani, RA
   dos Reis, RM
AF Sicchieri, Fernanda
   Silva, Aline Bomfim
   Japur de Sa Rosa e Silva, Ana Carolina
   de Albuquerque Sales Navarro, Paula Andrea
   Ferriani, Rui Alberto
   dos Reis, Rosana Maria
TI Prognostic factors in intrauterine insemination cycles
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Article
DE intrauterine insemination; sperm motility; pregnancy rate
ID ASSISTED REPRODUCTIVE TECHNOLOGY; MOTILE SPERM COUNT; PREDICTIVE
   FACTORS; PREGNANCY RATES; EUROPEAN REGISTERS; POOR RESPONDERS; SUCCESS;
   IUI; SEMEN; INFERTILITY
AB Objective: This study aimed to evaluate the clinical pregnancy rate of intrauterine insemination cycles in relation to patient age, cause of infertility, ovulation induction method, number of mature follicles and sperm with progressive motility.
   Methods: This retrospective observational study included 237 intrauterine insemination cycles performed from 2011 to 2015 at the Assisted Reproduction Service of the Hospital das Clinicas of the Ribeirao Preto Medical School, University of Sao Paulo. Student's t-test was used to compare quantitative variables and the chi-square test was used to compare qualitative variables.
   Results: Patient age was inversely and significantly correlated with pregnancy rates (p=0.001) (Pregnant women = 32.56 +/- 5.64 years, non-pregnant women = 36.64 +/- 5.03 years). Cause of infertility, ovulation induction method, number of mature follicles and sperm with progressive motility were not associated with pregnancy rates. The overall clinical pregnancy rate was 7.59%. In the subgroup of patients (n=102 cycles) considered ideal for intrauterine insemination (age <= 35 years, unexplained infertility, ovarian factor infertility or minimal endometriosis, and a partner with sperm count >= 2.5 x 10(6) retrieved on the day of insemination) the pregnancy rate was 12.74%.
   Conclusion: In the studied group, female patient age was the only variable significantly correlated with intrauterine insemination success rates.
C1 [Sicchieri, Fernanda; Silva, Aline Bomfim; Japur de Sa Rosa e Silva, Ana Carolina; de Albuquerque Sales Navarro, Paula Andrea; Ferriani, Rui Alberto; dos Reis, Rosana Maria] Univ Sao Paulo, Dept Gynecol & Obstet, Ribeirao Preto Med Sch, Sect Human Reprod, Sao Paulo, SP, Brazil.
RP dos Reis, RM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil.
EM romareis@fmrp.usp.br
RI Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR Akl LD, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-120
   Ashrafi M, 2013, INT J FERTIL STERIL, V7, P100
   Azantee Y W, 2011, Med J Malaysia, V66, P195
   Badawy A, 2009, FERTIL STERIL, V91, P777, DOI 10.1016/j.fertnstert.2007.12.010
   Barros Delgadillo Juan Carlos, 2006, Ginecol Obstet Mex, V74, P611
   Cao S, 2014, ANDROLOGIA, V46, P529, DOI 10.1111/and.12109
   Dinelli L, 2014, FERTIL STERIL, V101, P994, DOI 10.1016/j.fertnstert.2014.01.009
   Erdem A, 2008, REPROD BIOMED ONLINE, V17, P199, DOI 10.1016/S1472-6483(10)60195-2
   Fauque P, 2014, FERTIL STERIL, V101, P1618, DOI 10.1016/j.fertnstert.2014.03.015
   Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255
   Freour T, 2010, ARCH GYNECOL OBSTET, V282, P445, DOI 10.1007/s00404-010-1515-0
   Geisler ME, 2017, EUR J OBSTET GYN R B, V210, P342, DOI 10.1016/j.ejogrb.2017.01.016
   Ghaffari F, 2015, INT J FERTIL STERIL, V9, P300
   Honda Tetsuro, 2015, Reproductive Medicine and Biology, V14, P27, DOI 10.1007/s12522-014-0192-2
   Iberico G, 2004, FERTIL STERIL, V81, P1308, DOI 10.1016/j.fertnstert.2003.09.062
   Kupka MS, 2016, HUM REPROD, V31, P233, DOI 10.1093/humrep/dev319
   Lemmens L, 2016, FERTIL STERIL, V105, P1462, DOI 10.1016/j.fertnstert.2016.02.012
   Luco SM, 2014, EUR J OBSTET GYN R B, V179, P159, DOI 10.1016/j.ejogrb.2014.05.003
   Merviel P, 2010, FERTIL STERIL, V93, P79, DOI 10.1016/j.fertnstert.2008.09.058
   Nikbakht R, 2011, INT J FERTIL STERIL, V5, P168
   Norian JM, 2010, FERTIL STERIL, V94, P2073, DOI 10.1016/j.fertnstert.2009.12.056
   Ombelet W, 2013, MIDDLE EAST FERTIL S, V18, P74, DOI 10.1016/j.mefs.2013.01.001
   Ombelet W, 2014, REPROD BIOMED ONLINE, V28, P300, DOI 10.1016/j.rbmo.2013.10.023
   Shahine LK, 2009, FERTIL STERIL, V92, P1315, DOI 10.1016/j.fertnstert.2009.03.059
   Shohieb A, 2012, MIDDLE EAST FERTIL S, V17, P42, DOI 10.1016/j.mefs.2011.07.005
   Wu HM, 2013, TAIWAN J OBSTET GYNE, V52, P512, DOI 10.1016/j.tjog.2013.10.010
   Yousefi B, 2011, J PAK MED ASSOC, V61, P165
   Zadehmodarres S, 2009, J ASSIST REPROD GEN, V26, P7, DOI 10.1007/s10815-008-9273-7
NR 28
TC 9
Z9 9
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD JAN-MAR
PY 2018
VL 22
IS 1
BP 2
EP 7
DI 10.5935/1518-0557.20180002
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GC6LL
UT WOS:000429902900002
PM 29327861
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU da Luz, CM
   da Broi, MG
   Donabela, FC
   de Paz, CCP
   Meola, J
   Navarro, PA
AF da Luz, Caroline M.
   da Broi, Michele G.
   Donabela, Flavia Cappello
   Paro de Paz, Claudia Cristina
   Meola, Juliana
   Navarro, Paula A.
TI PTGS2 down-regulation in cumulus cells of infertile women with
   endometriosis
SO REPRODUCTIVE BIOMEDICINE ONLINE
LA English
DT Article
DE Cumulus cells; Endometriosis; Infertility; Oocyte quality; PTGS2
ID OOCYTE MATURATION; OXIDATIVE STRESS; GENE-EXPRESSION; ASSISTED
   REPRODUCTION; ECTOPIC ENDOMETRIUM; FOLLICULAR-FLUID; CYP19A1 GENE;
   CYCLOOXYGENASE-2; MECHANISMS; QUALITY
AB A deleterious effect of endometriosis on oocyte quality has been proposed. Evidence suggests that cumulus cells could be used as indirect biomarkers of oocyte quality. The PTGS2 gene, which encodes cyclooxygenase 2 (COX-2), is deregulated in endometriotic lesions and plays a crucial role in the acquisition of oocyte competence. To date, research evaluating PTGS2 expression in cumulus cells of infertile patients with endometriosis has not been conducted. The aim this study was to compare the expression levels of PTGS2 in cumulus cells of infertile women, with and without endometriosis, undergoing ovarian stimulation for intracytoplasmic sperm injection (ICSI). Therefore, a case-control study compared PTGS2 gene expression in the cumulus cells of 38 infertile patients with endometriosis and 40 without, using real-time polymerase chain reaction. For the first time, decreased expression of PTGS2 was found in cumulus cells of infertile women with endometriosis compared with controls (7.2 +/- 10.5 versus 12.4 +/- 15.7), which might be related to reduced levels of COX-2 in the cumulus cells of women with the disease. Consequently, we hypothesize that lower transcript levels of PTGS2 in cumulus cells may be involved in the impairment of oocyte quality, suggesting a possible mechanism involved in disease-related infertility. (C) 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
C1 [da Luz, Caroline M.; da Broi, Michele G.; Donabela, Flavia Cappello; Meola, Juliana; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, 3900 Bandeirantes Ave, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Paro de Paz, Claudia Cristina] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Genet, 3900 Bandeirantes Ave, BR-14049900 Ribeirao Preto, SP, Brazil.
RP da Luz, CM (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, 3900 Bandeirantes Ave, BR-14049900 Ribeirao Preto, SP, Brazil.
EM carollinemantovani@gmail.com
RI de Paz, Claudia Cristina Paro/A-8852-2014; Lovato, Juliana
   Meola/E-3440-2012; de Paz, Claudia Cristina Paro/E-8791-2012; Navarro,
   Paula/G-2744-2012; Luz, Caroline M/D-3961-2014; Da Broi, Michele
   G/E-7753-2012
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; Lovato, Juliana
   Meola/0000-0003-2514-4011; de Paz, Claudia Cristina
   Paro/0000-0002-7267-4552; Da Broi, Michele G/0000-0003-4256-0228;
   Navarro, Paula Andrea/0000-0003-2368-4188
CR Ahn SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795976
   Allersma T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010550.pub2
   Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032
   Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barcelos IDES, 2015, REPROD BIOMED ONLINE, V30, P532, DOI 10.1016/j.rbmo.2015.01.012
   Bukulmez O, 2008, ENDOCRINOLOGY, V149, P1190, DOI 10.1210/en.2007-0665
   Bulun SE, 2002, J REPROD IMMUNOL, V55, P21, DOI 10.1016/S0165-0378(01)00132-2
   Bulun SE, 2001, J STEROID BIOCHEM, V79, P19, DOI 10.1016/S0960-0760(01)00134-0
   Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690
   Calder MD, 2001, BIOL REPROD, V65, P135, DOI 10.1095/biolreprod65.1.135
   Canis M, 1997, FERTIL STERIL, V67, P817
   Chen Q, 2012, AUST NZ J OBSTET GYN, V52, P140, DOI 10.1111/j.1479-828X.2011.01405.x
   Cho S, 2010, GYNECOL OBSTET INVES, V69, P93, DOI 10.1159/000261017
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2016, CELL TISSUE RES, V364, P1, DOI 10.1007/s00441-015-2339-9
   de Andrade AZ, 2010, REV BRAS GINECOL OBS, V32, P279, DOI 10.1590/S0100-72032010000600005
   Dell'Aquila Maria Elena, 2004, Reprod Biol Endocrinol, V2, P44, DOI 10.1186/1477-7827-2-44
   Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160
   Donabela FC, 2015, REPROD SCI, V22, P1452, DOI 10.1177/1933719115585146
   Du YB, 2013, ARCH GYNECOL OBSTET, V287, P123, DOI 10.1007/s00404-012-2567-0
   Furger C, 1996, MOL HUM REPROD, V2, P541, DOI 10.1093/molehr/2.8.541
   Garcia-Velasco JA, 1999, HUM REPROD, V14, P77, DOI 10.1093/humrep/14.suppl_2.77
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Hosseini E, 2016, J ASSIST REPROD GEN, V33, P1105, DOI 10.1007/s10815-016-0727-z
   Hou YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18858
   Julious SA, 2005, PHARM STAT, V4, P5
   Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x
   Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6
   Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X
   Livak F, 2000, J EXP MED, V192, P1191, DOI 10.1084/jem.192.8.1191
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu X, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.055
   Ma JY, 2013, CELL CYCLE, V12, P1928, DOI 10.4161/cc.24991
   McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535
   Murdoch WJ, 1996, PROSTAGLANDINS, V52, P497, DOI 10.1016/S0090-6980(96)00127-X
   MURDOCH WJ, 1988, CELL TISSUE RES, V252, P459, DOI 10.1007/BF00214389
   Nuttinck F, 2002, MOL REPROD DEV, V61, P93, DOI 10.1002/mrd.1135
   Ota H, 2001, HUM REPROD, V16, P561, DOI 10.1093/humrep/16.3.561
   Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172
   Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179
   Ozkan S, 2008, ANN NY ACAD SCI, V1127, P92, DOI 10.1196/annals.1434.007
   Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463
   Rakhila H, 2013, FERTIL STERIL, V100, P1650, DOI 10.1016/j.fertnstert.2013.08.016
   Rambags BPB, 2014, THERIOGENOLOGY, V81, P959, DOI 10.1016/j.theriogenology.2014.01.020
   Russell DL, 2016, THERIOGENOLOGY, V86, P62, DOI 10.1016/j.theriogenology.2016.04.019
   Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504
   Sim J, 2012, J CLIN EPIDEMIOL, V65, P301, DOI 10.1016/j.jclinepi.2011.07.011
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Simsek-Duran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064955
   Sugimoto Takeshi, 2007, Kobe J Med Sci, V53, P177
   Sung L, 1997, J ASSIST REPROD GEN, V14, P152, DOI 10.1007/BF02766132
   Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102
   Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19
   Wang DB, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-12
   Wunder DM, 2005, J ASSIST REPROD GEN, V22, P257, DOI 10.1007/s10815-005-5149-2
   Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3
   Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573
NR 61
TC 5
Z9 6
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1472-6483
EI 1472-6491
J9 REPROD BIOMED ONLINE
JI Reprod. Biomed. Online
PD OCT
PY 2017
VL 35
IS 4
BP 379
EP 386
DI 10.1016/j.rbmo.2017.06.021
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FL4JN
UT WOS:000414195900006
PM 28734688
OA Bronze
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Rocha, CV
   Carvalho, FM
   Martins, WP
   Ferriani, RA
   Navarro, PA
AF Da Broi, Michele G.
   Rocha, Carlos V., Jr.
   Carvalho, Filomena M.
   Martins, Wellington P.
   Ferriani, Rui A.
   Navarro, Paula A.
TI Ultrastructural Evaluation of Eutopic Endometrium of Infertile Women
   With and Without Endometriosis During the Window of Implantation: A
   Pilot Study
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE endometriosis; female infertility; endometrial receptivity; pinopodes
ID LEUKEMIA INHIBITORY FACTOR; MESSENGER-RNA EXPRESSION; EMBRYO
   IMPLANTATION; MOLECULAR-MECHANISMS; RECEPTIVITY MARKERS; INTEGRIN
   EXPRESSION; PINOPODE EXPRESSION; UTERINE RECEPTIVITY;
   SURFACE-MORPHOLOGY; STROMAL CELLS
AB Endometriosis is frequently associated with infertility and it is believed that the impairment of endometrial receptivity may be one of the mechanisms involved in this condition. Pinopodes are endometrial cycle-dependent structures that seem to participate in embryo implantation, and alterations in their presence and/or morphology during the window of implantation could affect the endometrial receptivity and be involved in the disease-related infertility. However, the data on pinopodes in these women are scarce and inconclusive. This pilot study aimed to evaluate the cell pattern, including the presence and developmental stage of pinopodes, in eutopic endometrium of infertile patients with and without endometriosis during the window of implantation, using scanning electron microscopy (SEM). Endometrial biopsies were performed using a Pipelle catheter, and 12 samples classified in the window of implantation (6 infertile women with endometriosis and 6 infertile controls) were analyzed by SEM. The frequencies of cell types (microvilli, ciliated, and pinopodes) and the developmental stage of pinopodes were compared between groups using Mann-Whitney U test. Although the study was limited by its sample size, no large differences were detected between the groups regarding the presence and developmental stage of pinopodes, suggesting the absence of large structural changes in the endometrium of infertile women with endometriosis during the window of implantation.
C1 [Da Broi, Michele G.; Rocha, Carlos V., Jr.; Martins, Wellington P.; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Human Reprod Div, Dept Obstet & Gynecol, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
   [Carvalho, Filomena M.] Univ Sao Paulo, Dept Pathol, Sao Paulo, Brazil.
   [Navarro, Paula A.] CNPq, Natl Inst Hormones & Womens Hlth, Porto Alegre, RS, Brazil.
RP Da Broi, MG (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Human Reprod Div, Dept Obstet & Gynecol, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM michi.dabroi@gmail.com
RI Navarro, Paula/G-2744-2012; Carvalho, Filomena M/D-3987-2012; Da Broi,
   Michele G/E-7753-2012; Martins, Wellington/B-1284-2008
OI Carvalho, Filomena M/0000-0002-5838-3636; Da Broi, Michele
   G/0000-0003-4256-0228; Martins, Wellington/0000-0002-7593-5607; Navarro,
   Paula Andrea/0000-0003-2368-4188
FU National Council for Scientific and Technological Development
   (CNPq-Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [471943/2012-6, 140137/2015-7, 311444/2013-0]; Sao
   Paulo Research Foundation (FAPESP-Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) [2011/17614-6]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   received financial support from the National Council for Scientific and
   Technological Development (CNPq-Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico; 471943/2012-6; 140137/2015-7; 311444/2013-0)
   and Sao Paulo Research Foundation (FAPESP-Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo; 2011/17614-6).
CR Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004
   Acosta AA, 2000, FERTIL STERIL, V73, P788, DOI 10.1016/S0015-0282(99)00605-6
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Agarwal A, 2006, REPROD BIOMED ONLINE, V13, P126
   Aghajanova L, 2009, BIOL REPROD, V80, P105, DOI 10.1095/biolreprod.108.070300
   Aghajanova L, 2003, FERTIL STERIL, V79, P808, DOI 10.1016/S0015-0282(02)04830-6
   Alizadeh Zohreh, 2011, Iranian Biomedical Journal, V15, P66
   Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897
   Bagot CN, 2001, DEV DYNAM, V222, P538, DOI 10.1002/dvdy.1209.abs
   Bedaiwy MA, 2015, REPROD SCI, V22, P1153, DOI 10.1177/1933719115585145
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037
   Cakmak H, 2010, SEMIN REPROD MED, V28, P69, DOI 10.1055/s-0029-1242996
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cho S, 2009, AM J REPROD IMMUNOL, V61, P286, DOI 10.1111/j.1600-0897.2009.00692.x
   Cohen J, 1988, STAT POWER ANAL BEHA
   Fraser IS, 2007, FERTIL STERIL, V87, P466, DOI 10.1016/j.fertnstert.2007.01.023
   Garcia-Velasco JA, 2001, FERTIL STERIL, V75, P1231, DOI 10.1016/S0015-0282(01)01774-5
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Giudice LC, 2002, ANN NY ACAD SCI, V955, P252, DOI 10.1111/j.1749-6632.2002.tb02786.x
   GIUDICE LC, 2002, ANN NY ACAD SCI, V955, P293
   GIUDICE LC, 2002, ANN NY ACAD SCI, V955, P396
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Hoozemans DA, 2004, REPROD BIOMED ONLINE, V9, P692, DOI 10.1016/S1472-6483(10)61781-6
   Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043
   LESSEY BA, 1994, J CLIN ENDOCR METAB, V79, P643, DOI 10.1210/jc.79.2.643
   LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835
   Makrigiannakis A, 2009, HISTOCHEM CELL BIOL, V132, P159, DOI 10.1007/s00418-009-0593-1
   Matsuzaki S, 2006, FERTIL STERIL, V85, P308, DOI 10.1016/j.fertnstert.2005.08.017
   Matsuzaki S, 2010, HUM REPROD, V25, P742, DOI 10.1093/humrep/dep435
   Minjarez DA, 2000, OBSTET GYN CLIN N AM, V27, P641, DOI 10.1016/S0889-8545(05)70161-3
   Moberg C, 2015, ARCH GYNECOL OBSTET, V292, P429, DOI 10.1007/s00404-015-3626-0
   Nardo LG, 2002, EUR J OBSTET GYN R B, V101, P104, DOI 10.1016/S0301-2115(01)00523-1
   Nikas G, 1999, HUM REPROD, V14, P99, DOI 10.1093/humrep/14.suppl_2.99
   Nikas G, 2000, SEMIN REPROD MED, V18, P229, DOI 10.1055/s-2000-12561
   Nikas G, 2003, ANN NY ACAD SCI, V997, P120, DOI 10.1196/annals.1290.042
   Nikas G, 1997, ANN NY ACAD SCI, V816, P129, DOI 10.1111/j.1749-6632.1997.tb52136.x
   Nikas G, 2000, ANN NY ACAD SCI, V900, P316
   Noyes R W, 1975, Am J Obstet Gynecol, V122, P262
   Ordi J, 2003, J ASSIST REPROD GEN, V20, P465, DOI 10.1023/B:JARG.0000006709.61216.6f
   Osteen KG, 1999, GYNECOL OBSTET INVES, V48, P2, DOI 10.1159/000052863
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS156
   Quinn CE, 2009, HUM REPROD UPDATE, V15, P229, DOI 10.1093/humupd/dmn052
   Quinn C, 2007, FERTIL STERIL, V87, P1015, DOI 10.1016/j.fertnstert.2006.08.101
   Sharkey AM, 2003, BEST PRACT RES CL OB, V17, P289, DOI 10.1016/S1521-6934(02)00130-X
   Sharma Alok, 2012, J Hum Reprod Sci, V5, P2, DOI 10.4103/0974-1208.97777
   Shen FR, 2015, ARCH GYNECOL OBSTET, V291, P439, DOI 10.1007/s00404-014-3419-x
   Sugawara J, 1997, FERTIL STERIL, V68, P468, DOI 10.1016/S0015-0282(97)00226-4
   Surrey ES, 2007, J ASSIST REPROD GEN, V24, P553, DOI 10.1007/s10815-007-9164-3
   Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328
   Usadi RS, 2003, FERTIL STERIL, V79, P970, DOI 10.1016/S0015-0282(02)04929-4
   Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121
   Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304
   Xu BF, 2012, FERTIL STERIL, V98, P389, DOI 10.1016/j.fertnstert.2012.04.032
NR 57
TC 6
Z9 7
U1 1
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD OCT
PY 2017
VL 24
IS 10
BP 1469
EP 1475
DI 10.1177/1933719117691142
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FH3WD
UT WOS:000411079900014
PM 28173742
DA 2020-12-17
ER

PT J
AU Bertelli, TS
   Da Broi, M
   Martins, WP
   Ferriani, R
   Navarro, PA
AF Bertelli, T. S.
   Da Broi, M.
   Martins, W. P.
   Ferriani, R.
   Navarro, P. A.
TI MACS (MAGNETIC ACTIVATED CELL SORTING) BEFORE OR AFTER DENSITY GRADIENT
   CENTRIFUGATION FOR SEMINAL CRYOPRESERVATION
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
ID HUMAN SPERMATOZOA; ANNEXIN-V; HUMAN SPERM; DNA FRAGMENTATION;
   SEPARATION; MEMBRANE; INFERTILITY; INTEGRITY; APOPTOSIS; CASPASES
C1 [Bertelli, T. S.; Martins, W. P.; Navarro, P. A.] Univ Sao Paulo, Ribeirao Preto Med Sch FMRP, Human Reprod Dept, Ribeirao Preto, Brazil.
   [Da Broi, M.] Univ Sao Paulo, Ribeirao Preto, Brazil.
   [Ferriani, R.] Univ Sao Paulo, Obstet & Gynecol, Ribeirao Preto, Brazil.
RI Martins, Wellington/B-1284-2008; Da Broi, Michele G/E-7753-2012;
   Navarro, Paula/G-2744-2012
OI Martins, Wellington/0000-0002-7593-5607; Da Broi, Michele
   G/0000-0003-4256-0228; 
FU National Institute of Hormones and Women's Health, CNPq, Brazil
FX Supported by: National Institute of Hormones and Women's Health, CNPq,
   Brazil
CR Ainsworth C, 2007, HUM REPROD, V22, P197, DOI 10.1093/humrep/del351
   Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68
   Anger JT, 2003, J UROLOGY, V170, P1079, DOI 10.1097/01.ju.0000084820.98430.b8
   Aziz N, 2007, HUM REPROD, V22, P1413, DOI 10.1093/humrep/dem016
   Beshay VE, 2012, CURR OPIN OBSTET GYN, V24, P172, DOI 10.1097/GCO.0b013e32835211b5
   Brahem S, 2011, J ASSIST REPROD GEN, V28, P425, DOI 10.1007/s10815-011-9537-5
   Bucar S, 2015, J ASSIST REPROD GEN, V32, P147, DOI 10.1007/s10815-014-0370-5
   Delbes G, 2013, ANDROLOGY-US, V1, P698, DOI 10.1111/j.2047-2927.2013.00106.x
   Di Santo M, 2012, ADV UROL, V2012, DOI 10.1155/2012/854837
   Duru NK, 2001, J ANDROL, V22, P646
   Faezah SSM, 2014, ZYGOTE, V22, P378, DOI 10.1017/S0967199412000597
   Glander HJ, 1999, MOL HUM REPROD, V5, P109, DOI 10.1093/molehr/5.2.109
   Grunewald Sonja, 2006, Cell and Tissue Banking, V7, P99, DOI 10.1007/s10561-005-1367-1
   Grunewald Sonja, 2001, Cell and Tissue Banking, V2, P127, DOI 10.1023/A:1020188913551
   Herrero MB, 2013, J ASSIST REPROD GEN, V30, P1415, DOI 10.1007/s10815-013-0086-y
   Lee TH, 2010, HUM REPROD, V25, P839, DOI 10.1093/humrep/deq009
   Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678
   Makker K, 2008, INDIAN J EXP BIOL, V46, P491
   Organization W. H., 2010, WHO LAB MAN EX PROC
   Paasch U, 2005, ASIAN J ANDROL, V7, P61, DOI 10.1111/j.1745-7262.2005.00009.x
   Paasch U, 2004, FERTIL STERIL, V81, P802, DOI 10.1016/j.fertnstert.2003.09.030
   Paasch U, 2004, BIOL REPROD, V71, P1828, DOI 10.1095/biolreprod.103.025627
   Paasch U, 2003, J ANDROL, V24, P246
   Said TM, 2008, J ANDROL, V29, P134, DOI 10.2164/jandrol.107.003632
   Said TM, 2006, REPROD BIOMED ONLINE, V13, P336, DOI 10.1016/S1472-6483(10)61437-X
   Said TM, 2005, REPROD BIOMED ONLINE, V10, P740, DOI 10.1016/S1472-6483(10)61118-2
   Said TM, 2005, FERTIL STERIL, V83, P1442, DOI 10.1016/j.fertnstert.2004.11.052
   Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046
   Shamsi MB, 2011, J ASSIST REPROD GEN, V28, P1073, DOI 10.1007/s10815-011-9631-8
   Tavalaee M, 2012, J ASSIST REPROD GEN, V29, P31, DOI 10.1007/s10815-011-9686-6
   Watson PF, 1995, REPROD FERT DEVELOP, V7, P871, DOI 10.1071/RD9950871
NR 31
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-56
BP E129
EP E130
DI 10.1016/j.fertnstert.2017.07.392
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446000320
OA Bronze
DA 2020-12-17
ER

PT J
AU da Luz, CM
   Meola, J
   Da Broi, M
   Silva, LF
   Placa, JR
   Silva, WA
   Ferriani, RA
   Navarro, PA
AF da Luz, C. M.
   Meola, J.
   Da Broi, M.
   Silva, L. F.
   Placa, J. R.
   Silva, W. A., Jr.
   Ferriani, R. A.
   Navarro, P. A.
TI DIFFERENTIAL TRANSCRIPT PROFILE OF CUMULUS CELLS OF INFERTILE WOMEN WITH
   AND WITHOUT INITIAL ENDOMETRIOSIS WHO UNDERWENT OVARIAN STIMULATION
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
C1 [da Luz, C. M.; Meola, J.; Da Broi, M.; Silva, L. F.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Human Reprod Div, Fac Med Ribeirao Preto, Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Placa, J. R.; Silva, W. A., Jr.] Univ Sao Paulo, Lab Mol Genet & Bioinformat, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; Da Broi, Michele G/E-7753-2012; Lovato,
   Juliana Meola/E-3440-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Lovato, Juliana
   Meola/0000-0003-2514-4011
FU Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/02683-0, 2014/05878-7]
FX Supported by: Sao Paulo Research Foundation - FAPESP (2014/02683-0,
   2014/05878-7).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-250
BP E202
EP E203
DI 10.1016/j.fertnstert.2017.07.598
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446001187
OA Bronze
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Wang, FH
   Robinson, LG
   Pimentel, RN
   Radjabi, RA
   Kramer, YG
   Keefe, DL
AF Navarro, P. A.
   Wang, F. H.
   Robinson, L. G.
   Pimentel, R. N.
   Radjabi, R. A.
   Kramer, Y. G.
   Keefe, D. L.
TI ZIDOVUDINE INHIBITS TELOMERE ELONGATION, INCREASES THE TRANSPOSABLE
   ELEMENT LINE1 COPY NUMBER AND COMPROMISES MOUSE EMBRYO DEVELOPMENT.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 73rd Scientific Congress and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 28-NOV 01, 2017
CL San Antonio, TX
SP Amer Soc Reprod Med
ID REVERSE-TRANSCRIPTASE
C1 [Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ob Gyn, Ribeirao Preto, Brazil.
   [Navarro, P. A.; Wang, F. H.; Robinson, L. G.; Pimentel, R. N.; Radjabi, R. A.; Kramer, Y. G.; Keefe, D. L.] NYU, Ob Gyn, New York, NY USA.
RI Navarro, Paula/G-2744-2012
FU FAPESP, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/21907-0]; Stanley H. Kaplan Fund
FX Supported by: Scholarship from FAPESP, Brazil (Process 2015/21907-0) and
   Stanley H. Kaplan Fund
CR Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664
   Pittoggi C, 2003, MOL REPROD DEV, V66, P225, DOI 10.1002/mrd.10349
   Spadafora C, 2015, ANN NY ACAD SCI, V1341, P164, DOI 10.1111/nyas.12637
   TOLTZIS P, 1991, J INFECT DIS, V163, P1212, DOI 10.1093/infdis/163.6.1212
   Vitullo P, 2012, MOL REPROD DEV, V79, P118, DOI 10.1002/mrd.22003
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2017
VL 108
IS 3
SU S
MA P-124
BP E154
EP E155
DI 10.1016/j.fertnstert.2017.07.466
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FG0MW
UT WOS:000409446001064
OA Bronze
DA 2020-12-17
ER

PT J
AU Jianini, BTGM
   Giorgi, VSI
   Da Broi, MG
   de Paz, CCP
   Silva, JCRE
   Ferriani, RA
   Navarro, PA
AF Gazeto Melo Jianini, Bruna Talita
   Innocenti Giorgi, Vanessa Silvestre
   Da Broi, Michele Gomes
   Paro de Paz, Claudia Cristina
   Rosa e Silva, Julio Cesar
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Peritoneal Fluid From Infertile Women With Minimal/Mild Endometriosis
   Compromises the Meiotic Spindle of Metaphase II Bovine Oocytes: A Pilot
   Study
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE female infertility; minimal and mild endometriosis; peritoneal fluid;
   oocyte; quality; meiotic spindle
ID OXIDATIVE STRESS MARKERS; IN-VITRO FERTILIZATION; MILD ENDOMETRIOSIS;
   FOLLICULAR-FLUID; DEVELOPMENTAL COMPETENCE; UNEXPLAINED INFERTILITY;
   MOUSE OOCYTES; CUMULUS CELLS; MATURATION; APOPTOSIS
AB Some studies have demonstrated alterations in the composition of peritoneal fluid (PF) from women with endometriosis. Controversial studies have suggested that impaired oocyte quality may be involved in the pathogenesis of endometriosis-related infertility. The aim of this study was to evaluate the spindle and chromosome distribution of in vitro-matured oocytes in the presence of 2 concentrations of PF from infertile women with minimal/mild endometriosis (EI/II) compared to fertile controls. We performed an experimental study using a bovine model. Samples of PF were obtained from 12 women who underwent videolaparoscopy6 infertile women with EI/II and 6 fertile women without endometriosis (control group). Immature bovine oocytes underwent in vitro maturation (IVM) in the absence of PF and in the presence of 2 concentrations (1% and 10%) of PF from fertile women and from infertile women with EI/II. After 22 to 24 hours of IVM, oocytes were fixed for subsequent immunofluorescence staining for the visualization of microtubules and chromosomes by confocal microscopy. The percentage of meiotically normal oocytes was significantly lower for oocytes that underwent IVM in the presence of 1% (62.50%) and 10% (56.25%) of PF from infertile women with EI/II than in the absence of PF (88.46%) and in the presence of 1% (78.57%) and 10% (84.61%) of PF from fertile women (P < .01). We demonstrated that PF from infertile women with EI/II promotes meiotic abnormalities in in vitro-matured bovine oocytes. Therefore, our results contribute to the understanding of the etiopathogenic mechanisms of infertility related to EI/II.
C1 [Gazeto Melo Jianini, Bruna Talita; Innocenti Giorgi, Vanessa Silvestre; Da Broi, Michele Gomes; Rosa e Silva, Julio Cesar; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Sch Med, Human Reprod Div, Dept Gynecol & Obstet, Ave Bandeirantes 3900, Sao Paulo, Brazil.
   [Paro de Paz, Claudia Cristina] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Genet, Sao Paulo, Brazil.
   [Ferriani, Rui Alberto; Navarro, Paula Andrea] CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
RP Jianini, BTGM (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Human Reprod Div, Dept Gynecol & Obstet, Ave Bandeirantes 3900, Sao Paulo, Brazil.
EM brunagazeto@hotmail.com
RI de Paz, Claudia Cristina Paro/E-8791-2012; Rosa e Silva, Julio
   C/K-5407-2016; Da Broi, Michele G/E-7753-2012; Navarro,
   Paula/G-2744-2012; de Paz, Claudia Cristina Paro/A-8852-2014
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; Rosa e Silva, Julio
   C/0000-0001-6930-1328; Da Broi, Michele G/0000-0003-4256-0228; de Paz,
   Claudia Cristina Paro/0000-0002-7267-4552; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU Coordination for the Improvement of Higher Education Personnel (CAPES),
   BrazilCAPES; Foundation to Support Education, Research and Care,
   University Hospital; Ribeirao Preto School of Medicine, University of
   Sao Paulo (FAEPA), Brazil; National Institute of Hormones and Women's
   Health, CNPq, Brazil
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by the Coordination for the Improvement of Higher
   Education Personnel (CAPES), Brazil; the Foundation to Support
   Education, Research and Care, University Hospital, Ribeirao Preto School
   of Medicine, University of Sao Paulo (FAEPA), Brazil; and the National
   Institute of Hormones and Women's Health, CNPq, Brazil.
CR Adona PR, 2004, ZYGOTE, V12, P197, DOI 10.1017/S0967199404002771
   Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2006, REPROD BIOMED ONLINE, V13, P126
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   Bedaiwy MA, 2003, MINERVA GINECOL, V55, P333
   Berube S, 1998, FERTIL STERIL, V69, P1034, DOI 10.1016/S0015-0282(98)00081-8
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Eichenlaub-Ritter Ursula, 2002, Reprod Biomed Online, V5, P117
   Barcelos IDES, 2008, REV BRAS GINECOL OBS, V30, P413, DOI 10.1590/S0100-72032008000800007
   Ferreira EM, 2009, EUR J OBSTET GYN R B, V145, P76, DOI 10.1016/j.ejogrb.2009.03.016
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Giorgi VSI, 2016, REPROD SCI, V23, P342, DOI 10.1177/1933719115602772
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Hashimoto S, 2002, BIOL REPROD, V66, P1696, DOI 10.1095/biolreprod66.6.1696
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025
   Li Y, 2006, FERTIL STERIL, V85, P827, DOI 10.1016/j.fertnstert.2005.06.064
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Ma CH, 2010, FERTIL STERIL, V93, P920, DOI 10.1016/j.fertnstert.2009.01.131
   Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002
   Malhi PS, 2005, BIOL REPROD, V73, P45, DOI 10.1095/biolreprod.104.038745
   Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   Mier-Cabrera J, 2011, BJOG-INT J OBSTET GY, V118, P6, DOI 10.1111/j.1471-0528.2010.02777.x
   Minici F, 2008, HUM REPROD, V23, P530, DOI 10.1093/humrep/dem399
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Murphy AA, 1998, J CLIN ENDOCR METAB, V83, P2110, DOI 10.1210/jc.83.6.2110
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Pellicer A, 2001, ANN NY ACAD SCI, V943, P122, DOI 10.1111/j.1749-6632.2001.tb03796.x
   Carvalho LFP, 2012, REV ASSOC MED BRAS, V58, P607, DOI 10.1590/S0104-42302012000500020
   Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011
   Santulli P, 2015, HUM REPROD, V30, P49, DOI 10.1093/humrep/deu290
   Shaeib F, 2016, REPROD SCI, V23, P498, DOI 10.1177/1933719115607993
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805
NR 47
TC 5
Z9 6
U1 0
U2 14
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD SEP
PY 2017
VL 24
IS 9
BP 1304
EP 1311
DI 10.1177/1933719116687658
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FE0GY
UT WOS:000407900000010
PM 28110632
DA 2020-12-17
ER

PT J
AU Robinson, LG
   Kramer, Y
   Pimentel, R
   Wang, F
   Navarro, P
   Keefe, DL
AF Robinson-, L. G., Jr.
   Kramer, Y.
   Pimentel, R.
   Wang, F.
   Navarro, P.
   Keefe, D. L.
TI Single-Cell Analysis of Telomere Length Dynamics and DNA Damage Across
   Early Human Development Suggest Alternative Lengthening of Telomeres
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUL 02-05, 2017
CL Geneva, SWITZERLAND
SP European Soc Human Reprod & Embryol
C1 [Robinson-, L. G., Jr.; Kramer, Y.; Pimentel, R.; Wang, F.; Navarro, P.; Keefe, D. L.] NYU, Langone Med Ctr, Obstet & Gynecol, New York, NY USA.
   [Navarro, P.] Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Navarro, P.] FAPESP, Sao Paulo, Brazil.
RI Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2017
VL 32
SU 1
MA O-115
BP 52
EP 52
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FN9VH
UT WOS:000416390500108
DA 2020-12-17
ER

PT J
AU Luz, CM
   Meola, J
   Da Broi, MG
   Silva, LFI
   Placa, JR
   Silva, WA
   Ferriani, RA
   Navarro, PA
AF Luz, C. M.
   Meola, J.
   Da Broi, M. G.
   Silva, L. F. I.
   Placa, J. R.
   Silva, W. A., Jr.
   Ferriani, R. A.
   Navarro, P. A.
TI Differential transcript profile of cumulus cells of infertile women with
   and without advanced endometriosis who underwent ovarian stimulation
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUL 02-05, 2017
CL Geneva, SWITZERLAND
SP European Soc Human Reprod & Embryol
C1 [Luz, C. M.; Meola, J.; Da Broi, M. G.; Silva, L. F. I.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Obstet & Gynecol, Ribeirao Preto Sch Med, Human Reprod Div, Ribeirao Preto, Brazil.
   [Placa, J. R.; Silva, W. A., Jr.] Univ Sao Paulo, Lab Mol Genet & Bioinformat, Ribeirao Preto Sch Med, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; Silva, Wilson Araujo/E-9487-2011; Da Broi,
   Michele G/E-7753-2012; Lovato, Juliana Meola/E-3440-2012
OI Silva, Wilson Araujo/0000-0001-9364-2886; Da Broi, Michele
   G/0000-0003-4256-0228; Lovato, Juliana Meola/0000-0003-2514-4011
NR 0
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2017
VL 32
SU 1
MA P-302
BP 275
EP 275
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FN9VH
UT WOS:000416390502177
DA 2020-12-17
ER

PT J
AU Berteli, TS
   Da Broi, MG
   Martins, WP
   Ferriani, RA
   Navarro, PA
AF Berteli, T. S.
   Da Broi, M. G.
   Martins, W. P.
   Ferriani, R. A.
   Navarro, P. A.
TI Magnetic-activated cell sorting before density gradient centrifugation
   improves recovery of high-quality spermatozoa
SO ANDROLOGY
LA English
DT Article
DE DNA integrity; magnetic-activated cell sorting; sperm motility; sperm
   selection
ID ASSISTED REPRODUCTION OUTCOMES; NON-APOPTOTIC SPERMATOZOA; IN-VITRO
   FERTILIZATION; MOTILE SPERM COUNT; INTRAUTERINE INSEMINATION;
   NONAPOPTOTIC SPERMATOZOA; PLASMA-MEMBRANE; DNA-DAMAGE; SWIM-UP;
   SELECTION
AB Recent studies have evaluated the use of magnetic-activated cell sorting (MACS) to reduce apoptotic spermatozoa and improve sperm quality. However, the efficiency of using MACS alone, before or after sperm processing by density gradient centrifugation (DGC) has not yet been established. The purpose of this study is to determine the optimal protocol of MACS in assisted reproduction techniques (ART). Thus, we compared sperm quality obtained by DGC alone (DGC), DGC followed by MACS (DGC-MACS), MACS followed by DGC (MACS-DGC), and MACS alone (MACS), and found that the combined methods (MACS-DGC and DGC-MACS) led to retrieval of less spermatozoa with fragmented DNA compared to the single protocols. However, MACS-DGC protocol led to a significantly higher percentage of spermatozoa with progressive motility and normal morphology than DGC-MACS protocol. These findings suggest the potential clinical value of using MACS-DGC to improve sperm quality in seminal preparation for ART.
C1 [Berteli, T. S.; Da Broi, M. G.; Martins, W. P.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Human Reprod Div, Ribeirao Preto, SP, Brazil.
RP Berteli, TS (corresponding author), Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM thalitabertelli@gmail.com
RI Martins, Wellington/B-1284-2008; Navarro, Paula/G-2744-2012; Da Broi,
   Michele G/E-7753-2012
OI Martins, Wellington/0000-0002-7593-5607; Da Broi, Michele
   G/0000-0003-4256-0228; Navarro, Paula Andrea/0000-0003-2368-4188
FU National Institute of Hormones and Women's Health, CNPq, Brazil
FX This study was financially supported by the National Institute of
   Hormones and Women's Health, CNPq, Brazil. The authors affirm that there
   are no conflicts of interest.
CR Ainsworth C, 2005, HUM REPROD, V20, P2261, DOI 10.1093/humrep/dei024
   Ainsworth C, 2007, HUM REPROD, V22, P197, DOI 10.1093/humrep/del351
   Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68
   Sedo CA, 2010, FERTIL STERIL, V94, pS232
   Aziz N, 2007, HUM REPROD, V22, P1413, DOI 10.1093/humrep/dem016
   Berker B, 2012, UROLOGY, V80, P1262, DOI 10.1016/j.urology.2012.07.004
   Beshay VE, 2012, CURR OPIN OBSTET GYN, V24, P172, DOI 10.1097/GCO.0b013e32835211b5
   Brahem S, 2011, J ASSIST REPROD GEN, V28, P425, DOI 10.1007/s10815-011-9537-5
   Bucar S, 2015, J ASSIST REPROD GEN, V32, P147, DOI 10.1007/s10815-014-0370-5
   Cakar Z, 2016, J ASSIST REPROD GEN, V33, P1059, DOI 10.1007/s10815-016-0742-0
   Delbes G, 2013, ANDROLOGY-US, V1, P698, DOI 10.1111/j.2047-2927.2013.00106.x
   Dirican EK, 2008, J ASSIST REPROD GEN, V25, P375, DOI 10.1007/s10815-008-9250-1
   Fortunato A, 2013, J FERTILI IN VITRO, V1, P101
   Gil M, 2013, J ASSIST REPROD GEN, V30, P479, DOI 10.1007/s10815-013-9962-8
   GORCZYCA W, 1993, EXP CELL RES, V207, P202, DOI 10.1006/excr.1993.1182
   Grunewald S, 2009, FERTIL STERIL, V92, P572, DOI 10.1016/j.fertnstert.2008.07.1705
   Ishihara O, 2015, FERTIL STERIL, V103, P402, DOI 10.1016/j.fertnstert.2014.11.004
   Khalid SN, 2011, FERTIL STERIL, V96, pS169, DOI 10.1016/j.fertnstert.2011.07.659
   Khalid SN, 2011, FERTIL STERIL, V96, pS25, DOI 10.1016/j.fertnstert.2011.07.104
   Lee TH, 2010, HUM REPROD, V25, P839, DOI 10.1093/humrep/deq009
   Makker K, 2008, INDIAN J EXP BIOL, V46, P491
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   McDowell S, COCHRANE DATABASE SY, V10
   Nadalini M, 2014, J ASSIST REPROD GEN, V31, P1045, DOI 10.1007/s10815-014-0267-3
   Nasr-Esfahani MH, 2012, INT J ANDROL, V35, P475, DOI 10.1111/j.1365-2605.2011.01227.x
   Nikbakht R, 2011, INT J FERTIL STERIL, V5, P168
   Organization W. H., 2010, WHO LAB MAN EX PROC
   Paasch U, 2003, J ANDROL, V24, P246
   Pfeifer S, 2013, FERTIL STERIL, V99, P673, DOI 10.1016/j.fertnstert.2012.12.049
   Rappa KL, 2016, BIOTECHNOL ADV, V34, P578, DOI 10.1016/j.biotechadv.2016.01.007
   Rawe VY, 2010, REPROD BIOMED ONLINE, V20, P320, DOI 10.1016/j.rbmo.2009.12.004
   Romany L, 2010, FERTIL STERIL, V94, pS14, DOI 10.1016/j.fertnstert.2010.07.055
   Romany L, 2012, REPROD BIOMEDICIN S1, V24, pS2
   Romany L, 2014, FERTIL STERIL, V102, P1567, DOI 10.1016/j.fertnstert.2014.09.001
   Said T, 2006, BIOL REPROD, V74, P530, DOI 10.1095/biolreprod.105.046607
   Said TM, 2008, J ANDROL, V29, P134, DOI 10.2164/jandrol.107.003632
   Said TM, 2005, REPROD BIOMED ONLINE, V10, P740, DOI 10.1016/S1472-6483(10)61118-2
   Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586
   Sakkas D, 2015, HUM REPROD UPDATE, V21, P711, DOI 10.1093/humupd/dmv042
   Sakkas D, 2013, FERTIL STERIL, V99, P1023, DOI 10.1016/j.fertnstert.2012.12.025
   Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046
   San Celestino M, 2011, HUM REPROD, V26, pI140
   Shamsi MB, 2011, J ASSIST REPROD GEN, V28, P1073, DOI 10.1007/s10815-011-9631-8
   Tavalaee M, 2012, J ASSIST REPROD GEN, V29, P31, DOI 10.1007/s10815-011-9686-6
   Troya J, 2015, J BRAS REPROD ASSIST, V19, P66, DOI 10.5935/1518-0557.20150015
   Van Thillo G, 2011, FERTIL STERIL, V96, pS160, DOI 10.1016/j.fertnstert.2011.07.629
   Van Voorhis BJ, 2001, FERTIL STERIL, V75, P661, DOI 10.1016/S0015-0282(00)01783-0
NR 47
TC 11
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-2919
EI 2047-2927
J9 ANDROLOGY-US
JI Andrology
PD JUL
PY 2017
VL 5
IS 4
BP 776
EP 782
DI 10.1111/andr.12372
PG 7
WC Andrology
SC Endocrinology & Metabolism
GA FC6DP
UT WOS:000406930900023
PM 28622434
OA Bronze
DA 2020-12-17
ER

PT J
AU Joaquim, DC
   Borges, ED
   Viana, IGR
   Navarro, PA
   Vireque, AA
AF Joaquim, Daniel C.
   Borges, Eduardo D.
   Viana, Iara G. R.
   Navarro, Paula A.
   Vireque, Alessandra A.
TI Risk of Contamination of Gametes and Embryos during Cryopreservation and
   Measures to Prevent Cross-Contamination
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID MOUSE EMBRYOS; HUMAN OOCYTES; MICROBIAL-CONTAMINATION; CLOSED
   VITRIFICATION; SEXUAL TRANSMISSION; HEPATITIS-B; ZIKA VIRUS; SEMEN;
   SURVIVAL; STORAGE
AB The introduction and widespread application of vitrification are one of the most important achievements in human assisted reproduction techniques (ART) of the past decade despite controversy and unclarified issues, mostly related to concerns about disease transmission. Guidance documents published by US Food and Drug Administration, which focused on the safety of tissue/organ donations during Zika virus spread in 2016, as well as some reports of virus, bacteria, and fungi survival to cryogenic temperatures, highlighted the need for a review of the way how potentially infectious material is handled and stored in ART-related procedures. It was experimentally demonstrated that cross-contamination between liquid nitrogen (LN2) and embryos may occur when infectious agents are present in LN2 and oocytes/embryos are not protected by a hermetically sealed device. Thus, this review summarizes pertinent data and opinions regarding the potential hazard of infectious transmission through cryopreserved and banked reproductive cells and tissues in LN2. Special attention is given to the survival of pathogens in LN2, the risk of cross-contamination, vitrification methods, sterility of LN2, and the risks associated with the use of straws, cryovials, and storage dewars.
C1 [Joaquim, Daniel C.; Borges, Eduardo D.; Vireque, Alessandra A.] Assisted Reprod Technol Ltd, Invitra, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
   [Borges, Eduardo D.; Viana, Iara G. R.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Navarro, Paula A.] CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
RP Vireque, AA (corresponding author), Assisted Reprod Technol Ltd, Invitra, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
EM alessandra@invitra.com.br
RI Vireque, Alessandra/G-2208-2012; Borges, Eduardo/Y-5712-2019; Navarro,
   Paula/G-2744-2012
OI Borges, Eduardo/0000-0002-0131-1121; Navarro, Paula
   Andrea/0000-0003-2368-4188; Vireque, Alessandra/0000-0002-2597-531X
CR Arav A, 2016, REPROD BIOMED ONLINE, V33, P71, DOI 10.1016/j.rbmo.2016.03.010
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bielanski A, 2005, THERIOGENOLOGY, V63, P1946, DOI 10.1016/j.theriogenology.2004.09.003
   Bielanski A, 2000, CRYOBIOLOGY, V40, P110, DOI 10.1006/cryo.1999.2227
   Bielanski A, 2014, ADV EXP MED BIOL, V753, P429, DOI 10.1007/978-1-4939-0820-2_17
   Bielanski A, 2012, THERIOGENOLOGY, V77, P467, DOI 10.1016/j.theriogenology.2011.07.043
   Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8
   British Fertility Society, 2016, ZIK VIR FERT TREATM
   Bujan L., 2016, ZIKA VIRUS ASSISTED
   Chen Y, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-107
   Chian RC, 2014, J ASSIST REPROD GEN, V31, P411, DOI 10.1007/s10815-014-0180-9
   Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006
   De Munck N, 2013, J ASSIST REPROD GEN, V30, P361, DOI 10.1007/s10815-013-9930-3
   De Munck N., 2015, HUMAN REPROD, V31, P377
   Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016
   Fuller B, 2004, REPROD BIOMED ONLINE, V9, P680, DOI 10.1016/S1472-6483(10)61780-4
   Fuller Barry J, 2007, Methods Mol Biol, V368, P325
   Gook DA, 2016, J ASSIST REPROD GEN, V33, P1247, DOI 10.1007/s10815-016-0748-7
   Grout BWW, 2009, THERIOGENOLOGY, V71, P1079, DOI 10.1016/j.theriogenology.2008.12.011
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hesters L, 2013, GYNECOL OBSTET FERTI, V41, P554, DOI 10.1016/j.gyobfe.2013.07.003
   Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4
   JONES SK, 1989, BRIT J DERMATOL, V121, P481, DOI 10.1111/j.1365-2133.1989.tb15515.x
   Kuleshova L, 1999, HUM REPROD, V14, P3077, DOI 10.1093/humrep/14.12.3077
   Kuleshova LL, 2000, HUM REPROD, V15, P2604, DOI 10.1093/humrep/15.12.2604
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   LEIBO SP, 1984, THERIOGENOLOGY, V21, P767, DOI 10.1016/0093-691X(84)90022-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mazzilli F., 2006, Cell and Tissue Banking, V7, P75, DOI 10.1007/s10561-005-1966-x
   McBurnie LD, 2002, PHARM TECHNOLOGY N A, V26, P74
   Morris GJ, 2005, CRYOBIOLOGY, V50, P231, DOI 10.1016/j.cryobiol.2005.01.005
   Mukaida T, 1998, HUM REPROD, V13, P2874, DOI 10.1093/humrep/13.10.2874
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Parmegiani L, 2008, HUM REPROD, V23, P1771, DOI 10.1093/humrep/den119
   Parmegiani L, 2011, REPROD BIOMED ONLINE, V23, P505, DOI 10.1016/j.rbmo.2011.07.003
   Parmegiani L, 2012, FERTIL STERIL, V98, P870, DOI 10.1016/j.fertnstert.2012.06.028
   Parmegiani L, 2009, HUM REPROD, V24, P2969, DOI 10.1093/humrep/dep329
   Piasecka-Serafin M., 1972, B ACAD POL SCI, P20
   RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0
   Ruppert-Lingham CJ, 2006, CRYOBIOLOGY, V52, P219, DOI 10.1016/j.cryobiol.2005.11.004
   Schaffer TW., 1976, CAME PE BIOHAZARD PO, P13
   Stoop D, 2012, REPROD BIOMED ONLINE, V24, P180, DOI 10.1016/j.rbmo.2011.10.015
   Tan FCK, 2007, CRYOLETTERS, V28, P445
   TEDDER RS, 1995, LANCET, V346, P137, DOI 10.1016/S0140-6736(95)91207-X
   Tedeschi R, 2011, METHODS MOL BIOL, V675, P313, DOI 10.1007/978-1-59745-423-0_18
   Tomlinson Mathew, 2008, Hum Fertil (Camb), V11, P33, DOI 10.1080/14647270701553280
   U. S. Food, 2016, FDA ISS REC RED RISK
   Vajta G, 2015, REPROD BIOMED ONLINE, V30, P325, DOI 10.1016/j.rbmo.2014.12.012
   WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411
   WILMUT I, 1972, LIFE SCI 2-BIOCH GEN, V11, P1071, DOI 10.1016/0024-3205(72)90215-9
NR 51
TC 10
Z9 10
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2017
VL 2017
AR 1840417
DI 10.1155/2017/1840417
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA FD4JV
UT WOS:000407498300001
PM 28890894
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Melo, AS
   Rodrigues, JK
   Jordao, AA
   Ferriani, RA
   Navarro, PA
AF de Melo, Anderson Sanches
   Rodrigues, Jhenifer Kliemchen
   Jordao Junior, Alceu Afonso
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Oxidative stress and polycystic ovary syndrome: an evaluation during
   ovarian stimulation for intracytoplasmic sperm injection
SO REPRODUCTION
LA English
DT Article
ID FOLLICULAR-FLUID; WOMEN; GLUTATHIONE; INFERTILITY; PREVALENCE;
   MATURATION; SYMPTOMS; HORMONE; SERUM; YOUNG
AB Oxidative stress (OS) may affect the natural fertility and the results of assisted reproduction techniques (ARTs). Subfertility associated with polycystic ovary syndrome (PCOS) may be related to OS. This process may intensify during controlled ovarian stimulation (COS) for ARTs because of increased ovarian metabolic activity and hypoestrogenism with the use of gonadotropin-releasing hormone agonists (GnRHas). The objective of this study was to investigate the presence of systemic OS in non-stimulated cycles and to determine OS markers (malondialdehyde (MDA), advanced oxidation protein products (AOPP), hydroperoxides (FOX), glutathione (GSH) and vitamin E) during COS in non-obese infertile women with and without PCOS who were subjected to ARTs. A prospective cohort study was conducted on non-obese women (16 with PCOS and 60 ovulatory patients with infertility due to male and/or tubal factors). The OS markers were determined during the following time points: the follicular phase of the natural cycle (D1), after pituitary downregulation with GnRHa and before the use of gonadotropins (D2), on the day of administration of human chorionic gonadotropin (D3), and at oocyte retrieval (D4). Intergroup analysis showed that serum MDA concentrations were higher in the PCOS group at D3 (P = 0.048) and D4 (P = 0.002). On an intragroup analysis, the control group had higher MDA concentrations at D2 than at D1 (P = 0.01) or D4 (P = 0.004). The AOPP concentrations were higher at D2 (P < 0.0001), D3 (P < 0.001) and D4 (P < 0.0001) compared to D1. The FOX concentrations were lower at D2 (P < 0.0001), D3 (P < 0.0001) and D4 (P < 0.001) than at D1. Serum GSH concentrations were significantly higher at D4 than at D1 (P = 0.02). An intragroup analysis of the PCOS subjects showed that the five OS markers did not differ significantly among the four time points when they were analyzed (D1, D2, D3 and D4). In conclusion, non-obese infertile women with PCOS showed evidence of systemic OS after COS with gonadotropins for ICSI. On the other hand, non-obese ovulatory infertile women and women with infertility due to male and/or tubal factors showed a possible systemic oxidative balance until the final COS.
C1 [de Melo, Anderson Sanches; Rodrigues, Jhenifer Kliemchen; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Obstet & Gynecol, Ave Bandeirantes, BR-05508 Sao Paulo, SP, Brazil.
   [Jordao Junior, Alceu Afonso] Univ Sao Paulo, Med Sch Ribeirao Preto, Nutr & Metab Lab, Ave Bandeirantes, BR-05508 Sao Paulo, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Obstet & Gynecol, Ave Bandeirantes, BR-05508 Sao Paulo, SP, Brazil.
EM drapaulanavarro@gmail.com
RI Jordao, Alceu Afonso/D-7545-2014; Navarro, Paula/G-2744-2012; Melo,
   Anderson/L-6758-2014
OI Navarro, Paula Andrea/0000-0003-2368-4188; Melo,
   Anderson/0000-0002-4606-7791; /0000-0003-1288-0802
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/58197-6, 2008/52789-9]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [474858/2009-0]; Instituto N acional de
   Ciencias e Tecnologia - INCT/CNPq - Hormonios e Saude da Mulher
FX FAPESP (Grants 2008/58197-6 and 2008/52789-9), CNPq (Grant
   474858/2009-0) and Instituto N acional de Ciencias e Tecnologia -
   INCT/CNPq - Hormonios e Saude da Mulher.
CR Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037
   ARNAUD J, 1991, J CHROMATOGR-BIOMED, V572, P103, DOI 10.1016/0378-4347(91)80476-S
   Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046
   Barash A, 1998, FERTIL STERIL, V69, P496, DOI 10.1016/S0015-0282(97)00542-6
   Bornoden WR, 1994, NUTR TOXICOLOGY, P19
   Cagnacci A, 2015, CLIMACTERIC, V18, P631, DOI 10.3109/13697137.2014.999659
   Cohen J, 1988, STAT POWER ANAL BEHA
   Costa Carolina M. da, 2006, J. Bras. Patol. Med. Lab., V42, P345, DOI 10.1590/S1676-24442006000500006
   de Matos DG, 2000, THERIOGENOLOGY, V53, P761, DOI 10.1016/S0093-691X(99)00278-2
   Elting MW, 2001, HUM REPROD, V16, P556, DOI 10.1093/humrep/16.3.556
   Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098
   Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005
   HU ML, 1994, METHOD ENZYMOL, V233, P380
   Kaya C, 2009, FERTIL STERIL, V92, P1372, DOI 10.1016/j.fertnstert.2008.08.016
   Kelly CJG, 2002, J CLIN ENDOCR METAB, V87, P742, DOI 10.1210/jc.87.2.742
   Kingsley PD, 1998, MOL REPROD DEV, V49, P343, DOI 10.1002/(SICI)1098-2795(199804)49:4<343::AID-MRD1>3.3.CO;2-T
   Kocer D, 2014, GYNECOL ENDOCRINOL, V30, P367, DOI 10.3109/09513590.2014.887063
   Li HWR, 2014, J ASSIST REPROD GEN, V31, P205, DOI 10.1007/s10815-013-0151-6
   Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162
   Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001
   Nasiri N, 2015, EUR J OBSTET GYN R B, V184, P112, DOI 10.1016/j.ejogrb.2014.11.008
   Patel SS, 2008, SEMIN REPROD MED, V26, P196, DOI 10.1055/s-2008-1042958
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P302, DOI 10.1016/j.fertnstert.2012.05.032
   Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032
   REGAN L, 1990, LANCET, V336, P1141, DOI 10.1016/0140-6736(90)92765-A
   Santilli F, 2015, VASC PHARMACOL, V74, P23, DOI 10.1016/j.vph.2015.09.003
   Tarlatzis BC, 2008, FERTIL STERIL, V89, P505, DOI 10.1016/j.fertnstert.2007.09.041
   Turan V, 2015, J PEDIATR ADOL GYNEC, V28, P119, DOI 10.1016/j.jpag.2014.05.003
   Verit FF, 2007, FERTIL STERIL, V88, P418, DOI 10.1016/j.fertnstert.2006.11.172
   Wang SP, 2013, SEMIN REPROD MED, V31, P365, DOI 10.1055/s-0033-1348895
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
   Yeste M, 2016, HUM REPROD UPDATE, V22, P23, DOI 10.1093/humupd/dmv040
NR 36
TC 3
Z9 4
U1 0
U2 1
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 1470-1626
J9 REPRODUCTION
JI Reproduction
PD JAN
PY 2017
VL 153
IS 1
BP 97
EP 105
DI 10.1530/REP-16-0084
PG 9
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA EF7RH
UT WOS:000390526400012
OA Bronze
DA 2020-12-17
ER

PT J
AU Neto, MDC
   Martins, WD
   de Melo, AS
   Ferriani, RA
   Navarro, PA
AF Coelho Neto, Marcela de Alencar
   Martins, Wellington de Paula
   de Melo, Anderson Sanches
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Subclinical Hypothyroidism and Intracytoplasmic Sperm Injection Outcomes
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE thyrotropin (TSH); subclinical hypothyroidism; intracytoplasmic sperm
   injection (ICSI); live birth; miscarriage
ID THYROID-STIMULATING HORMONE; CONTROLLED OVARIAN HYPERSTIMULATION;
   IN-VITRO FERTILIZATION; LEVOTHYROXINE TREATMENT; WOMEN; PREGNANCY;
   AUTOIMMUNITY; GUIDELINES; TSH; METAANALYSIS
AB Purpose Whether preconception elevated concentrations of thyroid-stimulating hormone (TSH) compromises reproductive outcomes in patients undergoing assisted reproduction techniques (ARTs) remains unclear. This study therefore compared the reproductive outcomes in patients with TSH concentrations of < 2.5 mIU/L, 2.5-4.0 mIU/L, and 4.0-10.0mIU/L undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).
   Methods This retrospective cohort study evaluated the medical records of all women with measured TSH concentrations who underwent IVF/ICSI between January 2011 and December 2012. The patients were divided into three groups: TSH < 2.5mIU/L (group 1); THS >= 2.5 and < 4.0 mIU/L (group 2); and THS >= 4 mIU/L and < 10.0 mIU/L (group 3). Patients who were administered levothyroxine for treating hypothyroidism were excluded from the analysis. The primary endpoints were clinical pregnancy, miscarriage, live birth and multiple pregnancy rates.
   Results During the study period, 787 women underwent IVF/ICSI. Sixty were excluded because their TSH concentrations were unavailable, and 77 were excluded due to their use of levothyroxine. The prevalence of patients presenting elevated concentrations of TSHwas of 5.07% (using a TSH threshold of 4.0 mIU/L) and of 29.99% (using a TSH threshold of 2.5 mIU/L). Patient characteristics, type of COS, and response to COS did not differ among the three groups, and there were no differences in clinical pregnancy (24.4% versus 25.9% versus 24.2%, p = 0.93); miscarriage (17.1% versus 14.3% versus 12.5%, p = 0.93); live birth (20.2% versus 22.2% versus 21.2%, p = 0.86); and multiple pregnancy rates (27.0% versus 21.4% versus 25.0%, p = 0.90) respectively.
   Conclusion Response to COS, live birth, and miscarriage rates were not altered in women with elevated concentrations of TSH undergoing IVF/ICSI, regardless of using a TSH threshold of 2.5mIU/L or 4.0mIU/L. These findings reinforce the uncertainties related to the impact of subclinical hypothyroidism on reproductive outcomes in women undergoing COS for ARTs.
C1 [Coelho Neto, Marcela de Alencar; Martins, Wellington de Paula; de Melo, Anderson Sanches; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, FRMP, DGO, Ribeirao Preto, SP, Brazil.
RP Neto, MDC (corresponding author), Univ Sao Paulo, HCRP, Ave Bandeirantes 3900,8 Andar,Campus Univ, BR-14049900 Ribeirao Preto, SP, Brazil.
EM marcelalencar@hotmail.com
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008; Melo,
   Anderson/L-6758-2014
OI Martins, Wellington/0000-0002-7593-5607; Melo,
   Anderson/0000-0002-4606-7791; Navarro, Paula Andrea/0000-0003-2368-4188
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Brazilian official agency: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian official
   agency: Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)
FX Marcela Coelho Neto received financial support from a scholarship
   granted by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES). The other authors received a salary from their institutions and
   were funded by two Brazilian official agencies: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Apoio ao
   Ensino, Pesquisa e Assistencia (FAEPA). The funders had no role in the
   design of the study, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aghahosseini Marziyeh, 2014, Med J Islam Repub Iran, V28, P46
   Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037
   Beckett G, 2007, ANN CLIN BIOCHEM, V44, P203, DOI 10.1258/000456307780480945
   Benaglia L, 2014, EUR J OBSTET GYN R B, V173, P53, DOI 10.1016/j.ejogrb.2013.11.003
   Bloomgarden ZT, 2012, ENDOCR PRACT, V18, P6, DOI 10.4158/EP12300.RA
   Busnelli A, 2014, THYROID, V24, P1650, DOI 10.1089/thy.2014.0088
   Chai J, 2014, CLIN ENDOCRINOL, V80, P122, DOI 10.1111/cen.12220
   De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803
   Figueiredo JBP, 2013, ARCH GYNECOL OBSTET, V287, P779, DOI 10.1007/s00404-012-2672-0
   Gracia CR, 2012, FERTIL STERIL, V97, P585, DOI 10.1016/j.fertnstert.2011.12.023
   Green KA, 2015, J ASSIST REPROD GEN, V32, P1469, DOI 10.1007/s10815-015-0549-4
   Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489
   Karmon AE, 2015, FERTIL STERIL, V103, P258, DOI 10.1016/j.fertnstert.2014.09.035
   Kim CH, 2011, FERTIL STERIL, V95, P1650, DOI 10.1016/j.fertnstert.2010.12.004
   Magri F, 2013, THYROID, V23, P1312, DOI 10.1089/thy.2013.0022
   Martins WP, 2014, ULTRASOUND OBST GYN, V43, P25, DOI 10.1002/uog.12566
   Michalakis KG, 2011, FERTIL STERIL, V95, P2634, DOI 10.1016/j.fertnstert.2011.02.056
   Mintziori G, 2014, GYNECOL OBSTET INVES, V77, P84, DOI 10.1159/000357193
   NICE, 2013, FERT ASS TREATM PEOP
   Penarrubia J, 2005, HUM REPROD, V20, P622, DOI 10.1093/humrep/deh674
   Pfeifer S, 2015, FERTIL STERIL, V104, P545, DOI 10.1016/j.fertnstert.2015.05.028
   Poppe K, 2008, NAT CLIN PRACT ENDOC, V4, P394, DOI 10.1038/ncpendmet0846
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P302, DOI 10.1016/j.fertnstert.2012.05.032
   Reh A, 2010, FERTIL STERIL, V94, P2920, DOI 10.1016/j.fertnstert.2010.06.041
   Reinblatt S, 2013, J ASSIST REPROD GEN, V30, P1347, DOI 10.1007/s10815-013-0081-3
   Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087
   Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228
   Unuane D, 2011, BEST PRACT RES CL EN, V25, P861, DOI 10.1016/j.beem.2011.08.001
   van den Boogaard E, 2011, HUM REPROD UPDATE, V17, P605, DOI 10.1093/humupd/dmr024
   Velkeniers B, 2013, HUM REPROD UPDATE, V19, P251, DOI 10.1093/humupd/dms052
   Weghofer A, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0162-0
   Weghofer A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0041-0
NR 32
TC 5
Z9 5
U1 0
U2 3
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD NOV
PY 2016
VL 38
IS 11
BP 552
EP 558
DI 10.1055/s-0036-1593986
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4QT
UT WOS:000410250900005
PM 27852097
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bedoschi, G
   Navarro, PA
   Oktay, K
AF Bedoschi, Giuliano
   Navarro, Paula Andrea
   Oktay, Kutluk
TI Chemotherapy-induced damage to ovary: mechanisms and clinical impact
SO FUTURE ONCOLOGY
LA English
DT Review
DE anti-Mullerian hormone; antral follicle count; chemotherapy; fertility
   preservation; follicle-stimulating hormone; ovarian aging; ovarian
   damage; ovarian reserve
ID ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; ANTRAL FOLLICLE COUNT;
   ASSISTED REPRODUCTIVE TECHNOLOGY; STAGE BREAST-CANCER; ANTIMULLERIAN
   HORMONE; INHIBIN-B; CHILDHOOD-CANCER; YOUNG-WOMEN; COMBINATION
   CHEMOTHERAPY
AB Cancer is a major public health problem around the world. Currently, about 5% of women diagnosed with cancer are of reproductive age. These young survivors may face compromised fertility. The effects of chemotherapeutic agents on ovarian reserve and its clinical consequences are generally inferred from a variety of surrogate markers of ovarian reserve, all aiming to provide prognostic information on fertility or the likelihood of success of infertility treatment. Until recently, the mechanisms that are responsible for chemotherapy-induced ovarian damage were not fully elucidated. The understanding of these mechanisms may lead to targeted treatments to preserve fertility. In this manuscript, we will review the current knowledge on the mechanism of ovarian damage and clinical impact of chemotherapy agents on fertility.
C1 [Bedoschi, Giuliano; Oktay, Kutluk] Innovat Inst Fertil Preservat & In Vitro Fertiliz, New York, NY 10019 USA.
   [Bedoschi, Giuliano; Oktay, Kutluk] New York Med Coll, Lab Mol Reprod & Fertil Preservat, Obstet & Gynecol, Valhalla, NY 10595 USA.
   [Bedoschi, Giuliano; Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Div Reprod Med, Ribeirao Preto, SP, Brazil.
RP Oktay, K (corresponding author), Innovat Inst Fertil Preservat & In Vitro Fertiliz, New York, NY 10019 USA.; Oktay, K (corresponding author), New York Med Coll, Lab Mol Reprod & Fertil Preservat, Obstet & Gynecol, Valhalla, NY 10595 USA.
EM koktay@fertilitypreservation.org
RI Navarro, Paula/G-2744-2012; Bedoschi, Giuliano/E-2225-2013
OI Bedoschi, Giuliano/0000-0003-3104-1297; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development (NICHD)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [RO1 HD053112]; National Cancer InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI); NICHDUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [R21 HD061259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF
   CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [R21HD061259, R01HD053112, R01HD053112, R01HD053112,
   R01HD053112, R01HD053112] Funding Source: NIH RePORTER; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [R01HD053112, R21HD061259,
   R01HD053112, R01HD053112, R01HD053112, R01HD053112] Funding Source: NIH
   RePORTER
FX K Oktay is supported by RO1 HD053112 by Eunice Kennedy Shriver National
   Institute of Child Health and Human Development (NICHD) and National
   Cancer Institute; in addition, the laboratory work was supported by R21
   HD061259 by NICHD. The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.
CR Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028
   Anders C, 2008, CANCER INVEST, V26, P286, DOI 10.1080/07357900701829777
   Anderson RA, 2013, FERTIL STERIL, V99, P1469, DOI 10.1016/j.fertnstert.2013.03.014
   Anderson RA, 2011, J CLIN ENDOCR METAB, V96, P1336, DOI 10.1210/jc.2010-2582
   Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492
   Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473
   Bedoschi G, 2013, FERTIL STERIL, V99, P1496, DOI 10.1016/j.fertnstert.2013.03.020
   Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034
   D'Avila AM, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0209-4
   Decanter C, 2010, REPROD BIOMED ONLINE, V20, P280, DOI 10.1016/j.rbmo.2009.11.010
   Dillon KE, 2013, FERTIL STERIL, V99, P477, DOI 10.1016/j.fertnstert.2012.09.039
   DOLL DC, 1986, J CLIN ONCOL, V4, P1405, DOI 10.1200/JCO.1986.4.9.1405
   Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789
   Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601
   FAMILIARI G, 1993, HUM REPROD, V8, P2080, DOI 10.1093/oxfordjournals.humrep.a137985
   Fong SL, 2008, HUM REPROD, V23, P674, DOI 10.1093/humrep/dem392
   Fong SL, 2009, HUM REPROD, V24, P982, DOI 10.1093/humrep/den487
   Frattarelli JL, 2003, FERTIL STERIL, V80, P350, DOI 10.1016/S0015-0282(03)00664-2
   Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033
   Gracia CR, 2012, FERTIL STERIL, V97, P134, DOI 10.1016/j.fertnstert.2011.10.040
   Hall JE, 1999, HUM REPROD, V14, P409, DOI 10.1093/humrep/14.2.409
   Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fertnstert.2004.10.011
   HIMELSTEINBRAW R, 1978, BRIT J CANCER, V38, P82, DOI 10.1038/bjc.1978.166
   Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316
   Jung M, 2010, ANN SURG ONCOL, V17, P3259, DOI 10.1245/s10434-010-1172-3
   Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402
   Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017
   Kerr JB, 2012, NAT MED, V18, P1170, DOI 10.1038/nm.2889
   Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588
   Knauff EAH, 2009, J CLIN ENDOCR METAB, V94, P786, DOI 10.1210/jc.2008-1818
   Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877
   Lawrenz B, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.021
   Lee S, 2011, J ASSIST REPROD GEN, V28, P651, DOI 10.1007/s10815-011-9567-z
   Li F, 2014, HUM REPROD, V29, P107, DOI 10.1093/humrep/det391
   Loverro G, 2007, HEMATOLOGY, V12, P141, DOI 10.1080/10245330600954072
   MARCELLO MF, 1990, CANCER, V66, P2099, DOI 10.1002/1097-0142(19901115)66:10<2099::AID-CNCR2820661010>3.0.CO;2-3
   Meirow D, 2004, HUM REPROD, V19, P1294, DOI 10.1093/humrep/deh257
   Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535
   Meirow D, 2001, HUM REPROD, V16, P632, DOI 10.1093/humrep/16.4.632
   Morita Y, 2000, NAT MED, V6, P1109
   Muttukrishna S, 2005, BJOG-INT J OBSTET GY, V112, P1384, DOI 10.1111/j.1471-0528.2005.00670.x
   Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051
   NICOSIA SV, 1985, CANCER, V55, P2364, DOI 10.1002/1097-0142(19850515)55:10<2364::AID-CNCR2820551011>3.0.CO;2-E
   Nielsen SN, 2013, REPROD BIOMED ONLINE, V27, P192, DOI 10.1016/j.rbmo.2013.04.003
   Oktay K, 2006, J CLIN ONCOL, V24, P4044, DOI 10.1200/JCO.2006.06.9823
   Oktay K, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.001
   Oktay K, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132290
   Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042
   Oktem O, 2007, CANCER-AM CANCER SOC, V110, P2222, DOI 10.1002/cncr.23071
   Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901
   Partridge AH, 2010, FERTIL STERIL, V94, P638, DOI 10.1016/j.fertnstert.2009.03.045
   Peigne M, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-26
   Penarrubia J, 2005, HUM REPROD, V20, P915, DOI 10.1093/humrep/deh718
   Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969
   Roness H, 2016, FERTIL STERIL, V105, P20, DOI 10.1016/j.fertnstert.2015.11.043
   SCOTT RT, 1989, FERTIL STERIL, V51, P651
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814
   Sklar CA, 2006, J NATL CANCER I, V98, P890, DOI 10.1093/jnci/djj243
   Soleimani R, 2011, AGING-US, V3, P782, DOI 10.18632/aging.100363
   Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475
   Tarlatzis BC, 2003, ANN NY ACAD SCI, V997, P93, DOI 10.1196/annals.1290.011
   Titus S, 2014, SOC STUD REPR 2014 G
   Toner JP, 2013, FERTIL STERIL, V99, P1825, DOI 10.1016/j.fertnstert.2013.03.001
   TONER JP, 1991, FERTIL STERIL, V55, P784
   Tschudin S, 2009, HUM REPROD UPDATE, V15, P587, DOI 10.1093/humupd/dmp015
   Tsepelidis S, 2007, HUM REPROD, V22, P1837, DOI 10.1093/humrep/dem101
   van Beek RD, 2007, J CLIN ENDOCR METAB, V92, P3869, DOI 10.1210/jc.2006-2374
   Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772
   Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015
   WHITEHEAD E, 1983, CANCER, V52, P988, DOI 10.1002/1097-0142(19830915)52:6<988::AID-CNCR2820520610>3.0.CO;2-6
NR 71
TC 75
Z9 81
U1 2
U2 13
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1479-6694
EI 1744-8301
J9 FUTURE ONCOL
JI Future Oncol.
PD OCT
PY 2016
VL 12
IS 20
BP 2333
EP 2344
DI 10.2217/fon-2016-0176
PG 12
WC Oncology
SC Oncology
GA DZ8OZ
UT WOS:000386131700007
PM 27402553
OA Green Published
DA 2020-12-17
ER

PT J
AU Sfontouris, IA
   Martins, WP
   Nastri, CO
   Viana, IGR
   Navarro, PA
   Raine-Fenning, N
   van der Poel, S
   Rienzi, L
   Racowsky, C
AF Sfontouris, Ioannis A.
   Martins, Wellington P.
   Nastri, Carolina O.
   Viana, Iara G. R.
   Navarro, Paula A.
   Raine-Fenning, Nick
   van der Poel, Sheryl
   Rienzi, Laura
   Racowsky, Catherine
TI Blastocyst culture using single versus sequential media in clinical IVF:
   a systematic review and meta-analysis of randomized controlled trials
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Review
DE Single; Sequential; Medium; Culture; Extended; Blastocyst
ID INFLUENCE BIRTH-WEIGHT; EMBRYO CULTURE; TIME-LAPSE; IN-VITRO;
   PREIMPLANTATION EMBRYOS; VIABLE BLASTOCYSTS; STEP; OUTCOMES; SELECTION;
   ZYGOTES
AB The purpose of this study was to undertake a review of the available evidence comparing the use of a single medium versus sequential media for embryo culture to the blastocyst stage in clinical IVF.
   We searched the Cochrane Central, PubMed, Scopus, ClinicalTrials.gov, Current Controlled Trials and WHO International Clinical Trials Registry Platform to identify randomized controlled trials comparing single versus sequential media for blastocyst culture and ongoing pregnancy rate. Included studies randomized either oocytes/zygotes or women. Eligible oocyte/zygote studies were analyzed to assess the risk difference (RD) and 95 % confidence intervals (CI) between the two media systems; eligible woman-based studies were analyzed to assess the risk ratio (RR) and 95 % CI for clinical pregnancy rate.
   No differences were observed between single and sequential media for either ongoing pregnancy per randomized woman (relative risk (RR) = 0.9, 95 % CI = 0.7 to 1.3, two studies including 246 women, I (2) = 0 %) or clinical pregnancy per randomized woman (RR = 1.0, 95 % CI = 0.7 to 1.4, one study including 100 women); or miscarriage per clinical pregnancy: RR = 1.3, 95 % CI = 0.4 to 4.3, two studies including 246 participants, I (2) = 0 %). Single media use was associated with an increase blastocyst formation per randomized oocyte/zygote (relative distribution (RD) = +0.06, 95 % CI = +0.01 to +0.12, ten studies including 7455 oocytes/zygotes, I (2) = 83 %) but not top/high blastocyst formation (RD = +0.05, 95 % CI = -0.01 to +0.11, five studies including 3879 oocytes/zygotes, I (2) = 93 %). The overall quality of the evidence was very low for all these four outcomes.
   Although using a single medium for extended culture has some practical advantages and blastocyst formation rates appear to be higher, there is insufficient evidence to recommend either sequential or single-step media as being superior for the culture of embryos to days 5/6. Future studies comparing these two media systems in well-designed trials should be performed.
C1 [Sfontouris, Ioannis A.; Raine-Fenning, Nick] Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham, England.
   [Sfontouris, Ioannis A.] Eugonia Assisted Reprod Unit, Athens, Greece.
   [Martins, Wellington P.; Nastri, Carolina O.; Viana, Iara G. R.; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Nastri, Carolina O.; Viana, Iara G. R.] SEMEAR Fertilidade, Reprod Med, Ribeirao Preto, Brazil.
   [van der Poel, Sheryl] HRP, Geneva, Switzerland.
   [van der Poel, Sheryl] Populat Council, Reprod Hlth Programme, 1230 York Ave, New York, NY 10021 USA.
   [Rienzi, Laura] Clin Valle Giulia, GENERA Ctr Reprod Med, Rome, Italy.
   [Racowsky, Catherine] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA.
RP Racowsky, C (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA.
EM cracowsky@partners.org
RI Nastri, Carolina O/E-1172-2012; Sfontouris, Ioannis/I-2231-2019;
   Raine-Fenning, Nicholas J/C-3005-2008; Navarro, Paula/G-2744-2012;
   Martins, Wellington/B-1284-2008
OI Nastri, Carolina O/0000-0001-7073-1616; Raine-Fenning, Nicholas
   J/0000-0001-5521-9059; Martins, Wellington/0000-0002-7593-5607; Navarro,
   Paula Andrea/0000-0003-2368-4188; Sfontouris,
   Ioannis/0000-0001-8122-8434
CR Alteri A, 2014, HUM REPROD, V29
   Basile N, 2013, HUM REPROD, V28, P634, DOI 10.1093/humrep/des462
   Biggers JD, 2005, HUM REPROD, V20, P3376, DOI 10.1093/humrep/dei228
   Biggers JD, 2008, FERTIL STERIL, V90, P473, DOI 10.1016/j.fertnstert.2008.08.010
   Biggers John D, 2002, Reprod Biomed Online, V5, P133
   Bolton VN, 2014, HUM FERTIL, V17, P239, DOI 10.3109/14647273.2014.944417
   BOLTON VN, 1991, FERTIL STERIL, V55, P830
   Bouillon C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150857
   Ciray HN, 2012, J ASSIST REPROD GEN, V29, P891, DOI 10.1007/s10815-012-9818-7
   Costa-Borges N, 2016, FERTIL STERIL, V105, P707, DOI 10.1016/j.fertnstert.2015.11.038
   de la Calle JFV, 2013, FERTIL STERIL, V100, pS253
   De Vos A, 2015, HUM REPROD, V30, P20, DOI 10.1093/humrep/deu286
   DOKRAS A, 1993, HUM REPROD, V8, P2119, DOI 10.1093/oxfordjournals.humrep.a137993
   Donmez E, 2008, FERTIL STERIL, V90, pS431
   Eaton JL, 2012, HUM REPROD, V27, P375, DOI 10.1093/humrep/der381
   Gardner DK, 1998, HUM REPROD, V13, P148, DOI 10.1093/humrep/13.suppl_3.148
   Gardner DK, 1996, FERTIL STERIL, V65, P349, DOI 10.1016/S0015-0282(16)58097-2
   Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367
   Gardner DK, 2000, HUM REPROD, V15, P9
   Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   Hardarson T, 2015, FERTIL STERIL, V104, P1452, DOI 10.1016/j.fertnstert.2015.08.037
   HARDY K, 1989, DEVELOPMENT, V107, P597
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
   Kemeter P, 2011, J GYNAKOLO ENDOKRINO, V21, P2
   Khoury C, 2012, FERTIL STERIL, V97, pS4, DOI DOI 10.1016/J.FERTNSTERT.2012.01.008
   Kleijkers SHM, 2015, HUM REPROD, V30, P2303, DOI 10.1093/humrep/dev179
   Kleijkers SHM, 2014, HUM REPROD, V29, P661, DOI 10.1093/humrep/deu025
   Koscinski I, 2014, HUM REPROD, V29, P187
   Koyner P, 2013, FERTIL STERIL, V100, pS26, DOI 10.1016/j.fertnstert.2013.07.1743
   LAWITTS JA, 1991, J REPROD FERTIL, V91, P543, DOI 10.1530/jrf.0.0910543
   Legro RS, 2014, HUM REPROD, V29, P2075, DOI 10.1093/humrep/deu218
   Legro RS, 2014, FERTIL STERIL, V102, P952, DOI 10.1016/j.fertnstert.2014.08.002
   Lemmen JG, 2014, HUM REPROD, V29, P2326, DOI 10.1093/humrep/deu188
   Machtinger Ronit, 2012, Methods Mol Biol, V912, P199, DOI 10.1007/978-1-61779-971-6_12
   Macklon NS, 2002, HUM REPROD, V17, P2700, DOI 10.1093/humrep/17.10.2700
   Morbeck DE, 2014, FERTIL STERIL, V102, P759, DOI 10.1016/j.fertnstert.2014.05.043
   Nelissen EC, 2012, HUM REPROD, V27, P1966, DOI 10.1093/humrep/des145
   Nelissen ECM, 2013, HUM REPROD, V28, P2067, DOI 10.1093/humrep/det131
   NODA Y, 1994, FERTIL STERIL, V62, P1022
   Paternot G, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-83
   Patrick JL, 2013, FERTIL STERIL, V100, pS28, DOI 10.1016/j.fertnstert.2013.07.1748
   Pelinck MJ, 2010, REPROD BIOMED ONLINE, V21, P245, DOI 10.1016/j.rbmo.2010.04.024
   Quinn Patrick, 2012, Methods Mol Biol, V912, P211, DOI 10.1007/978-1-61779-971-6_13
   Racowsky C, 2015, J ASSIST REPROD GEN, V32, P1025, DOI 10.1007/s10815-015-0510-6
   Reed ML, 2009, FERTIL STERIL, V92, P1783, DOI 10.1016/j.fertnstert.2009.05.008
   Scarica C, 2015, HUM REPROD, V30, P24
   Schneider DT, 2009, FERTIL STERIL, V92, pS231
   Sepulveda S, 2009, FERTIL STERIL, V91, P1765, DOI 10.1016/j.fertnstert.2008.02.169
   Sfontouris IA, 2015, HUM REPROD, V30, P232
   Sfontouris IA, 2014, HUM REPROD, V29, P2
   Summers MC, 2003, HUM REPROD UPDATE, V9, P557, DOI 10.1093/humupd/dmg039
   Summers MC, 2013, HUM FERTIL, V16, P278, DOI 10.3109/14647273.2013.806823
   Vansteenbrugge A, 2007, FERTIL STERIL, V88, pS319, DOI 10.1016/j.fertnstert.2007.07.1071
   Vergouw CG, 2012, HUM REPROD, V27, P2619, DOI 10.1093/humrep/des252
   Werner MD, 2016, FERTIL STERIL, V105, P1215, DOI 10.1016/j.fertnstert.2016.01.005
   Wiemer Klaus E, 2002, Reprod Biomed Online, V5, P323
   Xie Y, 2007, MOL REPROD DEV, V74, P1287, DOI 10.1002/mrd.20563
   Yang Z, 2013, HUM REPROD, V28, P73
   Youssef MMA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007876.pub2
   Zandstra H, 2015, HUM REPROD, V30, P530, DOI 10.1093/humrep/deu346
   Zhu JL, 2014, HUM REPROD, V29, P1387, DOI 10.1093/humrep/deu103
NR 62
TC 30
Z9 31
U1 1
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD OCT
PY 2016
VL 33
IS 10
BP 1261
EP 1272
DI 10.1007/s10815-016-0774-5
PG 12
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA EA1SW
UT WOS:000386373200003
PM 27491772
OA Green Published
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   de Albuquerque, FO
   de Andrade, AZ
   Cardoso, RL
   Jordao, AA
   Navarro, P
AF Da Broi, Michele G.
   de Albuquerque, Felipe O.
   de Andrade, Aline Z.
   Cardoso, Rafaela L.
   Jordao Junior, Alceu A.
   Navarro, Paula A.
TI Increased concentration of 8-hydroxy-2 '-deoxyguanosine in follicular
   fluid of infertile women with endometriosis
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Endometriosis; Infertility; Oxidative stress; Follicular fluid;
   8-hydroxy-2 '-deoxyguanosine
ID OXIDATIVE STRESS MARKERS; IN-VITRO FERTILIZATION; SERUM MARKERS;
   VITAMIN-E; ANTIOXIDANT CAPACITY; OOCYTES; GLUTATHIONE; SYSTEM; DAMAGE;
   SIZE
AB Impaired oocyte quality and oxidative stress might be involved in the pathogenesis of endometriosis-related infertility. To improve our understanding of the role of oxidative stress in this condition, we compare eight oxidative stress markers from each stage, including the simultaneous analysis of lipids, proteins and DNA damage, in the serum and follicular fluid of infertile women with endometriosis and infertile controls undergoing controlled ovarian stimulation for intracytoplasmic sperm injection. In total, 87 serum samples (43 with endometriosis, 44 controls) and 61 follicular fluid samples (29 with endometriosis, 32 controls) free of blood contamination upon visual inspection and presenting granulosa cells alone or granulosa cells plus a retrieved mature oocyte were collected on the day of oocyte retrieval. Total hydroperoxides, malondialdehyde, advanced oxidation protein products, glutathione, superoxide dismutase (SOD) and total antioxidant capacity (TAC) were determined by spectrophotometry, vitamin E by high-performance liquid chromatography and 8-hydroxy-2'-deoxyguanosine (8OHdG) by enzyme-linked immunosorbent assay. The endometriosis group showed higher serum concentrations of glutathione and SOD, lower serum concentrations of TAC and higher follicular concentrations of 8OHdG and vitamin E compared with infertile controls. These data indicate both systemic and follicular oxidative stress in infertile patients with endometriosis. For the first time, we demonstrate the presence of oxidative DNA damage, represented by higher 8OHdG concentrations in the follicular microenvironment of these patients, possibly related to compromised oocyte quality and associated with the pathogenesis of endometriosis-related infertility.
C1 [Da Broi, Michele G.; de Albuquerque, Felipe O.; de Andrade, Aline Z.; Cardoso, Rafaela L.; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Human Reprod Div, Dept Obstet & Gynecol, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Jordao Junior, Alceu A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Nutr & Metab Lab, Dept Internal Med, Ribeirao Preto, SP, Brazil.
RP Da Broi, MG (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Human Reprod Div, Dept Obstet & Gynecol, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM michi.dabroi@gmail.com
RI Jordao, Alceu Afonso/D-7545-2014; Navarro, Paula/G-2744-2012; Da Broi,
   Michele G/E-7753-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188; /0000-0003-1288-0802
FU National Council for Scientific and Technological Development (CNPq -
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [474858/2009-0, 309056/2009-8, 503867/2010-1]; Sao Paulo Research
   Foundation (FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/58197-6, 2008/56373-1, 2014/15866-6]
FX This study received financial support from the National Council for
   Scientific and Technological Development (CNPq - Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico; 474858/2009-0; 309056/2009-8;
   503867/2010-1) and the Sao Paulo Research Foundation (FAPESP - Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo; 2008/58197-6; 2008/56373-1;
   2014/15866-6).
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088
   Agarwal A, 2006, REPROD BIOMED ONLINE, V13, P126
   ARNAUD J, 1991, J CHROMATOGR-BIOMED, V572, P103, DOI 10.1016/0378-4347(91)80476-S
   Attaran M, 2000, INT J FERTIL WOMEN M, V45, P314
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Bordin L, 2010, FERTIL STERIL, V94, P1616, DOI 10.1016/j.fertnstert.2009.10.038
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   Canis M, 1997, FERTIL STERIL, V67, P817
   Choi YS, 2015, REPRODUCTION, V149, P155, DOI 10.1530/REP-14-0438
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   Costa CM, 2006, J BRAS PATOL MED LAB, V42, P5
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2016, CELL TISSUE RES, V364, P1, DOI 10.1007/s00441-015-2339-9
   de Andrade AZ, 2010, REV BRAS GINECOL OBS, V32, P279, DOI 10.1590/S0100-72032010000600005
   Donabela FC, 2010, FERTIL STERIL, V94, pS40, DOI 10.1016/j.fertnstert.2010.07.154
   El-Shahat KH, 2012, THERIOGENOLOGY, V77, P1513, DOI 10.1016/j.theriogenology.2011.11.018
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43
   Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686
   Giorgi VSI, 2016, REPROD SCI, V23, P342, DOI 10.1177/1933719115602772
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   HU ML, 1994, METHOD ENZYMOL, V233, P380
   Jackson LW, 2005, HUM REPROD, V20, P2014, DOI 10.1093/humrep/dei001
   Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185
   Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135
   Lambrinoudaki IV, 2009, FERTIL STERIL, V91, P46, DOI 10.1016/j.fertnstert.2007.11.021
   Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x
   Levay PE, 1997, J ASSIST REPROD GEN, V14, P212, DOI 10.1007/BF02766112
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   MEISTER A, 1983, BIOCHEM SOC T, V11, P793, DOI 10.1042/bst0110793
   Mier-Cabrera J, 2008, INT J GYNECOL OBSTET, V100, P252, DOI 10.1016/j.ijgo.2007.08.018
   Murphy AA, 1998, SEMIN REPROD ENDOCR, V16, P263, DOI 10.1055/s-2007-1016286
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Nwose EU, 2008, MED HYPOTHESES, V70, P1002, DOI 10.1016/j.mehy.2007.07.048
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011
   Seino T, 2002, FERTIL STERIL, V77, P1184, DOI 10.1016/S0015-0282(02)03103-5
   Sim J, 2012, J CLIN EPIDEMIOL, V65, P301, DOI 10.1016/j.jclinepi.2011.07.011
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X
   Tatemoto H, 2004, BIOL REPROD, V71, P1150, DOI 10.1095/biolreprod.104.029264
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
NR 52
TC 25
Z9 26
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD OCT
PY 2016
VL 366
IS 1
BP 231
EP 242
DI 10.1007/s00441-016-2428-4
PG 12
WC Cell Biology
SC Cell Biology
GA DY5KS
UT WOS:000385139100019
PM 27250533
DA 2020-12-17
ER

PT J
AU Bertelli, TS
   Da Broi, MG
   Navarro, PA
   Martins, W
   Ferriani, R
AF Bertelli, T. S.
   Da Broi, M. G.
   Navarro, P. A.
   Martins, W.
   Ferriani, R.
TI MAGNETIC ACTIVATED CELL SORTING PERFORMED BEFORE DOUBLE GRADIENT
   CENTRIFUGATION IMPROVE THE RECOVERY OF GOOD QUALITY SPERMATOZOA.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
C1 [Bertelli, T. S.] Univ Sao Paulo, Ribeirao Preto Med Sch FMRP, Human Reprod Dept, Ribeirao Preto, Brazil.
   [Da Broi, M. G.] Univ Sao Paulo, Ribeirao Preto, Brazil.
   [Navarro, P. A.] Fac O, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Martins, W.] Univ Sao P, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ferriani, R.] Univ Sao Paulo, Obstet & Gynecol, Ribeirao Preto, Brazil.
RI Martins, Wellington/B-1284-2008; Navarro, Paula/G-2744-2012; Da Broi,
   Michele G/E-7753-2012
OI Martins, Wellington/0000-0002-7593-5607; Da Broi, Michele
   G/0000-0003-4256-0228
CR Ainsworth C, 2005, HUM REPROD, V20, P2261, DOI 10.1093/humrep/dei024
   Ainsworth C, 2007, HUM REPROD, V22, P197, DOI 10.1093/humrep/del351
   Sedo CA, 2010, FERTIL STERIL, V94, pS232
   Aziz N, 2007, HUM REPROD, V22, P1413, DOI 10.1093/humrep/dem016
   Bucar S, 2015, J ASSIST REPROD GEN, V32, P147, DOI 10.1007/s10815-014-0370-5
   Delbes G, 2013, ANDROLOGY-US, V1, P698, DOI 10.1111/j.2047-2927.2013.00106.x
   Dirican EK, 2008, J ASSIST REPROD GEN, V25, P375, DOI 10.1007/s10815-008-9250-1
   Gil M, 2013, J ASSIST REPROD GEN, V30, P479, DOI 10.1007/s10815-013-9962-8
   Herrero MB, 2013, J ASSIST REPROD GEN, V30, P1415, DOI 10.1007/s10815-013-0086-y
   Ishihara O, 2015, FERTIL STERIL, V103, P402, DOI 10.1016/j.fertnstert.2014.11.004
   Khalid SN, 2011, FERTIL STERIL, V96, pS169, DOI 10.1016/j.fertnstert.2011.07.659
   Khalid SN, 2011, FERTIL STERIL, V96, pS25, DOI 10.1016/j.fertnstert.2011.07.104
   Lee H, 2009, FERTIL STERIL, pS143
   Lee TH, 2010, HUM REPROD, V25, P839, DOI 10.1093/humrep/deq009
   Makker K, 2008, INDIAN J EXP BIOL, V46, P491
   Marchetti F, 2007, P NATL ACAD SCI USA, V104, P17725, DOI 10.1073/pnas.0705257104
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   Nadalini M, 2014, J ASSIST REPROD GEN, V31, P1045, DOI 10.1007/s10815-014-0267-3
   Pfeifer S, 2013, PRACT COMM AM SOC RE
   Polak de Fried E, 2010, FERTIL STERIL, V94
   Rawe VY, 2010, REPROD BIOMED ONLINE, V20, P320, DOI 10.1016/j.rbmo.2009.12.004
   Romany L, 2010, FERTIL STERIL, V94, pS14, DOI 10.1016/j.fertnstert.2010.07.055
   Romany L, 2012, REPROD BIOMEDICIN S1, V24, pS2
   Romany L, 2014, FERTIL STERIL, V102, P1567, DOI 10.1016/j.fertnstert.2014.09.001
   Said T, 2006, BIOL REPROD, V74, P530, DOI 10.1095/biolreprod.105.046607
   Said TM, 2005, REPROD BIOMED ONLINE, V10, P740, DOI 10.1016/S1472-6483(10)61118-2
   Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586
   Carchenilla MS, 2013, HUM REPROD, V28, P118
   Sheikhi A, 2013, ANDROLOGY-US, V1, P845, DOI 10.1111/j.2047-2927.2013.00140.x
   Shulman A, 1998, J ASSIST REPROD GEN, V15, P381, DOI 10.1023/A:1022585000740
   SN K, FERTILITY STERILITY, V96
   Tavalaee M, 2012, J ASSIST REPROD GEN, V29, P31, DOI 10.1007/s10815-011-9686-6
   Van Thillo G, 2011, FERTIL STERIL, V96, pS160, DOI 10.1016/j.fertnstert.2011.07.629
   Vendrell X, 2014, REPROD BIOMED ONLINE, V28, P492, DOI 10.1016/j.rbmo.2013.12.001
   W.H. Organization, 2010, J ANDROL, P1, DOI 10.1038/aja.2008.57.
NR 35
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2016
VL 106
IS 3
SU S
MA P-491
BP E290
EP E291
DI 10.1016/j.fertnstert.2016.07.827
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA VH0PS
UT WOS:000449962500743
OA Bronze
DA 2020-12-17
ER

PT J
AU da Luz, CM
   Giorgi, VSI
   Neto, MAC
   Martins, WD
   Ferriani, RA
   Navarro, PA
AF da Luz, Caroline Mantovani
   Innocenti Giorgi, Vanessa Silvestre
   Coelho Neto, Marcela Alencar
   Martins, Wellington de Paula
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Association between Number of Formed Embryos, Embryo Morphology and
   Clinical Pregnancy Rate after Intracytoplasmic Sperm Injection
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE number of embryos; morphological evaluation; embryo quality; clinical
   pregnancy; ICSI
ID ASSISTED REPRODUCTIVE TECHNOLOGY; CONTROLLED OVARIAN STIMULATION;
   IN-VITRO FERTILIZATION; PREVALENCE
AB Introduction Infertility has a high prevalence in the general population, affecting similar to 5 to 15% of couples in reproductive age. The assisted reproduction techniques (ART) include in vitro manipulation of gametes and embryos and are an important treatment indicated to these couples. It is well accepted that the implantation rate is positively influenced by the morphology of transferred embryos. However, we question if, apart from the assessment of embryo morphology, the number of produced embryos per cycle is also related to pregnancy rates in the first fresh transfer cycle.
   Purpose To evaluate the clinical pregnancy rate according to the number of formed embryos and the transfer of top quality embryos (TQEs).
   Methods In a retrospective cohort study, between January 2011 and December 2012, we evaluated women who underwent intracytoplasmic sperm injection (ICSI), aged < 40 years, and with at least 1 formed embryo fresh transferred in cleavage stage. These women were stratified into 3 groups according to the number of formed embryos (1 embryo, 2-3 and >= 4 embryos). Each group was divided into 2 subgroups according to the presence or not of at least 1 transferred TQE (1 with TQE; 1 without TQE; 2-3 with TQE, 2-3 without TQE; >= 4 with TQE; >= 4 without TQE). The clinical pregnancy rates were compared in each subgroup based on the presence or absence of at least one transferred TQE.
   Results During the study period, 636 women had at least one embryo to be transferred in the first fresh cycle (17.8% had 1 formed embryo [32.7% with TQE versus 67.3% without TQE], 42.1% of women had 2-3 formed embryos [55.6% with TQE versus 44.4% without TQE], and 40.1% of patients had >= 4 formed embryos [73.7% with TQE versus 26.3% without TQE]). The clinical pregnancy rate was significantly higher in the subgroup with >= 4 formed embryos with at least 1 transfered TQE (45.2%) compared with the subgroup without TQE (28.4%).
   Conclusions Having at least two available embryos and at least one TQE for embryo transfer are predictors of the pregnancy rates.
C1 [da Luz, Caroline Mantovani; Innocenti Giorgi, Vanessa Silvestre; Coelho Neto, Marcela Alencar; Martins, Wellington de Paula; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, Obstet & Gynecol Dept, DGO,FMRP,USP, Ribeirao Preto, SP, Brazil.
RP da Luz, CM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Obstet & Gynecol Dept, Ave Bandeirantes 3-900,8 Andar, BR-14048900 Ribeirao Preto, SP, Brazil.
EM carollinemantovani@gmail.com
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188; Silvestre Innocenti Giorgi,
   Vanessa/0000-0001-6760-283X
FU Universidade de Sao Paulo (USP); Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia do Hospital das Clinicas da Faculdade de Medicina de
   Ribeirao Preto (Foundation for Support in Teaching, Research and
   Assistance - FAEPA); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (Brazilian National Council for Research and Development (-
   CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The authors are grateful to Universidade de Sao Paulo (USP), the
   Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das
   Clinicas da Faculdade de Medicina de Ribeirao Preto (Foundation for
   Support in Teaching, Research and Assistance - FAEPA), and the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (Brazilian National
   Council for Research and Development (- CNPq) for their financial
   support.
CR Abdullah UH, 2016, J MATERN-FETAL NEO M, P1
   Al-Inany HG, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub4
   Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037
   Baker MJ, 2013, CRYOBIOLOGY, V66, P43, DOI 10.1016/j.cryobiol.2012.10.007
   Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046
   CHECK JH, 1991, FERTIL STERIL, V56, P1173
   Devreker F, 1999, HUM REPROD, V14, P3002, DOI 10.1093/humrep/14.12.3002
   Fauser BCJM, 2008, HUM REPROD UPDATE, V14, P1, DOI 10.1093/humupd/dmm034
   Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870
   Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175
   Luke B, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1242
   Macaluso M, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2008.09.046
   Martins WP, 2014, ULTRASOUND OBST GYN, V43, P25, DOI 10.1002/uog.12566
   Opsahl MS, 2001, J ASSIST REPROD GEN, V18, P551, DOI 10.1023/A:1011906024170
   Queenan JT, 2000, CLIN OBSTET GYNECOL, V43, P942, DOI 10.1097/00003081-200012000-00023
   Racowsky C, 2011, FERTIL STERIL, V95, P1985, DOI 10.1016/j.fertnstert.2011.02.009
   Revelli A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0080-6
   Salha O, 2000, J ASSIST REPROD GEN, V17, P335, DOI 10.1023/A:1009457112230
   Shrestha D, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.09
   Sunderam S, 2015, MMWR SURVEILL SUMM, V64, P1
   van Loendersloot L, 2014, J ADV RES, V5, P295, DOI 10.1016/j.jare.2013.05.002
   Weitzman VN, 2010, FERTIL STERIL, V93, P658, DOI 10.1016/j.fertnstert.2009.02.032
   WOOD C, 1985, FERTIL STERIL, V43, P245
   Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009
NR 24
TC 3
Z9 5
U1 0
U2 1
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD SEP
PY 2016
VL 38
IS 9
BP 465
EP 470
DI 10.1055/s-0036-1592338
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4PX
UT WOS:000410248100007
PM 27652995
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Barbosa, MWP
   Silva, LR
   Navarro, PA
   Ferriani, RA
   Nastri, CO
   Martins, WP
AF Barbosa, M. W. P.
   Silva, L. R.
   Navarro, P. A.
   Ferriani, R. A.
   Nastri, C. O.
   Martins, W. P.
TI Dydrogesterone vs progesterone for luteal-phase support: systematic
   review and meta-analysis of randomized controlled trials
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE assisted reproductive technique; dydrogesterone; infertility;
   luteal-phase supplementation; progesterone
ID IN-VITRO FERTILIZATION; HYPERSTIMULATION SYNDROME PATHOPHYSIOLOGY; ORAL
   DYDROGESTERONE; MICRONIZED PROGESTERONE; VAGINAL PROGESTERONE;
   INTRAMUSCULAR PROGESTERONE; ART CYCLES; IVF; ULTRASOUND; WORLDWIDE
AB Objectives To compare the effects of dydrogesterone and progesterone for luteal-phase support (LPS) in women undergoing assisted reproductive techniques (ART).
   Methods We performed a systematic review to identify relevant randomized controlled trials (RCTs) by searching the following electronic databases: Cochrane CENTRAL, PubMed, Scopus, Web of Science, ClinicalTrials.gov, ISRCTN Registry and WHO ICTRP.
   Results The last search was performed in October 2015. Eight RCTs were considered eligible and were included in the review and meta-analyses. There was no relevant difference between oral dydrogesterone and vaginal progesterone for LPS with respect to rate of ongoing pregnancy (risk ratio (RR), 1.04 (95% CI, 0.92-1.18); I-2, 0%; seven RCTs, 3134 women), clinical pregnancy (RR, 1.07 (95% CI, 0.93-1.23); I-2, 34%; eight RCTs, 3809 women) or miscarriage (RR, 0.77 (95% CI, 0.53-1.10); I-2, 0%; seven RCTs, 906 clinical pregnancies). Two of the three studies reporting on dissatisfaction of treatment identified lower levels of dissatisfaction among women using oral dydrogesterone than among women using vaginal progesterone (oral dydrogesterone vs vaginal progesterone capsules: 2/79 (2.5%) vs 90/351 (25.6%), respectively; oral dydrogesterone vs vaginal progesterone gel: 19/411 (4.6%) vs 74/411 (18.0%), respectively). The third study showed no difference in dissatisfaction rate (oral dydrogesterone vs vaginal progesterone capsules: 8/96 (8.3%) vs 8/114 (7.0%), respectively).
   Conclusions Oral dydrogesterone seems to be as effective as vaginal progesterone for LPS in ART cycles, and appears to be better tolerated. Copyright (C) 2016 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Barbosa, M. W. P.; Silva, L. R.; Navarro, P. A.; Ferriani, R. A.; Nastri, C. O.; Martins, W. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), HCRP, Ave Bandeirantes 3900,8 Andar,Campus Univ, BR-14048900 Sao Paulo, Brazil.
EM wpmartins@gmail.com
RI Nastri, Carolina O/E-1172-2012; Navarro, Paula/G-2744-2012; Martins,
   Wellington/B-1284-2008
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU CAPESCAPES; FAPESPl; CNPqNational Council for Scientific and
   Technological Development (CNPq); FMRP-USP
FX The authors received financial support from Brazilian official funding
   centers: CAPES (M.W.P.B.), FAPESPl (C.O.N.), CNPq (P.A.N., R.A.F.,
   W.P.M.) and FMRP-USP (P.A.N., R.A.F., W.P.M.). These institutions had no
   influence on the study design, interpretation of data or decision to
   publish the results.
CR Abbott, 2013, MULT STUD COMP EFF S
   Abbott, 2015, RAND OP LAB 2 ARM MU
   Abbott, 2013, EUCTR201200221500222
   Allahbadia GN, 2004, FERTIL STERIL, V82, pS194, DOI 10.1016/j.fertnstert.2004.07.513
   Carp H, 2015, GYNECOL ENDOCRINOL, V31, P422, DOI 10.3109/09513590.2015.1006618
   Chakravarty BN, 2006, HUM REPROD, V21, pI83
   Chakravarty BN, 2005, J STEROID BIOCHEM, V97, P416, DOI 10.1016/j.jsbmb.2005.08.012
   Chakravarty BN, 2004, HUMAN REPROD, V19, pi126
   Chakravarty BN, 2005, HUM REPROD, V20, pi139
   Daya S, 2003, HUM REPROD, V18, P1005, DOI 10.1093/humrep/deg238
   De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323
   Domitrz J, 1999, Ginekol Pol, V70, P8
   Fatemi HM, 2007, HUM REPROD UPDATE, V13, P581, DOI 10.1093/humupd/dmm021
   Fatemi H M, 2009, Reprod Biomed Online, V19 Suppl 4, P4331
   Ganesh A, 2011, FERTIL STERIL, V95, P1961, DOI 10.1016/j.fertnstert.2011.01.148
   Ghanem ME, 2012, ENHANCING SUCCESS AS, V1, P155
   Guo Wei, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P861
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
   HOLMDAHL TH, 1971, ACTA ENDOCRINOL-COP, V67, P353, DOI 10.1530/acta.0.0670353
   Iwase A, 2008, ARCH GYNECOL OBSTET, V277, P319, DOI 10.1007/s00404-007-0484-4
   JONES GS, 1991, CURR OPIN OBSTET GYN, V3, P641
   Khosravi D, 2015, INT J REPROD BIOMED, V13, P433
   KUPFERMINC MJ, 1990, HUM REPROD, V5, P271, DOI 10.1093/oxfordjournals.humrep.a137087
   Lockwood G, 2014, FERTIL STERIL, V101, P112, DOI 10.1016/j.fertnstert.2013.09.010
   Maher MA, 2013, ACTA OBSTET GYN SCAN, V92, P215, DOI 10.1111/aogs.12017
   Martins WP, 2016, ULTRASOUND OBST GYN, V47, P144, DOI 10.1002/uog.14874
   Martins WP, 2014, ULTRASOUND OBST GYN, V43, P25, DOI 10.1002/uog.12566
   Merriam KS, 2015, INT J ENDOCRINOL, DOI 10.1155/2015/685281
   NAHOUL K, 1993, MATURITAS, V16, P185, DOI 10.1016/0378-5122(93)90064-O
   Nastri CO, 2015, ULTRASOUND OBST GYN, V45, P377, DOI 10.1002/uog.14684
   Nastri CO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009517.pub3
   Nastri CO, 2010, J ASSIST REPROD GEN, V27, P121, DOI 10.1007/s10815-010-9387-6
   Patki A, 2007, GYNECOL ENDOCRINOL, V23, P68, DOI 10.1080/09513590701584857
   Saharkhiz N., 2014, COMP ORAL PROGESTERO
   Saharkhiz N, 2016, GYNECOL ENDOCRINOL, V32, P213, DOI 10.3109/09513590.2015.1110136
   Salehpour S., 2013, COMP ORAL DYDROGESTR
   Salehpour S, 2013, IRAN J REPROD MED, V11, P913
   Schindler AE, 2009, MATURITAS, V65, pS3, DOI 10.1016/j.maturitas.2009.10.011
   Schroder AK, 2004, REPROD BIOMED ONLINE, V8, P600, DOI 10.1016/S1472-6483(10)61110-8
   Schweppe KW, 2009, MATURITAS, V65, pS23, DOI 10.1016/j.maturitas.2009.11.011
   Shapiro D, 2014, REPROD BIOMED ONLINE, V29, pS4, DOI 10.1016/S1472-6483(14)50063-6
   Sotiriadis A, 2016, ULTRASOUND OBST GYN, V47, P386, DOI 10.1002/uog.15762
   Teixeira DM, 2015, ULTRASOUND OBST GYN, V45, P139, DOI 10.1002/uog.14639
   Tomic V., 2010, DYDROGESTERONE VERSU
   Tomic V, 2015, EUR J OBSTET GYN R B, V186, P49, DOI 10.1016/j.ejogrb.2014.11.002
   Vaisbuch E, 2014, REPROD BIOMED ONLINE, V28, P330, DOI 10.1016/j.rbmo.2013.10.022
   Vaisbuch E, 2012, REPROD BIOMED ONLINE, V25, P139, DOI 10.1016/j.rbmo.2012.04.005
   van der Linden M, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009154.pub2, 10.1002/14651858.CD009154.pub3]
   van Dulmen S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-55
   Yang Rui, 2014, Zhonghua Yi Xue Za Zhi, V94, P3256
NR 51
TC 15
Z9 18
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD AUG
PY 2016
VL 48
IS 2
BP 161
EP U53
DI 10.1002/uog.15814
PG 11
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DW5PV
UT WOS:000383699600005
PM 26577241
OA Bronze
DA 2020-12-17
ER

PT J
AU Da Broi, M
   Rocha, CV
   Placa, J
   Peronni, K
   Meola, J
   Silva, W
   Ferriani, RA
   Navarro, PA
AF Da Broi, M.
   Rocha, C. V., Jr.
   Placa, J.
   Peronni, K.
   Meola, J.
   Silva, W., Jr.
   Ferriani, R. A.
   Navarro, P. A.
TI Differential profile of transcripts detected by RNA-Seq in eutopic
   endometrium of infertile women with endometriosis and fertile controls
   during the implantation window
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
C1 [Da Broi, M.; Rocha, C. V., Jr.; Meola, J.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Placa, J.; Silva, W., Jr.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Genet, Ribeirao Preto, Brazil.
   [Peronni, K.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cellular & Mol Biol & Pathogen Bioagents, Ribeirao Preto, Brazil.
RI Da Broi, Michele G/E-7753-2012; Navarro, Paula/G-2744-2012
OI Da Broi, Michele G/0000-0003-4256-0228; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2016
VL 31
SU 1
MA P-357
BP 282
EP 283
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA VH6AN
UT WOS:000453583902164
DA 2020-12-17
ER

PT J
AU Lara, LAD
   Neto, MDC
   Martins, WD
   Ferriani, RA
   Navarro, PA
AF da Silva Lara, Lucia Alves
   Coelho Neto, Marcela de Alencar
   Martins, Wellington de Paula
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Assessment of Sexual Function in Infertile Women in a Gynecological Care
   Setting
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Article
DE Sexual; Sterility; Gynecology; Coitus; Sexual Intercourse
ID QUALITY-OF-LIFE; DIFFERENT MODEL; NATIONAL-SURVEY; INTERCOURSE;
   DYSFUNCTION; FREQUENCY; EDUCATION; HEALTH; COMMUNICATION; PREVALENCE
AB Introduction: Infertility has a high prevalence worldwide. There is also a high prevalence of sexual problems, mainly in gynecological care settings, but many women are unlikely to discuss sexual problems with their physicians.
   Aims: To verify how second-year gynecology residents (SGRs) assess the sexual function of infertile women who are undergoing assisted reproductive techniques (ART) at a single infertility tertiary care center in Brazil.
   Main Outcome Measures: Medical records of patients.
   Methods: This retrospective cohort study evaluated all medical records of women who underwent in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) between January 2011 and December 2012 at a fertility clinic of the Hospital das Clinicas of Ribeirao Preto Medical School, University of Sao Paulo.
   Results: A total of 616 women underwent ART during the study period. The mean patient age was 34.5 +/- 4.4 years, mean weight was 65.6 +/- 12.4 kg, mean height was 163 +/- 0.6 cm, and mean body mass index (BMI) was 24.8 +/- 4.3 kg/m(2). We classified the methods that medical residents used to assess the sexual frequency of these women as a numerical method, by categorization, or none (no assessment). A total of 26.7% (n = 166) of the SGRs did not assess female sexual function and 26.2% (n = 163) made assessments using categorization. SGRs who used a numerical method rather than categorization to classify the sexual frequency of their female patients were more likely to record answers to other questions on sexual desire, arousal, and orgasm.
   Conclusion: SGRs typically do not assess female sexual function in infertile couples. There was considerable heterogeneity among SGRs in their assessment of coital frequency and female sexual function. Copyright (C) 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
C1 [da Silva Lara, Lucia Alves; Coelho Neto, Marcela de Alencar; Martins, Wellington de Paula; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Sect Human Reprod, Dept Gynecol & Obstet, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Lara, LAD (corresponding author), Univ Sao Paulo, Sect Human Reprod, Dept Gynecol & Obstet, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM luciaalvess@yahoo.com.br
RI Lara, Lucia A/F-6873-2013; Navarro, Paula/G-2744-2012; Martins,
   Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Basson R, 2001, J SEX MARITAL THER, V27, P395, DOI 10.1080/713846827
   Basson R, 2000, J SEX MARITAL THER, V26, P51, DOI 10.1080/009262300278641
   Bitzer J, 2007, J SEX MED, V4, P29, DOI 10.1111/j.1743-6109.2006.00395.x
   Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046
   Brody S, 2004, J SEX MARITAL THER, V30, P251, DOI 10.1080/00926230490422368
   Ciocca G, 2015, J ENDOCRINOL INVEST, V38, P999, DOI 10.1007/s40618-015-0286-7
   ESKEW PN, 1981, OBSTET GYNECOL, V58, P642
   Estcourt C, 2009, INT J STD AIDS, V20, P324, DOI 10.1258/ijsa.2008.008325
   Huber LRB, 2014, MATERN CHILD HLTH J, V18, P1293, DOI 10.1007/s10995-013-1396-5
   Humphery S, 2001, FAM PRACT, V18, P516, DOI 10.1093/fampra/18.5.516
   Khanam M, 2011, J PAK MED ASSOC, V61, P648
   Klemetti R, 2010, ACTA OBSTET GYN SCAN, V89, P677, DOI 10.3109/00016341003623746
   Kottmel A, 2014, J SEX MED, V11, P2048, DOI 10.1111/jsm.12603
   Lamont J, 2012, J OBSTET GYNAECOL CA, V34, P769, DOI 10.1016/S1701-2163(16)35341-5
   Lara LAS, 2015, RECENT PATENTS ENDOC, V9, P46, DOI 10.2174/1872214809666150416151811
   Latif EZ, 2013, FERTIL STERIL, V100, P898, DOI 10.1016/j.fertnstert.2013.08.006
   Louis GMB, 2011, PAEDIATR PERINAT EP, V25, P413, DOI 10.1111/j.1365-3016.2011.01205.x
   McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623
   Monga M, 2004, UROLOGY, V63, P126, DOI 10.1016/j.urology.2003.09.015
   Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016
   Nelson CJ, 2008, J SEX MED, V5, P1907, DOI 10.1111/j.1743-6109.2008.00880.x
   Pan Bo-Chen, 2013, Zhonghua Nan Ke Xue, V19, P1087
   Pancholy AB, 2011, J SEX MED, V8, P361, DOI 10.1111/j.1743-6109.2010.02117.x
   Perlis N, 2013, FERTIL STERIL, V100, P511, DOI 10.1016/j.fertnstert.2013.04.020
   Polotsky AJ, 2015, J CLIN ENDOCR METAB, V100, P2405, DOI 10.1210/jc.2015-1178
   Practice Comm Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P631, DOI 10.1016/j.fertnstert.2013.07.011
   Rosen R, 2006, J SEX MED, V3, P37, DOI 10.1111/j.1743-6109.2005.00135.x
   Shindel AW, 2013, J SEX MED, V10, P4, DOI 10.1111/j.1743-6109.2012.02987.x
   Smith NK, 2015, J SEX MED, V12, P985, DOI 10.1111/jsm.12824
   Song SH, 2016, BJU INT, V117, P173, DOI 10.1111/bju.13201
   Vieira TCSB, 2015, J SEX MED, V12, P1154, DOI 10.1111/jsm.12875
   Stanford JB, 2007, AM J EPIDEMIOL, V165, P1088, DOI 10.1093/aje/kwk111
   Traish AM, 2007, EUR UROL, V52, P54, DOI 10.1016/j.eururo.2007.02.034
   WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301
   Xiao BL, 2010, FERTIL STERIL, V94, P1208, DOI 10.1016/j.fertnstert.2009.05.054
   Xing Xin, 2013, Zhonghua Nan Ke Xue, V19, P223
   Yulevitch A, 2013, J SEX MED, V10, P3059, DOI 10.1111/jsm.12322
NR 37
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD JUN
PY 2016
VL 13
IS 6
BP 938
EP 944
DI 10.1016/j.jsxm.2016.04.065
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA DX9PT
UT WOS:000384728300006
PM 27215689
DA 2020-12-17
ER

PT J
AU Neto, MAC
   Martins, WD
   da Luz, CM
   Jianini, BTGM
   Ferriani, RA
   Navarro, PA
AF Coelho Neto, Marcela Alencar
   Martins, Wellington de Paula
   da Luz, Caroline Mantovani
   Gazeto Melo Jianini, Bruna Talita
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Endometriosis, Ovarian Reserve and Live Birth Rate Following In Vitro
   Fertilization/Intracytoplasmic Sperm Injection
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE endometriosis; ovarian reserve; assisted reproduction; IVF; ICSI
ID ASSISTED REPRODUCTION; TRANSVAGINAL ULTRASOUND; DEEP ENDOMETRIOSIS;
   INFERTILITY; FERTILIZATION; DIAGNOSIS; PREVALENCE; ACCURACY; IMPACT;
   WOMEN
AB Purpose To evaluate whether women with endometriosis have different ovarian reserves and reproductive outcomes when compared with women without this diagnosis undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), and to compare the reproductive outcomes between women with and without the diagnosis considering the ovarian reserve assessed by antral follicle count (AFC).
   Methods This retrospective cohort study evaluated all women who underwent IVF/ICSI in a university hospital in Brazil between January 2011 and December 2012. All patients were followed up until a negative pregnancy test or until the end of the pregnancy. The primary outcomes assessed were number of retrieved oocytes and live birth. Women were divided into two groups according to the diagnosis of endometriosis, and each group was divided again into a group that had AFC <= 6 (poor ovarian reserve) and another that had AFC <= 7 (normal ovarian reserve). Continuous variables with normal distribution were compared using unpaired t-test, and those without normal distribution, using Mann-Whitney test. Binary data were compared using either Fisher's exact test or Chi-square (chi(2)) test. The significance level was set as p < 0.05.
   Results 787 women underwent IVF/ICSI (241 of which had endometriosis). Although the mean age has been similar between women with and without the diagnosis of endometriosis (33.8 +/- 4 versus 33.7 +/- 4.4 years, respectively), poor ovarian reserves were much more common in women with endometriosis (39.8 versus 22.7%). The chance of achieving live birth was similar between women with the diagnosis of endometriosis and those without it (19.1 versus 22.5%), and also when considering only women with a poor ovarian reserve (9.4 versus 8.9%) and only those with a normal ovarian reserve (25.5 versus 26.5%).
   Conclusions Women diagnosed with endometriosis are more likely to have a poor ovarian reserve; however, their chance of conceiving by IVF/ICSI is similar to the one observed in patients without endometriosis and with a comparable ovarian reserve.
C1 [Coelho Neto, Marcela Alencar; Martins, Wellington de Paula; da Luz, Caroline Mantovani; Gazeto Melo Jianini, Bruna Talita; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Hosp Clin Ribeirao Preto, Dept Ginecol & Obstet, Ctr Reprod Humana,Fac Med Ribeirao Preto, Ave Bandeirantes 3-900,8o Andar, BR-14048900 Ribeirao Preto, SP, Brazil.
EM pnavarro@fmrp.usp.br
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU Universidade de Sao Paulo (USP); Foundation for Support in Teaching,
   Research and Assistance (Faepa); Brazilian National Council for Research
   and Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors are grateful to Universidade de Sao Paulo (USP), the
   Foundation for Support in Teaching, Research and Assistance (Faepa), and
   the Brazilian National Council for Research and Development (CNPq) for
   their financial support.
CR Ahn SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795976
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   Bhattacharya S, 2009, HUM REPROD, V24, P3096, DOI 10.1093/humrep/dep287
   Bushnik T, 2012, HUM REPROD, V27, P738, DOI 10.1093/humrep/der465
   Neto MAC, 2015, ULTRASOUND OBST GYN, V46, P501, DOI 10.1002/uog.14884
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4
   Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457
   Exacoustos C, 2014, BEST PRACT RES CL OB, V28, P655, DOI 10.1016/j.bpobgyn.2014.04.010
   Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092
   Figueiredo JBP, 2013, ARCH GYNECOL OBSTET, V287, P779, DOI 10.1007/s00404-012-2672-0
   Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870
   Guerriero S, 2016, ULTRASOUND OBST GYN, V47, P281, DOI 10.1002/uog.15662
   Guerriero S, 2015, ULTRASOUND OBST GYN, V46, P534, DOI 10.1002/uog.15667
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Harb HM, 2013, BJOG-INT J OBSTET GY, V120, P1308, DOI 10.1111/1471-0528.12366
   Lima ML, 2015, ULTRASOUND OBST GYN, V46, P239, DOI 10.1002/uog.14763
   Lin XN, 2012, CHINESE MED J-PEKING, V125, P2688, DOI 10.3760/cma.j.issn.0366-6999.2012.15.008
   Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009591.pub2
   Noventa M, 2015, FERTIL STERIL, V104, P366, DOI 10.1016/j.fertnstert.2015.05.002
   Ozkan S, 2008, ANN NY ACAD SCI, V1127, P92, DOI 10.1196/annals.1434.007
   Picinato MC, 2014, FERTIL STERIL, V101, P379, DOI 10.1016/j.fertnstert.2013.10.009
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Ruth KS, 2016, HUM REPROD, V31, P473, DOI 10.1093/humrep/dev318
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Sotiriadis A, 2016, ULTRASOUND OBST GYN, V47, P386, DOI 10.1002/uog.15762
   Stern JE, 2013, J ASSIST REPROD GEN, V30, P1445, DOI 10.1007/s10815-013-0092-0
   Surrey ES, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/482959
   Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037
NR 31
TC 7
Z9 7
U1 0
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAY
PY 2016
VL 38
IS 5
BP 218
EP 224
DI 10.1055/s-0036-1584126
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4PJ
UT WOS:000410246000003
PM 27196950
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Navarro, PA
AF Da Broi, Michele Gomes
   Navarro, Paula Andrea
TI Oxidative stress and oocyte quality: ethiopathogenic mechanisms of
   minimal/mild endometriosis-related infertility
SO CELL AND TISSUE RESEARCH
LA English
DT Review
DE Early endometriosis; Infertility; Oocyte quality; Oxidative stress;
   Follicular microenvironment
ID IN-VITRO FERTILIZATION; MATURED HUMAN OOCYTES; FOLLICULAR-FLUID; MILD
   ENDOMETRIOSIS; PERITONEAL ENDOMETRIOSIS; ASSISTED REPRODUCTION; MOUSE
   OOCYTES; CUMULUS CELLS; FREE-RADICALS; WOMEN
AB Endometriosis, a highly prevalent gynecological disease, is often associated with infertility, even in its milder forms (minimal and mild endometriosis). However, no consensus has been established with regard to this relationship and the possible mechanisms involved have not been completely elucidated. The oocyte is believed to have an important role in the infertility presented by these patients. Hence, oxidative stress events associated with alterations in the peritoneal, serum and/or follicular microenvironments might result in poor oocyte quality and compromise the reproductive potential of these women. Here, we review possible mechanisms involved in oocyte quality impairment that might lead to infertility in patients with early endometriosis.
C1 [Da Broi, Michele Gomes; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, 3900 Ave Bandeirantes, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Da Broi, MG (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Human Reprod Div, 3900 Ave Bandeirantes, BR-14049900 Ribeirao Preto, SP, Brazil.
EM michi.dabroi@gmail.com
RI Navarro, Paula/G-2744-2012; Da Broi, Michele G/E-7753-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Agarwal A, 2006, REPROD BIOMED ONLINE, V13, P126
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5
   Alpay Z, 2006, J SOC GYNECOL INVEST, V13, P390, DOI 10.1016/j.jsgi.2006.05.002
   Appasamy M, 2008, FERTIL STERIL, V89, P912, DOI 10.1016/j.fertnstert.2007.04.034
   Attaran M, 2000, INT J FERTIL WOMEN M, V45, P314
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Barcelos IDES, 2015, REPROD BIOMED ONLINE, V30, P532, DOI 10.1016/j.rbmo.2015.01.012
   Bellelis P, 2010, REV ASSOC MED BRAS, V56, P467, DOI 10.1590/S0104-42302010000400022
   Bergqvist A, 2002, HUM REPROD UPDATE, V8, P79, DOI 10.1093/humupd/8.1.79
   BRIZEK CL, 1995, J ASSIST REPROD GEN, V12, P106, DOI 10.1007/BF02211378
   Da Broi MG, 2013, FERTIL STERIL, V100, pS425, DOI 10.1016/j.fertnstert.2013.07.581
   Da Broi MG, 2014, FERTIL STERIL, V102, pE79, DOI 10.1016/j.fertnstert.2014.07.267
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Da Broi MG, 2014, JBRA ASSIST REPROD, V18, P117
   De Santis L, 2005, REPROD BIOMED ONLINE, V11, P36, DOI 10.1016/S1472-6483(10)61296-5
   Donabela F, 2011, FERTIL STERIL, V96, pS236, DOI 10.1016/j.fertnstert.2011.07.909
   Eichenlaub-Ritter Ursula, 2002, Reprod Biomed Online, V5, P117
   Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699
   Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023
   Ferriani RA, 2013, 5 INT IVI C SEV SPAI
   Garcia-Velasco JA, 1999, HUM REPROD, V14, P77, DOI 10.1093/humrep/14.suppl_2.77
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Giorgi VS, 2015, REPROD SCI IN PRESS
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048
   Haouzi D, 2009, CURR MED CHEM, V16, P1905, DOI 10.2174/092986709788186075
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   HUGHES EG, 1993, FERTIL STERIL, V59, P963
   Jackson LW, 2005, HUM REPROD, V20, P2014, DOI 10.1093/humrep/dei001
   Jianini BTGM, 2014, JBRA ASSIST REPROD, V18, P117
   Kim NH, 1998, HUM REPROD, V13, P2217, DOI 10.1093/humrep/13.8.2217
   Kumbak B, 2008, GYNECOL OBSTET INVES, V65, P212, DOI 10.1159/000112310
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Ma CH, 2010, FERTIL STERIL, V93, P920, DOI 10.1016/j.fertnstert.2009.01.131
   Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Murphy AA, 1998, J CLIN ENDOCR METAB, V83, P2110, DOI 10.1210/jc.83.6.2110
   Navarro PA, 2013, 5 INT IVI C SEV SPAI
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804
   Parazzini F, 1999, HUM REPROD, V14, P1332
   Pasqualotto EB, 2004, FERTIL STERIL, V81, P973, DOI 10.1016/j.fertnstert.2003.11.021
   Pellicer A, 1995, HUM REPROD, V10, P91, DOI 10.1093/humrep/10.suppl_2.91
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Carvalho LFP, 2012, ARCH GYNECOL OBSTET, V286, P1033, DOI 10.1007/s00404-012-2439-7
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108
   Signorile PG, 2010, INT J BIOCHEM CELL B, V42, P778, DOI 10.1016/j.biocel.2010.03.008
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Singh Neeta, 2014, J Hum Reprod Sci, V7, P143, DOI 10.4103/0974-1208.138874
   Sung L, 1997, J ASSIST REPROD GEN, V14, P152, DOI 10.1007/BF02766132
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102
   Tesfaye D, 2009, REPROD FERT DEVELOP, V21, P451, DOI 10.1071/RD08190
   Van Blerkom J, 2001, HUM REPROD, V16, P757, DOI 10.1093/humrep/16.4.757
   Van Langendonckt A, 2002, FERTIL STERIL, V77, P861, DOI 10.1016/S0015-0282(02)02959-X
   Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
NR 68
TC 35
Z9 38
U1 0
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD APR
PY 2016
VL 364
IS 1
BP 1
EP 7
DI 10.1007/s00441-015-2339-9
PG 7
WC Cell Biology
SC Cell Biology
GA DI2AL
UT WOS:000373298000001
PM 26685866
DA 2020-12-17
ER

PT J
AU Giorgi, VSI
   Da Broi, MG
   Paz, CCP
   Ferriani, RA
   Navarro, PA
AF Giorgi, Vanessa S. I.
   Da Broi, Michele G.
   Paz, Claudia C. P.
   Ferriani, Rui A.
   Navarro, Paula A.
TI N-Acetyl-Cysteine and l-Carnitine Prevent Meiotic Oocyte Damage Induced
   by Follicular Fluid From Infertile Women With Mild Endometriosis
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE female infertility; endometriosis; follicular fluid; oocyte quality;
   oxidative stress
ID IN-VITRO FERTILIZATION; METAPHASE II OOCYTES; OXIDATIVE STRESS;
   DEVELOPMENTAL COMPETENCE; REACTIVE OXYGEN; BOVINE OOCYTES; PORCINE
   OOCYTES; UNEXPLAINED INFERTILITY; NUCLEAR MATURATION; MAMMALIAN OOCYTES
AB This study evaluated the potential protective effect of the antioxidants, l-carnitine (LC) and N-acetyl-cysteine (NAC), in preventing meiotic oocyte damage induced by follicular fluid (FF) from infertile women with mild endometriosis (ME). We performed an experimental study. The FF samples were obtained from 22 infertile women undergoing stimulated cycles for intracytoplasmic sperm injection (11 with ME and 11 without endometriosis). Immature bovine oocytes were submitted to in vitro maturation (IVM) divided into 9 groups: no-FF (No-FF); with FF from control (CFF) or ME (EFF) groups; and with LC (C + LC and E + LC), NAC (C + NAC and E + NAC), or both antioxidants (C + 2Ao and E + 2Ao). After IVM, oocytes were immunostained for visualization of microtubules and chromatin by confocal microscopy. The percentage of meiotically normal metaphase II (MII) oocytes was significantly lower in the EFF group (51.35%) compared to No-FF (86.36%) and CFF (83.52%) groups. The E + NAC (62.22%), E + LC (80.61%), and E + 2Ao (61.40%) groups showed higher percentage of normal MII than EFF group. The E + LC group showed higher percentage of normal MII than E + NAC and E + 2Ao groups and a similar percentage to No-FF and CFF groups. Therefore, FF from infertile women with ME causes meiotic abnormalities in bovine oocytes, and, for the first time, we demonstrated that the use of NAC and LC prevents these damages. Our findings elucidate part of the pathogenic mechanisms involved in infertility associated with ME and open perspectives for further studies investigating whether the use of LC could improve the natural fertility and/or the results of in vitro fertilization of women with ME.
C1 [Giorgi, Vanessa S. I.; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Human Reprod Div, BR-14049 Ribeirao Preto, SP, Brazil.
   [Da Broi, Michele G.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.
   [Paz, Claudia C. P.; Ferriani, Rui A.; Navarro, Paula A.] CNPq, Natl Inst Hormones & Womens Hlth, Brasilia, DF, Brazil.
RP Giorgi, VSI (corresponding author), Ave Bandeirantes, BR-3900 Ribeirao Preto, SP, Brazil.
EM vanessasig@gmail.com
RI de Paz, Claudia Cristina Paro/A-8852-2014; de Paz, Claudia Cristina
   Paro/E-8791-2012; Navarro, Paula/G-2744-2012; Da Broi, Michele
   G/E-7753-2012
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; de Paz, Claudia
   Cristina Paro/0000-0002-7267-4552; Da Broi, Michele
   G/0000-0003-4256-0228; Navarro, Paula Andrea/0000-0003-2368-4188;
   Silvestre Innocenti Giorgi, Vanessa/0000-0001-6760-283X
FU Foundation for Research Support of the State of Sao Paulo (FAPESP,
   Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/15070-1]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: Foundation for
   Research Support of the State of Sao Paulo (FAPESP, grant number
   2012/15070-1, Brazil).
CR Adona PR, 2004, ZYGOTE, V12, P197, DOI 10.1017/S0967199404002771
   Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045
   ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Beckman KB, 1998, PHYSIOL REV, V78, P547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Berube S, 1998, FERTIL STERIL, V69, P1034, DOI 10.1016/S0015-0282(98)00081-8
   BREMER J, 1985, BIOCHIM BIOPHYS ACTA, V833, P9, DOI 10.1016/0005-2760(85)90247-4
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Canis M, 1997, FERTIL STERIL, V67, P817
   Coticchio G, 2010, FERTIL STERIL, V93, P2056, DOI 10.1016/j.fertnstert.2008.12.011
   D'Hooghe TM, 2003, SEMIN REPROD MED, V21, P243
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   Das S, 2006, HUM REPROD, V21, P2403, DOI 10.1093/humrep/del156
   DEFLORA S, 1985, CARCINOGENESIS, V6, P1735
   Dekhuijzen PNR, 2004, EUR RESPIR J, V23, P629, DOI 10.1183/09031936.04.00016804
   Diaz I, 2000, FERTIL STERIL, V74, P31, DOI 10.1016/S0015-0282(00)00570-7
   Eichenlaub-Ritter Ursula, 2002, Reprod Biomed Online, V5, P117
   Ferreira EM, 2009, EUR J OBSTET GYN R B, V145, P76, DOI 10.1016/j.ejogrb.2009.03.016
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Goud PT, 2014, FERTIL STERIL, V102
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   Hashimoto S, 2002, BIOL REPROD, V66, P1696, DOI 10.1095/biolreprod66.6.1696
   Holubcova Z, 2015, SCIENCE, V348, P1143, DOI 10.1126/science.aaa9529
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025
   Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154
   Limoli CL, 1998, CANCER RES, V58, P3712
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Liu JM, 2012, HUM REPROD, V27, P1411, DOI 10.1093/humrep/des019
   Liu L, 2004, BIOL REPROD, V71, P1724, DOI 10.1095/biolreprod.104.028985
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692
   Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2005, FERTIL STERIL, V83, P1197, DOI 10.1016/j.fertnstert.2004.07.983
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   O'Gorman A, 2013, REPRODUCTION, V146, P389, DOI 10.1530/REP-13-0184
   Pandey AN, 2010, J CELL BIOCHEM, V111, P521, DOI 10.1002/jcb.22736
   Pellicer A, 2001, ANN NY ACAD SCI, V943, P122, DOI 10.1111/j.1749-6632.2001.tb03796.x
   Phongnimitr T, 2013, ANIM SCI J, V84, P719, DOI 10.1111/asj.12067
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Sharma RK, 2013, REPROD SCI, V20, P1293, DOI 10.1177/1933719113483018
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Somfai T, 2011, REPROD FERT DEVELOP, V23, P912, DOI 10.1071/RD10339
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Varnagy A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-67
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
   Whitaker BD, 2012, REPROD FERT DEVELOP, V24, P1048, DOI 10.1071/RD12002
   Whitaker BD, 2010, REPROD DOMEST ANIM, V45, P755, DOI 10.1111/j.1439-0531.2009.01344.x
   Yalcinkaya E, 2013, J TURK-GER GYNECOL A, V14, P136, DOI 10.5152/jtgga.2013.53323
   Yang X, 2012, FERTIL STERIL, V97, P1438, DOI 10.1016/j.fertnstert.2012.02.034
   Yazaki T, 2013, ANIM SCI J, V84, P395, DOI 10.1111/asj.12016
NR 65
TC 20
Z9 20
U1 0
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2016
VL 23
IS 3
BP 342
EP 351
DI 10.1177/1933719115602772
PG 10
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DE6BW
UT WOS:000370719100009
PM 26342050
DA 2020-12-17
ER

PT J
AU Martins, WP
   Ferriani, RA
   Navarro, PA
   Nastri, CO
AF Martins, W. P.
   Ferriani, R. A.
   Navarro, P. A.
   Nastri, C. O.
TI GnRH agonist during luteal phase in women undergoing assisted
   reproductive techniques: systematic review and meta-analysis of
   randomized controlled trials
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE assisted reproduction; ICSI; infertility; IVF; luteal phase support;
   subfertility
ID GONADOTROPIN-RELEASING-HORMONE; ANTEPARTUM STILLBIRTH; RISK-FACTORS;
   ICSI CYCLES; SUPPORT; IMPLANTATION; IMPROVE; TIME
AB ObjectiveTo identify, evaluate and summarize the available evidence regarding the effectiveness and safety of administering a gonadotropin releasing hormone (GnRH) agonist during the luteal phase in women undergoing assisted reproductive techniques.
   MethodsIn this systematic review and meta-analysis, we searched for randomized controlled trials (RCTs) comparing the addition of a GnRH agonist during the luteal phase, compared with standard luteal-phase support. We searched seven electronic databases and hand-searched the reference lists of included studies and related reviews. Our primary outcome was live birth or ongoing pregnancy per randomized woman. Our secondary outcomes were clinical pregnancy per randomized woman, miscarriage per clinical pregnancy, adverse perinatal outcome and congenital malformations.
   ResultsThe evidence from eight studies examining 2776 women showed a relative risk (RR) for live birth or ongoing pregnancy of 1.26 (95% CI, 1.04-1.53; I-2 = 58%). Sensitivity analysis when excluding the studies that did not report live birth and those at high risk of bias resulted in one study examining 181 women with an RR of 1.07 (95% CI, 0.73-1.58). Subgroup analysis separating the studies by single/multiple doses of GnRH agonists or by ovarian stimulation with GnRH agonist/antagonist was unable to explain the observed heterogeneity. The quality of the evidence was deemed to be very low: it was downgraded because of the limitation of the included studies, imprecision, inconsistency across the studies' results, and suspicion of publication bias. None of the included studies reported adverse perinatal outcomes or congenital malformations.
   ConclusionsThere is evidence that adding GnRH agonist during the luteal phase improves the likelihood of ongoing pregnancy. However, this evidence is of very low quality and there is no evidence for adverse perinatal outcome and congenital malformations. We therefore believe that including this intervention in clinical practice would be premature. Copyright (c) 2015 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Martins, W. P.; Ferriani, R. A.; Navarro, P. A.; Nastri, C. O.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, DGO FMRP USP, BR-14049 Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), HCRP, Av Bandeirantes 3900,8 Andar,Campus Univ, BR-14048900 Ribeirao Preto, SP, Brazil.
EM wpmartins@gmail.com
RI Nastri, Carolina O/E-1172-2012; Martins, Wellington/B-1284-2008;
   Navarro, Paula/G-2744-2012
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU Medical School of Ribeirao Preto, University of Sao Paulo (FMRP-USP),
   Brazil; National Council for Scientific and Technological Development
   (CNPq), BrazilNational Council for Scientific and Technological
   Development (CNPq); Foundation to Support Education, Research and Care,
   University Hospital, Medical School of Ribeirao Preto, University of Sao
   Paulo (FAEPA), Brazil
FX We thank Dr Abha Majumdar and Dr Abdelhamid Benmachiche who kindly
   provided additional information regarding their studies. Funding was
   received from the Medical School of Ribeirao Preto, University of Sao
   Paulo (FMRP-USP), Brazil; The National Council for Scientific and
   Technological Development (CNPq), Brazil; Foundation to Support
   Education, Research and Care, University Hospital, Medical School of
   Ribeirao Preto, University of Sao Paulo (FAEPA), Brazil. The funders had
   no role in study design, data collection and analysis, decision to
   publish or preparation of the manuscript.
CR AboHamila F, 2011, KASR AL AINI J OBSTE, V2, P14
   Aboulghar MA, 2015, REPROD BIOMED ONLINE, V30, P52, DOI 10.1016/j.rbmo.2014.09.017
   Ata B, 2008, HUM REPROD, V23, P668, DOI 10.1093/humrep/dem421
   Ata B, 2009, SINGLE DOSE GONADOTR
   Bellver J, 2010, FERTIL STERIL, V94, P1065, DOI 10.1016/j.fertnstert.2009.04.044
   Benmachiche A, 2014, LUTEAL SUPPLEMENTATI
   Brigante CMM, 2013, FERTIL STERIL, V100, pS299, DOI 10.1016/j.fertnstert.2013.07.1020
   Casan EM, 1999, MOL HUM REPROD, V5, P234, DOI 10.1093/molehr/5.3.234
   Cengaver N., 2014, EFFECT GNRH AGONIST
   Fatemi H M, 2009, Reprod Biomed Online, V19 Suppl 4, P4331
   Fujii S, 2001, HUM REPROD, V16, P1671, DOI 10.1093/humrep/16.8.1671
   Gizzo S, 2014, GYNECOL ENDOCRINOL, V30, P902, DOI 10.3109/09513590.2014.964638
   Gordon A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-12
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
   Inamdar Dattaprasad B, 2012, J Hum Reprod Sci, V5, P279, DOI 10.4103/0974-1208.106341
   Isik AZ, 2009, REPROD BIOMED ONLINE, V19, P472, DOI 10.1016/j.rbmo.2009.04.001
   Isikoglu M, 2007, J REPROD MED, V52, P639
   Kyrou D, 2011, HUM REPROD UPDATE, V17, P734, DOI 10.1093/humupd/dmr029
   Loumaye E, 2004, ABSTRACTS 20 ANN M E, V19, pi4
   Nam DH, 2005, THERIOGENOLOGY, V63, P190, DOI 10.1016/j.theriogenology.2004.04.004
   Oliveira JBA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-107
   Ozgur K, 2002, FERTIL STERIL, V78, pS53, DOI 10.1016/S0015-0282(02)03518-5
   Pirard C, 2006, HUM REPROD, V21, P1894, DOI 10.1093/humrep/del072
   QFS, 2014, GNRH PROG VERS PROG
   Qublan H, 2008, Hum Fertil (Camb), V11, P43, DOI 10.1080/14647270701704768
   Raga F, 1999, ENDOCRINOLOGY, V140, P3705, DOI 10.1210/en.140.8.3705
   Razieh DF, 2009, TAIWAN J OBSTET GYNE, V48, P245, DOI 10.1016/S1028-4559(09)60297-7
   Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8
   Tesarik J, 2004, HUM REPROD, V19, P1176, DOI 10.1093/humrep/deh235
   Tesarik J, 2006, HUM REPROD, V21, P2572, DOI 10.1093/humrep/del173
   Tsafrir A, 2007, LUTEAL PHASE GNRH AG
   van der Linden M, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009154.pub2, 10.1002/14651858.CD009154.pub3]
   Yildiz GA, 2014, EUR J OBSTET GYN R B, V182, P66, DOI 10.1016/j.ejogrb.2014.08.026
   ZAFARDOUST S, 2015, J REPROD INFERTIL, V16, P116
NR 35
TC 14
Z9 16
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD FEB
PY 2016
VL 47
IS 2
BP 144
EP +
DI 10.1002/uog.14874
PG 9
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DD3PP
UT WOS:000369835100003
PM 25854891
OA Bronze
DA 2020-12-17
ER

PT J
AU Lara, LAD
   Lima, MLD
   Romao, GS
   Ferriani, RA
   Navarro, PADS
AF da Silva Lara, Lucia Alves
   dos Santos Lima, Maria Lucia
   Romao, Gustavo Salata
   Ferriani, Rui Alberto
   de Albuquerque Salles Navarro, Paula Andrea
TI Response to Letter to Editor Entitled "Obesity, Overweight, Female
   Sexual Function, and Penile-Vaginal Intercourse Frequency"
SO JOURNAL OF SEX & MARITAL THERAPY
LA English
DT Letter
ID PROVOKED VESTIBULODYNIA; PARTNER RESPONSES; WOMENS WAIST; SATISFACTION;
   DYSFUNCTION; PREVALENCE; DEFINITIONS; ASSOCIATION; PREDICTORS; IMPACT
C1 [da Silva Lara, Lucia Alves; dos Santos Lima, Maria Lucia; Romao, Gustavo Salata; Ferriani, Rui Alberto; de Albuquerque Salles Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, Sect Human Reprod, Sexual Med Serv,Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Ferriani, Rui Alberto; de Albuquerque Salles Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, INCt CNPq Hormones Protect & Risks Womens Hlth, Ribeirao Preto, SP, Brazil.
RP Lara, LAD (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Sect Human Reprod, Dept Gynecol & Obstet, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM luciaalvess@yahoo.com.br
RI Lara, Lucia A/F-6873-2013; Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR Abdo CHN, 2004, INT J IMPOT RES, V16, P160, DOI 10.1038/sj.ijir.3901198
   Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7
   Basson R, 2000, J SEX MARITAL THER, V26, P51, DOI 10.1080/009262300278641
   Basson R, 2012, J SEX MED, V9, P2077, DOI 10.1111/j.1743-6109.2012.02803.x
   Brody S, 2004, J SEX MARITAL THER, V30, P251, DOI 10.1080/00926230490422368
   Brody S, 2013, ARCH SEX BEHAV, V42, P1191, DOI 10.1007/s10508-012-0058-9
   Castellini G, 2010, J SEX MED, V7, P3969, DOI 10.1111/j.1743-6109.2010.01990.x
   Chang SCH, 2013, J SEX RES, V50, P502, DOI 10.1080/00224499.2012.661488
   Costa RM, 2014, EUR J OBSTET GYN R B, V182, P118, DOI 10.1016/j.ejogrb.2014.09.007
   Lara LAD, 2016, J SEX MARITAL THER, V42, P403, DOI 10.1080/0092623X.2015.1053024
   Degauquier C, 2012, Rev Med Brux, V33, P153
   Esposito K, 2007, INT J IMPOT RES, V19, P353, DOI 10.1038/sj.ijir.3901548
   Fahs B, 2011, ARCH SEX BEHAV, V40, P903, DOI 10.1007/s10508-010-9681-5
   Huber LRB, 2014, ANN EPIDEMIOL, V24, P655, DOI 10.1016/j.annepidem.2014.06.004
   HURLBERT DF, 1993, J SEX MARITAL THER, V19, P154, DOI 10.1080/00926239308404899
   Ishak IH, 2010, J SEX MED, V7, P3080, DOI 10.1111/j.1743-6109.2010.01848.x
   MARSIGLIO W, 1991, J GERONTOL, V46, pS338, DOI 10.1093/geronj/46.6.S338
   Press G. G., 2008, CAMBRIDGE ADV LEARNE
   Rosen NO, 2015, J SEX MED, V12, P1028, DOI 10.1111/jsm.12840
   Rosen NO, 2014, HEALTH PSYCHOL, V33, P823, DOI 10.1037/a0034550
   Smith KB, 2014, J SEX MED, V11, P1283, DOI 10.1111/jsm.12484
   Wahlin-Jacobsen S, 2015, J SEX MED, V12, P358, DOI 10.1111/jsm.12774
   Zueff LN, 2015, J SEX MARITAL THER, V41, P227, DOI 10.1080/0092623X.2013.864369
NR 23
TC 0
Z9 0
U1 0
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0092-623X
EI 1521-0715
J9 J SEX MARITAL THER
JI J. Sex Marital Ther.
PY 2016
VL 42
IS 5
BP 387
EP 390
DI 10.1080/0092623X.2015.1113592
PG 4
WC Psychology, Clinical; Family Studies
SC Psychology; Family Studies
GA DR3AF
UT WOS:000379774300001
PM 26644003
DA 2020-12-17
ER

PT J
AU Lara, LAD
   Lima, MLD
   Romao, GS
   Ferriani, RA
   Navarro, PADS
AF da Silva Lara, Lucia Alves
   dos Santos Lima, Maria Lucia
   Romao, Gustavo Salata
   Ferriani, Rui Alberto
   de Albuquerque Salles Navarro, Paula Andrea
TI Factors Related to Coital Frequency of Women in Their Thirties
SO JOURNAL OF SEX & MARITAL THERAPY
LA English
DT Article
ID LOW SEXUAL FUNCTION; MIDDLE-AGED WOMEN; BODY-MASS INDEX; RISK-FACTORS;
   HETEROSEXUAL MEN; OLDER-ADULTS; SATISFACTION; PREVALENCE; INTERCOURSE;
   POPULATION
AB This cross-sectional study aimed to identify factors related to coital frequency (CF) among 254 women in their 30s using a semistructured interview to collect sociodemographic, anthropometric, reproductive, clinical, and relationship data. CF was characterized as (a) never, (b) rarely (1times/month), (c) occasionally (1times /week), (d) regularly (2-3times/week), or (e) frequently (>3times/week). The mean age was 34.38 +/- 0.43years, mean body mass index (BMI) was 27.86 +/- 6.52 kg, mean family income was US$1,044.18 +/- 796.19, mean number of children was 1.71 +/- 0.89, and mean relationship duration was 8.87 +/- 5.11years. Eighty-seven women (35.2%) were taking hormonal contraceptives, 143 (98.0%) were employed, 239 (96.48%) had a secondary or higher education, and 9 (3.62%) had primary schooling. CF was classified as >3times/week in 22 (8.66%), 2-3times/week for 98 (38.58%), 1times/week in 40 (15.75%), 1times/month in 14 (5.51%), and never in 5 (1.97%). Women who reported having coitus >3times/week a week had significantly higher body mass index (BMI; 32.72 +/- 7.42kg/m(2)) than those who had coitus 2-3times/week (28.45 +/- 6.76kg/m(2)) and 1times /week (26.81 +/- 5.39kg/m(2)) (p < 0.01 for both comparisons). Thus, coital frequency varies in women in their 30s. Obese women had a higher CF than normal-weight and overweight women.
C1 [da Silva Lara, Lucia Alves; dos Santos Lima, Maria Lucia; Romao, Gustavo Salata; Ferriani, Rui Alberto; de Albuquerque Salles Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, Sexual Med Serv, Sect Human Reprod,Dept Gynecol & Obstet, Sao Paulo, Brazil.
   [Ferriani, Rui Alberto; de Albuquerque Salles Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, INCt CNPq Hormones Protect & Risks Womens Hlth, Sao Paulo, Brazil.
RP Lara, LAD (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Sect Human Reprod, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM luciaalvess@yahoo.com.br
RI Navarro, Paula/G-2744-2012; Lara, Lucia A/F-6873-2013
OI Navarro, Paula Andrea/0000-0003-2368-4188
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [Proc. 2013/16118-0]
FX Maria L. S. Lima received a scholarship from FAPESP (Proc.
   2013/16118-0).
CR Ackard DM, 2000, INT J EAT DISORDER, V28, P422, DOI 10.1002/1098-108X(200012)28:4<422::AID-EAT10>3.3.CO;2-T
   Aslan E, 2008, J SEX MED, V5, P2044, DOI 10.1111/j.1743-6109.2008.00873.x
   Aslan E, 2009, J SEX MED, V6, P1491, DOI 10.1111/j.1743-6109.2009.01259.x
   Avis NE, 2005, MENOPAUSE, V12, P385, DOI 10.1097/01.GME.0000151656.92317.A9
   Beckman N, 2014, J SEX MED, V11, P401, DOI 10.1111/jsm.12381
   Benetti-Pinto CL, 2015, ARCH GYNECOL OBSTET, V291, P451, DOI 10.1007/s00404-014-3423-1
   Blumel JE, 2004, MENOPAUSE, V11, P78, DOI 10.1097/01.GME.0000072481.97324.7F
   Castellanos-Torres E, 2013, ANN EPIDEMIOL, V23, P150, DOI 10.1016/j.annepidem.2012.12.010
   Colson MH, 2006, J SEX MED, V3, P121, DOI 10.1111/j.1743-6109.2005.00166.x
   Davison SL, 2008, J SEX MED, V5, P1214, DOI 10.1111/j.1743-6109.2008.00780.x
   Degauquier C, 2012, Rev Med Brux, V33, P153
   Dennerstein L, 2001, FERTIL STERIL, V76, P456, DOI 10.1016/S0015-0282(01)01978-1
   EVANS DJ, 1983, J CLIN ENDOCR METAB, V57, P304, DOI 10.1210/jcem-57-2-304
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
   Gast MJ, 2009, MENOPAUSE, V16, P247, DOI 10.1097/gme.0b013e318184c440
   Hall KS, 2014, J SEX MED, V11, P1982, DOI 10.1111/jsm.12607
   Hendrickx L, 2014, J SEX RES, V51, P1, DOI 10.1080/00224499.2013.819065
   Huber LRB, 2014, ANN EPIDEMIOL, V24, P655, DOI 10.1016/j.annepidem.2014.06.004
   Johannes CB, 1997, MATURITAS, V26, P175, DOI 10.1016/S0378-5122(97)01102-X
   Kontula O, 2009, J SEX RES, V46, P46, DOI 10.1080/00224490802624414
   Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423
   Lindau ST, 2010, DIABETES CARE, V33, P2202, DOI 10.2337/dc10-0524
   Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810
   Lo SST, 2013, MATURITAS, V74, P190, DOI 10.1016/j.maturitas.2012.11.006
   Mitchell KR, 2009, J SEX MED, V6, P2434, DOI 10.1111/j.1743-6109.2009.01368.x
   Morotti E, 2013, J SEX MED, V10, P1034, DOI 10.1111/jsm.12045
   Mulhall J, 2008, J SEX MED, V5, P788, DOI 10.1111/j.1743-6109.2007.00765.x
   Nicolosi A, 2005, BJU INT, V95, P609, DOI 10.1111/j.1464-410X.2005.05348.x
   Pagidas K, 2010, FERTIL STERIL, V94, P1447, DOI 10.1016/j.fertnstert.2009.05.048
   Pascoal PM, 2014, J SEX RES, V51, P22, DOI 10.1080/00224499.2013.815149
   Richters J, 2003, AUST NZ J PUBL HEAL, V27, P171, DOI 10.1111/j.1467-842X.2003.tb00805.x
   Sanchez DT, 2007, ARCH SEX BEHAV, V36, P808, DOI 10.1007/s10508-007-9205-0
   Smith A, 2011, J SEX MARITAL THER, V37, P104, DOI 10.1080/0092623X.2011.560531
   Song SH, 2008, J SEX MED, V5, P1694, DOI 10.1111/j.1743-6109.2008.00840.x
   Tchernof A, 2000, HORM METAB RES, V32, P526, DOI 10.1055/s-2007-978681
   Wee C. C., 2014, J GEN INTERNAL MED
   WILSON CA, 1986, PHARMACOL BIOCHEM BE, V24, P1175, DOI 10.1016/0091-3057(86)90167-X
NR 37
TC 1
Z9 1
U1 0
U2 8
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0092-623X
EI 1521-0715
J9 J SEX MARITAL THER
JI J. Sex Marital Ther.
PY 2016
VL 42
IS 5
BP 403
EP 412
DI 10.1080/0092623X.2015.1053024
PG 10
WC Psychology, Clinical; Family Studies
SC Psychology; Family Studies
GA DR3AF
UT WOS:000379774300004
PM 26036273
DA 2020-12-17
ER

PT J
AU Donabela, FC
   Meola, J
   Padovan, CC
   de Paz, CCP
   Navarro, PA
AF Donabela, Flavia Cappello
   Meola, Juliana
   Padovan, Cristiana Carolina
   Paro de Paz, Claudia Cristina
   Navarro, Paula Andrea
TI Higher SOD1 Gene Expression in Cumulus Cells From Infertile Women With
   Moderate and Severe Endometriosis
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE SOD1; cumulus cells; endometriosis; infertility; ICSI
ID IN-VITRO FERTILIZATION; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; OXIDATIVE
   STRESS; SUPEROXIDE-DISMUTASE; FOLLICULAR-FLUID; ASSISTED REPRODUCTION;
   OOCYTES; MARKERS; LOCALIZATION; BIOMARKERS
AB It is questioned whether worsening of oocyte quality and oxidative stress (OS) are involved in the pathogenesis of infertility related to endometriosis and in compromised intracytoplasmic sperm injection (ICSI) outcomes. Cumulus cells (CCs) protect oocytes from entering apoptosis induced by OS. Thus, we carried out a case-control study comparing expression of superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), and glutathione peroxidase 4 (GPX4; genes encoding for the main antioxidant enzymes) in CCs from mature oocytes of 26 infertile patients with minimal/mild endometriosis, 14 patients with moderate/severe endometriosis, and 41 controls undergoing controlled ovarian stimulation for ICSI, using real-time polymerase chain reaction. As a secondary objective, we investigated the interaction between the expression of these genes and clinical pregnancy (CP) by a statistical model. Only infertile women with moderate/severe endometriosis showed increased expression of the SOD1 in CCs compared to women with minimal/mild endometriosis and controls, with a positive interaction between increased expression and the occurrence of CP, suggesting that SOD1 might be a potential biomarker of CP following ICSI.
C1 [Donabela, Flavia Cappello; Meola, Juliana; Padovan, Cristiana Carolina; Navarro, Paula Andrea] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Gynecol & Obstet, Lab Biol Reprod, BR-05508 Sao Paulo, Brazil.
   [Paro de Paz, Claudia Cristina] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Genet, Genet Lab, BR-05508 Sao Paulo, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, HC FMRP, Sch Med Ribeirao Preto, Dept Gynecol & Obstet, Av Bandeirantes 3900, BR-05508 Sao Paulo, Brazil.
EM drapaulanavarro@gmail.com
RI Navarro, Paula/G-2744-2012; de Paz, Claudia Cristina Paro/A-8852-2014;
   de Paz, Claudia Cristina Paro/E-8791-2012; Lovato, Juliana
   Meola/E-3440-2012
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; de Paz, Claudia
   Cristina Paro/0000-0002-7267-4552; Lovato, Juliana
   Meola/0000-0003-2514-4011; Navarro, Paula Andrea/0000-0003-2368-4188
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/581976]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [309056/2009-8, 503867/2010-1, 474858/2009-0];
   National Institute of Hormones and Women's Health, Brazil
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was financially supported by FAPESP (Grant 2008/581976), CNPq (Grants
   309056/2009-8; 503867/2010-1; 474858/2009-0), and the National Institute
   of Hormones and Women's Health, Brazil.
CR Aboulghar Mohamed A., 2003, Archives of Gynecology and Obstetrics, V267, P177
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037
   Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067
   Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065
   Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   BECK Y, 1987, NUCLEIC ACIDS RES, V15, P9076, DOI 10.1093/nar/15.21.9076
   BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292
   Canis M, 1997, FERTIL STERIL, V67, P817
   CHADA S, 1990, GENOMICS, V6, P268, DOI 10.1016/0888-7543(90)90566-D
   Cohen J, 1988, STAT POWER ANAL BEHA
   de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4
   Diaz I, 2000, FERTIL STERIL, V74, P31, DOI 10.1016/S0015-0282(00)00570-7
   Donnez J, 2002, GYNECOL OBSTET INVES, V54, P2, DOI 10.1159/000066288
   El Mouatassim S, 1999, MOL HUM REPROD, V5, P720, DOI 10.1093/molehr/5.8.720
   Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43
   Gasca S, 2007, REPROD BIOMED ONLINE, V14, P175, DOI 10.1016/S1472-6483(10)60785-7
   Gomes FM, 2008, EUR J OBSTET GYN R B, V138, P60, DOI 10.1016/j.ejogrb.2007.12.008
   Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048
   Haouzi D, 2009, HUM REPROD, V24, P198, DOI 10.1093/humrep/den360
   Harb HM, 2013, BJOG-INT J OBSTET GY, V120, P1308, DOI 10.1111/1471-0528.12366
   Harlow CR, 1996, J CLIN ENDOCR METAB, V81, P426, DOI 10.1210/jc.81.1.426
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Januel C, 2006, BBA-MOL CELL BIOL L, V1761, P1228, DOI 10.1016/j.bbalip.2006.07.015
   LAPOLT PS, 1995, ENDOCRINOLOGY, V136, P5533, DOI 10.1210/en.136.12.5533
   Lin XN, 2012, CHINESE MED J-PEKING, V125, P2688, DOI 10.3760/cma.j.issn.0366-6999.2012.15.008
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Matos L, 2009, MOL HUM REPROD, V15, P411, DOI 10.1093/molehr/gap034
   Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Opoien HK, 2012, FERTIL STERIL, V97, P912, DOI 10.1016/j.fertnstert.2012.01.112
   Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172
   Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179
   Carvalho LFP, 2012, ARCH GYNECOL OBSTET, V286, P1033, DOI 10.1007/s00404-012-2439-7
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   ROVERI A, 1992, J BIOL CHEM, V267, P6142
   SAS INSTITUTE, 2003, SAS STAT 2003 US GUI
   Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753
   Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Suzuki T, 1999, FERTIL STERIL, V72, P720, DOI 10.1016/S0015-0282(99)00332-5
   Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805
   Verit FF, 2007, FERTIL STERIL, V88, P418, DOI 10.1016/j.fertnstert.2006.11.172
   WARDLE PG, 1985, LANCET, V2, P236
NR 54
TC 12
Z9 12
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD NOV
PY 2015
VL 22
IS 11
BP 1452
EP 1460
DI 10.1177/1933719115585146
PG 9
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA CT8IM
UT WOS:000363058900016
PM 25947891
DA 2020-12-17
ER

PT J
AU Neto, MAC
   Martins, WP
   Lima, MLS
   Barbosa, MAP
   Nastri, CO
   Ferriani, RA
   Navarro, PA
AF Coelho Neto, M. A.
   Martins, W. P.
   Lima, M. L. S.
   Barbosa, M. A. P.
   Nastri, C. O.
   Ferriani, R. A.
   Navarro, P. A.
TI Ovarian response is a better predictor of clinical pregnancy rate
   following embryo transfer than is thin endometrium or presence of an
   endometrioma
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
DE endometrial receptivity; endometrial thickness; endometriosis; ICSI;
   IVF; poor ovarian response; ultrasound
ID IN-VITRO FERTILIZATION; ANTRAL FOLLICLE COUNT; ASSISTED REPRODUCTION;
   GNRH ANTAGONIST; LIVE BIRTH; FREEZE-ALL; THICKNESS; RESERVE; IMPACT;
   HYPERSTIMULATION
AB Objectives To examine whether endometrial thickness and the presence of endometrioma are independent predictors of clinical pregnancy rate or simply associated with poor ovarian response (POR).
   Methods This was a retrospective cohort study assessing the first cycle of all women undergoing in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) in a university hospital in Brazil between January 2011 and December 2012. Only the first cycle of each woman within the study period was considered. Women over 40 years of age and those who used clomiphene citrate during controlled ovarian stimulation (COS) or did not undergo embryo transfer were excluded from analysis. POR was defined as <= three oocytes retrieved and a thin endometrium was defined as endometrial thickness <= 7.0mm on the day of human chorionic gonadotropin (hCG) administration. We performed a multiple regression analysis to identify which of the following parameters were independent predictors of clinical pregnancy: age, number of oocytes retrieved, endometrial thickness or the presence of endometrioma.
   Results Within the study period, 787 women began COS, but 270 were excluded from analysis. Among the 517 women analyzed, those who achieved pregnancy were younger and yielded more oocytes. The proportion of POR was higher in women with a thin endometrium (17/57 (29.8%) vs 80/460 (17.4%); P=0.03) and in women with endometrioma (15/39 (38.5%) vs 82/478 (17.2%); P=0.002). The results of regression analysis showed that only age and the number of oocytes retrieved were independent predictors of pregnancy. Additionally, we observed higher clinical pregnancy rates in women with a thin endometrium from whom >= seven oocytes were retrieved (11/25 (44.0%)) compared to women with normal endometrial thickness (99/241 (41.1%)). Considering only women from whom >= four oocytes were retrieved, we observed reasonable pregnancy rates in those with a thin endometrium (14/40 (35.0%)) and in those with endometrioma (9/24 (37.5%)).
   Conclusion Both a thin endometrium and the presence of endometrioma are associated with POR but are not important independent predictors of clinical pregnancy. Good pregnancy rates can be observed when these conditions are present in women with a good ovarian response. Copyright (C) 2015 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Coelho Neto, M. A.; Martins, W. P.; Lima, M. L. S.; Barbosa, M. A. P.; Nastri, C. O.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo DGO FMRP USP, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Av Bandeirantes,3900-8 Andar HCRP Campus Univ, BR-14048900 Ribeirao Preto, SP, Brazil.
EM wpmartins@gmail.com
RI Navarro, Paula/G-2744-2012; Nastri, Carolina O/E-1172-2012; Martins,
   Wellington/B-1284-2008
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAEPA
FX We thank the staff of the Laboratory of Assisted Reproduction,
   particularly Sandra Aparecida Cavichiollo, Marisa Blanco, Maria Cristina
   Picinato and Ricardo Perussi e Silva for technical support. Authors were
   funded by two Brazilian official agencies: CNPq and FAEPA. The funders
   had no role in the study design, data collection and analysis, decision
   to publish or preparation of the manuscript.
CR Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037
   Ashrafi M, 2014, INT J FERTIL STERIL, V8, P29
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Dain L, 2013, FERTIL STERIL, V100, P1289, DOI 10.1016/j.fertnstert.2013.07.1966
   DICKEY RP, 1992, HUM REPROD, V7, P418, DOI 10.1093/oxfordjournals.humrep.a137661
   Esmailzadeh S, 2007, FERTIL STERIL, V88, P432, DOI 10.1016/j.fertnstert.2006.12.010
   Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092
   Figueiredo JBP, 2013, ARCH GYNECOL OBSTET, V287, P779, DOI 10.1007/s00404-012-2672-0
   Friedler S, 1996, HUM REPROD UPDATE, V2, P323, DOI 10.1093/humupd/2.4.323
   Harb HM, 2013, BJOG-INT J OBSTET GY, V120, P1308, DOI 10.1111/1471-0528.12366
   Kaponis A, 2015, OBSTET GYNECOL SURV, V70, P183, DOI 10.1097/OGX.0000000000000157
   Kasius A, 2014, HUM REPROD UPDATE, V20, P530, DOI 10.1093/humupd/dmu011
   Khalaf Y, 2000, FERTIL STERIL, V74, P63, DOI 10.1016/S0015-0282(00)00569-0
   Kumbak B, 2009, REPROD BIOMED ONLINE, V18, P79, DOI 10.1016/S1472-6483(10)60428-2
   Lebovitz O, 2014, GYNECOL ENDOCRINOL, V30, P409, DOI 10.3109/09513590.2014.906571
   Lima ML, 2015, ULTRASOUND OBST GYN, V46, P239, DOI 10.1002/uog.14763
   Lima MLS, 2015, HUM REPROD, V30, P250, DOI 10.1093/humrep/deu310
   Mahutte NG, 2002, CURR OPIN OBSTET GYN, V14, P275, DOI 10.1097/00001703-200206000-00005
   Martins WP, 2014, ULTRASOUND OBST GYN, V43, P25, DOI 10.1002/uog.12566
   Nastri CO, 2013, ULTRASOUND OBST GYN, V42, P375, DOI 10.1002/uog.12539
   Picinato MC, 2014, FERTIL STERIL, V101, P379, DOI 10.1016/j.fertnstert.2013.10.009
   Polyzos NP, 2013, FERTIL STERIL, V99, P422, DOI 10.1016/j.fertnstert.2012.09.043
   Raffi F, 2012, J CLIN ENDOCR METAB, V97, P3146, DOI 10.1210/jc.2012-1558
   Roque M, 2015, FERTIL STERIL, V103, P1190, DOI 10.1016/j.fertnstert.2015.01.045
   Roustan A, 2015, HUM REPROD, V30, P840, DOI 10.1093/humrep/dev029
   Sanchez AM, 2014, HUM REPROD UPDATE, V20, P217, DOI 10.1093/humupd/dmt053
   Scheffer GJ, 2003, HUM REPROD, V18, P700, DOI 10.1093/humrep/deg135
   Shapiro BS, 2014, REPROD BIOMED ONLINE, V29, P286, DOI 10.1016/j.rbmo.2014.04.009
   Somigliana E, 2012, FERTIL STERIL, V98, P1531, DOI 10.1016/j.fertnstert.2012.08.009
   Stern JE, 2013, J ASSIST REPROD GEN, V30, P1445, DOI 10.1007/s10815-013-0092-0
   Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106
   Teixeira DM, 2015, ULTRASOUND OBST GYN, V45, P139, DOI 10.1002/uog.14639
   Uncu G, 2013, HUM REPROD, V28, P2140, DOI 10.1093/humrep/det123
   VALLE RF, 1993, INT J GYNECOL OBSTET, V41, P3, DOI 10.1016/0020-7292(93)90147-O
   Warming L, 2002, ULTRASOUND OBST GYN, V20, P492, DOI 10.1046/j.1469-0705.2002.00828.x
   Zhang XQ, 2005, FERTIL STERIL, V83, P336, DOI 10.1016/j.fertnstert.2004.09.020
NR 36
TC 14
Z9 15
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD OCT
PY 2015
VL 46
IS 4
BP 501
EP 505
DI 10.1002/uog.14884
PG 5
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA CS8XM
UT WOS:000362373200020
PM 25914103
OA Bronze
DA 2020-12-17
ER

PT J
AU Giorgi, VS
   Jianini, BT
   Da Broi, MG
   De Paz, CC
   Ferriani, R
   Navarro, PA
AF Giorgi, V. S.
   Jianini, B. T.
   Da Broi, M. G.
   De Paz, C. C.
   Ferriani, R.
   Navarro, P. A.
TI FOLLICULAR FLUID FROM INFERTILE WOMEN WITH MILD ENDOMETRIOSIS IMPAIRS IN
   VITRO BOVINE EMBRYO DEVELOPMENT AND N-ACETYL-CYSTEINE STIMULATES THE
   EMBRYO HATCHING.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2015
CL Baltimore, MD
SP Amer Soc Reprod Med
C1 [Giorgi, V. S.; Jianini, B. T.; Da Broi, M. G.; Ferriani, R.; Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
   [De Paz, C. C.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil.
RI de Paz, Claudia Cristina Paro/A-8852-2014; Da Broi, Michele
   G/E-7753-2012; Navarro, Paula/G-2744-2012
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; Da Broi, Michele
   G/0000-0003-4256-0228; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2015
VL 104
IS 3
SU S
MA P-110
BP E144
EP E144
DI 10.1016/j.fertnstert.2015.07.444
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DR6NP
UT WOS:000380018900378
OA Bronze
DA 2020-12-17
ER

PT J
AU Martins, W
   Barbosa, MW
   Silva, LR
   Navarro, PA
   Ferriani, R
   Nastri, CO
AF Martins, W.
   Barbosa, M. W.
   Silva, L. R.
   Navarro, P. A.
   Ferriani, R.
   Nastri, C. O.
TI DYDROGESTERONE VERSUS PROGESTERONE FOR LUTEAL-PHASE SUPPORT: SYSTEMATIC
   REVIEWAND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2015
CL Baltimore, MD
SP Amer Soc Reprod Med
C1 [Martins, W.; Barbosa, M. W.; Silva, L. R.; Navarro, P. A.; Nastri, C. O.] Univ Sao P, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ferriani, R.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2015
VL 104
IS 3
SU S
MA P-697
BP E345
EP E346
DI 10.1016/j.fertnstert.2015.07.1077
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DR6NP
UT WOS:000380018900942
DA 2020-12-17
ER

PT J
AU Palhares, MB
   Ferriani, RA
   Martins, WP
   Navarro, PA
AF Palhares, M. B.
   Ferriani, R. A.
   Martins, W. P.
   Navarro, P. A.
TI A FORMULA COMBINING AGE, AMH, AFC AND FSH IS MORE ACCURATE THAN
   INDIVIDUAL MARKERS IN PREDICTING POOR RESPONSE TO CONTROLLED OVARIAN
   STIMULATION IN GOOD PROGNOSIS PATIENTS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 71st Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 17-21, 2015
CL Baltimore, MD
SP Amer Soc Reprod Med
C1 [Palhares, M. B.; Ferriani, R. A.; Martins, W. P.; Navarro, P. A.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2015
VL 104
IS 3
SU S
MA P-654
BP E330
EP E331
DI 10.1016/j.fertnstert.2015.07.1031
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DR6NP
UT WOS:000380018900899
OA Bronze
DA 2020-12-17
ER

PT J
AU Lima, ML
   Martins, WP
   Neto, MAC
   Nastri, CO
   Ferriani, RA
   Navarro, PA
AF Lima, M. L.
   Martins, W. P.
   Coelho Neto, M. A.
   Nastri, C. O.
   Ferriani, R. A.
   Navarro, P. A.
TI Assessment of ovarian reserve by antral follicle count in ovaries with
   endometrioma
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
DE antral follicle count; assisted reproduction; endometriomas;
   endometriosis; ovarian follicle; reproductive techniques
ID BILATERAL ENDOMETRIOMAS; HORMONE-LEVEL; METAANALYSIS; EXCISION; IMPACT;
   PATHOPHYSIOLOGY; PREDICTION; CYSTECTOMY; SURGERY
AB Objective To evaluate whether the antral follicle count (AFC) is underestimated in the presence of an endometrioma.
   Methods This was a retrospective cohort study assessing all women undergoing in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) at our clinic between January 2011 and December 2012 who had both ovaries and unilateral endometrioma. The primary outcome of the study was the difference between AFC and the number of oocytes retrieved per ovary.
   Results Within the study period 787 women underwent IVF/ICSI at our clinic. Sixty of these women had at least one endometrioma, but 23 were excluded from the analysis as six had only one ovary and 17 had bilateral endometriomas. Therefore a total of 37 women were included in this study and analysis. Compared with the contralateral ovaries, ovaries with an endometrioma were significantly larger in volume (median, 10.3 (interquartile range (IQR), 4.7-18.9) cm(3) vs median, 3.6 (IQR, 2.7-6.5) cm(3); P < 0.001) and presented a significantly lower AFC (median, 3.0 (IQR, 1.0-6.0) vs median, 5.0 (IQR, 2.0-6.5); P = 0.001). However, the median number of oocytes retrieved was similar (P = 0.60) between ovaries with an endometrioma (2.0 (IQR, 0.5-5.0)) and the contralateral ovaries (2.0 (IQR, 0.0-4.0)). Accordingly, the median difference between AFC and number of oocytes retrieved was significantly smaller (P = 0.005) for ovaries with an endometrioma (0.0 (IQR, -1.0 to 1.5) than for those without (2.0 (IQR, 0.0-4.0)).
   Conclusions Although the AFC is reduced in ovaries with an endometrioma, the number of oocytes retrieved is similar, suggesting that the AFC is underestimated in such ovaries. We believe that this is a consequence of an impaired ability to detect small follicles in the presence of an endometrioma. Copyright (C) 2014 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Lima, M. L.; Martins, W. P.; Coelho Neto, M. A.; Nastri, C. O.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, BR-14049 Ribeirao Preto, Brazil.
   [Nastri, C. O.] Ultrasonog Sch Ribeirao Preto, Sch Hlth Technol, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), Ave Bandeirantes 3900,8 Andar HCRP Campus Univ, BR-14048900 Sao Paulo, Brazil.
EM wpmartins@gmail.com
RI Nastri, Carolina O/E-1172-2012; Martins, Wellington/B-1284-2008;
   Navarro, Paula/G-2744-2012
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAEPA
FX We thank the staff of the Laboratory of Assisted Reproduction,
   particularly Sandra Aparecida Cavichiollo, Marisa Blanco, Maria Cristina
   Picinato and Ricardo Perussi e Silva for technical support. The authors
   received salaries from their institutions and were funded by two
   Brazilian official agencies: CNPq and FAEPA. The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Alborzi S, 2014, FERTIL STERIL, V101, P427, DOI 10.1016/j.fertnstert.2013.10.019
   Aldrich JE, 2007, CRIT CARE MED, V35, pS131, DOI 10.1097/01.CCM.0000260624.99430.22
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Busacca M, 2006, AM J OBSTET GYNECOL, V195, P421, DOI 10.1016/j.ajog.2006.03.064
   Coccia ME, 2011, HUM REPROD, V26, P3000, DOI 10.1093/humrep/der286
   Halis G, 2004, ANN NY ACAD SCI, V1034, P300, DOI 10.1196/annals.1335.032
   Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fertnstert.2004.10.011
   Jayaprakasan K, 2007, ULTRASOUND OBST GYN, V29, P335, DOI 10.1002/uog.3913
   Kitajima M, 2014, FERTIL STERIL, V101, P1031, DOI 10.1016/j.fertnstert.2013.12.049
   Kwon SK, 2014, FERTIL STERIL, V101, P435, DOI 10.1016/j.fertnstert.2013.10.043
   La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036
   Lima MLS, HUM REPROD IN PRESS
   Martins WP, 2013, ULTRASOUND OBST GYN, V41, P595, DOI 10.1002/uog.12449
   Muzii L, 2014, HUM REPROD, V29, P2190, DOI 10.1093/humrep/deu199
   Narouze SN, 2011, ATLAS OF ULTRASOUND-GUIDED PROCEDURES IN INTERVENTIONAL PAIN MANAGEMENT, P1, DOI 10.1007/978-1-4419-1681-5
   Nastri CO, 2015, ULTRASOUND OBST GYN, V45, P377, DOI 10.1002/uog.14684
   Raffi F, 2012, J CLIN ENDOCR METAB, V97, P3146, DOI 10.1210/jc.2012-1558
   Riccabona M, 2014, EUR J RADIOL, V83, P1487, DOI 10.1016/j.ejrad.2014.04.032
   Sanchez AM, 2014, HUM REPROD UPDATE, V20, P217, DOI 10.1093/humupd/dmt053
   Somigliana E, 2012, FERTIL STERIL, V98, P1531, DOI 10.1016/j.fertnstert.2012.08.009
NR 20
TC 23
Z9 24
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD AUG
PY 2015
VL 46
IS 2
BP 239
EP 242
DI 10.1002/uog.14763
PG 4
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA CN8UY
UT WOS:000358721700018
PM 25504940
OA Bronze
DA 2020-12-17
ER

PT J
AU Nascimento, JXPT
   Chein, MBC
   de Sousa, RML
   Ferreira, AD
   Navarro, PA
   Brito, LMO
AF Prado Teixeira Nascimento, Joelma Ximenes
   da Costa Chein, Maria Bethania
   Lopes de Sousa, Rosangela Maria
   Ferreira, Alexsandro dos Santos
   Navarro, Paula Andrea
   Oliveira Brito, Luciane Maria
TI Importance of lipid accumulation product index as a marker of CVD risk
   in PCOS women
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE Polycystic ovary syndrome; Cardiovascular diseases; Lipid accumulation
   product
ID POLYCYSTIC-OVARY-SYNDROME; CARDIOVASCULAR RISK; METABOLIC SYNDROME;
   GLUCOSE-METABOLISM; YOUNG-WOMEN; PREVALENCE; OBESITY; ABNORMALITIES;
   MORTALITY
AB Background: The polycystic ovary syndrome (PCOS) is considered the most common endocrine disease during the woman's reproductive life, with prevalence ranging from 5 to 10 % of women of reproductive age. There is a paucity of studies regarding the use of the lipid accumulation product (LAP) as a risk marker for the development of cardiovascular disease (CVD).
   Methods: A cross-sectional study was conducted on 78 women aged 18 to 42 years seen at University Hospital of Maranhao, with a diagnosis of polycystic ovary syndrome according to the Rotterdam criteria. The following variables of interest were recorded on a protocol form: sociodemographic and behavioral data, body mass index, waist circumference, fasting glucose, total cholesterol, triglycerides, low density lipoprotein cholesterol, high-density lipoprotein cholesterol, and systolic and diastolic blood pressure.
   Results: Logistic regression showed that, except for HDL, all cardiovascular risk markers presented a higher chance of being altered when the lipid accumulation product was above the cut off value of 37.9 cm. mmol/L.
   Conclusion: The lipid accumulation product seems to be sufficient to indicate a risk of cardiovascular diseases in women with polycystic ovary syndrome.
C1 [Prado Teixeira Nascimento, Joelma Ximenes; da Costa Chein, Maria Bethania; Lopes de Sousa, Rosangela Maria; Ferreira, Alexsandro dos Santos; Oliveira Brito, Luciane Maria] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil.
   [Navarro, Paula Andrea] Univ Sao Paulo, BR-09500900 Sao Paulo, SP, Brazil.
RP Nascimento, JXPT (corresponding author), Univ Fed Maranhao, Sao Luis, Maranhao, Brazil.
EM joelmaximenes@yahoo.com.br
RI Brito, Luciane/C-3523-2015; da Costa Chein, Maria
   Bethania/AAP-3883-2020; Nascimento, Joelma X P T/P-3856-2018; Navarro,
   Paula/G-2744-2012
OI Brito, Luciane/0000-0002-8574-9680; da Costa Chein, Maria
   Bethania/0000-0002-6554-8080; Nascimento, Joelma X P
   T/0000-0002-2871-8685; Navarro, Paula Andrea/0000-0003-2368-4188
FU FAPEMA (Fundo de Amparo a Pesquisa do Maranhao) [004/2010, APP -
   01006/10]
FX FAPEMA (Fundo de Amparo a Pesquisa do Maranhao) by edict 004/2010 and
   request APP - 01006/10.
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045
   Atkin SL, 2013, CLIN ENDOCRINOL, V78, P823, DOI 10.1111/cen.12151
   Barcellos CRG, 2007, ARQ BRAS ENDOCRINOL, V51, P601, DOI 10.1590/S0004-27302007000400015
   Cabrera Marcos A. S., 2005, Cad. Saúde Pública, V21, P767, DOI 10.1590/S0102-311X2005000300010
   Cascella T, 2008, HUM REPROD, V23, P153, DOI 10.1093/humrep/dem356
   Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004
   Cobin RH, 2013, INTERN EMERG MED, V8, pS61, DOI 10.1007/s11739-013-0924-z
   Costa EC, 2010, ARQ BRAS ENDOCRINOL, V54, P630, DOI 10.1590/S0004-27302010000700007
   Costa EC, 2010, ARQ BRAS CARDIOL, V94, P633, DOI 10.1590/S0066-782X2010005000029
   Diamanti-Kandarakis E, 2013, CURR PHARM DES PCOS
   Dilbaz B, 2011, ENDOCRINE, V39, P272, DOI 10.1007/s12020-011-9437-6
   Gil AB, 2010, REV BRAS GINECOL OBS, V32, P541, DOI 10.1590/S0100-72032010001100005
   Godinjak Amina, 2012, Med Arch, V66, P409, DOI 10.5455/medarh.2012.66.409-411
   Barcellos CRG, 2013, GYNECOL ENDOCRINOL, V29, P370, DOI 10.3109/09513590.2012.743009
   GRINER PF, 1981, ANN INTERN MED, V94, P553, DOI 10.7326/0003-4819-94-4-571
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Huber-Buchholz MM, 1999, J CLIN ENDOCR METAB, V84, P1470, DOI 10.1210/jc.84.4.1470
   Ioachimescu AG, 2010, OBESITY, V18, P1836, DOI 10.1038/oby.2009.453
   Kablak-Ziembicka A, 2010, ATHEROSCLEROSIS, V209, P125, DOI 10.1016/j.atherosclerosis.2009.08.019
   Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26
   Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014
   Kohen-Avramoglu R, 2003, CLIN BIOCHEM, V36, P413, DOI 10.1016/S0009-9120(03)00038-9
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430
   Martins WD, 2009, REV BRAS GINECOL OBS, V31, P111, DOI 10.1590/S0100-72032009000300002
   Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162
   Metz Charles E, 2006, J Am Coll Radiol, V3, P413, DOI 10.1016/j.jacr.2006.02.021
   Ministerio da Saude. Datasus, 2007, INF SAUD EST VIT MOR
   de Oliveira RDM, 2013, REV BRAS GINECOL OBS, V35, P21, DOI 10.1590/S0100-72032013000100005
   Morgan CL, 2012, J CLIN ENDOCR METAB, V97, P3251, DOI 10.1210/jc.2012-1690
   Moro F, 2012, FERTIL STERIL, V98, P1609, DOI 10.1016/j.fertnstert.2012.08.015
   Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2
   Pitanga FJG, 2007, REV BRAS EPIDEMIOL, V10, DOI [10.1590/S1415-790X2007000200011, DOI 10.1590/S1415-790X2007000200011]
   Rajkhowa M, 1997, J CLIN ENDOCR METAB, V82, P3389, DOI 10.1210/jc.82.10.3389
   Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611
   Sposito AC, 2007, ARQ BRAS CARDIOL, V88, P2, DOI 10.1590/S0066-782X2007000700002
   STEVENS J, 1992, AM J EPIDEMIOL, V135, P1137, DOI 10.1093/oxfordjournals.aje.a116214
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Wiltgen D, 2009, HUM REPROD, V24, P1726, DOI 10.1093/humrep/dep072
   Word Health Organization (WHO), 1997, OB PREV MAN GLOB EP
   Yarak Samira, 2005, An. Bras. Dermatol., V80, P395, DOI 10.1590/S0365-05962005000400011
   Zhang JX, 2012, HUM REPROD, V27, P2484, DOI 10.1093/humrep/des191
NR 43
TC 21
Z9 25
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD JUN 24
PY 2015
VL 14
AR 62
DI 10.1186/s12944-015-0061-y
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA CL4HU
UT WOS:000356914000001
PM 26104466
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Silveira, LR
   Romao, APMS
   Vieira, CS
   Silva, ACJDRE
   Reis, RM
   Ferriani, RA
   Navarro, PADS
   Lara, LAD
AF Silveira, Liliam Renata
   Mariano Salata Romao, Adriana Peterson
   Vieira, Carolina Sales
   Japur de Sa Rosa e Silva, Ana Carolina
   Reis, Rosana Maria
   Ferriani, Rui Alberto
   de Albuquerque Salles Navarro, Paula Andrea
   da Silva Lara, Lucia Alves
TI Sexual Function of Women Practicing Sex in Nonconventional Settings
SO JOURNAL OF SEX & MARITAL THERAPY
LA English
DT Article
ID MAJOR DEPRESSION; UNITED-STATES; RISK-FACTORS; DYSFUNCTION; DESIRE;
   POPULATION; PREVALENCE; AGE; ADOLESCENTS; INTERCOURSE
AB The quality of sexual intercourse in the context of conjugal visits by women to their jailed partners is unknown. This study aimed to assess the quality of the sex lives and psychological conditions of women attending conjugal visits with their jailed inmate partners. This controlled study involved 124 women between the ages of 18 to 40years who engaged in sexual relations with their inmate partners (conjugal visit group) or with their partners at home (control group). Sexual function was assessed using a semi-structured questionnaire and the Female Sexual Function Index, and psychological parameters were evaluated using the Hospital Anxiety and Depression scale. The total Female Sexual Function Index scores was similar in the 2 groups. The percentage of women reporting good quality of the relationship was significantly higher in the conjugal visit group. Also, the Hospital Anxiety and Depression scale scores were higher in the conjugal visit group. Depression was a risk factor for sexual dysfunction and had a negative effect on scores in the desire, excitement, lubrication, and sexual satisfaction domains, whereas anxiety was associated with lower sexual desire scores. A regular + poor quality of the relationship and being religious were factors associated with sexual dysfunction. Sexual practices in jail were not a risk for sexual dysfunction in this sample.
C1 [Silveira, Liliam Renata; Mariano Salata Romao, Adriana Peterson; Japur de Sa Rosa e Silva, Ana Carolina; da Silva Lara, Lucia Alves] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynaecol, Sexual Med Serv,Sect Human Reprod, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Vieira, Carolina Sales; Reis, Rosana Maria; Ferriani, Rui Alberto; de Albuquerque Salles Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynaecol, Sect Human Reprod, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Lara, LAD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM luciaalvess@yahoo.com.br
RI Reis, Rosana M. dos/E-3346-2012; Vieira, Carolina Sales/N-6855-2015;
   Navarro, Paula/G-2744-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; Vieira, Carolina
   Sales/0000-0003-2933-5755; Navarro, Paula Andrea/0000-0003-2368-4188
CR Abdo Carmita Helena Najjar, 2005, Sao Paulo Med. J., V123, P11, DOI 10.1590/S1516-31802005000100003
   Abdo CHN, 2004, INT J IMPOT RES, V16, P160, DOI 10.1038/sj.ijir.3901198
   Angst J, 1998, INT CLIN PSYCHOPHARM, V13, pS1, DOI 10.1097/00004850-199807006-00001
   Basson R, 2002, J SEX MARITAL THER, V28, P17, DOI 10.1080/00926230252851168
   Beckman N, 2014, J SEX MED, V11, P401, DOI 10.1111/jsm.12381
   Carvalheira AA, 2010, J SEX MED, V7, P1454, DOI 10.1111/j.1743-6109.2009.01693.x
   Dialmy A, 2010, EUR J CONTRACEP REPR, V15, P160, DOI 10.3109/13625181003793339
   Dunn KM, 1999, J EPIDEMIOL COMMUN H, V53, P144, DOI 10.1136/jech.53.3.144
   Escajadillo V. N., 2011, J SEX MED, V8, P1701, DOI [10.1111/j.1743-6109.2011.02259.x,2, DOI 10.1111/J.1743-6109.2011.02259.X,2]
   Galinsky AM, 2013, ARCH SEX BEHAV, V42, P93, DOI 10.1007/s10508-012-0003-y
   Goldberg RE, 2013, DEMOGRAPHY, V50, P725, DOI 10.1007/s13524-012-0150-8
   Goldey KL, 2012, J SEX MED, V9, P2315, DOI 10.1111/j.1743-6109.2012.02845.x
   Graziottin A, 2009, MATURITAS, V63, P128, DOI 10.1016/j.maturitas.2009.04.007
   Hatta S, 2013, CLIN TER, V164, P11, DOI [10.7417/T.2013.1503, 10.7417/CT.2013.1503]
   Hawes ZC, 2010, J SEX RES, V47, P137, DOI 10.1080/00224490903509399
   Hayes RD, 2008, J SEX MED, V5, P1681, DOI 10.1111/j.1743-6109.2008.00838.x
   Kennedy SH, 1999, J AFFECT DISORDERS, V56, P201, DOI 10.1016/S0165-0327(99)00050-6
   Kim J, 2012, SEX HEALTH, V9, P459, DOI 10.1071/SH11124
   Lam D, 2013, STUD FAMILY PLANN, V44, P147, DOI 10.1111/j.1728-4465.2013.00350.x
   Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537
   Le Gall A, 2002, J SEX RES, V39, P207, DOI 10.1080/00224490209552143
   Lefkowitz ES, 2004, J SEX RES, V41, P150, DOI 10.1080/00224490409552223
   Lykins AD, 2006, J SEX RES, V43, P136, DOI 10.1080/00224490609552308
   Marcolino José Álvaro Marques, 2007, Rev. Bras. Anestesiol., V57, P52, DOI 10.1590/S0034-70942007000100006
   Marston M, 2013, INT PERSPECT SEX R H, V39, P22, DOI 10.1363/3902213
   Mathew R J, 1980, Psychopharmacol Bull, V16, P58
   Pacagnella RD, 2009, CAD SAUDE PUBLICA, V25, P2333
   Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088
   Pakpour AH, 2012, ARCH GYNECOL OBSTET, V286, P1589, DOI 10.1007/s00404-012-2489-x
   PAYKEL ES, 1977, J PSYCHOSOM RES, V21, P401, DOI 10.1016/0022-3999(77)90049-6
   POLLITT JD, 1960, COMPR PSYCHIAT, V1, P381, DOI 10.1016/S0010-440X(60)80062-4
   Reisen CA, 2010, AIDS CARE, V22, P697, DOI 10.1080/09540120903325433
   Robinson BE, 2002, HEALTH EDUC RES, V17, P43, DOI 10.1093/her/17.1.43
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   RUST J, 1988, BRIT J PSYCHIAT, V152, P629, DOI 10.1192/bjp.152.5.629
   *SAS I, 2002, SAS STAT US GUID
   Schnatz PF, 2010, J WOMENS HEALTH, V19, P1843, DOI 10.1089/jwh.2009.1800
   SCHREINERENGEL P, 1986, J NERV MENT DIS, V174, P646, DOI 10.1097/00005053-198611000-00002
   Valadares AL, 2008, MENOPAUSE, V15, P706, DOI 10.1097/gme.0b013e31815cd3fb
   Wight D, 2008, PERSPECT SEX REPRO H, V40, P226, DOI 10.1363/4022608
   Woo JST, 2008, J SEX MED, V5, P571, DOI 10.1111/j.1743-6109.2007.00740.x
   Woodard TL, 2008, J SEX MED, V5, P146, DOI 10.1111/j.1743-6109.2007.00641.x
   Worly B, 2010, INT J GYNECOL OBSTET, V111, P241, DOI 10.1016/j.ijgo.2010.06.019
   Young M, 2000, PSYCHOL REP, V86, P1107, DOI 10.2466/PR0.86.3.1107-1122
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 45
TC 0
Z9 0
U1 0
U2 15
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 0092-623X
EI 1521-0715
J9 J SEX MARITAL THER
JI J. Sex Marital Ther.
PD MAY 4
PY 2015
VL 41
IS 3
BP 294
EP 303
DI 10.1080/0092623X.2014.889055
PG 10
WC Psychology, Clinical; Family Studies
SC Psychology; Family Studies
GA CD1GE
UT WOS:000350822000006
PM 24512136
DA 2020-12-17
ER

PT J
AU Barcelos, IDES
   Donabella, FC
   Ribas, CP
   Meola, J
   Ferriani, RA
   de Paz, CCP
   Navarro, PA
AF Barcelos, Ionara Diniz E. S.
   Donabella, Flavia Capello
   Ribas, Cristiana Padovan
   Meola, Juliana
   Ferriani, Rui Alberto
   Paro de Paz, Claudia Cristina
   Navarro, Paula A.
TI Down-regulation of the CYP19A1 gene in cumulus cells of infertile women
   with endometriosis
SO REPRODUCTIVE BIOMEDICINE ONLINE
LA English
DT Article
DE cumulus cells; CYP19A1 gene; endometriosis; follicular fluid;
   infertility
ID IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; AROMATASE
   MESSENGER-RNA; OXIDATIVE STRESS; GRANULOSA-CELLS; ASSISTED REPRODUCTION;
   ESTRADIOL PRODUCTION; OVARIAN STIMULATION; BIOCHEMICAL MARKERS;
   EXPRESSION PROFILE
AB Aromatase plays a fundamental role in the establishment of oocyte quality, which might be compromised in infertile women with endometriosis. The expression of the CYP19A1 gene (that encodes aromatase) was compared in cumulus cells and oestradiol concentrations in the follicular fluid of infertile women with and without endometriosis submitted to ovarian stimulation for intracytoplasmic sperm injection. Cumulus cells were isolated and the expression of the CYP19A1 was quantitated through real-time polymerase chain reaction. Oestradiol concentrations in follicular fluid were measured by chemiluminescence immunoassay. A lower expression of the CYP19A1 in the cumulus cells of infertile women with endometriosis was observed compared with controls (0.17 +/- 0.13 and 0.56 +/- 0.12, respectively), and no significant difference in the follicular fluid oestradiol concentrations was observed between groups. Our results show reduced expression of the CYP19A1 in cumulus cells of infertile women with endometriosis, which may play a role in the pathogenesis of endometriosis-related infertility. (C) 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
C1 [Barcelos, Ionara Diniz E. S.; Donabella, Flavia Capello; Ribas, Cristiana Padovan; Meola, Juliana; Ferriani, Rui Alberto; Navarro, Paula A.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Paro de Paz, Claudia Cristina] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Genet, Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
EM navarro@fmrp.usp.br
RI de Paz, Claudia Cristina Paro/E-8791-2012; Navarro, Paula/G-2744-2012;
   de Paz, Claudia Cristina Paro/A-8852-2014; Lovato, Juliana
   Meola/E-3440-2012
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; de Paz, Claudia
   Cristina Paro/0000-0002-7267-4552; Lovato, Juliana
   Meola/0000-0003-2514-4011; Navarro, Paula Andrea/0000-0003-2368-4188
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/58197-6]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [474858/2009-0]; National Institute of Hormones and
   Women's Health, Brazil
FX The authors would like to thank the patients who participated in this
   study and the multidisciplinary team at the Laboratory of Human
   Reproduction, Department of Gynecology and Obstetrics, FMRP-USP,
   particularly Professor Rui Alberto Ferriani, the coordinator of the IVF
   Unit, and Maria Cristina Picinato and Roberta Cristina Georgenon for
   cumulus cell sample collection. This research was supported through
   funding from the FAPESP (Grant 2008/58197-6), CNPq (Grant 474858/2009-0)
   and the National Institute of Hormones and Women's Health, Brazil. This
   manuscript was reviewed by a professional science editor and by a native
   English speaking copy editor to improve readability.
CR Aboulghar MA, 2003, AM J OBSTET GYNECOL, V188, P371, DOI 10.1067/mob.2003.13
   Abreu L.G., 2011, J ENDOMETR, V3, P177
   ADASHI EY, 1994, HUM REPROD, V9, P815, DOI 10.1093/oxfordjournals.humrep.a138602
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067
   Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065
   Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032
   Attaran M, 2000, INT J FERTIL WOMEN M, V45, P314
   Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543
   Bulun SE, 2004, SEMIN REPROD MED, V22, P45
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cetica PD, 2001, IUBMB LIFE, V51, P57, DOI 10.1080/15216540152035073
   Da Broi MG, 2014, HUM REPROD, V29, P315, DOI 10.1093/humrep/det378
   De Abreu LG, 2006, GYNECOL ENDOCRINOL, V22, P432, DOI 10.1080/09513590600902937
   de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4
   DELOOS FAM, 1991, THERIOGENOLOGY, V35, P527, DOI 10.1016/0093-691X(91)90449-N
   Diaz I, 2000, FERTIL STERIL, V74, P31, DOI 10.1016/S0015-0282(00)00570-7
   Donnez J, 2002, GYNECOL OBSTET INVES, V54, P52, DOI 10.1159/000066295
   Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699
   ERICKSON GF, 1989, J CLIN ENDOCR METAB, V69, P716, DOI 10.1210/jcem-69-4-716
   Fair T, 2003, ANIM REPROD SCI, V78, P203, DOI 10.1016/S0378-4320(03)00091-5
   Foldesi I, 1998, HUM REPROD, V13, P1455, DOI 10.1093/humrep/13.6.1455
   Gasca S, 2007, REPROD BIOMED ONLINE, V14, P175, DOI 10.1016/S1472-6483(10)60785-7
   Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017
   Hamamah S, 2006, REPROD BIOMED ONLINE, V13, P807, DOI 10.1016/S1472-6483(10)61028-0
   Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048
   Haouzi D, 2009, CURR MED CHEM, V16, P1905, DOI 10.2174/092986709788186075
   Harb HM, 2013, BJOG-INT J OBSTET GY, V120, P1308, DOI 10.1111/1471-0528.12366
   Harlow CR, 1996, J CLIN ENDOCR METAB, V81, P426, DOI 10.1210/jc.81.1.426
   Hatok J, 2011, GYNECOL ENDOCRINOL, V27, P331, DOI 10.3109/09513590.2010.491925
   HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   LAPOLT PS, 1995, ENDOCRINOLOGY, V136, P5533, DOI 10.1210/en.136.12.5533
   Levay PE, 1997, J ASSIST REPROD GEN, V14, P212, DOI 10.1007/BF02766112
   Lin XN, 2012, CHINESE MED J-PEKING, V125, P2688, DOI 10.3760/cma.j.issn.0366-6999.2012.15.008
   Liu F, 2013, CLIN EXP OBSTET GYN, V40, P372
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu X, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.055
   Maia H, 2012, WOMENS HEALTH, V8, P647, DOI [10.2217/whe.12.52, 10.2217/WHE.12.52]
   Makabe S, 2006, MICROSC RES TECHNIQ, V69, P436, DOI 10.1002/jemt.20303
   Murray AA, 2001, REPRODUCTION, V121, P89, DOI 10.1530/rep.0.1210089
   Navarro P, 2013, HUM REPROD, V28, P219
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Noble LS, 1996, J CLIN ENDOCR METAB, V81, P174, DOI 10.1210/jc.81.1.174
   Ola SI, 2012, J REPROD DEVELOP, V58, P385, DOI 10.1262/jrd.11-084H
   Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172
   Ouandaogo ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027179
   Pasqualotto EB, 2004, FERTIL STERIL, V81, P973, DOI 10.1016/j.fertnstert.2003.11.021
   Carvalho LFP, 2012, ARCH GYNECOL OBSTET, V286, P1033, DOI 10.1007/s00404-012-2439-7
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40
   Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753
   Senbon S, 2003, J REPROD DEVELOP, V49, P259
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Singh AK, 2013, REPROD TOXICOL, V42, P116, DOI 10.1016/j.reprotox.2013.08.005
   Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020
   Sisco B, 2003, ENDOCRINOLOGY, V144, P3904, DOI 10.1210/en.2003-0485
   Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P59, DOI 10.1016/j.mce.2008.07.020
   Tesarik J, 1997, HUM REPROD UPDATE, V3, P95, DOI 10.1093/humupd/3.2.95
   Tesfaye D, 2009, REPROD FERT DEVELOP, V21, P451, DOI 10.1071/RD08190
   Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281
   Verit FF, 2007, FERTIL STERIL, V88, P418, DOI 10.1016/j.fertnstert.2006.11.172
   Webb RJ, 2002, REPRODUCTION, V123, P41, DOI 10.1530/rep.0.1230041
   WHITELAW PF, 1992, J MOL ENDOCRINOL, V9, P309, DOI 10.1677/jme.0.0090309
NR 69
TC 15
Z9 17
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1472-6483
EI 1472-6491
J9 REPROD BIOMED ONLINE
JI Reprod. Biomed. Online
PD MAY
PY 2015
VL 30
IS 5
BP 532
EP 541
DI 10.1016/j.rbmo.2015.01.012
PG 10
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA CH2TY
UT WOS:000353878800011
PM 25773531
OA Bronze
DA 2020-12-17
ER

PT J
AU Aznar, J
   Navarro, P
AF Aznar, J.
   Navarro, P.
TI Medical abortion: Teratogenic effects of misoprostol
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
ID 1ST TRIMESTER; MIFEPRISTONE
C1 [Aznar, J.] Catholic Univ Valencia, Inst Life Sci, Valencia 46003, Spain.
   [Navarro, P.] Catholic Univ Valencia, Fac Nursing, Valencia 46003, Spain.
RP Aznar, J (corresponding author), Catholic Univ Valencia, Inst Life Sci, C Guillem de Castro 94, Valencia 46003, Spain.
EM justo.aznar@ucv.es
CR Barnett AA, 1996, LANCET, V348, P256, DOI 10.1016/S0140-6736(05)65549-3
   Bos-Thompson MA, 2008, ANN PHARMACOTHER, V42, P888, DOI 10.1345/aph.1K550
   COLES P, 1988, NATURE, V335, P486, DOI 10.1038/335486b0
   Dal Pizzol TD, 2006, REPROD TOXICOL, V22, P666, DOI 10.1016/j.reprotox.2006.03.015
   FONSECA W, 1991, LANCET, V338, P56, DOI 10.1016/0140-6736(91)90046-R
   Gary MM, 2006, ANN PHARMACOTHER, V40, P191, DOI 10.1345/aph.1G481
   Gonzalez CH, 1998, LANCET, V351, P1624, DOI 10.1016/S0140-6736(97)12363-7
   GONZALEZ CH, 1993, AM J MED GENET, V47, P59, DOI 10.1002/ajmg.1320470113
   Orioli IM, 2000, BRIT J OBSTET GYNAEC, V107, P519, DOI 10.1111/j.1471-0528.2000.tb13272.x
   Schuler L., 1997, Teratology, V55, P36
NR 10
TC 0
Z9 0
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0144-3615
EI 1364-6893
J9 J OBSTET GYNAECOL
JI J. Obstet. Gynaecol.
PD APR
PY 2015
VL 35
IS 3
BP 323
EP U168
DI 10.3109/01443615.2014.948405
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH3IP
UT WOS:000353924500034
PM 25923993
DA 2020-12-17
ER

PT J
AU Rodrigues, JK
   Navarro, PA
   Zelinski, MB
   Stouffer, RL
   Xu, J
AF Rodrigues, J. K.
   Navarro, P. A.
   Zelinski, M. B.
   Stouffer, R. L.
   Xu, J.
TI Direct actions of androgens on the survival, growth and secretion of
   steroids and anti-Mullerian hormone by individual macaque follicles
   during three-dimensional culture
SO HUMAN REPRODUCTION
LA English
DT Article
DE androgens; testosterone; dihydrotestosterone; follicle culture; follicle
   development
ID MESSENGER-RNA EXPRESSION; IN-VITRO FERTILIZATION; RHESUS-MONKEYS;
   STIMULATING-HORMONE; MENSTRUAL-CYCLE; SECONDARY FOLLICLES;
   FOLLICULAR-GROWTH; OOCYTE MATURATION; GRANULOSA-CELLS; PRIMATE OVARY
AB STUDY QUESTION: What are the direct effects of androgens on primate follicular development and function at specific stages of folliculogenesis?
   SUMMARY ANSWER: Androgen addition altered primate follicle survival, growth, steroid and anti-Mullerian hormone (AMH) production, and oocyte quality in vitro, in a dose- and stage-dependent manner.
   WHAT IS KNOWN ALREADY: Androgens have local actions in the ovary, particularly in the developing follicles. It is hypothesized that androgen promotes early follicular growth, but becomes detrimental to the antral follicles in primates.
   STUDY DESIGN, SIZE, DURATION: In vitro follicle maturation was performed using rhesus macaques. Secondary (125-225 mu m) follicles were mechanically isolated from 14 pairs of ovaries, encapsulated into alginate (0.25% w/v), and cultured for 40 days.
   PARTICIPANTS/MATERIALS, SETTING, METHODS: Individual follicles were cultured in a 5% O-2 environment, in alpha minimum essential medium supplemented with recombinant human FSH. Follicles were randomly assigned to experiments of steroid ablation by trilostane (TRL), testosterone (T) replacement and dihydrotestosterone (DHT) replacement. Follicle survival and growth were assessed. Follicles with diameters >= 500 mu m at Week 5 were categorized as fast-grow follicles. Pregnenolone (P5), progesterone (P4), estradiol (E2) and AMH concentrations in media were measured. Meiotic maturation and fertilization of oocytes from recombinant human chorionic gonadotrophin-treated follicles were assessed at the end of culture.
   MAIN RESULTS AND THE ROLE OF CHANCE: Compared with controls, TRL exposure reduced (P < 0.05) follicle survival, antrum formation rate and follicle diameters at Week 5. While P5 concentrations increased (P < 0.05) following TRL treatment, P4 levels decreased (P < 0.05) in fast-grow follicles at Week 5. Few healthy oocytes were retrieved from antral follicles developed in the presence of TRL. T replacement with TRL increased (P < 0.05) follicle survival and antrum formation at Week 5, compared with TRL alone, to levels comparable to controls. However, high-dose T with TRL decreased (P < 0.05) diameters of fast-grow follicles. Although P4 concentrations produced by fast-grow follicles were not altered by Tin the presence of TRL, there was a dose-dependent increase (P < 0.05) in E2 levels at Week 5. High-dose T with TRL decreased (P < 0.05) AMH production by fast-grow follicles at Week 3. More healthy oocytes were retrieved from antral follicles developed in TRL-PT compared with TRL alone. DHT had the similar effects to those of high-dose T, except that DHT replacement decreased (P < 0.05) E2 concentrations produced by fast-grow follicles at Week 5 regardless of TRL treatment.
   LIMITATION, REASONS FOR CAUTION: This study reports T and DHT actions on in vitro-developed individual primate (macaque) follicles, which are limited to the interval from the secondary to small antral stage.
   WIDER IMPLICATION OF THE FINDINGS: The above findings provide novel information on the role(s) of androgens in primate follicular development and oocyte maturation. We hypothesize that androgens promote pre-antral follicle development, but inhibit antral follicle growth and function in primates. While androgens can act positively, excess levels of androgens may have negative impacts on primate folliculogenesis.
C1 [Rodrigues, J. K.; Zelinski, M. B.; Stouffer, R. L.; Xu, J.] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA.
   [Rodrigues, J. K.; Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, BR-14049 Sao Paulo, Brazil.
   [Rodrigues, J. K.] ProCriar Med Reprod, Dept Pesquisa & Desenvolvimento, BR-30140 Belo Horizonte, MG, Brazil.
   [Zelinski, M. B.; Stouffer, R. L.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA.
RP Xu, J (corresponding author), Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.
EM xujin@ohsu.edu
RI Jing, Xu/AAF-2502-2020; Navarro, Paula/G-2744-2012
OI Zelinski, Mary/0000-0002-8513-1549; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54 UL1DE019587,
   RL1HD058294, PL1EB008542]; Eunice Kennedy Shriver National Institute of
   Child Health and Human Development through cooperative agreement as part
   of the Specialized Cooperative Center Program in Reproduction and
   Infertility Research [U54HD071836, 2K12HD043488]; Fogarty International
   CenterUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW/HD00668]; ONPRC [8P51OD011092]; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [P50HD071836, P50HD071836, U54HD071836, P50HD071836,
   K12HD043488, U54HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, P50HD071836, K12HD043488, P50HD071836, U54HD071836,
   P50HD071836, P50HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, P50HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, P50HD071836, P50HD071836, U54HD071836, P50HD071836,
   P50HD071836, U54HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, P50HD071836, K12HD043488, U54HD071836, P50HD071836,
   P50HD071836, P50HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, U54HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, P50HD071836, K12HD043488, P50HD071836, K12HD043488,
   U54HD071836, P50HD071836, P50HD071836, P50HD071836, U54HD071836,
   P50HD071836, P50HD071836, P50HD071836, P50HD071836, P50HD071836,
   P50HD071836, K12HD043488, K12HD043488, P50HD071836] Funding Source: NIH
   RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH
   &HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12HD043488, K12HD043488, K12HD043488, K12HD043488, RL1HD058294,
   RL1HD058294, K12HD043488, RL1HD058294, K12HD043488, RL1HD058294,
   RL1HD058294, K12HD043488, K12HD043488, K12HD043488, K12HD043488] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND
   BIOENGINEERINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Biomedical Imaging & Bioengineering (NIBIB) [PL1EB008542,
   PL1EB008542, PL1EB008542, PL1EB008542, PL1EB008542] Funding Source: NIH
   RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD011092,
   P51OD011092] Funding Source: NIH RePORTER
FX This work was supported by the National Institute of Health U54
   UL1DE019587, RL1HD058294, PL1EB008542 (the Oncofertility Consortium),
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development through cooperative agreement as part of the Specialized
   Cooperative Center Program in Reproduction and Infertility Research
   U54HD071836, 2K12HD043488 (Building Interdisciplinary Research Careers
   in Women's Health), Fogarty International Center TW/HD00668 (to P.
   Michael Conn), and ONPRC 8P51OD011092.
CR Agarwal SK, 1996, J CLIN ENDOCR METAB, V81, P3686, DOI 10.1210/jc.81.10.3686
   Cardenas H, 1997, J ANIM SCI, V75, P202
   Drummond AE, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-16
   Drummond AE, 2010, J ENDOCRINOL, V205, P15, DOI 10.1677/JOE-09-0379
   Duffy DM, 2002, HUM REPROD, V17, P2825, DOI 10.1093/humrep/17.11.2825
   DUFFY DM, 1994, J CLIN ENDOCR METAB, V79, P1587, DOI 10.1210/jc.79.6.1587
   Duffy DM, 1996, BIOL REPROD, V54, P888, DOI 10.1095/biolreprod54.4.888
   Duffy DM, 1999, ENDOCRINE, V11, P23, DOI 10.1385/ENDO:11:1:23
   Freour T, 2007, CLIN CHIM ACTA, V375, P162, DOI 10.1016/j.cca.2006.06.013
   Hampton JH, 2004, DOMEST ANIM ENDOCRIN, V27, P81, DOI 10.1016/j.domaniend.2004.01.005
   HARLOW CR, 1988, ENDOCRINOLOGY, V122, P2780, DOI 10.1210/endo-122-6-2780
   Hibbert ML, 1996, P NATL ACAD SCI USA, V93, P1897, DOI 10.1073/pnas.93.5.1897
   Hickey TE, 2004, BIOL REPROD, V71, P45, DOI 10.1095/biolreprod.103.026484
   Hillier SG, 1997, BAILLIERE CLIN OB GY, V11, P249, DOI 10.1016/S0950-3552(97)80036-3
   HORIE K, 1992, HUM REPROD, V7, P184, DOI 10.1093/oxfordjournals.humrep.a137614
   LANZENDORF SE, 1990, MOL REPROD DEV, V25, P61, DOI 10.1002/mrd.1080250111
   Lebbe M, 2013, MOL HUM REPROD, V19, P828, DOI 10.1093/molehr/gat065
   Lenie S, 2009, BIOL REPROD, V80, P685, DOI 10.1095/biolreprod.107.067280
   Peluso JJ, 2006, BIOL REPROD, V75, P2, DOI 10.1095/biolreprod.105.049924
   Rosenfeld CS, 2001, REPRODUCTION, V122, P215, DOI 10.1530/rep.0.1220215
   Sanchez F, 2010, BIOL REPROD, V83, P514, DOI 10.1095/biolreprod.109.083311
   SCHANE HP, 1979, FERTIL STERIL, V32, P464
   Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006
   Simpson ER, 2002, FERTIL STERIL, V77, pS6
   SUZUKI T, 1994, HUM REPROD, V9, P1589, DOI 10.1093/oxfordjournals.humrep.a138757
   Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353
   Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081
   Visser JA, 2005, MOL CELL ENDOCRINOL, V234, P81, DOI 10.1016/j.mce.2004.09.008
   Wang H, 2001, ENDOCRINOLOGY, V142, P4930, DOI 10.1210/en.142.11.4930
   Weil S, 1999, J CLIN ENDOCR METAB, V84, P2951, DOI 10.1210/jc.84.8.2951
   Weston AM, 1996, HUM REPROD, V11, P608, DOI 10.1093/HUMREP/11.3.608
   Wiser A, 2010, HUM REPROD, V25, P2496, DOI 10.1093/humrep/deq220
   WOLF DP, 1989, BIOL REPROD, V41, P335, DOI 10.1095/biolreprod41.2.335
   Xu J, 2013, HUM REPROD, V28, P2187, DOI 10.1093/humrep/det093
   Xu J, 2011, HUM REPROD, V26, P1061, DOI 10.1093/humrep/der049
   Xu J, ENDOCRINOLO IN PRESS
   Xu J, 2013, ADV EXP MED BIOL, V761, P43, DOI 10.1007/978-1-4614-8214-7_5
   Xu J, 2010, REPRODUCTION, V140, P685, DOI 10.1530/REP-10-0284
   Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732
   Yang MY, 2006, BIOL REPROD, V75, P924, DOI 10.1095/biolreprod.106.051813
   Yeung TWY, 2014, FERTIL STERIL, V102, P108, DOI 10.1016/j.fertnstert.2014.03.044
NR 41
TC 33
Z9 33
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD MAR
PY 2015
VL 30
IS 3
BP 664
EP 674
DI 10.1093/humrep/deu335
PG 11
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA CC2AV
UT WOS:000350147900019
PM 25567619
OA Bronze, Green Published
DA 2020-12-17
ER

PT B
AU Navarro, P
   Selfa, V
   Sahuquillo, J
   Gomez, ME
   Gomez, C
AF Navarro, Paula
   Selfa, Vicent
   Sahuquillo, Julio
   Gomez, Maria E.
   Gomez, Crispin
BE Daneshtalab, M
   Aldinucci, M
   Leppanen, V
   Lilius, J
   Brorsson, M
TI Row Tables: Design Choices to Exploit Bank Locality in Multiprogram
   Workloads
SO 23RD EUROMICRO INTERNATIONAL CONFERENCE ON PARALLEL, DISTRIBUTED, AND
   NETWORK-BASED PROCESSING (PDP 2015)
LA English
DT Proceedings Paper
CT 23rd Euromicro International Conference on Parallel, Distributed, and
   Network-Based Processing (PDP)
CY MAR 04-06, 2015
CL Turku, FINLAND
SP CPS
ID MEMORY
AB Main memory is a major performance bottleneck in current chip multiprocessors. Current DRAM banks latch the last accessed row in an internal buffer, namely row buffer (RB), which allows fast subsequent accesses to that row. This throughput-oriented approach was originally designed for single-thread processors and pursues to take advantage of the spatial locality that individual applications exhibit. This paper proposes row tables, a pool of row buffers shared among threads. Depending on the needs of each thread, row buffers are dynamically allocated to threads. Two design approaches are devised differing on the table location, and referred to as BRT (Bank Row Table) and CRT (Controller Row Table), which place the table at the bank, as traditionally done in existing modules, and at the memory controller side, respectively. CRT performs better than BRT in high RB locality applications (or mixes) but performs worse in poor RB locality applications since the increase in transfer times is not later amortized. A variant of CRT referred to as CRT1/x has been devised to reduce this performance penalty. Results for a 4-core system show that, on average, BRT and CRT1/x mechanisms save energy by 23% and 7%-16% (depending on the X value) and improve IPC by 10% and 9%-14%, respectively.
C1 [Navarro, Paula; Selfa, Vicent; Sahuquillo, Julio; Gomez, Maria E.] Univ Politecn Valencia, Valencia, Spain.
   [Gomez, Crispin] Univ Castilla La Mancha, Albacete, Spain.
RP Navarro, P (corresponding author), Univ Politecn Valencia, Valencia, Spain.
EM paunaal@disca.upv.es; viselol@disca.upv.es; jsahuqui@disca.upv.es;
   megomez@disca.upv.es; crispin.gomez@uclm.es
CR Ahn JH, 2009, IEEE COMPUT ARCHIT L, V8, P5, DOI 10.1109/L-CA.2008.13
   [Anonymous], 2011, MICRON TECHNOLOGY 4G
   Ebrahimi E., 2011, P ISCA
   Herrero E, 2013, IEEE T COMPUT, V62, P1879, DOI 10.1109/TC.2012.173
   Hongzhong Zheng, 2008, 2008 37th International Conference on Parallel Processing (ICPP), P406, DOI 10.1109/ICPP.2008.53
   Kim Y., 2010, P MICRO
   Lee BC, 2009, CONF PROC INT SYMP C, P2, DOI 10.1145/1555815.1555758
   Lee CJ, 2011, IEEE T COMPUT, V60, P1406, DOI 10.1109/TC.2010.214
   Meza J, 2012, PR IEEE COMP DESIGN, P484, DOI 10.1109/ICCD.2012.6378685
   Micron Technology Inc, TN 41 01 CALC MEM SY
   Mutlu O, 2008, CONF PROC INT SYMP C, P63, DOI 10.1109/ISCA.2008.7
   Mutlu O, 2007, INT SYMP MICROARCH, P146
   N. D. G, 2012, P 26 ACM INT C SUP, P257, DOI DOI 10.1145/2304576.2304613
   Rixner S, 2000, PROCEEDING OF THE 27TH INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P128, DOI 10.1109/ISCA.2000.854384
   Ubal R, 2007, INT SYM COMP ARCHIT, P62, DOI 10.1109/SBAC-PAD.2007.17
   Udipi AN, 2010, CONF PROC INT SYMP C, P175
   Yoon DH, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P295
   Zheng HZ, 2008, INT SYMP MICROARCH, P210, DOI 10.1109/MICRO.2008.4771792
   Zuravleff W. K., 1997, U.S. patent, Patent No. 5630096
NR 19
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-8490-9
PY 2015
BP 22
EP 26
DI 10.1109/PDP.2015.100
PG 5
WC Computer Science, Hardware & Architecture; Computer Science, Theory &
   Methods
SC Computer Science
GA BF2IW
UT WOS:000380471500004
DA 2020-12-17
ER

PT J
AU Lima, MLS
   Nastri, CO
   Neto, MAC
   Ferriani, RA
   Navarro, PA
   Martins, WP
AF Lima, Maria Lucia S.
   Nastri, Carolina O.
   Coelho Neto, Marcela A.
   Ferriani, Rui A.
   Navarro, Paula A.
   Martins, Wellington P.
TI Antral follicle count might be underestimated in the presence of an
   ovarian endometrioma
SO HUMAN REPRODUCTION
LA English
DT Letter
ID ANTIMULLERIAN HORMONE-LEVELS; BILATERAL ENDOMETRIOMAS; RESERVE;
   CYSTECTOMY; EXCISION; IMPACT; METAANALYSIS
C1 [Lima, Maria Lucia S.; Nastri, Carolina O.; Coelho Neto, Marcela A.; Ferriani, Rui A.; Navarro, Paula A.; Martins, Wellington P.] Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
EM wpmartins@gmail.com
RI Navarro, Paula/G-2744-2012; Nastri, Carolina O/E-1172-2012; Martins,
   Wellington/B-1284-2008
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Alborzi S, 2014, FERTIL STERIL, V101, P427, DOI 10.1016/j.fertnstert.2013.10.019
   Celik HG, 2012, FERTIL STERIL, V97, P1472, DOI 10.1016/j.fertnstert.2012.03.027
   Halis G, 2004, ANN NY ACAD SCI, V1034, P300, DOI 10.1196/annals.1335.032
   Kwon SK, 2014, FERTIL STERIL, V101, P435, DOI 10.1016/j.fertnstert.2013.10.043
   Muzii L, 2014, HUM REPROD, V29, P2190, DOI 10.1093/humrep/deu199
   Raffi F, 2012, J CLIN ENDOCR METAB, V97, P3146, DOI 10.1210/jc.2012-1558
   Somigliana E, 2012, FERTIL STERIL, V98, P1531, DOI 10.1016/j.fertnstert.2012.08.009
   Var T, 2011, FERTIL STERIL, V95, P2247, DOI 10.1016/j.fertnstert.2011.03.078
   Zaitoun MM, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-76
NR 9
TC 11
Z9 11
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JAN
PY 2015
VL 30
IS 1
BP 250
EP 250
DI 10.1093/humrep/deu310
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA CC2AF
UT WOS:000350146100031
PM 25406183
OA Bronze
DA 2020-12-17
ER

PT J
AU Salomao, P
   Romao, A
   Reis, R
   Navarro, P
   Lerri, M
   Rosa-e-Silva, A
   Ferriani, R
   Lara, L
AF Salomao, P.
   Romao, A.
   Reis, R.
   Navarro, P.
   Lerri, M.
   Rosa-e-Silva, A.
   Ferriani, R.
   Lara, L.
TI SEXUAL FUNCTION OF WOMEN UNDER TREATMENT FOR INFERTILITY
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Meeting Abstract
C1 [Salomao, P.; Romao, A.; Reis, R.; Navarro, P.; Lerri, M.; Rosa-e-Silva, A.; Ferriani, R.; Lara, L.] Fac Med Ribeirao Univ Sao Paulo FMRP USP, Sao Paulo, Brazil.
RI Lerri, Maria Rita/C-8337-2014; Rosa-e-Silva, Ana Carolina
   JS/L-2723-2016; Lara, Lucia A/F-6873-2013; Navarro, Paula/G-2744-2012
OI Lerri, Maria Rita/0000-0001-8597-2615; Rosa-e-Silva, Ana Carolina
   JS/0000-0001-7025-344X; 
NR 0
TC 0
Z9 0
U1 1
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD JAN
PY 2015
VL 12
SU 1
SI SI
MA 201
BP 60
EP 60
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA CA2IG
UT WOS:000348731500169
DA 2020-12-17
ER

PT J
AU Melo, AS
   Ferriani, RA
   Navarro, PA
AF Melo, Anderson Sanches
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Treatment of infertility in women with polycystic ovary syndrome:
   approach to clinical practice
SO CLINICS
LA English
DT Review
DE Polycystic Ovary Syndrome; Infertility; Clomiphene Citrate; Ovarian
   Drilling; In Vitro Fertilization
ID OVULATION INDUCTION; CLOMIPHENE CITRATE; PCOS; OUTCOMES; METAANALYSIS;
   PREVALENCE; PREGNANCY; METFORMIN; CYCLES
AB Polycystic ovary syndrome represents 80% of anovulatory infertility cases. Treatment initially includes preconception guidelines, such as lifestyle changes (weight loss), folic acid therapy to prevent the risk of fetal neural tube defects and halting the consumption of tobacco and alcohol. The first-line pharmacological treatment for inducing ovulation consists of a clomiphene citrate treatment for timed intercourse. The second-line pharmacological treatment includes the administration of exogenous gonadotropins or laparoscopic ovarian surgery (ovarian drilling). Ovulation induction using clomiphene citrate or gonadotropins is effective with cumulative live birth rates of approximately 70%. Ovarian drilling should be performed when laparoscopy is indicated; this procedure is typically effective in approximately 50% of cases. Finally, a high-complexity reproduction treatment (in vitro fertilization or intracytoplasmic sperm injection) is the third-line treatment and is recommended when the previous interventions fail. This option is also the first choice in cases of bilateral tubal occlusion or semen alterations that impair the occurrence of natural pregnancy. Evidence for the routine use of metformin in infertility treatment of anovulatory women with polycystic ovary syndrome is not available. Aromatase inhibitors are promising and longer term studies are necessary to prove their safety.
C1 [Melo, Anderson Sanches; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, BR-14049 Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, BR-14049 Ribeirao Preto, SP, Brazil.
EM pnavarro@fmrp.usp.br
RI Navarro, Paula/G-2744-2012; Melo, Anderson/L-6758-2014
OI Navarro, Paula Andrea/0000-0003-2368-4188; Melo,
   Anderson/0000-0002-4606-7791
CR AAKVAAG A, 1985, BRIT J OBSTET GYNAEC, V92, P1258, DOI 10.1111/j.1471-0528.1985.tb04872.x
   AHLGREN M, 1976, ACTA OBSTET GYN SCAN, V55, P371, DOI 10.3109/00016347609158516
   Al-Inany HG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub3
   Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P63, DOI 10.1016/j.fertnstert.2012.09.023
   Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046
   Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035
   Balen AH, 2013, MOL CELL ENDOCRINOL, V373, P77, DOI 10.1016/j.mce.2012.10.008
   Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036
   Brown J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002249.pub4
   Carvajal R, 2013, HUM REPROD, V28, P2235, DOI 10.1093/humrep/det116
   Eijkemans MJC, 2005, HUM REPROD, V20, P2830, DOI 10.1093/humrep/dei164
   Farquhar C, 2014, COCHRANE DB SYST REV, V6
   Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098
   Franik S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010287.pub2
   George K, 2014, COCHRANE DB SYST REV, V1
   Griesinger G, 2011, FERTIL STERIL, V95, P2029, DOI 10.1016/j.fertnstert.2011.01.163
   Imani B, 2002, FERTIL STERIL, V77, P91, DOI 10.1016/S0015-0282(01)02929-6
   Kdous M, 2009, J GYNECOL OBST BIO R, V38, P133, DOI 10.1016/j.jgyn.2008.12.001
   Kosmas IP, 2007, FERTIL STERIL, V87, P607, DOI 10.1016/j.fertnstert.2006.10.003
   Kousta E, 1997, HUM REPROD UPDATE, V3, P359, DOI 10.1093/humupd/3.4.359
   Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517
   Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162
   Messinis IE, 2005, HUM REPROD, V20, P2688, DOI 10.1093/humrep/dei128
   Misso ML, 2012, HUM REPROD UPDATE, V18, P301, DOI 10.1093/humupd/dms003
   Moran LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub3
   Nahuis MJ, 2013, FERTIL STERIL, V100, P219, DOI 10.1016/j.fertnstert.2013.03.015
   Nangia AK, 2011, FERTIL STERIL, V96, P609, DOI 10.1016/j.fertnstert.2011.06.026
   Naver KV, 2014, BJOG-INT J OBSTET GY, V121, P575, DOI 10.1111/1471-0528.12558
   Palomba S, 2013, BJOG-INT J OBSTET GY, V120, P267, DOI 10.1111/1471-0528.12070
   Palomba S, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-3
   Perales-Puchalt A, 2013, STEROIDS, V78, P767, DOI 10.1016/j.steroids.2013.05.005
   Practice Comm Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P631, DOI 10.1016/j.fertnstert.2013.07.011
   Qin JZ, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-56
   Roos N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6460
   Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5
   Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008, HUM REPROD, V23, P462
   Tso LO, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006105.pub2
   Unlu C, 2006, CURR OPIN OBSTET GYN, V18, P286, DOI 10.1097/01.gco.0000193020.82814.9d
   Veltman-Verhulst SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001838.pub4
   Wainer R, 2004, HUM REPROD, V19, P2060, DOI 10.1093/humrep/deh390
   Wang SP, 2013, SEMIN REPROD MED, V31, P365, DOI 10.1055/s-0033-1348895
   Xiao JS, 2013, GYNECOL ENDOCRINOL, V29, P187, DOI 10.3109/09513590.2012.736561
   Zawadzki JK, 1995, POLYCYSTIC OVARY SYN, P377
NR 43
TC 23
Z9 24
U1 0
U2 17
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2015
VL 70
IS 11
BP 765
EP 769
DI 10.6061/clinics/2015(11)09
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA CY0QF
UT WOS:000366109900009
PM 26602525
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Lara, LAS
   Salomao, PB
   Romao, APMS
   Reis, RM
   Navarro, PA
   Rosa-e-Silva, ACJS
   Ferriani, RA
AF Lara, Lucia A. S.
   Salomao, Priscilla B.
   Romao, Adriana P. M. S.
   Reis, Rosana M.
   Navarro, Paula A.
   Rosa-e-Silva, Ana Carolina J. S.
   Ferriani, Rui A.
TI Effect of Infertility on the Sexual Function of Couples: State of the
   Art
SO RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY
LA English
DT Article
DE Infertile couples; infertility; partnership quality; self-esteem;
   sexuality; sexual dysfunction; sexual function
AB Objective: Assess the state of the art on the relationship between infertility and the sexual function of couples. Data Sources: The PubMed, Lilacs, and Google Scholar databases were searched for articles that assessed the sexual function of infertile couples (IC). Recent patents on this subject were assessed. Study Selection: Quantitative studies published in the English language (case-control, cross-sectional, cohort, multicenter, observational studies, randomized controlled trials, meta-analyses, systematic reviews) that used structured and semi-structured questionnaires for quantitative assessment of the sexual function of infertile couples were identified using the search terms: "infertile couple" and "sexuality", "sexual dysfunction", "sexual function", "sexual disorder", "hypoactive sexual desire". Data Extraction: One researcher identified 12 studies, and extracted data on 1871 IC. Five studies used different instruments to assess different aspects of sexual function and 7 studies assessed sexual function based on sub-domains of instruments used to evaluate marital relationships. Data Synthesis: Incongruent results due to different objectives and methodologies, the lack of specific questionnaires to assess sexual function, and uncontrolled social and relationship variables that could have interfered with sexual function were evident in most studies. Conclusion: The lack of standardized methodology or validated tools in most studies prevents to establish the impact of infertility on the sexual function of IC.
C1 [Lara, Lucia A. S.; Salomao, Priscilla B.; Romao, Adriana P. M. S.; Reis, Rosana M.; Navarro, Paula A.; Rosa-e-Silva, Ana Carolina J. S.; Ferriani, Rui A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Human Reprod Sect,Sexual Med Serv, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Lara, LAS (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Human Reprod Sect,Sexual Med Serv, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM luciaalvess@yahoo.com.br
RI Navarro, Paula/G-2744-2012; Reis, Rosana M. dos/E-3346-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Akyuz A, 2013, INT J FERTIL STERIL, V6, P286
   Al-Homaidan HT, 2011, INT J HEALTH SCI-IJH, V5, P108
   Bayar U, 2014, J PAK MED ASSOC, V64, P138
   BENAZON N, 1992, J SEX MARITAL THER, V18, P273, DOI 10.1080/00926239208412852
   Beutel M, 1999, ANDROLOGIA, V31, P27, DOI 10.1046/j.1439-0272.1999.00231.x
   Bhatti LI, 1999, SOC SCI MED, V49, P637, DOI 10.1016/S0277-9536(99)00142-2
   Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046
   Carvalheira AA, 2010, J SEX MED, V7, P1454, DOI 10.1111/j.1743-6109.2009.01693.x
   Chachamovich JR, 2010, J PSYCHOSOM OBST GYN, V31, P101, DOI 10.3109/0167482X.2010.481337
   Coeffin-Driol C, 2004, Gynecol Obstet Fertil, V32, P624, DOI 10.1016/j.gyobfe.2004.06.004
   CONNOLLY KJ, 1992, J PSYCHOSOM RES, V36, P459, DOI 10.1016/0022-3999(92)90006-N
   D'Aniello S, 2014, Use of a combination of d-aspartic and l-aspartic acids or salts thereof for the treatment of male infertility, Patent No. [US20140271595, 20140271595]
   DANILUK JC, 1988, FERTIL STERIL, V49, P982
   Drosdzol A, 2009, J SEX MED, V6, P3335, DOI 10.1111/j.1743-6109.2009.01355.x
   Drosdzol A, 2009, J PSYCHOSOM OBST GYN, V30, P11, DOI 10.1080/01674820902830276
   Fajewonyomi BA, 2007, J HEALTH POPUL NUTR, V25, P101
   Ferraresi SR, 2013, RECENT PATENTS ENDOC, V7, P198, DOI 10.2174/18722148113079990009
   Fledderjohann JJ, 2012, HUM REPROD, V27, P1383, DOI 10.1093/humrep/des035
   Frohlich P, 2002, J SEX RES, V39, P321, DOI 10.1080/00224490209552156
   Galhardo A, 2011, HUM REPROD, V26, P2408, DOI 10.1093/humrep/der209
   Gao JJ, 2013, J SEX MED, V10, P1935, DOI 10.1111/jsm.12207
   Huyghe E, 2013, PROG UROL, V23, P745, DOI 10.1016/j.purol.2013.02.004
   Jiann BP, 2009, J SEX MED, V6, P3364, DOI 10.1111/j.1743-6109.2009.01494.x
   JINDAL UN, 1990, INT J FERTIL, V35, P222
   Keramat A, 2014, J RES HEALTH SCI, V14, P57
   Klapilova K, 2015, J SEX MED, V12, P667, DOI 10.1111/jsm.12766
   Klemetti R, 2010, ACTA OBSTET GYN SCAN, V89, P677, DOI 10.3109/00016341003623746
   Lee TY, 2001, HUM REPROD, V16, P1762, DOI 10.1093/humrep/16.8.1762
   Masoumi SZ, 2013, IRAN J PUBLIC HEALTH, V42, P458
   McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623
   Monga M, 2004, UROLOGY, V63, P126, DOI 10.1016/j.urology.2003.09.015
   Nelson CJ, 2008, J SEX MED, V5, P1907, DOI 10.1111/j.1743-6109.2008.00880.x
   Nene Ujjwal A, 2005, Patient Educ Couns, V59, P234, DOI 10.1016/j.pec.2005.08.005
   Onat G, 2012, EUR J OBSTET GYN R B, V165, P243, DOI 10.1016/j.ejogrb.2012.07.033
   Pakpour AH, 2012, ARCH GYNECOL OBSTET, V286, P1589, DOI 10.1007/s00404-012-2489-x
   Palleja M. C. P, 2012, PHOSPHODIESTERASE IN, Patent No. P2724716
   Park J. K., 2014, Composition for treating male infertility using natural substance, Patent No. [WO2014126362, O2014126362]
   Perlis N, 2013, FERTIL STERIL, V100, P511, DOI 10.1016/j.fertnstert.2013.04.020
   Peterson BD, 2003, FAM PROCESS, V42, P59, DOI 10.1111/j.1545-5300.2003.00059.x
   Pinto-Gouveia J, 2012, HUM FERTIL, V15, P27, DOI 10.3109/14647273.2011.654310
   Reder F, 2009, J GYNECOL OBST BIO R, V38, P377, DOI 10.1016/j.jgyn.2009.05.002
   Repokari L, 2007, HUM REPROD, V22, P1481, DOI 10.1093/humrep/dem013
   Revonta M, 2010, SEX REPROD HEALTHC, V1, P91, DOI 10.1016/j.srhc.2010.06.002
   Shindel AW, 2008, J UROLOGY, V179, P1056, DOI 10.1016/j.juro.2007.10.069
   Smith JF, 2009, J SEX MED, V6, P2505, DOI 10.1111/j.1743-6109.2009.01383.x
   Tabong PTN, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-72
   Tao Peng, 2012, J Reprod Infertil, V13, P71
   Ter Kuile MM, 1999, J SEX MARITAL THER, V25, P59
   Wirtberg I, 2007, HUM REPROD, V22, P598, DOI 10.1093/humrep/del401
   Wischmann T, 2014, GEBURTSH FRAUENHEILK, V74, P759, DOI 10.1055/s-0034-1368461
   Wischmann T, 2012, HUM REPROD, V27, P3226, DOI 10.1093/humrep/des293
   Wischmann T, 2001, HUM REPROD, V16, P1753, DOI 10.1093/humrep/16.8.1753
   Wischmann TH, 2010, J SEX MED, V7, P1868, DOI 10.1111/j.1743-6109.2010.01717.x
   Yan W, 2014, Infertility treatment instrument, Patent No. [CN203736284, 203736284]
   Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343
   Zegers-Hochschild F, 2014, FERTIL STERIL, V101, P366, DOI 10.1016/j.fertnstert.2013.10.005
NR 56
TC 7
Z9 7
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1872-2148
EI 2212-3334
J9 RECENT PATENTS ENDOC
JI Recent Patents Endocr. Metab. Immune Drug Discov.
PY 2015
VL 9
IS 1
BP 46
EP 53
DI 10.2174/1872214809666150416151811
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA VG4AD
UT WOS:000446726900005
PM 25879957
DA 2020-12-17
ER

PT J
AU Polanski, LT
   Neto, MAC
   Nastri, CO
   Navarro, PA
   Ferriani, RA
   Raine-Fenning, N
   Martins, WP
AF Polanski, L. T.
   Coelho Neto, M. A.
   Nastri, C. O.
   Navarro, P. A.
   Ferriani, R. A.
   Raine-Fenning, N.
   Martins, W. P.
TI Time-lapse embryo imaging for improving reproductive outcomes:
   systematic review and meta-analysis
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE assisted reproductive techniques; ICSI; IVF; review; time-lapse imaging
ID ASSISTED REPRODUCTION; UNITED-STATES; HUMAN OOCYTES; SELECTION;
   TECHNOLOGY; PREVALENCE; MULTICENTER; INFERTILITY; INCUBATOR; CULTURE
AB Objective To identify, appraise and summarize the available evidence regarding the effectiveness and safety of time-lapse embryo monitoring on the main outcomes of assisted reproductive techniques.
   Methods In this systematic review and meta-analysis, we included only randomized controlled trials (RCTs) comparing time-lapse embryo imaging with standard embryo monitoring. Our primary outcomes were live births (efficacy) and congenital abnormalities (safety). The secondary outcomes were clinical pregnancy, ongoing pregnancy and miscarriage.
   Results Two RCTs were considered eligible, and their data were extracted and included in a meta-analysis. In both studies embryos were transferred at the blastocyst stage. No studies reported rates of live birth or congenital abnormalities. Our estimates were not sufficiently precise to identify whether time-lapse monitoring provided a small benefit, no effect or minor harm on rates of clinical pregnancy (relative risk (RR), 1.05 (95% CI, 0.80-1.38)) or ongoing pregnancy (RR, 1.05 (95% CI, 0.76-1.45)), based on two studies involving 138 women with moderate-quality evidence. Considering the available data, we were unable to determine whether the intervention poses substantial benefit, no effect or substantial harm in the risk of miscarriage (RR, 0.95 (95% CI, 0.30-2.99)), based on two studies involving 76 clinical pregnancies with low-quality evidence.
   Conclusions Time-lapse embryo imaging is unlikely to have a large effect on the chance of achieving clinical and/or ongoing pregnancy when transferring embryos at the blastocyst stage. More studies are required to improve the quality of the current evidence and also to examine whether this intervention is useful when transferring embryos at the cleavage stage. Copyright (C) 2014 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Polanski, L. T.; Raine-Fenning, N.] Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Nottingham, England.
   [Coelho Neto, M. A.; Nastri, C. O.; Navarro, P. A.; Ferriani, R. A.; Martins, W. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, DGO,FMRP, BR-14049 Ribeirao Preto, Brazil.
   [Nastri, C. O.; Martins, W. P.] Ultrasonog Sch Ribeirao Preto, Sch Hlth Technol, FATESA, EURP, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), Av Bandeirantes,3900-8 Andar HCRP Campus Univ, BR-14048900 Sao Paulo, Brazil.
EM wpmartins@gmail.com
RI Navarro, Paula/G-2744-2012; Nastri, Carolina O/E-1172-2012; Martins,
   Wellington/B-1284-2008; Raine-Fenning, Nicholas J/C-3005-2008
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Raine-Fenning, Nicholas
   J/0000-0001-5521-9059; Navarro, Paula Andrea/0000-0003-2368-4188;
   Polanski, Lukasz/0000-0002-9678-8028
FU Foundation to Support Education, Research and Assistance (FAEPA),
   Brazil; Medical School of Ribeirao Preto, University of Sao Paulo,
   Ribeirao Preto (FMRP-USP), Ribeirao Preto, Brazil; National Council for
   Scientific and Technological Development (CNPq), BrazilNational Council
   for Scientific and Technological Development (CNPq); School of Health
   Technology - Ultrasonography School of Ribeirao Preto (FATESA-EURP),
   Ribeirao Preto, Brazil; University of Nottingham, Nottingham, UK
FX This study was supported by: Foundation to Support Education, Research
   and Assistance (FAEPA), Brazil (P.A.N., R. A. F., W. P. M.); Medical
   School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto
   (FMRP-USP), Ribeirao Preto, Brazil (P.A.N., R. A. F., W. P. M.);
   National Council for Scientific and Technological Development (CNPq),
   Brazil (R. A. F., W. P. M.); School of Health Technology -
   Ultrasonography School of Ribeirao Preto (FATESA-EURP), Ribeirao Preto,
   Brazil (C.O.N., W. P. M.); and University of Nottingham, Nottingham, UK
   (L. T. P. and N.R.F.).
CR Aparicio B, 2013, REPROD BIOMED ONLINE, V27, P654, DOI 10.1016/j.rbmo.2013.07.017
   Brozek J., 2008, GRADEPRO COMPUTER PR
   Bushnik T, 2012, HUM REPROD, V27, P738, DOI 10.1093/humrep/der465
   Cetinkaya M, 2013, BLASTOCYST CULTURE U
   Conaghan J, 2013, FERTIL STERIL, V100, P412, DOI 10.1016/j.fertnstert.2013.04.021
   Cruz M, 2011, J ASSIST REPROD GEN, V28, P569, DOI 10.1007/s10815-011-9549-1
   CUMMINS J M, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P284, DOI 10.1007/BF01133388
   Ferraretti AP, 2013, HUM REPROD, V28, P2318, DOI 10.1093/humrep/det278
   Figueiredo JBP, 2013, ARCH GYNECOL OBSTET, V287, P779, DOI 10.1007/s00404-012-2672-0
   Franasiak JM, 2013, FERTIL STERIL, V101, P656
   Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   Herrero J, 2013, FERTIL STERIL, V99, P1030, DOI 10.1016/j.fertnstert.2013.01.089
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Horsthemke B, 2005, HUM REPROD UPDATE, V11, P473, DOI 10.1093/humupd/dmi022
   Ingerslev HJ, 2011, HUM REPROD, V26, pI187
   Jungheim ES, 2010, FERTIL STERIL, V94, P1432, DOI 10.1016/j.fertnstert.2009.07.987
   Kahraman S, 2013, J REPROD STEM CELL B, V3, P55
   Kallen B, 2010, HUM REPROD, V25, P1026, DOI 10.1093/humrep/deq003
   Kalra SK, 2012, OBSTET GYNECOL, V120, P69, DOI 10.1097/AOG.0b013e31825b88fc
   Kirkegaard K, 2012, J ASSIST REPROD GEN, V29, P565, DOI 10.1007/s10815-012-9750-x
   Kovacs P, 2013, FERTIL STERIL, V100, pS90, DOI 10.1016/j.fertnstert.2013.07.1736
   Kovacs P, 2013, HUM REPROD, V28, P169
   Kovacs P., 2012, EMBRYO SELECTION TIM
   Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002
   Martins WP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010042.pub2
   Martins WP, 2011, HUM REPROD UPDATE, V17, P438, DOI 10.1093/humupd/dmr012
   Meseguer M, 2012, CLIN VALIDATION EMBR
   Nakahara T, 2010, J ASSIST REPROD GEN, V27, P93, DOI 10.1007/s10815-010-9385-8
   Nastri CO, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009517.pub2
   Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897
   Pai H, 2012, ASSESSMENT IMPLANTAT
   Payne D, 1997, HUM REPROD, V12, P532
   Picinato MC, 2014, FERTIL STERIL, V101, P379, DOI 10.1016/j.fertnstert.2013.10.009
   Scott L, 2003, HUM REPROD UPDATE, V9, P237, DOI 10.1093/humupd/dmg023
   Seko LMD, 2014, FERTIL STERIL, V101, P154, DOI 10.1016/j.fertnstert.2013.09.036
   Speksnijder J, 2011, HUM REPROD, V26, pI39, DOI 10.1093/humrep/26.s1.26
   Teixeira DM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010167.pub2
   Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037
   Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686
NR 40
TC 19
Z9 19
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD OCT
PY 2014
VL 44
IS 4
BP 394
EP 401
DI 10.1002/uog.13428
PG 8
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA AQ6BI
UT WOS:000342891900005
PM 24890582
OA Bronze
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Albuquerque, FO
   de Andrade, AZ
   Cardoso, RL
   Jordao, AA
   Navarro, PA
AF Da Broi, M. G.
   Albuquerque, F. O.
   de Andrade, A. Z.
   Cardoso, R. L.
   Jordao, A. A., Jr.
   Navarro, P. A.
TI SYSTEMIC AND FOLLICULAR OXIDATIVE STRESS IN INFERTILE WOMEN WITH
   ENDOMETRIOSIS UNDERGOING CONTROLLED OVARIAN STIMULATION FOR ICSI: IS
   THERE A ROLE IN THE ETIOPATHOGENESIS OF INFERTILITY?
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 18-22, 2014
CL Honolulu, HI
SP Amer Soc Reprod Med
C1 [Da Broi, M. G.; Albuquerque, F. O.; de Andrade, A. Z.; Cardoso, R. L.; Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Human Reprod Div, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Jordao, A. A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Nutr & Metab Lab, Sao Paulo, Brazil.
RI Navarro, Paula/G-2744-2012; Jordao, Alceu Afonso/D-7545-2014; Da Broi,
   Michele G/E-7753-2012
OI Da Broi, Michele G/0000-0003-4256-0228
NR 0
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD OCT
PY 2014
VL 102
IS 3
SU S
MA O-228
BP E79
EP E79
DI 10.1016/j.fertnstert.2014.07.267
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ0VG
UT WOS:000342500200229
DA 2020-12-17
ER

PT J
AU Giorgi, VSI
   Da Broi, MG
   Jianini, BTGM
   de Paz, CCP
   Ferriani, RA
   Navarro, PAAS
AF Giorgi, V. S. I.
   Da Broi, M. G.
   Jianini, B. T. G. M.
   de Paz, C. C. P.
   Ferriani, R. A.
   Navarro, P. A. A. S.
TI L-CARNITINE AND N-ACETYL-CYSTEINE SUPPLEMENTATION TO IN VITRO MATURATION
   MEDIA REDUCES OOCYTE MEIOTIC DAMAGE INDUCED BY INCUBATION IN FOLLICULAR
   FLUID FROM INFERTILE PATIENTS WITH MILD ENDOMETRIOSIS
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 18-22, 2014
CL Honolulu, HI
SP Amer Soc Reprod Med
C1 [Giorgi, V. S. I.; Da Broi, M. G.; Jianini, B. T. G. M.; Ferriani, R. A.; Navarro, P. A. A. S.] Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [de Paz, C. C. P.] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RI Navarro, Paula/G-2744-2012; Da Broi, Michele G/E-7753-2012; de Paz,
   Claudia Cristina Paro/E-8791-2012; de Paz, Claudia Cristina
   Paro/A-8852-2014
OI Da Broi, Michele G/0000-0003-4256-0228; de Paz, Claudia Cristina
   Paro/0000-0002-7267-4552; de Paz, Claudia Cristina
   Paro/0000-0002-7267-4552
NR 0
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD OCT
PY 2014
VL 102
IS 3
SU S
MA P-425
BP E279
EP E279
DI 10.1016/j.fertnstert.2014.07.948
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ0VG
UT WOS:000342500201181
DA 2020-12-17
ER

PT J
AU Barbosa, MAP
   Teixeira, DM
   Navarro, PAAS
   Ferriani, RA
   Nastri, CO
   Martins, WP
AF Barbosa, M. A. P.
   Teixeira, D. M.
   Navarro, P. A. A. S.
   Ferriani, R. A.
   Nastri, C. O.
   Martins, W. P.
TI Impact of endometriosis and its staging on assisted reproduction
   outcome: systematic review and meta-analysis
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE assisted reproductive techniques; embryo transfer; endometriosis;
   meta-analysis; review
ID IN-VITRO FERTILIZATION; CONTROLLED OVARIAN HYPERSTIMULATION;
   INTRACYTOPLASMIC SPERM INJECTION; GAMETE INTRAFALLOPIAN TRANSFER;
   EMBRYO-TRANSFER CYCLES; INVITRO FERTILIZATION; INTRAUTERINE
   INSEMINATION; INFERTILE WOMEN; LAPAROSCOPIC CYSTECTOMY; OXIDATIVE STRESS
AB Objective To evaluate whether the presence or severity of endometriosis affects the outcome of assisted reproductive techniques (ART).
   Methods In this systematic review, all studies comparing the outcome of ART in women with and those without endometriosis, or at different stages of the disease, were considered eligible. We used either risk ratio (RR) or mean difference (MD) and their 95% CIs for comparisons. The primary outcome was live birth; the secondary outcome was clinical pregnancy. Miscarriage and the number of oocytes retrieved were examined as additional outcomes.
   Results We included 92 studies in the review and 78 in themeta-analysis: 20 167 women with endometriosis were compared with 121 931 women without endometriosis, and 1703 women with Stage-III/IV endometriosis were compared with 2227 women with Stage-I/II endometriosis. The following results were observed for the comparison of women with endometriosis vs women without endometriosis: live birth, RR = 0.99 (95% CI, 0.92-1.06); clinical pregnancy, RR = 0.95 (95% CI, 0.89-1.02); miscarriage, RR = 1.31 (95% CI, 1.07-1.59); number of oocytes retrieved, MD = -1.56 (95% CI, -2.05 to -1.08). The following results were observed for the comparison of women with Stage-III/IV vs Stage-I/II endometriosis: live birth, RR = 0.94 (95% CI, 0.80-1.11); clinical pregnancy, RR = 0.90 (95% CI, 0.82-1.00); miscarriage, RR = 0.99 (95% CI, 0.73-1.36); number of oocytes retrieved, MD = -1.03 (95% CI, -1.67 to -0.39).
   Conclusions Women with endometriosis undergoing ART have practically the same chance of achieving clinical pregnancy and live birth as do women with other causes of infertility. No relevant difference was observed in the chance of achieving clinical pregnancy and live birth following ART when comparing Stage-III/IV with Stage-I/II endometriosis. The quality of the evidence for the additional examined outcomes was very low, not allowing meaningful conclusions to be drawn. Copyright (C) 2014 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Barbosa, M. A. P.; Teixeira, D. M.; Navarro, P. A. A. S.; Ferriani, R. A.; Nastri, C. O.; Martins, W. P.] Univ Sao Paulo FMRP USP, Med Sch Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
   [Nastri, C. O.; Martins, W. P.] Ultrasonog & Retraining Med Sch Ribeirao Preto EU, Ribeirao Preto, Brazil.
RP Martins, WP (corresponding author), Univ Sao Paulo FMRP USP, Med Sch Ribeirao Preto, Dept Obstet & Gynecol, HCRP, Av Bandeirantes 3900,8 Andar,Campus Univ, BR-14048900 Sao Paulo, Brazil.
EM wpmartins@gmail.com
RI Martins, Wellington/B-1284-2008; Navarro, Paula/G-2744-2012; Nastri,
   Carolina O/E-1172-2012
OI Martins, Wellington/0000-0002-7593-5607; Nastri, Carolina
   O/0000-0001-7073-1616; Navarro, Paula Andrea/0000-0003-2368-4188
FU CAPES, BrazilCAPES; CNPq, BrazilNational Council for Scientific and
   Technological Development (CNPq); FAPESP, BrazilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); HC-FMRP-USP, Brazil; FAEPA,
   Brazil
FX During the writing of this review, the authors received financial
   support from: CAPES, Brazil (C.O.N.); CNPq, Brazil (R. A. F., W. P. M.);
   FAPESP, Brazil (D. M. T.); HC-FMRP-USP, Brazil (W. P. M.); and FAEPA,
   Brazil (grant). These institutions had no influence on the study design,
   on the interpretation of data or on the decision to publish the results.
CR Aboulghar MA, 2003, AM J OBSTET GYNECOL, V188, P371, DOI 10.1067/mob.2003.13
   Abuzeid M, 2009, GYNECOL SURG, V6, P39, DOI 10.1007/s10397-008-0420-z
   Adamson GD, 2011, CURR OPIN OBSTET GYN, V23, P213, DOI 10.1097/GCO.0b013e328348a3ba
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Agnani G, 1991, Rev Fr Gynecol Obstet, V86, P331
   Al-Azemi M, 2000, HUM REPROD, V15, P72, DOI 10.1093/humrep/15.1.72
   Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   Almog B, 2011, FERTIL STERIL, V95, P525, DOI 10.1016/j.fertnstert.2010.03.011
   [Anonymous], 1979, Fertil Steril, V32, P633
   [Anonymous], 1985, Fertil Steril, V43, P351
   ANTOINE JM, 1989, CONTRACEPT FERTIL S, V17, P315
   Aoki T, 2005, REV BRAS GINECOL OBS, V27, P599, DOI 10.1590/S0100-72032005001000006
   Arici A, 1996, FERTIL STERIL, V65, P603, DOI 10.1016/S0015-0282(16)58162-X
   Azem F, 1999, FERTIL STERIL, V72, P1107, DOI 10.1016/S0015-0282(99)00392-1
   Ballester M, 2012, FERTIL STERIL, V97, P367, DOI 10.1016/j.fertnstert.2011.11.022
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   Benaglia L, 2013, FERTIL STERIL, V99, P1714, DOI 10.1016/j.fertnstert.2013.01.110
   Benaglia L, 2012, HUM REPROD, V27, P1663, DOI 10.1093/humrep/des054
   Bergendal A, 1998, J ASSIST REPROD GEN, V15, P530, DOI 10.1023/A:1022526002421
   Bianchi PH, 2007, FERTIL STERIL, V88, pS212, DOI 10.1016/j.fertnstert.2007.07.724
   Bongioanni F, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-81
   Bourdel N, 2012, GYNECOL OBSTET FERTI, V40, P337, DOI 10.1016/j.gyobfe.2011.07.037
   Bukulmez O, 2001, EUR J OBSTET GYN R B, V96, P102, DOI 10.1016/S0301-2115(00)00379-1
   Cahill DJ, 1996, HUM REPROD, V11, P647, DOI 10.1093/HUMREP/11.3.647
   Calhaz-Jorge C, 2004, Clin Exp Obstet Gynecol, V31, P25
   Canis M, 2001, HUM REPROD, V16, P2583, DOI 10.1093/humrep/16.12.2583
   Chapron C, 1999, HUM REPROD, V14, P329, DOI 10.1093/humrep/14.2.329
   Chardon C, 1992, Rev Fr Gynecol Obstet, V87, P355
   Check JH, 2010, CLIN EXP OBSTET GYN, V37, P108
   Cheewadhanaraks Sopon, 2004, Journal of the Medical Association of Thailand, V87, P361
   CHILLIK CF, 1985, FERTIL STERIL, V44, P56
   Coccia ME, 2011, ACTA OBSTET GYN SCAN, V90, P1232, DOI 10.1111/j.1600-0412.2011.01247.x
   Cunha-Filho JS, 2002, J BRAS REPROD ASSIST, V6, P109
   CURTIS P, 1993, EUR J OBSTET GYN R B, V52, P211, DOI 10.1016/0028-2243(93)90074-M
   d'Argent EM, 2010, FERTIL STERIL, V94, P2441, DOI 10.1016/j.fertnstert.2010.03.033
   DAMEWOOD MD, 1988, FERTIL STERIL, V50, P463
   de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4
   Dechanet C, 2011, GYNECOL OBSTET FERTI, V39, P3, DOI 10.1016/j.gyobfe.2010.08.018
   Demirol A, 2006, REPROD BIOMED ONLINE, V12, P639, DOI 10.1016/S1472-6483(10)61192-3
   Devroey P, 1987, Contrib Gynecol Obstet, V16, P332
   Diaz I, 2000, FERTIL STERIL, V74, P31, DOI 10.1016/S0015-0282(00)00570-7
   Dib LA, 2013, REPROD SCI, V20, P456, DOI 10.1177/1933719112459217
   DICKER D, 1992, FERTIL STERIL, V57, P597
   DMOWSKI WP, 1995, FERTIL STERIL, V63, P555, DOI 10.1016/S0015-0282(16)57425-1
   Dong XY, 2013, INT J CLIN EXP PATHO, V6, P1911
   Donnez J, 2001, FERTIL STERIL, V76, P662, DOI 10.1016/S0015-0282(01)02011-8
   dos Reis RM, 2004, J ASSIST REPROD GEN, V21, P311, DOI 10.1023/B:JARG.0000043706.57616.74
   Du YB, 2013, ARCH GYNECOL OBSTET, V287, P123, DOI 10.1007/s00404-012-2567-0
   el Amrani R, 2001, Gynecol Obstet Fertil, V29, P192, DOI 10.1016/S1297-9589(00)00074-6
   Elbeltagy K, 2009, FERTIL STERIL, V92, pS135
   Esinler I, 2006, FERTIL STERIL, V85, P1730, DOI 10.1016/j.fertnstert.2005.10.076
   Falconer H, 2009, REPROD BIOMED ONLINE, V18, P582, DOI 10.1016/S1472-6483(10)60138-1
   Fedele L, 2006, FERTIL STERIL, V85, P694, DOI 10.1016/j.fertnstert.2005.08.028
   Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092
   Figueiredo JBP, 2013, ARCH GYNECOL OBSTET, V287, P779, DOI 10.1007/s00404-012-2672-0
   Fortuno S, 2006, REV IBEROAM FERT REP, V23, P355
   Fuchs F, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P354
   Gandhi AR, 2014, J MINIM INVAS GYN, V21, P101, DOI 10.1016/j.jmig.2013.07.009
   Garcia-Velasco JA, 2004, FERTIL STERIL, V81, P1206, DOI 10.1016/j.fertnstert.2003.10.032
   Garrido N, 2012, FERTIL STERIL, V98, P341, DOI 10.1016/j.fertnstert.2012.04.039
   Geber Selmo, 2002, Reprod Biomed Online, V5, P162
   Genovese F, 2011, G ITAL OSTET GINECOL, V33, P189
   Giovannini M, 2012, INT J GYNECOL OBSTET, V119, pS419
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Guney G, 2010, GYNECOL SURG, V7, pS163
   Guo YH, 2012, CONTEMP CLIN TRIALS, V33, P1206, DOI 10.1016/j.cct.2012.07.009
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011
   GUZICK DS, 1994, FERTIL STERIL, V62, P1186
   Hagargi RP, 2011, INT J INFERTIL FETAL, V2, P23
   Harb HM, 2013, BJOG-INT J OBSTET GY, V120, P1308, DOI 10.1111/1471-0528.12366
   Herzog M, 2012, ZDR VESTN, V81, P453
   Hickman TN, 2002, J REPROD MED, V47, P801
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Huang HY, 1997, J AM ASSOC GYN LAP, V4, P299, DOI 10.1016/S1074-3804(05)80219-1
   Hull MGR, 1998, HUM REPROD, V13, P1825, DOI 10.1093/humrep/13.7.1825
   Inoue M, 1989, Nihon Sanka Fujinka Gakkai Zasshi, V41, P960
   INOUE M, 1992, AM J OBSTET GYNECOL, V167, P278, DOI 10.1016/S0002-9378(11)91675-5
   Inoue M., 1989, NIHON SANKA FUJINKA, V41, P1000
   Isaacs JD, 1997, J ASSIST REPROD GEN, V14, P551, DOI 10.1023/A:1022592715006
   Ismail A, 2012, INT J GYNECOL OBSTET, V119, pS376
   Isono Wataru, 2012, Reproductive Medicine and Biology, V11, P69, DOI 10.1007/s12522-011-0107-4
   Jasovic V, 2012, VOJNOSANIT PREGL, V69, P301, DOI 10.2298/VSP1204301J
   JONES HW, 1984, FERTIL STERIL, V42, P826
   Jungheim ES, 2013, J CLIN ENDOCR METAB, V98, pE1364, DOI 10.1210/jc.2012-4115
   Kably A, 1991, Ginecol Obstet Mex, V59, P151
   Kahyaoglu S, 2008, J OBSTET GYNAECOL RE, V34, P1010, DOI 10.1111/j.1447-0756.2008.00825.x
   Karuputhula NB, 2013, SYST BIOL REPROD MED, V59, P91, DOI 10.3109/19396368.2012.743197
   Katsoff B, 2006, Clin Exp Obstet Gynecol, V33, P201
   Kim C H, 1997, J Obstet Gynaecol Res, V23, P463
   Kim CH, 1996, HUM REPROD, V11, P398, DOI 10.1093/HUMREP/11.2.398
   Kiran H, 2012, BRATISL MED J, V113, P544, DOI 10.4149/BLL_2012_122
   Kirkegaard K, 2013, HUM REPROD, V28, P2643, DOI 10.1093/humrep/det300
   Kissler S, 2005, BJOG-INT J OBSTET GY, V112, P1391, DOI 10.1111/j.1471-0528.2005.00676.x
   Kodama H, 1996, FERTIL STERIL, V66, P974, DOI 10.1016/S0015-0282(16)58692-0
   Komsky-Elbaz A, 2013, J ASSIST REPROD GEN, V30, P251, DOI 10.1007/s10815-012-9922-8
   Kuivasaari P, 2005, HUM REPROD, V20, P3130, DOI 10.1093/humrep/dei176
   Kuivasaari-Pirinen Paula, 2012, ISRN Obstet Gynecol, V2012, P451915, DOI 10.5402/2012/451915
   Kumbak B, 2008, GYNECOL OBSTET INVES, V65, P212, DOI 10.1159/000112310
   Kuroda Keiji, 2009, Reproductive Medicine and Biology, V8, P113, DOI 10.1007/s12522-009-0021-1
   Kwon SK, 2012, FERTIL STERIL, V98, pS263, DOI 10.1016/j.fertnstert.2012.07.958
   Lamaita RM, 2012, J OBSTET GYNAECOL RE, V38, P810, DOI 10.1111/j.1447-0756.2011.01805.x
   Lin KC, 2001, J FORMOS MED ASSOC, V100, P466
   Lin XN, 2012, CHINESE MED J-PEKING, V125, P2688, DOI 10.3760/cma.j.issn.0366-6999.2012.15.008
   Lodhi S, 2004, GYNECOL ENDOCRINOL, V19, P152, DOI 10.1080/09513590400004710
   Loo TC, 2005, J ASSIST REPROD GEN, V22, P329, DOI 10.1007/s10815-005-5914-2
   LOPES P, 1988, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V17, P111
   Lossl K, 2009, EUR J OBSTET GYN R B, V144, P48, DOI 10.1016/j.ejogrb.2009.02.001
   Lukaszuk K, 2014, REPROD BIOMED ONLINE, V28, P64, DOI 10.1016/j.rbmo.2013.09.017
   Ma CH, 2008, INT J GYNECOL OBSTET, V100, P167, DOI 10.1016/j.ijgo.2007.08.021
   MAHADEVAN MM, 1983, FERTIL STERIL, V40, P755
   Mahapatra PD, 2012, BJOG-INT J OBSTET GY, V119, P131
   Mamas L, 2006, FERTIL STERIL, V85, P735, DOI 10.1016/j.fertnstert.2005.08.025
   Mao YH, 2009, J REPROD CONTRACEPT, V20, P19
   Marconi G, 2002, FERTIL STERIL, V78, P876, DOI 10.1016/S0015-0282(02)03326-5
   Martins WP, 2011, HUM REPROD UPDATE, V17, P438, DOI 10.1093/humupd/dmr012
   Matalliotakis IM, 2010, J OBSTET GYNAECOL, V30, P184, DOI 10.3109/01443610903470270
   Matalliotakis IM, 2007, FERTIL STERIL, V88, P1568, DOI 10.1016/j.fertnstert.2007.01.037
   Matalliotakis IM, 2011, J ENDOMETR PELVIC PA, V3, P86, DOI 10.5301/JE.2011.8528
   MATSON PL, 1986, FERTIL STERIL, V46, P432
   MECKE H, 1993, GEBURTSH FRAUENHEILK, V53, P693, DOI 10.1055/s-2007-1023611
   Meden-Vrtovec H., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P191
   Mekaru Keiko, 2013, Front Biosci (Elite Ed), V5, P720
   Mijatovic V, 2010, EUR J OBSTET GYN R B, V151, P62, DOI 10.1016/j.ejogrb.2010.02.047
   MILLS MS, 1992, HUM REPROD, V7, P490, DOI 10.1093/oxfordjournals.humrep.a137677
   Minguez Y, 1997, HUM REPROD, V12, P2282, DOI 10.1093/humrep/12.10.2282
   MOLLOY D, 1987, FERTIL STERIL, V47, P450
   Nakagawa K, 2000, NIHON FUNIN GAKKAI Z, V45, P1
   Nakagawa K, 2007, J OBSTET GYNAECOL RE, V33, P671, DOI 10.1111/j.1447-0756.2007.00630.x
   Nakahara K, 1998, FERTIL STERIL, V69, P931, DOI 10.1016/S0015-0282(98)00038-7
   Nakamura K., 1992, Advances in Contraceptive Delivery Systems, V8, P99
   Nastri CO, 2013, ULTRASOUND OBST GYN, V42, P375, DOI 10.1002/uog.12539
   Nastri CO, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009517.pub2
   Nejad EST, 2009, IRAN J REPROD MED, V7, P1
   Norenstedt SN, 2001, J ASSIST REPROD GEN, V18, P644, DOI 10.1023/A:1013111200251
   OEHNINGER S, 1988, J IN VITRO FERTIL EM, V5, P249, DOI 10.1007/BF01132172
   OLIVENNES F, 1995, FERTIL STERIL, V64, P392, DOI 10.1016/S0015-0282(16)57740-1
   Omland AK, 2001, HUM REPROD, V16, P2587, DOI 10.1093/humrep/16.12.2587
   Omland AK, 2005, HUM REPROD, V20, P722, DOI 10.1093/humrep/deh664
   Omland AK, 2006, J ASSIST REPROD GEN, V23, P351, DOI 10.1007/s10815-006-9060-2
   Opoien HK, 2011, REPROD BIOMED ONLINE, V23, P389, DOI 10.1016/j.rbmo.2011.06.002
   Opoien HK, 2012, FERTIL STERIL, V97, P912, DOI 10.1016/j.fertnstert.2012.01.112
   Pabuccu R, 2004, FERTIL STERIL, V82, P705, DOI 10.1016/j.fertnstert.2004.02.117
   Pabuccu R, 2007, FERTIL STERIL, V88, P832, DOI 10.1016/j.fertnstert.2006.12.046
   Pagidas K, 1996, FERTIL STERIL, V65, P791, DOI 10.1016/S0015-0282(16)58215-6
   Pal L, 1998, J ASSIST REPROD GEN, V15, P27, DOI 10.1023/A:1022574221115
   Papaleo E, 2011, ACTA OBSTET GYN SCAN, V90, P878, DOI 10.1111/j.1600-0412.2011.01161.x
   Patel BG, 2011, FERTIL STERIL, V96, pS276, DOI 10.1016/j.fertnstert.2011.07.1052
   Pauli SA, 2013, REPROD SCI, V20, P1116, DOI 10.1177/1933719113477487
   Pellicer A, 1998, FERTIL STERIL, V69, P1135, DOI 10.1016/S0015-0282(98)00085-5
   Penarrubia J, 1993, REC PROG GIN OBSTET, V36, P461
   Perello J, 2010, FERTIL STERIL, V94, pS206, DOI 10.1016/j.fertnstert.2010.07.798
   Peymer M, 1997, ARTA, V9, P79
   Polak G, 2013, EUR J OBSTET GYN R B, V168, P187, DOI 10.1016/j.ejogrb.2012.12.043
   Polanski LT, 2014, HUM REPROD, V29, P65, DOI 10.1093/humrep/det414
   Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Prieto Sanchez L, 2005, REV IBEROAM FERT REP, V22, P249
   Raffi F, 2012, J CLIN ENDOCR METAB, V97, P3146, DOI 10.1210/jc.2012-1558
   Ragni G, 2005, AM J OBSTET GYNECOL, V193, P1908, DOI 10.1016/j.ajog.2005.05.056
   Rajani Shweta, 2012, J Hum Reprod Sci, V5, P187, DOI 10.4103/0974-1208.101020
   Rickes D, 2002, FERTIL STERIL, V78, P757, DOI 10.1016/S0015-0282(02)03338-1
   Rinesi L, 2002, FERTIL STERIL, V77, P190, DOI 10.1016/S0015-0282(01)02936-3
   Rodriguez-Purata J, 2013, GYNECOL ENDOCRINOL, V29, P859, DOI 10.3109/09513590.2013.808327
   Salem HA, 2011, FERTIL STERIL, V96, pS173, DOI 10.1016/j.fertnstert.2011.07.675
   Saucedo-de-la-Llata ERM, 2004, REV IBEROAM FERT REP, V21, P327
   Seko LMD, 2014, FERTIL STERIL, V101, P154, DOI 10.1016/j.fertnstert.2013.09.036
   Shahine LK, 2009, J ASSIST REPROD GEN, V26, P69, DOI 10.1007/s10815-008-9287-1
   Shi WH, 2012, FERTIL STERIL, V97, P1338, DOI 10.1016/j.fertnstert.2012.02.051
   Shimizu Y, 2010, J OBSTET GYNAECOL RE, V36, P115, DOI 10.1111/j.1447-0756.2009.01119.x
   SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578
   Singh AK, 2013, FERTIL STERIL, V100, P127, DOI 10.1016/j.fertnstert.2013.03.006
   SOLIMAN S, 1993, FERTIL STERIL, V59, P1239
   Somigliana E, 2008, HUM REPROD, V23, P1526, DOI 10.1093/humrep/den133
   Stern JE, 2013, J ASSIST REPROD GEN, V30, P1445, DOI 10.1007/s10815-013-0092-0
   Suganuma N, 2002, GYNECOL OBSTET INVES, V54, P36, DOI 10.1159/000066293
   Sung L, 1997, J ASSIST REPROD GEN, V14, P152, DOI 10.1007/BF02766132
   Sunkara SK, 2012, FERTIL STERIL, V98, pS15, DOI 10.1016/j.fertnstert.2012.07.056
   Surrey ES, 2003, J ASSIST REPROD GEN, V20, P365, DOI 10.1023/A:1025429027610
   Surrey ES, 2002, FERTIL STERIL, V78, P699, DOI 10.1016/S0015-0282(02)03373-3
   Suzuki T, 2005, FERTIL STERIL, V83, P908, DOI 10.1016/j.fertnstert.2004.11.028
   TANBO T, 1995, ACTA OBSTET GYN SCAN, V74, P539, DOI 10.3109/00016349509024386
   Teixeira DM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010167.pub2
   Timberlake KS, 2013, FERTIL STERIL, V100, P1735, DOI 10.1016/j.fertnstert.2013.08.027
   Tinkanen H, 2000, ACTA OBSTET GYN SCAN, V79, P119, DOI 10.1034/j.1600-0412.2000.079002119.x
   Tsoumpou I, 2009, FERTIL STERIL, V92, P75, DOI 10.1016/j.fertnstert.2008.05.049
   TUMMON IS, 1991, J IN VITRO FERTIL EM, V8, P149, DOI 10.1007/BF01131705
   van Loendersloot LL, 2013, HUM REPROD, V28, P2972, DOI 10.1093/humrep/det315
   Velthut A, 2013, REPROD BIOMED ONLINE, V26, P345, DOI 10.1016/j.rbmo.2012.12.012
   Vogler A, 2010, GYNECOL SURG, V7, pS81
   WARDLE PG, 1985, LANCET, V2, P236
   Wells G, NEWCASTLE OTTAWA SCA
   Wong BC, 2004, AM J OBSTET GYNECOL, V191, P598, DOI 10.1016/j.ajog.2004.05.079
   WONG P C, 1988, Annals Academy of Medicine Singapore, V17, P247
   Wyns C, 2003, Gynecol Obstet Fertil, V31, P337, DOI 10.1016/S1297-9589(03)00069-9
   WYNS C, 2001, REF GYNECOL OBSTET, V8, P61
   Yamamoto Setsuko, 2010, Reproductive Medicine and Biology, V9, P43, DOI 10.1007/s12522-009-0039-4
   Yamashita Y, 2002, FERTIL STERIL, V78, P865, DOI 10.1016/S0015-0282(02)03339-3
   Yanushpolsky EH, 1998, J ASSIST REPROD GEN, V15, P193, DOI 10.1023/A:1023048318719
   Yazbeck C, 2006, Gynecol Obstet Fertil, V34, P808, DOI 10.1016/j.gyobfe.2006.07.003
   YOVICH JL, 1988, FERTIL STERIL, V50, P308
   Zarek SM, 2011, FERTIL STERIL, V95, P2449, DOI 10.1016/j.fertnstert.2011.04.041
   Zhao JZ, 2010, J WOMENS HEALTH, V19, P261, DOI 10.1089/jwh.2009.1491
   Zullo F, 2012, J MINIM INVAS GYN, V19, pS48
NR 205
TC 53
Z9 61
U1 3
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD SEP
PY 2014
VL 44
IS 3
BP 261
EP 278
DI 10.1002/uog.13366
PG 18
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA AO2KF
UT WOS:000341149800005
PM 24639087
OA Bronze
DA 2020-12-17
ER

PT J
AU Dib, LA
   Da Broi, MG
   Navarro, PA
AF Dib, Luciana Azor
   Da Broi, Michele Gomes
   Navarro, Paula Andrea
TI Comparative Analysis of the Spindle of Fresh In Vivo-Matured Human
   Oocytes Through Polarized Light and Confocal Microscopy: A Pilot Study
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE oocyte quality; meiotic spindle; polarization microscopy;
   high-performance confocal microscopy; meiotic anomalies
ID MEIOTIC SPINDLE; IN-VITRO; DEVELOPMENTAL COMPETENCE;
   EMBRYONIC-DEVELOPMENT; MAMMALIAN OOCYTES; BOVINE OOCYTES; ICSI;
   POLSCOPE; DYNAMICS; VISUALIZATION
AB Background: Considering the scarcity of literature data about the predictive capacity of polarization microscopy (PM) in identifying meiotic normality in human in vivo-matured oocytes, the main objective of the present study was to determine whether qualitative analysis of the spindle through PM can predict meiotic normality in fresh in vivo-matured human oocytes. Methods: Infertile patients undergoing controlled ovarian stimulation to intracytoplasmic sperm injection (ICSI) were selected. Fresh in vivo-matured oocytes were evaluated by PM and, immediately afterward, fixed for confocal microscopy (CM) analysis for evaluation of the spindle and chromosome distribution. We evaluated the percentage of oocytes with meiotic normality and abnormality determined by CM among oocytes with visible and nonvisible spindle and between oocytes with the spindle located at 0 degrees to 60 degrees angle to the first polar body (PB; normal position) and at 60 degrees to 90 degrees angle to the first PB (risky position) according to PM. Results: From 23 patients, 73 oocytes were analyzed. There were no significant differences in the percentage of oocytes with meiotic abnormalities among oocytes with visible and nonvisible spindles and among oocytes with the spindle in the normal and risky positions. Conclusions: Under the conditions tested, qualitative evaluation of the spindle through PM is not consistent with CM analysis and has limited predictive value of meiotic normality in fresh in vivo-matured human oocytes, which needs to be confirmed in larger studies. Our findings make questionable the usefulness of this methodology as a tool for noninvasive oocyte selection for ICSI.
C1 [Dib, Luciana Azor; Da Broi, Michele Gomes; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, BR-14049900 Sao Paulo, Brazil.
   [Dib, Luciana Azor; Da Broi, Michele Gomes; Navarro, Paula Andrea] Natl Inst Hormones & Womens Hlth, Sao Paulo, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM pnavarro@fmrp.usp.br
RI Da Broi, Michele G/E-7753-2012; Navarro, Paula/G-2744-2012
OI Da Broi, Michele G/0000-0003-4256-0228; Navarro, Paula
   Andrea/0000-0003-2368-4188
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2008/58197-6]; CNPq, BrazilNational Council for Scientific and
   Technological Development (CNPq) [474858/2009-0]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article: FAPESP
   (2008/58197-6) and CNPq (474858/2009-0), Brazil.
CR ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5
   ALLWORTH AE, 1993, DEV BIOL, V158, P101, DOI 10.1006/dbio.1993.1171
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Battaglia DE, 1996, HUM REPROD, V11, P2217
   Cohen Y, 2004, HUM REPROD, V19, P649, DOI 10.1093/humrep/deh113
   Cooke S, 2003, HUM REPROD, V18, P2397, DOI 10.1093/humrep/deg447
   Coticchio G, 2010, FERTIL STERIL, V93, P2056, DOI 10.1016/j.fertnstert.2008.12.011
   Dib LA, 2013, REPROD SCI, V20, P456, DOI 10.1177/1933719112459217
   Dib LA, 2012, REV BRAS GINECOL OBS, V34, P203, DOI 10.1590/S0100-72032012000500003
   Eichenlaub-Ritter Ursula, 2002, Reprod Biomed Online, V5, P117
   Fang C, 2007, J ASSIST REPROD GEN, V24, P547, DOI 10.1007/s10815-007-9171-4
   Ferreira EM, 2009, EUR J OBSTET GYN R B, V145, P76, DOI 10.1016/j.ejogrb.2009.03.016
   Heindryckx B, 2011, HUM REPROD, V26, P535, DOI 10.1093/humrep/deq376
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124
   Jones KT, 2012, EXP CELL RES, V318, P1394, DOI 10.1016/j.yexcr.2012.02.012
   Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025
   Kilani S, 2009, REPROD BIOMED ONLINE, V18, P674, DOI 10.1016/S1472-6483(10)60013-2
   Korkmaz C, 2011, GYNECOL ENDOCRINOL, V27, P737, DOI 10.3109/09513590.2010.509452
   KRENDEL M, 1995, BIOL BULL, V189, P204, DOI 10.1086/BBLv189n2p204
   Li Y, 2006, FERTIL STERIL, V85, P827, DOI 10.1016/j.fertnstert.2005.06.064
   Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692
   Madaschi C, 2008, FERTIL STERIL, V90, P194, DOI 10.1016/j.fertnstert.2007.05.071
   Magli MC, 2011, REPROD BIOMED ONLINE, V23, P747, DOI 10.1016/j.rbmo.2011.07.019
   Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005
   MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411
   Miyara F, 2003, HUM REPROD, V18, P1494, DOI 10.1093/humrep/deg272
   Montag M, 2011, HUM REPROD UPDATE, V17, P654, DOI 10.1093/humupd/dmr016
   Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2005, FERTIL STERIL, V83, P1197, DOI 10.1016/j.fertnstert.2004.07.983
   OLMSTED JB, 1973, BIOCHEMISTRY-US, V12, P4282, DOI 10.1021/bi00745a037
   Petersen CG, 2009, REPROD BIOMED ONLINE, V18, P235, DOI 10.1016/S1472-6483(10)60261-1
   Raju GAR, 2007, REPROD BIOMED ONLINE, V14, P166, DOI 10.1016/S1472-6483(10)60784-5
   Reinzi L, 2003, HUM REPROD, V18, P1289, DOI 10.1093/humrep/deg274
   Roberts R, 2002, HUM REPROD, V17, P2950, DOI 10.1093/humrep/17.11.2950
   Shen Y, 2006, REPROD BIOMED ONLINE, V12, P737, DOI 10.1016/S1472-6483(10)61086-3
   Taylor TH, 2008, REPROD BIOMED ONLINE, V17, P515, DOI 10.1016/S1472-6483(10)60238-6
   Tomari H, 2011, J ASSIST REPROD GEN, V28, P1099, DOI 10.1007/s10815-011-9634-5
   VANBLERKOM J, 1992, HUM REPROD, V7, P379, DOI 10.1093/oxfordjournals.humrep.a137655
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
   Wang WH, 2001, HUM REPROD, V16, P1464, DOI 10.1093/humrep/16.7.1464
   Woodward BJ, 2008, REPROD BIOMED ONLINE, V16, P232, DOI 10.1016/S1472-6483(10)60579-2
   Yu Y, 2011, FERTIL STERIL, V96, P73, DOI 10.1016/j.fertnstert.2011.04.077
NR 45
TC 3
Z9 3
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD AUG
PY 2014
VL 21
IS 8
BP 984
EP 992
DI 10.1177/1933719113519174
PG 9
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AN6SD
UT WOS:000340726200005
PM 24429679
DA 2020-12-17
ER

PT J
AU Picinato, MC
   Martins, WP
   Giorgenon, RC
   Santos, CKB
   Ferriani, RA
   Navarro, PAAS
   Rosa-e-Silva, ACJD
AF Picinato, Maria C.
   Martins, Wellington P.
   Giorgenon, Roberta C.
   Santos, Camila K. B.
   Ferriani, Rui A.
   Navarro, Paula A. A. S.
   de Sa Rosa-e-Silva, Ana C. J.
TI The impact of examining the meiotic spindle by polarization microscopy
   on assisted reproduction outcomes
SO FERTILITY AND STERILITY
LA English
DT Article
DE Oocytes; polarization microscopy; assisted reproductive techniques;
   comparative study
ID MATURED HUMAN OOCYTES; LIVING HUMAN OOCYTES; IN-VITRO;
   EMBRYONIC-DEVELOPMENT; ICSI OUTCOMES; MOUSE OOCYTES; VISUALIZATION;
   POLSCOPE; MORPHOLOGY; FERTILIZATION
AB Objective: To examine the effect of submitting oocytes to polarization microscopy (PM) before intracytoplasmic sperm injection (ICSI).
   Design: Retrospective observational study. Setting: University hospital in Brazil.
   Patient(s): Couples undergoing ICSI.
   Intervention(s): PM before ICSI (PM group) compared with no PM before ICSI (No-PM group)
   Main Outcomes Measure(s): Fertilization and cleavage rates, formation of top-quality embryos (TQEs), and implantation, clinical pregnancy, miscarriage, and live-birth rates. Result(s): The PM group consisted of 1,000 consecutive oocytes from 201 couples submitted to PM during the year of 2008. The No-PM group consisted of 1,400 oocytes from 249 couples: 700 consecutive oocytes were retrieved before we started using PM and 700 consecutive oocytes were retrieved after we stopped using PM. In the PM group, we observed an increased fertilization rate (79.7% vs. 72.5%, PM group vs. No-PM group, respectively) but reduced cleavage rate (86.2% vs. 92.5%) and TQE formation (33.1% vs. 49.9%). Implantation (18.7% vs. 20.6%), clinical pregnancy (31.8% vs. 33.3%), miscarriage (21.9% vs. 15.7%), and live-birth (24.9% vs. 28.1%) rates were not significantly different between groups.
   Conclusion(s): Use of PM was associated with increased fertilization rate but reduced cleavage rate and TQE formation; no significant difference was observed for implantation, clinical pregnancy, or live-birth rates. (c) 2014 by American Society for Reproductive Medicine.
C1 [Picinato, Maria C.; Martins, Wellington P.; Giorgenon, Roberta C.; Santos, Camila K. B.; Ferriani, Rui A.; Navarro, Paula A. A. S.; de Sa Rosa-e-Silva, Ana C. J.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, BR-14049900 Sao Paulo, Brazil.
   [Martins, Wellington P.; Ferriani, Rui A.; Navarro, Paula A. A. S.; de Sa Rosa-e-Silva, Ana C. J.] Natl Counsel Technol & Sci Dev Hormones & Womens, Natl Inst Sci & Technol, Sao Paulo, Brazil.
   [Martins, Wellington P.] Sch Ultrasonog & Med Recycling Ribeirao Preto, Sao Paulo, Brazil.
RP Rosa-e-Silva, ACJD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, Setor Reprod Humana, Ave Bandeirantes 3900-8, BR-14049900 Sao Paulo, Brazil.
EM anasars@fmrp.usp.br
RI Martins, Wellington/B-1284-2008; Rosa-e-Silva, Ana Carolina
   JS/L-2723-2016; Navarro, Paula/G-2744-2012
OI Martins, Wellington/0000-0002-7593-5607; Rosa-e-Silva, Ana Carolina
   JS/0000-0001-7025-344X; Navarro, Paula Andrea/0000-0003-2368-4188
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); Hospital das Clinicas da Faculdade de
   Medicina de Ribeirao Preto da Universidade de Sao Paulo; Fundacao de
   Apoio ao Ensino, Pesquisa e Assistencia Hospital das Clinicas a
   Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo
FX M.C.P. has nothing to disclose. W.P.M. reports personal fees from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo, and Hospital das Clinicas da
   Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo;
   and has received grants from Fundacao de Apoio ao Ensino, Pesquisa e
   Assistencia Hospital das Clinicas a Faculdade de Medicina de Ribeirao
   Preto da Universidade de Sao Paulo. R.C.G. has nothing to disclose.
   C.K.B.S. has nothing to disclose. R. A. F. has nothing to disclose.
   P.A.A.S.N. has nothing to disclose. A.C.J.d.S. has nothing to disclose.
CR Avery Susan, 2003, Hum Fertil (Camb), V6, P19, DOI 10.1080/1464770312331368933
   Battaglia DE, 1996, HUM REPROD, V11, P2217
   Chamayou S, 2006, REPROD BIOMED ONLINE, V13, P661, DOI 10.1016/S1472-6483(10)60656-6
   Cohen Y, 2004, HUM REPROD, V19, P649, DOI 10.1093/humrep/deh113
   Cooke S, 2003, HUM REPROD, V18, P2397, DOI 10.1093/humrep/deg447
   De Santis L, 2005, REPROD BIOMED ONLINE, V11, P36, DOI 10.1016/S1472-6483(10)61296-5
   Dib LA, 2012, REV BRAS GINECOL OBS, V34, P203, DOI 10.1590/S0100-72032012000500003
   Eichenlaub-Ritter Ursula, 2002, Reprod Biomed Online, V5, P117
   Fang C, 2007, J ASSIST REPROD GEN, V24, P547, DOI 10.1007/s10815-007-9171-4
   GARRISI GJ, 1993, FERTIL STERIL, V59, P366
   Gianaroli L, 2003, FERTIL STERIL, V80, P341, DOI 10.1016/S0015-0282(03)00596-X
   Gomes C, 2012, FERTIL STERIL, V97, P714, DOI 10.1016/j.fertnstert.2011.12.018
   Hammadeh ME, 1997, ARCH GYNECOL OBSTET, V259, P125
   Heindryckx B, 2011, HUM REPROD, V26, P535, DOI 10.1093/humrep/deq376
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   Konc J, 2004, J ASSIST REPROD GEN, V21, P349, DOI 10.1023/B:JARG.0000046202.00570.1d
   Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692
   Madaschi C, 2008, FERTIL STERIL, V90, P194, DOI 10.1016/j.fertnstert.2007.05.071
   Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005
   Montag M, 2011, HUM REPROD UPDATE, V17, P654, DOI 10.1093/humupd/dmr016
   Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Navarro PAAS, 2005, FERTIL STERIL, V83, P1197, DOI 10.1016/j.fertnstert.2004.07.983
   Petersen CG, 2009, REPROD BIOMED ONLINE, V18, P235, DOI 10.1016/S1472-6483(10)60261-1
   PICKERING SJ, 1990, FERTIL STERIL, V54, P102
   Raju GAR, 2007, REPROD BIOMED ONLINE, V14, P166, DOI 10.1016/S1472-6483(10)60784-5
   Reinzi L, 2003, HUM REPROD, V18, P1289, DOI 10.1093/humrep/deg274
   Rienzi L, 2005, REPROD BIOMED ONLINE, V10, P192, DOI 10.1016/S1472-6483(10)60940-6
   Roberts R, 2002, HUM REPROD, V17, P2950, DOI 10.1093/humrep/17.11.2950
   Shen Y, 2006, REPROD BIOMED ONLINE, V12, P737, DOI 10.1016/S1472-6483(10)61086-3
   Taylor T, 2006, HUM REPROD, V21, pO60
   Van Blerkom J, 2001, HUM REPROD, V16, P757, DOI 10.1093/humrep/16.4.757
   Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
   Wang WH, 2001, FERTIL STERIL, V75, P348, DOI 10.1016/S0015-0282(00)01692-7
   Wang WH, 2001, HUM REPROD, V16, P1464, DOI 10.1093/humrep/16.7.1464
   Woodward BJ, 2008, REPROD BIOMED ONLINE, V16, P232, DOI 10.1016/S1472-6483(10)60579-2
   Zenzes MT, 2001, FERTIL STERIL, V75, P769, DOI 10.1016/S0015-0282(00)01800-8
NR 38
TC 7
Z9 7
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD FEB
PY 2014
VL 101
IS 2
BP 379
EP +
DI 10.1016/j.fertnstert.2013.10.009
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 302CD
UT WOS:000330578000018
PM 24220701
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Malvezzi, H
   Paz, CCP
   Ferriani, RA
   Navarro, PAAS
AF Da Broi, M. G.
   Malvezzi, H.
   Paz, C. C. P.
   Ferriani, R. A.
   Navarro, P. A. A. S.
TI Follicular fluid from infertile women with mild endometriosis may
   compromise the meiotic spindles of bovine metaphase II oocytes
SO HUMAN REPRODUCTION
LA English
DT Article
DE female infertility; mild endometriosis; follicular fluid; oocyte
   quality; meiotic spindle
ID IN-VITRO FERTILIZATION; OXIDATIVE STRESS; DEVELOPMENTAL COMPETENCE;
   EMBRYO DEVELOPMENT; PERITONEAL-FLUID; MATURATION; APOPTOSIS; DYNAMICS;
   QUALITY; MOUSE
AB What is the potential impact of follicular fluid (FF) from infertile women with mild endometriosis (ME) on oocyte quality, especially on nuclear maturation and the meiotic spindle?
   FF from infertile women with ME may compromise nuclear maturation and the meiotic spindles of in vitro matured bovine oocytes.
   Controversial studies have suggested that impaired oocyte quality may be involved in the pathogenesis of endometriosis-related infertility. Moreover, some studies have demonstrated alterations in the composition of FF from infertile women with endometriosis. However, to date no study has evaluated the effect of FF from infertile women with ME on the genesis of meiotic oocyte anomalies.
   We performed an experimental study. Samples of FF were obtained from February 2009 to February 2011 from 22 infertile women, 11 with ME and 11 with tubal or male factors of infertility (control group), who underwent ovarian stimulation for ICSI at our university IVF Unit. From March 2011 to February 2012 we performed in vitro maturation (IVM) experiments using immature bovine oocytes as described below.
   FF free of blood and containing a mature oocyte was obtained from 22 infertile women during oocyte retrieval for ICSI. Immature bovine oocytes underwent IVM in the absence of FF (No-FF) and in the presence of four concentrations (1, 5, 10 and15) of FF from infertile women without endometriosis (C-FF) and with ME (ME-FF). Eleven replicates were performed, each one using FF from a control patient and a patient with ME. Each FF sample was used in only one experiment. After 2224 h of IVM, oocytes were denuded, fixed and immunostained for morphological visualization of microtubules and chromatin by confocal microscopy.
   A total of 1324 cumulusoocyte complexes were matured in vitro. Of these, 1128 were fixed and 1048 were analyzed by confocal microscopy. The percentage of meiotically normal oocytes was significantly higher for oocytes that underwent IVM in the absence of FF (No-FF; 76.5) and in the presence of 1 (80.9), 5 (76.6), 10 (75) and 15 (76.2) C-FF than in oocytes that underwent IVM in the presence of 1 (44.4), 5 (36.7), 10 (45.5) and 15 (51.2) ME-FF (P 0.01). No differences were observed among FF concentrations within each group. When the four concentrations from each group were pooled, the number of oocytes in metaphase I stage was significantly higher in the ME-FF (50 oocytes) than in the C-FF (29 oocytes) group and the percentage of meiotic abnormalities was significantly higher when oocytes were matured with ME-FF (55.8) than with C-FF (23.1), P 0.01.
   Owing to the strict selection criteria for FF donors, this study had a small sample size (11 cases and 11 controls), and thus further investigations using a large cohort of patients are needed to confirm these results. In addition, data obtained from studies using animal models may not necessarily be extrapolated to humans and studies evaluating in vivo matured oocytes from infertile women with ME are important to confirm our results.
   Our results open new insights into the pathogenic mechanisms of infertility related to mild endometriosis, suggesting that FF from infertile women with mild endometriosis may be involved in the worsening of oocyte quality of these women.
   This study was supported by the National Council for Scientific and Technological Development (CNPq), Brazil. The authors declare no conflicts of interest.
C1 [Da Broi, M. G.; Malvezzi, H.; Ferriani, R. A.; Navarro, P. A. A. S.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Gynecol & Obstet, Human Reprod Div, BR-14049 Ribeirao Preto, SP, Brazil.
   [Paz, C. C. P.] SAA APTA, Ribeirao Preto, SP, Brazil.
   [Paz, C. C. P.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.
   [Ferriani, R. A.; Navarro, P. A. A. S.] CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
RP Da Broi, MG (corresponding author), Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM michi.dabroi@gmail.com
RI de Paz, Claudia Cristina Paro/E-8791-2012; Da Broi, Michele
   G/E-7753-2012; de Paz, Claudia Cristina Paro/A-8852-2014; Navarro,
   Paula/G-2744-2012; Malvezzi, Helena/Z-1100-2019
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; Da Broi, Michele
   G/0000-0003-4256-0228; de Paz, Claudia Cristina
   Paro/0000-0002-7267-4552; Malvezzi, Helena/0000-0002-5504-6116; Navarro,
   Paula Andrea/0000-0003-2368-4188
FU National Council for Scientific and Technological Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq), Brazil.
CR Adona PR, 2004, ZYGOTE, V12, P197, DOI 10.1017/S0967199404002771
   Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8
   Agarwal A, 2006, REPROD BIOMED ONLINE, V13, P126
   Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5
   Augoulea A, 2012, ARCH GYNECOL OBSTET, V286, P99, DOI 10.1007/s00404-012-2357-8
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   BRIZEK CL, 1995, J ASSIST REPROD GEN, V12, P106, DOI 10.1007/BF02211378
   Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1
   Canis M, 1997, FERTIL STERIL, V67, P817
   Coticchio G, 2010, FERTIL STERIL, V93, P2056, DOI 10.1016/j.fertnstert.2008.12.011
   De Santis L, 2005, REPROD BIOMED ONLINE, V11, P36, DOI 10.1016/S1472-6483(10)61296-5
   Eichenlaub-Ritter Ursula, 2002, Reprod Biomed Online, V5, P117
   Ferreira EM, 2009, EUR J OBSTET GYN R B, V145, P76, DOI 10.1016/j.ejogrb.2009.03.016
   Fujii EY, 2008, REPROD SCI, V15, P1066, DOI 10.1177/1933719108323445
   Garcia-Velasco JA, 1999, HUM REPROD, V14, P77, DOI 10.1093/humrep/14.suppl_2.77
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Gianaroli L, 2010, HUM REPROD, V25, P2374, DOI 10.1093/humrep/deq123
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Hashimoto S, 2002, BIOL REPROD, V66, P1696, DOI 10.1095/biolreprod66.6.1696
   Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   Jackson LW, 2005, HUM REPROD, V20, P2014, DOI 10.1093/humrep/dei001
   Jacobson TZ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001398.pub2
   Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025
   Katsoff B, 2006, Clin Exp Obstet Gynecol, V33, P201
   Kumbak B, 2008, GYNECOL OBSTET INVES, V65, P212, DOI 10.1159/000112310
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692
   Ma CH, 2010, FERTIL STERIL, V93, P920, DOI 10.1016/j.fertnstert.2009.01.131
   Malhi PS, 2005, BIOL REPROD, V73, P45, DOI 10.1095/biolreprod.104.038745
   Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Marcoux S, 1997, NEW ENGL J MED, V337, P217, DOI 10.1056/NEJM199707243370401
   Matorras R, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.019
   MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411
   Minici F, 2008, HUM REPROD, V23, P530, DOI 10.1093/humrep/dem399
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2005, FERTIL STERIL, V83, P1197, DOI 10.1016/j.fertnstert.2004.07.983
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Parazzini F, 1999, HUM REPROD, V14, P1332
   Pellicer A, 2001, ANN NY ACAD SCI, V943, P122, DOI 10.1111/j.1749-6632.2001.tb03796.x
   Pellicer A, 1995, HUM REPROD, V10, P91, DOI 10.1093/humrep/10.suppl_2.91
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
NR 50
TC 35
Z9 36
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD FEB
PY 2014
VL 29
IS 2
BP 315
EP 323
DI 10.1093/humrep/det378
PG 9
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AA1FV
UT WOS:000330842800016
PM 24166595
OA Bronze
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Andrade, AZ
   Rodrigues, JK
   de Paz, CCP
   Jordao, AA
   Navarro, PA
AF Da Broi, M. G.
   Andrade, A. Z.
   Rodrigues, J. K.
   de Paz, C. C. P.
   Jordao, A. A., Jr.
   Navarro, P. A.
TI TOTAL ANTIOXIDANT CAPACITY (TAC) LEVELS IN FOLLICULAR FLUID OF INFERTILE
   PATIENTS UNDERGOING ICSI: A POSSIBLE PREDICTOR OF CLINICAL PREGNANCY
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT International-Federation-of-Fertility-Societies 21st World Congress on
   Fertility and Sterility / 69th Annual Meeting of the
   American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2013
CL Boston, MA
SP Int Federat Fertil Soc, Amer Soc Reprod Med
C1 [Da Broi, M. G.; Andrade, A. Z.; Rodrigues, J. K.; Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [de Paz, C. C. P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil.
   [Jordao, A. A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, Sao Paulo, Brazil.
RI de Paz, Claudia Cristina Paro/A-8852-2014; Navarro, Paula/G-2744-2012;
   Jordao, Alceu Afonso/D-7545-2014; Da Broi, Michele G/E-7753-2012; de
   Paz, Claudia Cristina Paro/E-8791-2012
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; Da Broi, Michele
   G/0000-0003-4256-0228; de Paz, Claudia Cristina Paro/0000-0002-7267-4552
NR 0
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2013
VL 100
IS 3
SU S
MA P-961
BP S425
EP S425
DI 10.1016/j.fertnstert.2013.07.581
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ1PY
UT WOS:000342554501732
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Palhares, MB
   Romao, GS
AF Navarro, P. A.
   Palhares, M. B., Jr.
   Romao, G. S.
TI IMPACT OF HYPOPHYSEAL SUPPRESSION AND CONTROLLED OVARIAN STIMULATION ON
   ANTI-MULLERIAN SERUM LEVELS IN PATIENTS WITH AND WITHOUT ENDOMETRIOSIS
   SUBMITTED TO ICSI.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT International-Federation-of-Fertility-Societies 21st World Congress on
   Fertility and Sterility / 69th Annual Meeting of the
   American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2013
CL Boston, MA
SP Int Federat Fertil Soc, Amer Soc Reprod Med
C1 [Navarro, P. A.; Palhares, M. B., Jr.; Romao, G. S.] Univ Sao Paulo, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil.
RI Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2013
VL 100
IS 3
SU S
MA P-1208
BP S496
EP S496
DI 10.1016/j.fertnstert.2013.07.361
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ1PY
UT WOS:000342554502218
DA 2020-12-17
ER

PT J
AU Navarro, P
   Meola, J
   Ribas, CP
   Paz, CP
   Ferriani, RA
   Donabela, FC
AF Navarro, P.
   Meola, J.
   Ribas, C. P.
   Paz, C. P.
   Ferriani, R. A.
   Donabela, F. C.
TI Expression of genes SOD1, SOD2 and GPX4 in cumulus oophorus cells of
   infertile women with and without endometriosis undergoing ovarian
   stimulation for ICSI
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 29th Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUL 07-10, 2013
CL London, ENGLAND
SP European Soc Human Reprod & Embryol (ESHRE)
C1 [Navarro, P.; Meola, J.; Ribas, C. P.; Paz, C. P.; Ferriani, R. A.; Donabela, F. C.] Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil.
RI Lovato, Juliana Meola/E-3440-2012; de Paz, Claudia Cristina
   Paro/E-8791-2012; Navarro, Paula/G-2744-2012; de Paz, Claudia Cristina
   Paro/A-8852-2014; RIBAS, CRISTIANA/J-3790-2013
OI Lovato, Juliana Meola/0000-0003-2514-4011; de Paz, Claudia Cristina
   Paro/0000-0002-7267-4552; de Paz, Claudia Cristina
   Paro/0000-0002-7267-4552; RIBAS, CRISTIANA/0000-0001-6648-8377
NR 0
TC 1
Z9 1
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
J9 HUM REPROD
JI Hum. Reprod.
PD JUN
PY 2013
VL 28
SU 1
BP 219
EP 219
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 165FD
UT WOS:000320467700519
DA 2020-12-17
ER

PT J
AU Malvezzi, H
   Aguiar, VG
   de Paz, CCP
   Tanus-Santos, JE
   Penna, IAD
   Navarro, PA
AF Malvezzi, Helena
   Aguiar, Valeria Gomes
   Paro de Paz, Claudia Cristina
   Tanus-Santos, Jose Eduardo
   de Araujo Penna, Ivan Andrade
   Navarro, Paula Andrea
TI Increased Circulating MMP-2 Levels in Infertile Patients With Moderate
   and Severe Pelvic Endometriosis
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE endometriosis; MMP-2; MMP-9; female infertility; follicular fluid; serum
ID MATRIX-METALLOPROTEINASE (MMP)-9; TISSUE INHIBITOR; FOLLICULAR-FLUID;
   WOMEN; SERUM; EXPRESSION; MATRIX-METALLOPROTEINASE-9
AB The current study compares the levels of matrix metalloproteinase (MMP)-2 and MMP-9 in the follicular fluid (FF) of infertile patients with and without endometriosis submitted to ovarian stimulation for in vitro fertilization and the levels of MMP-2 in the serum of the same patients. We also evaluated whether the severity of endometriosis can influence serum and/or FF concentration of these metalloproteinases. A cross-sectional study was conducted on 30 patients: stage I/II endometriosis (n = 10), stage III/IV endometriosis (n = 10), and control (infertility due to tubal and/or male factor; n = 10). Blood samples for the analysis of MMP-2 levels were obtained during the early follicular phase of the menstrual cycle. The FF samples for the analysis of MMP-2 and MMP-9 were obtained on the day of oocyte retrieval. The concentrations of MMP-2 and MMP-9 were determined by zymography. No intragroup or intergroup difference was observed in MMP-2 or MMP-9 levels in FF. Significantly higher MMP-2 levels were detected in the serum of infertile women with stage III/IV endometriosis compared to women with stage I/II endometriosis. In conclusion, no differences were observed in the follicular levels of MMP-2 and MMP-9 between infertile patients with and without endometriosis. However, the levels of MMP-2 were significantly higher in the serum of infertile women with advanced stages of endometriosis. Taken together, the present results demonstrate that advanced pelvic endometriosis severity is related to higher serum MMP-2 levels but does not influence follicular MMP-2 or MMP-9 levels in periovulatory follicles obtained from stimulated cycles.
C1 [Malvezzi, Helena; Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Aguiar, Valeria Gomes] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil.
   [Paro de Paz, Claudia Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Tanus-Santos, Jose Eduardo] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [de Araujo Penna, Ivan Andrade] Univ Fed Fluminense, Fac Med, Dept Maternoinfantil, Niteroi, RJ, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ginecol & Obstet, Setor Reprod Humana, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM pnavarro@fmrp.usp.br
RI Navarro, Paula/G-2744-2012; de Paz, Claudia Cristina Paro/E-8791-2012;
   de Paz, Claudia Cristina Paro/A-8852-2014; Tanus-Santos,
   Jose/A-4451-2008; Malvezzi, Helena/Z-1100-2019
OI de Paz, Claudia Cristina Paro/0000-0002-7267-4552; de Paz, Claudia
   Cristina Paro/0000-0002-7267-4552; Malvezzi, Helena/0000-0002-5504-6116;
   Navarro, Paula Andrea/0000-0003-2368-4188
CR Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   BRIZEK CL, 1995, J ASSIST REPROD GEN, V12, P106, DOI 10.1007/BF02211378
   Bruner KL, 1997, J CLIN INVEST, V99, P2851, DOI 10.1172/JCI119478
   Chung HW, 2002, FERTIL STERIL, V78, P787, DOI 10.1016/S0015-0282(02)03322-8
   D'Ascenzo S, 2004, EUR J ENDOCRINOL, V151, P87, DOI 10.1530/eje.0.1510087
   Demacq C, 2006, CLIN CHIM ACTA, V365, P183, DOI 10.1016/j.cca.2005.08.017
   Di Carlo C, 2009, FERTIL STERIL, V91, P2315, DOI 10.1016/j.fertnstert.2008.03.079
   Gerlach RF, 2007, CLIN BIOCHEM, V40, P119, DOI 10.1016/j.clinbiochem.2006.10.007
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Huang HF, 2004, FERTIL STERIL, V81, P1235, DOI 10.1016/j.fertnstert.2003.10.027
   Katsoff B, 2006, Clin Exp Obstet Gynecol, V33, P201
   Koninckx PR, 1998, HUM REPROD UPDATE, V4, P741, DOI 10.1093/humupd/4.5.741
   Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7
   Lee DM, 2005, BJOG-INT J OBSTET GY, V112, P946, DOI 10.1111/j.1471-0528.2005.00574.x
   Lurlaro M, 1999, EUR J CLIN INVEST, V29, P793
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Osteen KG, 2003, SEMIN REPROD MED, V21, P155
   Pellicer A, 2001, ANN NY ACAD SCI, V943, P122, DOI 10.1111/j.1749-6632.2001.tb03796.x
   Pellicer A, 1995, HUM REPROD, V10, P91, DOI 10.1093/humrep/10.suppl_2.91
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS156
   Salata IM, 2008, GYNECOL ENDOCRINOL, V24, P326, DOI 10.1080/09513590802090325
   Shibahara H, 2005, AM J REPROD IMMUNOL, V54, P186, DOI 10.1111/j.1600-0897.2005.00297.x
   Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020
   Szamatowicz J, 2002, HUM REPROD, V17, P284, DOI 10.1093/humrep/17.2.284
   Van Langendonckt A, 2002, FERTIL STERIL, V77, P861, DOI 10.1016/S0015-0282(02)02959-X
NR 29
TC 17
Z9 21
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAY
PY 2013
VL 20
IS 5
BP 557
EP 562
DI 10.1177/1933719112459234
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 131KF
UT WOS:000317991200008
PM 23171686
DA 2020-12-17
ER

PT J
AU Dib, LA
   Araujo, MCPM
   Giorgenon, RC
   Romao, GS
   Ferriani, RA
   Navarro, PA
AF Dib, Luciana A.
   Araujo, Maria C. P. M.
   Giorgenon, Roberta Cristina
   Romao, Gustavo S.
   Ferriani, Rui A.
   Navarro, Paula A.
TI Noninvasive Imaging of the Meiotic Spindle of In Vivo Matured Oocytes
   From Infertile Women With Endometriosis
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE endometriosis; human oocyte quality; meiotic spindle; polarization
   microscopy; ICSI
ID DEVELOPMENTAL COMPETENCE; EMBRYO DEVELOPMENT; PERITONEAL-FLUID;
   OXIDATIVE STRESS; VITRO; ICSI; FERTILIZATION; VISUALIZATION; QUALITY;
   IMPLANTATION
AB The objectives of this prospective study were to evaluate the nuclear maturation stage and the presence and location of meiotic spindles of in vivo matured oocytes from infertile women with and without endometriosis (male or tubal causes of infertility) undergoing stimulated cycles for intracytoplasmic sperm injection (ICSI). We also compared the ICSI outcomes among groups. We analyzed the meiotic spindles of oocytes from 36 patients with endometriosis I/II, 24 with endometriosis III/IV, and 60 without endometriosis (male or tubal causes of infertility). The oocytes were imaged using polarization microscopy. There were no differences in the number of oocytes in telophase I (mean [standard deviation]: 0.1 [0.5], 0.2 [0.4], and 0.2 [0.5], respectively, in the endometriosis I/II, endometriosis III/IV, and control groups), in metaphase II with visible spindles (4.2 [2.5], 3.1 [2.0], and 3.6 [2.2], respectively, in the endometriosis I/II, endometriosis III/IV, and control groups), and in spindle location among groups. We can conclude from this study that noninvasive analysis of spindles from in vivo matured oocytes of infertile patients with endometriosis did not demonstrate significant differences in terms of the nuclear maturation stage, the percentage of oocytes in metaphase II with visible spindles, and the spindle localization when compared to the control group. However, it is important to state that there are no studies evaluating the accuracy of polarization microscopy for the detection of meiotic anomalies in human oocytes, which would need to be better evaluated in future studies using an appropriate methodology.
C1 [Dib, Luciana A.; Araujo, Maria C. P. M.; Giorgenon, Roberta Cristina; Romao, Gustavo S.; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Dept Obstet & Gynecol, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil.
   [Ferriani, Rui A.; Navarro, Paula A.] Natl Inst Hormones & Womens Hlth, Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM paasnavarro@uol.com.br
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [Edital MCT/CNPq 15/2007, 478396/2007-4]; Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2008/58197-6]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Luciana A.
   Dib was supported by a scholarship granted by Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil. Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Edital
   MCT/CNPq 15/2007 - Processo 478396/2007-4. Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) - 2008/58197-6.
CR Agarwal A, 2006, REPROD BIOMED ONLINE, V13, P126
   Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   Armstrong DT, 2001, THERIOGENOLOGY, V55, P1303, DOI 10.1016/S0093-691X(01)00484-8
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   BRIZEK CL, 1995, J ASSIST REPROD GEN, V12, P106, DOI 10.1007/BF02211378
   Canis M, 1997, FERTIL STERIL, V67, P817
   Cohen Y, 2004, HUM REPROD, V19, P649, DOI 10.1093/humrep/deh113
   de Andrade AZ, 2010, REV BRAS GINECOL OBS, V32, P279, DOI 10.1590/S0100-72032010000600005
   Fang C, 2007, J ASSIST REPROD GEN, V24, P547, DOI 10.1007/s10815-007-9171-4
   Garrido N, 2002, HUM REPROD UPDATE, V8, P95, DOI 10.1093/humupd/8.1.95
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124
   Jackson LW, 2005, HUM REPROD, V20, P2014, DOI 10.1093/humrep/dei001
   LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107
   Madaschi C, 2008, FERTIL STERIL, V90, P194, DOI 10.1016/j.fertnstert.2007.05.071
   Mansour G, 2007, FERTIL STERIL, V88, pS311, DOI 10.1016/j.fertnstert.2007.07.1046
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165
   PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111
   Pellicer A, 1995, HUM REPROD, V10, P91, DOI 10.1093/humrep/10.suppl_2.91
   Petersen CG, 2009, REPROD BIOMED ONLINE, V18, P235, DOI 10.1016/S1472-6483(10)60261-1
   Prieto L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.052
   Reinzi L, 2003, HUM REPROD, V18, P1289, DOI 10.1093/humrep/deg274
   Roberts R, 2002, HUM REPROD, V17, P2950, DOI 10.1093/humrep/17.11.2950
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
NR 26
TC 7
Z9 8
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD APR
PY 2013
VL 20
IS 4
BP 456
EP 462
DI 10.1177/1933719112459217
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 131KE
UT WOS:000317991100013
PM 22991379
OA Green Published
DA 2020-12-17
ER

PT J
AU Teixeira, DM
   Barbosa, MAP
   Ferriani, RA
   Navarro, PA
   Raine-Fenning, N
   Nastri, CO
   Martins, WP
AF Teixeira, Danielle M.
   Barbosa, Mariana A. P.
   Ferriani, Rui A.
   Navarro, Paula A.
   Raine-Fenning, Nick
   Nastri, Carolina O.
   Martins, Wellington P.
TI Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection
   for assisted reproduction
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID INTRACYTOPLASMIC INJECTION; EMBRYO DEVELOPMENT; PREGNANCY RATES;
   MORPHOLOGY; BENEFITS; OUTCOMES; QUALITY; WOMEN
AB Background
   Subfertility is a condition found in up to 15% of couples of reproductive age. Gamete micromanipulation, such as intracytoplasmic sperm injection (ICSI), is very useful for treating couples with compromised sperm parameters. Recently a new method of sperm selection named 'motile sperm organelle morphology examination' (MSOME) has been described and the spermatozoa selected under high magnification (over 6000x) used for ICSI. This new technique, named intracytoplasmic morphologically selected sperm injection (IMSI), has a theoretical potential to improve reproductive outcomes among couples undergoing assisted reproduction techniques (ART).
   Objectives
   To compare the effectiveness and safety of IMSI and ICSI in couples undergoing ART.
   Search methods
   We searched for randomised controlled trials (RCT) in electronic databases (Cochrane Menstrual Disorders and Subfertility Group Specialized Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO, CINAHL, LILACS), trials registers (ClinicalTrials.gov, Current Controlled Trials, World Health Organization International Clinical Trials Registry Platform), conference abstracts (ISI Web of knowledge), and grey literature (OpenGrey); in addition, we handsearched the reference lists of included studies and similar reviews. We performed the last electronic search on 8 May 2013.
   Selection criteria
   We considered only truly randomised controlled trials comparing ICSI and IMSI to be eligible; we did not include quasi or pseudo-randomised trials. We included studies that permitted the inclusion of the same participant more than once (cross-over or 'per cycle' trials) only if data regarding the first treatment of each participant were available.
   Data collection and analysis
   Two review authors independently performed study selection, data extraction, and assessment of the risk of bias and we solved disagreements by consulting a third review author. We corresponded with study investigators in order to resolve any queries, as required.
   Main results
   The search retrieved 294 records; from those, nine parallel design studies were included, comprising 2014 couples (IMSI = 1002; ICSI = 1012). Live birth was evaluated by only one trial and there was no significant evidence of a difference between IMSI and ICSI (risk ratio (RR) 1.14, 95% confidence interval (CI) 0.79 to 1.64, 1 RCT, 168 women, I-2 = not applicable, low-quality evidence). IMSI was associated with a significant improvement in clinical pregnancy rate (RR 1.29, 95% CI 1.07 to 1.56, 9 RCTs, 2014 women, I-2 = 57%, very-low-quality evidence). We downgraded the quality of this evidence because of imprecision, inconsistency, and strong indication of publication bias. We found no significant difference in miscarriage rate between IMSI and ICSI (RR 0.82, 95% CI 0.59 to 1.14, 6 RCTs, 552 clinical pregnancies, I-2 = 17%, very-low-quality evidence). None of the included studies reported congenital abnormalities.
   Authors' conclusions
   Results from RCTs do not support the clinical use of IMSI. There is no evidence of effect on live birth or miscarriage and the evidence that IMSI improves clinical pregnancy is of very low quality. There is no indication that IMSI increases congenital abnormalities. Further trials are necessary to improve the evidence quality before recommending IMSI in clinical practice.
C1 [Teixeira, Danielle M.; Barbosa, Mariana A. P.; Ferriani, Rui A.; Navarro, Paula A.; Nastri, Carolina O.; Martins, Wellington P.] Univ Sao Paulo, Dept Obstet & Gynecol, Med Sch Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
   [Raine-Fenning, Nick] Univ Nottingham, Div Obstet & Gynaecol, Sch Clin Sci, Nottingham NG7 2RD, England.
RP Martins, WP (corresponding author), Univ Sao Paulo, Dept Obstet & Gynecol, Med Sch Ribeirao Preto, Hosp Clin FMRP USP, 8 Andar,Campus Univ,Campus Univ USP, BR-14048900 Sao Paulo, Brazil.
EM wpmartins@gmail.com
RI Nastri, Carolina O/E-1172-2012; Navarro, Paula/G-2744-2012; Martins,
   Wellington/B-1284-2008; Raine-Fenning, Nicholas J/C-3005-2008
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Raine-Fenning, Nicholas
   J/0000-0001-5521-9059; Navarro, Paula Andrea/0000-0003-2368-4188
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES; Hospital das Clinicas FMRP-USP, Brazil; Conselho Nacional
   de Desenvolvimento Cientfico e Tecnologico (CNPq), BrazilNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), BrazilFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Brazil.; Hospital das Clinicas FMRP-USP, Brazil.; Conselho Nacional de
   Desenvolvimento Cientfico e Tecnologico (CNPq), Brazil.; Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil.
CR Antinori M, 2008, REPROD BIOMED ONLINE, V16, P835, DOI 10.1016/S1472-6483(10)60150-2
   Antinori S, 2008, HUMAN REPROD S1, V23, pi165
   Apryshko VP, 2010, REPROD BIOMED ONLINE, V20, pS25, DOI DOI 10.1016/J.RBM0.2012.10.020]
   Apryshko VP, 2010, REPROD BIOMED ONL S3, V20, pS25
   Balaban B, 2011, REPROD BIOMED ONLINE, V22, P472, DOI 10.1016/j.rbmo.2010.11.003
   Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016
   Bartoov B, 2002, J ANDROL, V23, P1
   Berkovitz A, 2006, REPROD BIOMED ONLINE, V12, P634, DOI 10.1016/S1472-6483(10)61191-1
   Berkovitz A, 2005, HUM REPROD, V20, P185, DOI 10.1093/humrep/deh545
   Cassuto NG, 2011, FERTIL STERIL, V96, pS85, DOI 10.1016/j.fertnstert.2011.07.329
   Check JH, 2013, CLIN EXP OBSTET GYN, V40, P15
   Braga DPDF, 2011, UROLOGY, V78, P786, DOI 10.1016/j.urology.2011.06.018
   De Vos A, 2013, HUM REPROD, V28, P617, DOI 10.1093/humrep/des435
   Figueira RCS, 2010, J REPRODUKTIONSMEDIZ, V7, P250
   Figueira RDS, 2011, FERTIL STERIL, V95, P990, DOI 10.1016/j.fertnstert.2010.11.018
   Hazout A, 2006, REPROD BIOMED ONLINE, V12, P19, DOI 10.1016/S1472-6483(10)60975-3
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Iaconelli A, 2011, HUM REPROD, V26, pI71, DOI 10.1093/humrep/26.s1.48
   Jungheim ES, 2010, FERTIL STERIL, V94, P1432, DOI 10.1016/j.fertnstert.2009.07.987
   Knez K, 2012, REPROD BIOMED ONLINE, V25, P168, DOI 10.1016/j.rbmo.2012.03.011
   Knez K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-123
   Mahmoud K, 2011, HUM REPROD, V26, pI181
   Mauri AL, 2010, EUR J OBSTET GYN R B, V150, P42, DOI 10.1016/j.ejogrb.2010.01.004
   Oliveira JBA, 2010, FERTIL STERIL, V94, pS55, DOI 10.1016/j.fertnstert.2010.07.214
   Oliveira JBA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-99
   PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F
   Setti AS, 2012, FERTIL STERIL, V98, pS80, DOI 10.1016/j.fertnstert.2012.07.288
   Setti AS, 2012, REPROD BIOMED ONLINE, V24, P420, DOI 10.1016/j.rbmo.2012.01.007
   Setti AS, 2011, FERTIL STERIL, V95, P2711, DOI 10.1016/j.fertnstert.2011.03.003
   Setti AS, 2010, REPROD BIOMED ONLINE, V21, P450, DOI 10.1016/j.rbmo.2010.05.017
   Wilding M, 2011, J ASSIST REPROD GEN, V28, P253, DOI 10.1007/s10815-010-9505-5
NR 31
TC 61
Z9 64
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2013
IS 7
AR CD010167
DI 10.1002/14651858.CD010167.pub2
PG 42
WC Medicine, General & Internal
SC General & Internal Medicine
GA 193OD
UT WOS:000322568300052
PM 23884963
DA 2020-12-17
ER

PT J
AU Zembowicz, A
   Navarro, P
   Walters, S
   Lyle, SR
   Moschella, SL
   Miller, D
AF Zembowicz, Artur
   Navarro, Paula
   Walters, Stephanie
   Lyle, Stephen R.
   Moschella, Samuel L.
   Miller, Danielle
TI Subcutaneous Thrombotic Vasculopathy Syndrome: An Ominous Condition
   Reminiscent of Calciphylaxis: Calciphylaxis Sine Calcifications?
SO AMERICAN JOURNAL OF DERMATOPATHOLOGY
LA English
DT Article
DE calciphylaxis; thrombotic vasculopathy; skin ulcer
ID SKIN NECROSIS; PROTEIN-S; PATIENT; THERAPY; DEFICIENCY; DISEASE
AB Ischemic skin necrosis can be a cause of severe morbidity and mortality. It can be due to a number of systemic conditions such as (1) thrombotic vasculopathy syndromes, (2) calciphylaxis, (3) septic or cholesterol emboli, and (4) cutaneous vasculitis. We present 3 patients with a clinicopathological syndrome consisting of ischemic skin necrosis associated with histological pattern of subcutaneous thrombotic vasculopathy-extensive microvascular thrombosis confined to small vessels and capillaries of the subcutaneous tissue. All 3 patients were obese and had severe pre-existing medical conditions. Skin biopsies showed intravascular thrombosis involving small arterioles and capillaries of the subcutaneous tissue. Distribution of vascular involvement by thrombotic process was similar to that observed in calciphylaxis, but calcifications were not observed. Two patients died within 3 months of diagnosis. One patient died 2 years after the presentation. Review of 15 biopsies of calciphylaxis revealed areas of subcutaneous thrombotic vasculopathy in 11 cases (73%). Our study shows that subcutaneous thrombotic vasculopathy syndrome is a potentially lethal condition showing overlapping features between thrombotic vasculopathy syndromes and calciphylaxis. Clinicopathological analysis suggests that it may be a rare variant of calciphylaxis sine calcifications or an early prodromal stage of calciphylaxis. This conclusion is in keeping with increasing appreciation of importance of thrombosis and vascular injury in calciphylaxis.
C1 [Zembowicz, Artur; Navarro, Paula] Lahey Clin Fdn, Dept Pathol, Burlington, MA 01805 USA.
   [Zembowicz, Artur; Lyle, Stephen R.] DermatopathologyConsultations LLC, Boston, MA USA.
   [Navarro, Paula] Tufts Med Ctr, Dept Pathol, Boston, MA USA.
   [Walters, Stephanie; Lyle, Stephen R.] Univ Massachusetts, Dept Cellular Biol, Worcester, MA 01605 USA.
   [Moschella, Samuel L.; Miller, Danielle] Lahey Clin Fdn, Dept Dermatol, Burlington, MA 01805 USA.
RP Zembowicz, A (corresponding author), Lahey Clin Fdn, Dept Pathol, 41 Mall Rd, Burlington, MA 01805 USA.
EM dr.z@DermatopathologyConsultations.com
CR Almafragi A, 2009, ACTA CARDIOL, V64, P91, DOI 10.2143/AC.64.1.2034368
   ANDERSON DC, 1968, LANCET, V2, P323
   Asobie N, 2008, CLIN EXP DERMATOL, V33, P342, DOI 10.1111/j.1365-2230.2007.02626.x
   Bleyer AJ, 2000, INT J ARTIF ORGANS, V23, P351
   Coates T, 1998, AM J KIDNEY DIS, V32, P384, DOI 10.1053/ajkd.1998.v32.pm9740153
   Goldsmith DJA, 1997, NEPHROL DIAL TRANSPL, V12, P1082, DOI 10.1093/ndt/12.5.1082
   Goli AK, 2005, SOUTH MED J, V98, P736, DOI 10.1097/01.SMJ.0000154316.22472.97
   Kalajian AH, 2009, ARCH DERMATOL, V145, P451, DOI 10.1001/archdermatol.2008.602
   MEHTA RL, 1990, AM J MED, V88, P252, DOI 10.1016/0002-9343(90)90150-C
   Nigwekar SU, 2008, CLIN J AM SOC NEPHRO, V3, P1139, DOI 10.2215/CJN.00530108
   Ortiz A, 2009, CLIN RHEUMATOL, V28, pS65, DOI 10.1007/s10067-009-1161-8
   ROSTAING L, 1995, AM J NEPHROL, V15, P524, DOI 10.1159/000168900
   Rudwaleit M, 1996, AM J NEPHROL, V16, P344, DOI 10.1159/000169021
   Selye H., 1962, CALCIPHYLAXIS
   Swanson AM, 2009, ARCH DERMATOL, V145, P723, DOI 10.1001/archdermatol.2009.103
   Weenig RH, 2008, J AM ACAD DERMATOL, V58, P458, DOI 10.1016/j.jaad.2007.12.006
   Weenig RH, 2007, J AM ACAD DERMATOL, V56, P569, DOI 10.1016/j.jaad.2006.08.065
   Wong JJ, 2000, J AM ACAD DERMATOL, V42, P849, DOI 10.1067/mjd.2000.103276
NR 18
TC 9
Z9 10
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0193-1091
EI 1533-0311
J9 AM J DERMATOPATH
JI Am. J. Dermatopathol.
PD DEC
PY 2011
VL 33
IS 8
BP 796
EP 802
DI 10.1097/DAD.0b013e31820edb81
PG 7
WC Dermatology
SC Dermatology
GA 862JT
UT WOS:000298087700010
PM 21785327
DA 2020-12-17
ER

PT J
AU Melo, AS
   Vieira, CS
   Romano, LGM
   Ferriani, RA
   Navarro, PA
AF Melo, Anderson Sanches
   Vieira, Carolina Sales
   Romano, Lucas Gabriel Maltoni
   Ferriani, Rui A.
   Navarro, Paula A.
TI The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women
   With Menstrual Irregularity Plus Hyperandrogenism
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE polycystic ovary syndrome; metabolic syndrome; insulin resistance; PCOS
   phenotypes
ID POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; ROTTERDAM CRITERIA;
   PREVALENCE; CONSENSUS; DIAGNOSIS; OBESITY; TESTOSTERONE; ASSOCIATION;
   PHENOTYPES
AB Polycystic ovary syndrome (PCOS) has a heterogeneous phenotypic distribution that can potentially lead to variations in metabolic repercussions. A cross-sectional study was conducted with 372 women of reproductive age (146 of whom were ovulatory and 226 with PCOS) divided into groups according to PCOS phenotype: (i) complete phenotype involving menstrual irregularity (MI), hyperandrogenism (H), and ultrasound (US) findings of polycystic ovaries (132 patients); (ii) MI + H (18 patients); (iii) MI + US (51 patients); and (iv) H + US (25 patients). The frequencies of metabolic syndrome (MetS) were 45.4%, 38.9%, 33.3%, 36%, and 8.2% for the MI + H + US, MI + H, MI + US, H + US, and control groups (P < .01), respectively. In logistic regression, body mass index ([BMI] odds ratio [OR]: 1.1, 95% confidence interval [CI] 1.1-1.2) and the association of the complete phenotype with MI + H (OR: 5.8 CI95% [2.2-15.8) were independent predictors of the occurrence of MetS. The defining characteristics of MetS were more frequently found in women with PCOS than in controls, regardless of the phenotype (P < .01 for each variable). In conclusion, the frequency of MetS is similar for various PCOS phenotypes among young Brazilian women from the Southeast region of the country, although only BMI and the presence of MI + H, regardless of the presence of US findings, were more predictive of the development of MetS.
C1 [Melo, Anderson Sanches; Vieira, Carolina Sales; Romano, Lucas Gabriel Maltoni; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Dept Obstet & Gynecol, Ribeirao Preto Med Sch, BR-14049900 Sao Paulo, Brazil.
   [Melo, Anderson Sanches; Ferriani, Rui A.; Navarro, Paula A.] Natl Inst Hormones & Womens Hlth, Sao Paulo, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Dept Obstet & Gynecol, Ribeirao Preto Med Sch, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM pnavarro@fmrp.usp.br
RI Vieira, Carolina Sales/N-6855-2015; ferriani, rui alberto/G-9974-2012;
   Saude da mulher, Inct/J-9403-2013; Navarro, Paula/G-2744-2012; Melo,
   Anderson/L-6758-2014
OI Vieira, Carolina Sales/0000-0003-2933-5755; Melo,
   Anderson/0000-0002-4606-7791; Navarro, Paula Andrea/0000-0003-2368-4188
FU National Council for Scientific and Technological Development
   (CNPq-Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); Foundation for the Support of Research in the State
   of Sao Paulo (FAPESP-Fundacao de Amparo a Pesquisa do Estado)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57640-3]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: support from
   the National Council for Scientific and Technological Development
   (CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and
   from the Foundation for the Support of Research in the State of Sao
   Paulo (FAPESP-Fundacao de Amparo a Pesquisa do Estado), grant
   2008/57640-3.
CR Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045
   Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044
   Belosi C, 2006, HUM REPROD, V21, P3108, DOI 10.1093/humrep/del306
   Broekmans FJ, 2006, BJOG-INT J OBSTET GY, V113, P1210, DOI 10.1111/j.1471-0528.2006.01008.x
   Carmina E, 2006, EUR J ENDOCRINOL, V154, P141, DOI 10.1530/eje.1.02058
   Carmina E, 2004, FERTIL STERIL, V82, P661, DOI 10.1016/j.fertnstert.2004.01.041
   Castelo-Branco C, 2010, GYNECOL ENDOCRINOL, V26, P736, DOI 10.3109/09513590.2010.481025
   de Zegher F, 2006, FERTIL STERIL, V86, pS4, DOI 10.1016/j.fertnstert.2006.03.013
   DeFronzo RA, 1979, J CLIN ENDOCR METAB, V85, P2402
   Dewailly D, 2006, J CLIN ENDOCR METAB, V91, P3922, DOI 10.1210/jc.2006-1054
   Dokras A, 2006, FERTIL STERIL, V86, P1702, DOI 10.1016/j.fertnstert.2006.05.038
   Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329
   Elting MW, 2001, HUM REPROD, V16, P556, DOI 10.1093/humrep/16.3.556
   Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098
   FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Geloneze B, 2006, DIABETES RES CLIN PR, V72, P219, DOI 10.1016/j.diabres.2005.10.017
   Glueck CJ, 2003, METABOLISM, V52, P908, DOI 10.1016/S0026-0495(03)00104-5
   Goverde AJ, 2009, HUM REPROD, V24, P710, DOI 10.1093/humrep/den433
   GRIFFIN IJ, 1995, ACTA PAEDIATR, V84, P536, DOI 10.1111/j.1651-2227.1995.tb13689.x
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Guo M, 2010, REPROD BIOMED ONLINE, V21, P572, DOI 10.1016/j.rbmo.2010.04.032
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   Kauffman RP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.037
   Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5305, DOI 10.1210/jc.2010-1123
   Soares EMM, 2008, FERTIL STERIL, V89, P649, DOI 10.1016/j.fertnstert.2007.03.081
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162
   Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008
   Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001
   Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054
   Radikova Zofia, 2003, Endocr Regul, V37, P189
   Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864
   Soares GM, 2009, CLIN ENDOCRINOL, V71, P406, DOI 10.1111/j.1365-2265.2008.03506.x
   Straczkowski M, 2004, MED SCI MONITOR, V10, pCR480
   Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4842, DOI 10.1210/jc.2006-1327
   Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724
   Wiltgen D, 2010, FERTIL STERIL, V94, P2493, DOI 10.1016/j.fertnstert.2010.02.015
   Zhang HY, 2009, BJOG-INT J OBSTET GY, V116, P1633, DOI 10.1111/j.1471-0528.2009.02347.x
NR 41
TC 22
Z9 22
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD DEC
PY 2011
VL 18
IS 12
BP 1230
EP 1236
DI 10.1177/1933719111414205
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 850CZ
UT WOS:000297173500008
PM 22096008
DA 2020-12-17
ER

PT J
AU Barcelos, ID
   Donabela, FC
   Ribas, CP
   Meola, J
   Ferriani, RA
   Navarro, PA
AF Barcelos, I. D.
   Donabela, F. C.
   Ribas, C. P.
   Meola, J.
   Ferriani, R. A.
   Navarro, P. A.
TI GENE EXPRESSION OF AROMATASE (CYP19A1) AND 3 beta-HYDROXYSTEROID
   DEHYDROGENASE IN CUMULUS OOPHORUS CELLS OF ENDOMETRIOSIS AND CONTROL
   INFERTILE PATIENTS SUBMITTED TO ICSI
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 15-19, 2011
CL Orlando, FL
SP Amer Soc Reprod Med
C1 [Barcelos, I. D.; Donabela, F. C.; Ribas, C. P.; Meola, J.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RI RIBAS, CRISTIANA/J-3790-2013; Lovato, Juliana Meola/E-3440-2012;
   ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
OI RIBAS, CRISTIANA/0000-0001-6648-8377; Lovato, Juliana
   Meola/0000-0003-2514-4011; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2011
VL 96
IS 3
SU 1
BP S75
EP S75
DI 10.1016/j.fertnstert.2011.07.290
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 814KZ
UT WOS:000294452700255
DA 2020-12-17
ER

PT J
AU Da Broi, MG
   Malvezzi, H
   Vireque, AA
   Ferriani, RA
   Navarro, PA
AF Da Broi, M. G.
   Malvezzi, H.
   Vireque, A. A.
   Ferriani, R. A.
   Navarro, P. A.
TI FOLLICULAR FLUID FROM INFERTILE WOMEN WITH MILD ENDOMETRIOSIS MAY
   COMPROMISE THE SPINDLE OF META-PHASE II OOCYTES
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 15-19, 2011
CL Orlando, FL
SP Amer Soc Reprod Med
C1 [Da Broi, M. G.; Malvezzi, H.; Vireque, A. A.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RI Da Broi, Michele G/E-7753-2012; Navarro, Paula/G-2744-2012; ferriani,
   rui alberto/G-9974-2012; Vireque, Alessandra/G-2208-2012; Malvezzi,
   Helena/Z-1100-2019
OI Da Broi, Michele G/0000-0003-4256-0228; Malvezzi,
   Helena/0000-0002-5504-6116
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2011
VL 96
IS 3
SU 1
BP S134
EP S135
DI 10.1016/j.fertnstert.2011.07.522
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 814KZ
UT WOS:000294452700456
DA 2020-12-17
ER

PT J
AU Donabela, F
   Barcelos, I
   Padovan, C
   Meola, J
   Ferriani, RA
   Navarro, P
AF Donabela, F.
   Barcelos, I.
   Padovan, C.
   Meola, J.
   Ferriani, R. A.
   Navarro, P.
TI PTGS2 GENE EXPRESSION (COX2) IN CUMMULUS OOPHORUS CELLS OF ENDOMETRIOSIS
   AND CONTROL INFERTILE PATIENTS SUBMITTED TO ICSI
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 15-19, 2011
CL Orlando, FL
SP Amer Soc Reprod Med
C1 [Donabela, F.; Barcelos, I.; Padovan, C.; Meola, J.; Ferriani, R. A.; Navarro, P.] FMRP USP, Ribeirao Preto, SP, Brazil.
RI RIBAS, CRISTIANA/J-3790-2013; Navarro, Paula/G-2744-2012; ferriani, rui
   alberto/G-9974-2012; Lovato, Juliana Meola/E-3440-2012
OI RIBAS, CRISTIANA/0000-0001-6648-8377; Lovato, Juliana
   Meola/0000-0003-2514-4011
NR 0
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2011
VL 96
IS 3
SU 1
BP S236
EP S237
DI 10.1016/j.fertnstert.2011.07.909
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 814KZ
UT WOS:000294452701044
DA 2020-12-17
ER

PT J
AU Vieira, RC
   Barcelos, ID
   Ferreira, EM
   Martins, WP
   Ferriani, RA
   Navarro, PA
AF Vieira, Rodolpho C.
   Barcelos, Ionara D.
   Ferreira, Elisa M.
   Martins, Wellington P.
   Ferriani, Rui A.
   Navarro, Paula A.
TI Spindle and chromosome configurations of in vitro-matured oocytes from
   polycystic ovary syndrome and ovulatory infertile women: a pilot study
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article
DE Infertility; In vitro maturation; Meiotic spindle; Polycystic ovary
   syndrome
ID DEVELOPMENTAL COMPETENCE; IN-VITRO; LUTEINIZING-HORMONE; BOVINE OOCYTES;
   MOUSE OOCYTES; QUALITY; STIMULATION; MATURATION; MEIOSIS; MICE
AB To evaluate the meiotic spindle and chromosomal distribution of in vitro-matured oocytes from infertile nonobese women with PCOS and male or tubal causes of infertility (controls), and to compare in vitro maturation (IVM) rates between groups.
   Seventy four patients (26 with PCOS and 48 controls) undergoing stimulated cycles of oocyte retrieval for ICSI were selected prospectively. Thirteen PCOS patients and 27 controls had immature oocytes retrieved submitted to IVM. After IVM, oocytes showing extrusion of the first polar body were fixed and processed for evaluation of the meiotic spindle and chromosome distribution by immunofluorescence microscopy.
   There were no differences between PCOS and control groups with respect to IVM rates (50.0% and 42.9%, respectively) nor the percentage of meiotic abnormalities in metaphase II oocytes (35.3% and 25%, respectively).
   In vitro-matured oocytes obtained from stimulated cycles of nonobese PCOS did not have an increased ratio of meiotic abnormalities.
C1 [Vieira, Rodolpho C.; Barcelos, Ionara D.; Ferreira, Elisa M.; Martins, Wellington P.; Ferriani, Rui A.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, BR-14049900 Sao Paulo, Brazil.
   [Martins, Wellington P.] Escola Ultrasong & Reciclagem Med Ribeirao Preto, Sao Paulo, Brazil.
   [Vieira, Rodolpho C.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Inst Nacionais Ciencia & Tecnol INCT Hormonios &, BR-14049900 Sao Paulo, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM pnavarro@fmrp.usp.br
RI Saude da mulher, Inct/J-9403-2013; ferriani, rui alberto/G-9974-2012;
   Martins, Wellington/B-1284-2008; Navarro, Paula/G-2744-2012
OI Martins, Wellington/0000-0002-7593-5607; Ferreira,
   Evandro/0000-0002-1057-5508; Navarro, Paula Andrea/0000-0003-2368-4188
FU National Council of Research-CNPq-BrazilNational Council for Scientific
   and Technological Development (CNPq) [CNPq 478396/2007-4]
FX Rodolpho Cruz Vieira was supported by a scholarship granted by National
   Council of Research-CNPq-Brazil. CNPq 478396/2007-4
CR ALLWORTH AE, 1993, DEV BIOL, V158, P101, DOI 10.1006/dbio.1993.1171
   Baart EB, 2007, HUM REPROD, V22, P980, DOI 10.1093/humrep/del484
   Barcelos ID, 2009, FERTIL STERIL, V92, P1749, DOI 10.1016/j.fertnstert.2009.05.006
   Barrett SL, 2010, J ASSIST REPROD GEN, V27, P29, DOI 10.1007/s10815-009-9376-9
   De Santis L, 2005, REPROD BIOMED ONLINE, V11, P36, DOI 10.1016/S1472-6483(10)61296-5
   Fedorcsak P, 2001, HUM REPROD, V16, P1086, DOI 10.1093/humrep/16.6.1086
   Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023
   Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005
   Grupen CG, 2007, THERIOGENOLOGY, V68, P861, DOI 10.1016/j.theriogenology.2007.07.009
   Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036
   Homburg R, 2006, BEST PRACT RES CL EN, V20, P281, DOI 10.1016/j.beem.2006.03.009
   Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737
   KODAMA H, 1995, HUM REPROD, V10, P1962, DOI 10.1093/oxfordjournals.humrep.a136217
   Lee ST, 2006, MOL REPROD DEV, V73, P1022, DOI 10.1002/mrd.20500
   Li Y, 2006, FERTIL STERIL, V85, P827, DOI 10.1016/j.fertnstert.2005.06.064
   Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678
   Ludwig M, 1999, HUM REPROD, V14, P354, DOI 10.1093/humrep/14.2.354
   Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Patel SS, 2008, SEMIN REPROD MED, V26, P196, DOI 10.1055/s-2008-1042958
   REGAN L, 1990, LANCET, V336, P1141, DOI 10.1016/0140-6736(90)92765-A
   Sahu B, 2008, ARCH GYNECOL OBSTET, V277, P239, DOI 10.1007/s00404-007-0462-x
   TARLATZIS BC, 1995, HUM REPROD, V10, P2545, DOI 10.1093/oxfordjournals.humrep.a135742
   Van Blerkom J, 2001, HUM REPROD, V16, P757, DOI 10.1093/humrep/16.4.757
   Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154
   Wang JX, 2001, HUM REPROD, V16, P2606, DOI 10.1093/humrep/16.12.2606
   2004, FERTIL STERIL, V81, P19
NR 28
TC 10
Z9 10
U1 1
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD JAN
PY 2011
VL 28
IS 1
BP 15
EP 21
DI 10.1007/s10815-010-9475-7
PG 7
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA 726WA
UT WOS:000287756100004
PM 20821044
OA Green Published
DA 2020-12-17
ER

PT J
AU Navarro, P
   Garcia-Moliner, ML
   McMahon, JH
   Telford, SR
   Zoukhri, D
   Alroy, J
AF Navarro, Paula
   Garcia-Moliner, Maria L.
   McMahon, James H.
   Telford, Sam R., III
   Zoukhri, Driss
   Alroy, Joseph
TI Histologic, immunohistochemical, microbiological, molecular biological
   and ultrastructural characterization of pulmonary tularemia
SO PATHOLOGY RESEARCH AND PRACTICE
LA English
DT Article
DE Tularemia; Morphology; Microbiology; Molecular biology
ID FRANCISELLA-TULARENSIS; PATHOLOGY
AB Tularemia is a rare zoonotic disease caused by Francisella tularensis, a Gram-negative bacteria. The clinical manifestations of pulmonary tularemia resemble those of other airways infections. Recently, a case of pulmonary tularemia was diagnosed at Tufts Medical Center. The purpose of the current report is to document the utility of applying several diagnostic tools, including immunohistochemistry, electron microscopy, microbiology and molecular biology in confirming the diagnosis of pulmonary tularemia, particularly in convalescing cases (up to 3 weeks postpresentation) and after antibiotic therapy. Our study demonstrates the usefulness of microbiological studies followed by morphological evaluation and the limitation of the molecular biology analysis of posttherapy samples. (C) 2010 Elsevier GmbH. All rights reserved.
C1 [Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.
   [McMahon, James H.] Tufts Med Ctr, Dept Geog Med & Infect Dis, Boston, MA USA.
   [Telford, Sam R., III; Alroy, Joseph] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, Grafton, MA USA.
   [Zoukhri, Driss] Tufts Univ, Sch Dent Med, Dept Gen Dent, Boston, MA 02111 USA.
RP Alroy, J (corresponding author), Tufts Univ, Sch Med, Dept Pathol, 136 Harrison Ave, Boston, MA 02111 USA.
EM joseph.alroy@tufts.edu
OI McMahon, James/0000-0003-1460-5572; Zoukhri, Driss/0000-0003-1622-4431
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI 064218, N01 AI 30050]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R29AI030050, R29AI030050, R01AI064218, R29AI030050, R29AI030050,
   R01AI064218, R29AI030050, R29AI030050, R01AI064218, R01AI064218,
   R01AI064218] Funding Source: NIH RePORTER
FX The authors thanks Annette Shepard-Barry and Inna Lomakin for their
   technical assistance. This study was supported in part by grants from
   NIH to SRT (R01 AI 064218 and N01 AI 30050).
CR BASKERVILLE A, 1978, BRIT J EXP PATHOL, V59, P615
   BASKERVILLE A, 1976, BRIT J EXP PATHOL, V57, P339
   Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103
   DeBey BM, 2002, J VET DIAGN INVEST, V14, P162, DOI 10.1177/104063870201400213
   DENNIS DT, 2004, INFECT DIS, P1446
   EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006
   EYZAGUIRRE CJ, 2006, DIAGNOSTIC IMMUNOHIS, P55
   Fulop M, 1996, AM J TROP MED HYG, V54, P364, DOI 10.4269/ajtmh.1996.54.364
   Guarner J, 1999, APPL IMMUNOHISTO M M, V7, P122, DOI 10.1097/00022744-199906000-00004
   KUHN C, 1988, PATHOLOGY LUNG, P207
   Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013
   MILLER RP, 1969, AM REV RESPIR DIS, V99, P31
   STAAK C, 2000, ISOLATION IGY YOLK, P65
   Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903
   TRAVIS WD, 2002, ATLAS NONTUMOR PATHO, P565
NR 15
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0344-0338
J9 PATHOL RES PRACT
JI Pathol. Res. Pract.
PY 2011
VL 207
IS 1
BP 63
EP 66
DI 10.1016/j.prp.2010.07.002
PG 4
WC Pathology
SC Pathology
GA 715VJ
UT WOS:000286917600011
PM 20709464
DA 2020-12-17
ER

PT J
AU Donabela, FC
   Andrade, AZ
   Rodrigues, JK
   Dib, LA
   Jordao, AA
   Navarro, PA
AF Donabela, F. C.
   Andrade, A. Z.
   Rodrigues, J. K.
   Dib, L. A.
   Jordao, A. A., Jr.
   Navarro, P. A.
TI INFLUENCE OF PITUITARY SUPPRESSION AND CONTROLLED OVARIAN
   HYPERSTIMULATION (COH) ON OXIDATIVE STRESS MARKERS OF INFERTILE PATIENTS
   WITH ENDOMETRIOSIS AND CONTROLS
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine (ASRM
   2010)
CY OCT 23-27, 2010
CL Denver, CO
SP Amer Soc Reproductive Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ob Gyn, Ribeirao Preto, SP, Brazil.
   CNPq, Natl Inst Hormones & Womans Hlth, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Nutr & Metab Lab, Ribeirao Preto, SP, Brazil.
RI Jordao, Alceu Afonso/D-7545-2014; Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2010
VL 94
IS 4
SU 1
BP S205
EP S205
DI 10.1016/j.fertnstert.2010.07.793
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 645GR
UT WOS:000281441000700
DA 2020-12-17
ER

PT J
AU Donabela, FC
   Andrade, AZ
   Rodrigues, JK
   Dib, LA
   Jordao, AA
   Navarro, PA
AF Donabela, F. C.
   Andrade, A. Z.
   Rodrigues, J. K.
   Dib, L. A.
   Jordao, A. A., Jr.
   Navarro, P. A.
TI SERUM MARKERS OF OXIDATIVE STRESS IN INFERTILE WOMEN WITH ENDOMETRIOSIS
   AND CONTROLS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine (ASRM
   2010)
CY OCT 23-27, 2010
CL Denver, CO
SP Amer Soc Reproductive Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ob Gyn, Ribeirao Preto, SP, Brazil.
   CNPq, Natl Inst Hormones & Womans Hlth, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Nutr & Metab Lab, Ribeirao Preto, SP, Brazil.
RI Navarro, Paula/G-2744-2012; Jordao, Alceu Afonso/D-7545-2014
NR 0
TC 1
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2010
VL 94
IS 4
SU 1
BP S40
EP S40
DI 10.1016/j.fertnstert.2010.07.154
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 645GR
UT WOS:000281441000136
DA 2020-12-17
ER

PT J
AU Rocrigues, JK
   Dib, LA
   Leira, VH
   Ferriani, RA
   Jordao, AA
   Navarro, PAA
AF Rocrigues, J. K.
   Dib, L. A.
   Leira, V. H.
   Ferriani, R. A.
   Jordao, A. A., Jr.
   Navarro, P. A. A.
TI INFLUENCE OF PITUITARY SUPPRESSION AND CONTROLED OVARIAN HYPERSTIMULATIN
   (COH) ON OXIDATIVE STRESS MARKERS OF INFERTILE PATIENTS WITH POLYCYSTIC
   OVARY SYNDROME (PCOS) AND CONTROLS.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine (ASRM
   2010)
CY OCT 23-27, 2010
CL Denver, CO
SP Amer Soc Reproductive Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ob Gyn, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Nutr & Metab Lab, Sao Paulo, Brazil.
RI ferriani, rui alberto/G-9974-2012; Jordao, Alceu Afonso/D-7545-2014;
   Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2010
VL 94
IS 4
SU 1
BP S145
EP S145
DI 10.1016/j.fertnstert.2010.07.583
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 645GR
UT WOS:000281441000496
DA 2020-12-17
ER

PT J
AU Rodrigues, JK
   Dib, LA
   Donabella, FC
   Ferriani, RA
   Jordao, AA
   Navarro, PAAS
AF Rodrigues, J. K.
   Dib, L. A.
   Donabella, F. C.
   Ferriani, R. A.
   Jordao, A. A., Jr.
   Navarro, P. A. A. S.
TI OXIDATIVE STRESS MARKERS IN FOLLICULAR FLUID (FF) AND ASSISTED
   REPRODUCTION OUTCOMES IN PATIENTS WITH INFERTILITY DUE TO POLYCYSTIC
   OVARY SYNDROME (PCOS) OR TO TUBAL AND/OR MALE FACTOR.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Reproductive-Medicine (ASRM
   2010)
CY OCT 23-27, 2010
CL Denver, CO
SP Amer Soc Reproductive Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ob Gyn, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Met Lab, Ribeirao Preto, SP, Brazil.
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012; Jordao,
   Alceu Afonso/D-7545-2014
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2010
VL 94
IS 4
SU 1
BP S144
EP S144
DI 10.1016/j.fertnstert.2010.07.577
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 645GR
UT WOS:000281441000490
DA 2020-12-17
ER

PT J
AU Bedoschi, GM
   de Albuquerque, FO
   Ferriani, RA
   Navarro, PA
AF Bedoschi, Giuliano M.
   de Albuquerque, Felipe Oliveira
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Ovarian stimulation during the luteal phase for fertility preservation
   of cancer patients: case reports and review of the literature
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Review
DE Preservation of fertility; Ovarian stimulation; Luteal phase; GnRH
   antagonist; Mature oocytes
ID WOMEN
AB Purpose To report the case of a patient with a diagnosis of infiltrative ductal carcinoma of the breast (case 1) and of a patient with Hodgkin's lymphoma (case 2), both submitted to ovarian stimulation during the luteal phase of the menstrual cycle in order to cryopreserve embryos and oocytes, respectively, in view of the need to start chemotherapy within a maximum of three weeks.
   Methods Case reports
   Results Both patients were submitted to ovarian stimulation with recombinant follicle stimulating hormone together with pituitary blockade with a GnRH antagonist during the luteal phase of the cycle. Oocyte retrieval was performed nine days after the beginning of ovarian stimulation, with 12 mature oocytes being obtained in both cases. In case I, all mature oocytes were submitted to ICSI, with fertilization and cleavage rates of 83.3% and 70%, respectively, and with the formation of seven good quality embryos. In case 2, all of mature oocytes were cryopreserved.
   Conclusions These cases demonstrate that it is possible to obtain mature oocytes when ovarian stimulation is started in the luteal phase in situations in which there is not sufficient time for conventional stimulation.
C1 [Bedoschi, Giuliano M.; de Albuquerque, Felipe Oliveira; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Hosp, USP, Fac Med, Dept Gynecol & Obstet, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Ferriani, Rui Alberto; Navarro, Paula Andrea] CNPq, Natl Inst Hormones & Womens Hlth, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Hosp, USP, Fac Med, Dept Gynecol & Obstet, Av Bandeirantes,3900 Monte Alegre, BR-14049900 Ribeirao Preto, SP, Brazil.
EM pnavarro@fmrp.usp.br
RI Saude da mulher, Inct/J-9403-2013; Navarro, Paula/G-2744-2012; ferriani,
   rui alberto/G-9974-2012; Bedoschi, Giuliano/E-2225-2013
OI Bedoschi, Giuliano/0000-0003-3104-1297; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Anderson RA, 1999, HUM REPROD, V14, P2665, DOI 10.1093/humrep/14.10.2665
   Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772
   Chian RC, 2000, HUM REPROD, V15, P165, DOI 10.1093/humrep/15.1.165
   Cobo A, 2008, FERTIL STERIL, V89, P1657, DOI 10.1016/j.fertnstert.2007.05.050
   DOLMANS MM, 2005, FERTIL STERIL, P883
   Elizur SE, 2008, RHEUMATOLOGY, V47, P1506, DOI 10.1093/rheumatology/ken293
   Grifo JA, 2010, FERTIL STERIL, V93, P391, DOI 10.1016/j.fertnstert.2009.02.067
   HODGEN GD, 1982, FERTIL STERIL, V38, P281
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888
   MCNATTY KP, 1983, J CLIN ENDOCR METAB, V56, P1022, DOI 10.1210/jcem-56-5-1022
   Oktay K, 2004, LANCET, V364, P2091, DOI 10.1016/S0140-6736(04)17541-7
   PACHE TD, 1990, FERTIL STERIL, V54, P638
   Partridge A, 2007, EUR J CANCER, V43, P1646, DOI 10.1016/j.ejca.2007.04.006
   Seli E, 2005, CURR OPIN OBSTET GYN, V17, P299, DOI 10.1097/01.gco.0000169108.15623.34
   SHERMAN BM, 1967, INT J FERTIL, V12, P77
   Sonmezer M, 2004, HUM REPROD UPDATE, V10, P251, DOI 10.1093/humupd/dmh021
   von Wolff M, 2009, FERTIL STERIL, V92, P1360, DOI 10.1016/j.fertnstert.2008.08.011
NR 18
TC 63
Z9 67
U1 0
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD AUG
PY 2010
VL 27
IS 8
BP 491
EP 494
DI 10.1007/s10815-010-9429-0
PG 4
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA 658FE
UT WOS:000282475100010
PM 20455017
OA Green Published
DA 2020-12-17
ER

PT J
AU Melo, AS
   Rodrigues, JK
   Dib, LA
   Andrade, AZ
   Donabela, FC
   Ferriani, RA
   Navarro, PA
AF Melo, A. S.
   Rodrigues, J. K.
   Dib, L. A.
   Andrade, A. Z.
   Donabela, F. C.
   Ferriani, R. A.
   Navarro, P. A.
TI Serum markers of oxidative stress and lipid profiles of infertile women
   with endometriosis
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 26th Annual Meeting of ESHRE
CY JUN 27-30, 2010
CL Rome, ITALY
C1 [Melo, A. S.; Rodrigues, J. K.; Dib, L. A.; Andrade, A. Z.; Donabela, F. C.; Ferriani, R. A.; Navarro, P. A.] Univ Sao Paulo, Med Sch Ribeirao Preto, Human Reprod Setor, Dept Gynecol & Obstet, BR-14049 Ribeirao Preto, Brazil.
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
J9 HUM REPROD
JI Hum. Reprod.
PD JUN
PY 2010
VL 25
SU 1
BP I213
EP I213
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 625DU
UT WOS:000279875400531
DA 2020-12-17
ER

PT J
AU Ferreira, EM
   Vireque, AA
   Adona, PR
   Meirelles, FV
   Ferriani, RA
   Navarro, PAAS
AF Ferreira, E. M.
   Vireque, A. A.
   Adona, P. R.
   Meirelles, F. V.
   Ferriani, R. A.
   Navarro, P. A. A. S.
TI Cytoplasmic maturation of bovine oocytes: Structural and biochemical
   modifications and acquisition of developmental competence (vol 71, pg
   836, 2009)
SO THERIOGENOLOGY
LA English
DT Correction
C1 [Ferreira, E. M.; Vireque, A. A.; Adona, P. R.; Meirelles, F. V.; Ferriani, R. A.; Navarro, P. A. A. S.] HCFMRP USP, Setor Reprod Humana, Dept Obstet & Ginecol, BR-14048900 Ribeirao Preto, SP, Brazil.
RP Ferreira, EM (corresponding author), HCFMRP USP, Setor Reprod Humana, Dept Obstet & Ginecol, Av Bandetrantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
RI ferriani, rui alberto/G-9974-2012; Vireque, Alessandra/G-2208-2012;
   Meirelles, Flavio V/B-5048-2010; Navarro, Paula/G-2744-2012
OI Meirelles, Flavio V/0000-0003-0372-4920; Navarro, Paula
   Andrea/0000-0003-2368-4188; Ferreira, Evandro/0000-0002-1057-5508;
   Vireque, Alessandra/0000-0002-2597-531X
CR Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023
NR 1
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0093-691X
EI 1879-3231
J9 THERIOGENOLOGY
JI Theriogenology
PD MAY
PY 2010
VL 73
IS 8
BP 1164
EP 1164
DI 10.1016/j.theriogenology.2009.05.001
PG 1
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 585CH
UT WOS:000276801400019
DA 2020-12-17
ER

PT J
AU Romao, GS
   Araujo, MCPM
   de Melo, AS
   Navarro, PADS
   Ferriani, RA
   dos Reis, RM
AF Romao, Gustavo Salata
   Picinato Medeiros Araujo, Maria Cristina
   de Melo, Anderson Sanches
   de Albuquerque Salles Navarro, Paula Andrea
   Ferriani, Rui Alberto
   dos Reis, Rosana Maria
TI Oocyte diameter as a predictor of fertilization and embryo quality in
   assisted reproduction cycles
SO FERTILITY AND STERILITY
LA English
DT Article
DE Mean oocyte diameter; ICSI; fertilization; embryo quality; assisted
   reproduction
ID PREPUBERTAL GOAT OOCYTES; MEIOTIC COMPETENCE; IN-VITRO; MATURATIONAL
   COMPETENCE; MOUSE OOCYTES; GROWTH; ACQUISITION; INVITRO
AB Objective: To assess the impact of the mean oocyte diameter (MOD) on occurrence of fertilization and embryo quality in assisted reproduction cycles.
   Design: Prospective observational study.
   Setting: Sector of Human Reproduction of the University Hospital, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo (HCFMRP-USP).
   Patient(s): Thirty-five women undergoing intracytoplasmic sperm injection (ICSI) at the University Hospital of Ribeirao Preto from May to October 2007.
   Intervention(s): MOD assessment.
   Main Outcome Measure(s): Occurrence of fertilization and qualitative embryo classification on 2nd and 3rd day after ICSI.
   Result(s): We divided 160 metaphase II oocytes according to MOD into groups A (MOD below the 25th percentile), B (MOD between 25th and 75th percentile), and C (MOD above the 75th percentile). There was no statistically significant association between MOD and the occurrence of fertilization or the qualitative embryo classification on days 2 and 3. There was no statistically significant difference between groups regarding number of cells or the qualitative embryo classification on days 2 and 3.
   Conclusion(s): The MOD of mature oocytes does not seem to be related to the occurrence of fertilization or to the developmental quality of human embryos on days 2 and 3 after ICSI. (Fertil Steril(R) 2010;93:621-5. (C)2010 by American Society for Reproductive Medicine.)
C1 [Romao, Gustavo Salata; Picinato Medeiros Araujo, Maria Cristina; de Melo, Anderson Sanches; de Albuquerque Salles Navarro, Paula Andrea; Ferriani, Rui Alberto; dos Reis, Rosana Maria] Univ Sao Paulo, Dept Obstet & Gynecol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RP Romao, GS (corresponding author), Univ Fed Sao Carlos, Dept Med, Km 235,SP 310, BR-13565905 Sao Carlos, SP, Brazil.
EM gsalata@uol.com.br
RI Saude da mulher, Inct/J-9403-2013; Reis, Rosana M. dos/E-3346-2012;
   ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012; Melo,
   Anderson/L-6758-2014
OI Reis, Rosana M. dos/0000-0001-9631-4167; Navarro, Paula
   Andrea/0000-0003-2368-4188; Melo, Anderson/0000-0002-4606-7791
FU Faculty of Medicine of Ribeirao Preto, University of Sao Paulo
FX Supported by the Laboratory of Human Reproduction, Hospital of Clinics
   of the Faculty of Medicine of Ribeirao Preto, University of Sao Paulo.
CR Anguita B, 2007, THERIOGENOLOGY, V67, P526, DOI 10.1016/j.theriogenology.2006.09.003
   Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616
   Cavilla JL, 2008, HUM REPROD, V23, P37, DOI 10.1093/humrep/dem178
   Cavilla JL, 2001, HUM REPROD, V16, P547, DOI 10.1093/humrep/16.3.547
   CROZET N, 1981, BIOL CELL, V41, P35
   DANIEL SAJ, 1989, GAMETE RES, V24, P109, DOI 10.1002/mrd.1120240113
   DESMEDT V, 1994, J EXP ZOOL, V269, P128, DOI 10.1002/jez.1402690206
   DURINZI KL, 1995, FERTIL STERIL, V63, P404
   EDWARDS R, 1965, LANCET, V6, P926
   EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268
   FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410
   GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365
   Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2
   HIRAO Y, 1994, J REPROD FERTIL, V100, P333, DOI 10.1530/jrf.0.1000333
   HIRAO Y, 1993, J EXP ZOOL, V267, P543, DOI 10.1002/jez.1402670509
   MARTINO A, 1994, THERIOGENOLOGY, V41, P969, DOI 10.1016/0093-691X(94)90512-H
   Otoi T, 2000, THERIOGENOLOGY, V54, P535, DOI 10.1016/S0093-691X(00)00368-X
   SCHRAMM RD, 1993, BIOL REPROD, V48, P349, DOI 10.1095/biolreprod48.2.349
   SCHULTZ RM, 1977, J CELL SCI, V24, P167
   Veeck L.L., 1999, ATLAS HUMAN GAMETES, P57
NR 20
TC 15
Z9 17
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD JAN 15
PY 2010
VL 93
IS 2
BP 621
EP 625
DI 10.1016/j.fertnstert.2008.12.124
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 554KL
UT WOS:000274433800043
PM 19423095
DA 2020-12-17
ER

PT J
AU Vireque, AA
   Camargo, LSA
   Ferreira, EM
   Silva, AAMRE
   Watanabe, YF
   Bos-Mikich, A
   Martins, WP
   Campos, JR
   Navarro, PAAS
   Ferriani, RA
AF Vireque, A. A.
   Camargo, L. S. A.
   Ferreira, E. M.
   Rosa e Silva, A. A. M.
   Watanabe, Y. F.
   Bos-Mikich, A.
   Martins, W. P.
   Campos, J. R.
   Navarro, P. A. A. S.
   Ferriani, R. A.
TI EMBRYONIC DEVELOPMENT AND STEROIDOGENESIS OF BOVINE CUMULUS-OOCYTE
   COMPLEXES MATURED IN alpha-MEM MEDIUM SUPPLEMENTED WITH PVA OR PVP-40
SO REPRODUCTION FERTILITY AND DEVELOPMENT
LA English
DT Meeting Abstract
C1 [Vireque, A. A.; Ferreira, E. M.; Martins, W. P.; Campos, J. R.; Navarro, P. A. A. S.; Ferriani, R. A.] Univ Sao Paulo, BR-14049 Ribeirao Preto, SP, Brazil.
   [Camargo, L. S. A.] Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil.
   [Rosa e Silva, A. A. M.] Univ Brasilia, Brasilia, DF, Brazil.
   [Vireque, A. A.; Watanabe, Y. F.] Vitrogen Anim Reprod, Cravinhos, SP, Brazil.
   [Bos-Mikich, A.] Univ Fed Rio Grande do Sul, Porto Alegre, SP, Brazil.
RI Navarro, Paula/G-2744-2012; Ferreira, Elisa M/H-6530-2013; Bos-Mikich,
   Adriana/A-4883-2013; Martins, Wellington/B-1284-2008; ferriani, rui
   alberto/G-9974-2012; Vireque, Alessandra/G-2208-2012
OI Ferreira, Elisa M/0000-0002-8778-8050; Martins,
   Wellington/0000-0002-7593-5607; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CSIRO PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 1031-3613
J9 REPROD FERT DEVELOP
JI Reprod. Fertil. Dev.
PY 2010
VL 22
IS 1
MA 360
BP 336
EP 337
PG 2
WC Developmental Biology; Reproductive Biology; Zoology
SC Developmental Biology; Reproductive Biology; Zoology
GA 529CF
UT WOS:000272492600381
DA 2020-12-17
ER

PT J
AU Barcelos, ID
   Vieira, RC
   Ferreira, EM
   Martins, WP
   Ferriani, RA
   Navarro, PA
AF Barcelos, Ionara D.
   Vieira, Rodolpho C.
   Ferreira, Elisa M.
   Martins, Wellington P.
   Ferriani, Rui A.
   Navarro, Paula A.
TI Comparative analysis of the spindle and chromosome configurations of in
   vitro-matured oocytes from patients with endometriosis and from control
   subjects: a pilot study
SO FERTILITY AND STERILITY
LA English
DT Editorial Material
ID OVARIAN STIMULATION; FOLLICULAR-FLUID; DEVELOPMENTAL COMPETENCE;
   PERITONEAL-FLUID; INFERTILE WOMEN; IN-VIVO; EMBRYO; QUALITY;
   HYPERSTIMULATION; FERTILIZATION
AB Preliminary data from a prospective controlled study did not demonstrate an increased percentage of meiotic abnormalities for in vitro-matured oocytes obtained from stimulated cycles of endometriosis and control patients. However, the tendency toward a higher proportion of telophase I in apparently matured oocytes observed in endometriosis patients suggests an impairment or delay of the completion of meiosis I which requires further evaluation. (Fertil Steril (R) 2009;92:1749-52. (C) 2009 by American Society for Reproductive Medicine.)
C1 [Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, BR-14049900 Sao Paulo, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM paasnavarro@uol.com.br
RI ferriani, rui alberto/G-9974-2012; Ferreira, Elisa M/H-6530-2013; Saude
   da mulher, Inct/J-9403-2013; Martins, Wellington/B-1284-2008; Navarro,
   Paula/G-2744-2012
OI Ferreira, Elisa M/0000-0002-8778-8050; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188; Ferreira, Evandro/0000-0002-1057-5508
CR Al-Fadhli R, 2006, J OBSTET GYNAECOL CA, V28, P888, DOI 10.1016/S1701-2163(16)32285-X
   Baart EB, 2007, HUM REPROD, V22, P980, DOI 10.1093/humrep/del484
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   BRIZEK CL, 1995, J ASSIST REPROD GEN, V12, P106, DOI 10.1007/BF02211378
   Canis M, 1997, FERTIL STERIL, V67, P817
   Carbone MC, 2003, MOL HUM REPROD, V9, P639, DOI 10.1093/molehr/gag090
   De Santis L, 2005, REPROD BIOMED ONLINE, V11, P36, DOI 10.1016/S1472-6483(10)61296-5
   Fernando S, 2009, FERTIL STERIL, V91, P325, DOI 10.1016/j.fertnstert.2008.01.096
   Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023
   GARCIAHERAS JL, 1999, P 2 INT S AN DIG SOL, V2, P77
   Garrido N, 2002, HUM REPROD UPDATE, V8, P95, DOI 10.1093/humupd/8.1.95
   Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67
   Grupen CG, 2007, THERIOGENOLOGY, V68, P861, DOI 10.1016/j.theriogenology.2007.07.009
   Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093
   Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124
   Jozwik M, 1999, MOL HUM REPROD, V5, P409, DOI 10.1093/molehr/5.5.409
   Katsoff B, 2006, Clin Exp Obstet Gynecol, V33, P201
   Kumbak B, 2008, GYNECOL OBSTET INVES, V65, P212, DOI 10.1159/000112310
   Lee ST, 2006, MOL REPROD DEV, V73, P1022, DOI 10.1002/mrd.20500
   Li Y, 2006, FERTIL STERIL, V85, P827, DOI 10.1016/j.fertnstert.2005.06.064
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005
   Mansour G, 2007, FERTIL STERIL, V88, pS299, DOI 10.1016/j.fertnstert.2007.07.1007
   Mansour G, 2009, FERTIL STERIL, V91, P2079, DOI 10.1016/j.fertnstert.2008.02.097
   Navarro PAAS, 2006, FERTIL STERIL, V85, P1187, DOI 10.1016/j.fertnstert.2005.08.060
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Pellicer A, 2001, ANN NY ACAD SCI, V943, P122, DOI 10.1111/j.1749-6632.2001.tb03796.x
   Pellicer A, 1995, HUM REPROD, V10, P91, DOI 10.1093/humrep/10.suppl_2.91
   Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072
   Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007
   Van Blerkom J, 2001, HUM REPROD, V16, P757, DOI 10.1093/humrep/16.4.757
   Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
NR 33
TC 34
Z9 39
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD NOV
PY 2009
VL 92
IS 5
BP 1749
EP 1752
DI 10.1016/j.fertnstert.2009.05.006
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 518RG
UT WOS:000271710200038
PM 19523612
DA 2020-12-17
ER

PT J
AU Martins, WP
   Nastri, CO
   Barra, DA
   Navarro, PAAS
   Mauad, F
   Ferriani, RA
AF Martins, Wellington P.
   Nastri, Carolina O.
   Barra, Daniela A.
   Navarro, Paula A. A. S.
   Mauad Filho, Francisco
   Ferriani, Rui A.
TI Fetal volume and crown-rump length from 7 to 10 weeks of gestational age
   in singletons and twins
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Gestational age; Ultrasonography, Twins
ID 3-DIMENSIONAL ULTRASOUND; HEAD VOLUME; REPRODUCIBILITY; 1ST-TRIMESTER;
   CHORIONICITY; PREGNANCIES; FETUSES; TRUNK
AB Objective(s): We intend to verify if fetal volume and crown-rump length were different between singletons and twins in pregnancies aged from 7 to 10 weeks and to evaluate if fetal volume is more accurate to determine the gestational age than crown-rump length at this gestational age. Study design: From 52 days (7 weeks and 3 days) to 73 days (10 weeks and 3 days) weekly three-dimensional Ultrasonography was per-formed in 20 twin fetuses and 20 singletons. Crown-rump length and fetal volume using VOCAL were assessed in all examinations. The 'true' gestational age was based on oocyte retrieval.
   Results: At the age of 52 days, the crown-rump length was 11.74 +/- 0.27 mm (mean +/- S.D.) and 11.48 +/- 0.22 mm (singletons and twins, respectively), while the fetal volume was 0.354 +/- 0.015 cm(3) and 0.324 +/- 0.012 cm(3). At the gestational age of 73 days, the crown-rump length was 36.19 +/- 0.90 mm and 35.87 +/- 0.54 mm and the fetal volume was 6.204 +/- 0.090 cm(3) and 6.083 +/- 0.081 cm(3). The total relative increase observed was much higher for fetal volume than for CRL: 1705 +/- 301% vs. 210 +/- 33% in singletons and 1827 +/- 305% vs. 214 +/- 25% in twins. The 95% limits of agreement (+/- 2.3 days vs. +/- 3.2 days, fetal volume vs. crown-rump length) and the intraclass correlation coefficients (0.989 vs. 0.978) between the "true" gestational age and that predicted by fetal volume were better than those predicted by crown-rump length. No significant difference was identified between singletons and twins for both fetal volume and crown-rump length.
   Conclusion(s): Twins and singletons had similar fetal volume and crown-rump length between the 7th and 10th week of gestational age. Additionally, fetal volume assessed by VOCAL was better than crown-rump length to estimate the gestational age at the evaluated period. However, the improvement was small and probably without clinical significance. Condensation: Fetal volume and crown-rump length were similar between singletons and twins. Fetal volume relative increase was higher and the predicted gestational age was better. (c) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Martins, Wellington P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, EURP, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Martins, WP (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, Ave Bandeirantes 3900,8 Andar, BR-14049900 Ribeirao Preto, SP, Brazil.
EM wpmartins@gmail.com
RI Nastri, Carolina O/E-1172-2012; Navarro, Paula/G-2744-2012; Martins,
   Wellington/B-1284-2008; ferriani, rui alberto/G-9974-2012; Saude da
   mulher, Inct/J-9403-2013
OI Nastri, Carolina O/0000-0001-7073-1616; Martins,
   Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Ananth CV, 1998, OBSTET GYNECOL, V91, P917, DOI 10.1016/S0029-7844(98)00052-0
   [Anonymous], 2000, JAMA, V284, P3043
   Aviram R, 2004, EARLY HUM DEV, V80, P1, DOI 10.1016/j.earlhumdev.2004.02.005
   BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3
   Blaas HGK, 2006, ULTRASOUND OBST GYN, V27, P640, DOI 10.1002/uog.2794
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Falcon O, 2005, ULTRASOUND OBST GYN, V26, P263, DOI 10.1002/uog.1975
   Falcon O, 2005, ULTRASOUND OBST GYN, V26, P517, DOI 10.1002/uog.1990
   Hack KE, 2008, BJOG-INT J OBSTET GY, V115, P58, DOI 10.1111/j.1471-0528.2007.01556.x
   Junior EA, 2008, J MATERN-FETAL NEO M, V21, P81, DOI 10.1080/14767050701831280
   Lee YM, 2008, OBSTET GYNECOL, V111, P301, DOI 10.1097/AOG.0b013e318160d65d
   Martins WD, 2006, REV BRAS GINECOL OBS, V28, P38, DOI 10.1590/S0100-72032006000100007
   MARTINS WP, 2008, ULTRASOUND MED BIOL
   Merce LT, 2008, J ULTRAS MED, V27, P1053, DOI 10.7863/jum.2008.27.7.1053
   Ong S, 2002, BJOG-INT J OBSTET GY, V109, P753, DOI 10.1111/j.1471-0528.2002.01361.x
   Raine-Fenning N, 2002, ULTRASOUND OBST GYN, V19, P69, DOI 10.1046/j.0960-7692.2001.00608.x
   Raine-Fenning NJ, 2003, ULTRASOUND OBST GYN, V21, P283, DOI 10.1002/uog.61
   Salomon LJ, 2005, ULTRASOUND OBST GYN, V26, P512, DOI 10.1002/uog.1966
   Senoo M, 2000, OBSTET GYNECOL, V95, P656, DOI 10.1016/S0029-7844(99)00645-6
   Sladkevicius P, 2005, ULTRASOUND OBST GYN, V26, P504, DOI 10.1002/uog.1993
   Tunon K, 2000, ULTRASOUND OBST GYN, V15, P41, DOI 10.1046/j.1469-0705.2000.00004.x
   Victoria A, 2001, OBSTET GYNECOL, V97, P310, DOI 10.1016/S0029-7844(00)01111-X
NR 22
TC 27
Z9 28
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD JUL
PY 2009
VL 145
IS 1
BP 32
EP 35
DI 10.1016/j.ejogrb.2009.03.015
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 476KO
UT WOS:000268439400006
PM 19386409
DA 2020-12-17
ER

PT J
AU Ferreira, EM
   Vireque, AA
   Adona, PR
   Ferriani, RA
   Navarro, PA
AF Ferreira, Elisa Melo
   Vireque, Alessandra Aparecida
   Adona, Paulo Roberto
   Ferriani, Rui Alberto
   Navarro, Paula Andrea
TI Prematuration of bovine oocytes with butyrolactone I reversibly arrests
   meiosis without increasing meiotic abnormalities after in vitro
   maturation
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE IVM; Prematuration; Butyrolactone I; Bovine oocytes; Meiosis
ID DEVELOPMENTAL COMPETENCE; CYTOPLASMIC MATURATION; ROSCOVITINE;
   INHIBITION; PROGRESSION; CAPACITY; SPINDLE; NUCLEAR; CULTURE
AB Objectives: Asynchrony between nuclear and cytoplasmic maturation, and possibly damage to the oocyte meiotic spindle, limits the application of in vitro maturation (IVM) in assisted reproduction. Several studies have suggested that Prematuration with meiosis blockers may improve oocyte quality after IVM, favoring early embryogenesis. Thus, we investigated the effect of Prematuration with the nuclear maturation inhibitor butyrolactone I (BLI) on the meiotic spindle and chromosomal configuration of bovine oocytes.
   Study design: Immature oocytes obtained from cows slaughtered in a slaughterhouse (n = 840) were divided into the following groups: (1) control (n = 325), submitted only to IVM in TCM199 for 24 h; (2) BLI 18 h (n = 208) submitted to meiotic blockage with 100 mu M BLI for 24 h (Prematuration) and then induction of IVM in TCM199 for 18 h; and (3) BLI 24 h (n = 307), pre-matured with 100 mu m BLI for 24 h followed by 24 h of IVM in TCM199. The oocytes were then fixed, stained by immunofluorescence for morphological visualization of both microtubules and chromatin, and evaluated.
   Results: Meiotic arrest occurred in 90.2% of the oocytes cultured with BLI. Maturation rates were similar for all groups (80.3%, 73.6% and 82.7% for the control, BLI 18 h and BLI 24 h groups, respectively). We observed 81.3% normal oocytes in metaphase II in the control group, and 80.0% and 81.2% in the BLI 18 h and BLI 24 h groups, respectively. The incidence of meiotic anomalies did not differ between groups (18.7%, 20.0% and 18.8% for the control, BLI 18 h and BLI 24 h, respectively).
   Conclusion: Prematuration with butyrolactone I reversibly arrests meiosis without damaging the meiotic spindle or the chromosome distribution of bovine oocytes after in vitro maturation. (c) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Ferreira, Elisa Melo; Vireque, Alessandra Aparecida; Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Adona, Paulo Roberto] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Ciencias Basicas, BR-13630970 Pirassununga, SP, Brazil.
   [Ferriani, Rui Alberto; Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Div Human Reprod,CNPq,Natl Inst Hormones & Womans, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM paasnavarro@uol.com.br
RI Saude da mulher, Inct/J-9403-2013; Vireque, Alessandra/G-2208-2012;
   Ferreira, Elisa M/H-6530-2013; ferriani, rui alberto/G-9974-2012;
   Navarro, Paula/G-2744-2012
OI Ferreira, Elisa M/0000-0002-8778-8050; Navarro, Paula
   Andrea/0000-0003-2368-4188; Ferreira, Evandro/0000-0002-1057-5508;
   Vireque, Alessandra/0000-0002-2597-531X
FU FAPESP - BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [05/57852-2]
FX Financial support: EM Ferreira was supported by a scholarship granted by
   FAPESP - Brazil,e no. 05/57852-2.
CR Addinall SG, 2001, J BIOL CHEM, V276, P15939, DOI 10.1074/jbc.M011628200
   Adona PR, 2008, ANIM REPROD SCI, V108, P49, DOI 10.1016/j.anireprosci.2007.07.002
   Adona PR, 2004, ZYGOTE, V12, P197, DOI 10.1017/S0967199404002771
   Albarracin JL, 2005, THERIOGENOLOGY, V64, P1740, DOI 10.1016/j.theriogenology.2005.04.018
   Choi YH, 2006, ZYGOTE, V14, P1, DOI 10.1017/S0967199406003534
   Collier RJ, 2006, J DAIRY SCI, V89, P1244, DOI 10.3168/jds.S0022-0302(06)72193-2
   Coy P, 2005, REPRODUCTION, V129, P747, DOI 10.1530/rep.1.00691
   Dieleman SJ, 2002, THERIOGENOLOGY, V57, P5, DOI 10.1016/S0093-691X(01)00655-0
   Eppig JJ, 1996, MOL REPROD DEV, V44, P260, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;260::AID-MRD17&gt;3.0.CO;2-6
   Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023
   Grupen CG, 2006, REPROD FERT DEVELOP, V18, P309, DOI 10.1071/RD05125
   Hashimoto S, 2002, BIOL REPROD, V66, P1696, DOI 10.1095/biolreprod66.6.1696
   Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025
   KITAGAWA M, 1993, ONCOGENE, V8, P2425
   Kubelka M, 2000, BIOL REPROD, V62, P292, DOI 10.1095/biolreprod62.2.292
   Lanzendorf SE, 2006, FERTIL STERIL, V85, P836, DOI 10.1016/j.fertnstert.2005.09.057
   Li Y, 2006, FERTIL STERIL, V85, P827, DOI 10.1016/j.fertnstert.2005.06.064
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Lonergan P, 1998, THERIOGENOLOGY, V50, P417, DOI 10.1016/S0093-691X(98)00149-6
   Lonergan P, 2000, MOL REPROD DEV, V57, P204, DOI 10.1002/1098-2795(200010)57:2&lt;204::AID-MRD12&gt;3.0.CO;2-N
   Lonergan P, 2003, MOL REPROD DEV, V64, P369, DOI 10.1002/mrd.10206
   Malhi PS, 2005, BIOL REPROD, V73, P45, DOI 10.1095/biolreprod.104.038745
   Mandelbaum J, 2004, EUR J OBSTET GYN R B, V113, pS17, DOI 10.1016/j.ejogrb.2003.11.005
   Nogueira D, 2006, BIOL REPROD, V74, P177, DOI 10.1095/biolreprod.105.040485
   Pavlok A, 2000, ANIM REPROD SCI, V64, P1, DOI 10.1016/S0378-4320(00)00189-5
   Roberts R, 2002, HUM REPROD, V17, P2950, DOI 10.1093/humrep/17.11.2950
   Santos JEP, 2008, REPROD DOMEST ANIM, V43, P23, DOI 10.1111/j.1439-0531.2008.01139.x
   Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051
   Vanhoutte L, 2007, HUM REPROD, V22, P1239, DOI 10.1093/humrep/dem007
   Webb R, 2007, THERIOGENOLOGY, V68, pS22, DOI 10.1016/j.theriogenology.2007.04.036
NR 30
TC 16
Z9 18
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD JUL
PY 2009
VL 145
IS 1
BP 76
EP 80
DI 10.1016/j.ejogrb.2009.03.016
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 476KO
UT WOS:000268439400015
PM 19403233
DA 2020-12-17
ER

PT J
AU Ferreira, EM
   Vireque, AA
   Adona, PR
   Meirelles, FV
   Ferriani, RA
   Navarro, PAAS
AF Ferreira, E. M.
   Vireque, A. A.
   Adona, P. R.
   Meirelles, F. V.
   Ferriani, R. A.
   Navarro, P. A. A. S.
TI Cytoplasmic maturation of bovine oocytes: Structural and biochemical
   modifications and acquisition of developmental competence
SO THERIOGENOLOGY
LA English
DT Article
DE Cytoplasmic maturation; Bovine oocytes; Organelles; Cytoskeleton;
   Molecular maturation
ID IN-VITRO MATURATION; MESSENGER-RNA POLYADENYLATION; ELEMENT-BINDING
   PROTEIN; MAP KINASE ACTIVATION; ENDOPLASMIC-RETICULUM; MEIOTIC
   MATURATION; PREIMPLANTATION EMBRYOS; MAMMALIAN OOCYTE; GENE-EXPRESSION;
   MOUSE OOCYTES
AB Oocyte maturation is a long process during which oocytes acquire their intrinsic ability to support the subsequent stages of development in a stepwise manner, ultimately reaching activation of the embryonic genome. This process involves complex and distinct, although linked, events of nuclear and cytoplasmic maturation. Nuclear maturation mainly involves chromosomal segregation, whereas cytoplasmic maturation involves organelle reorganization and storage of mRNAs, proteins and transcription factors that act in the overall maturation process, fertilization and early embryogenesis. Thus, for didactic purposes, we subdivided cytoplasmic maturation into: (1) organelle redistribution, (2) cytoskeleton dynamics, and (3) molecular maturation. Ultrastructural analysis has shown that mitochondria, ribosomes, endoplasmic reticulum, cortical granules and the Golgi complex assume different positions during the transition from the germinal vesicle stage to metaphase II. The cytoskeletal microfilaments and microtubules present in the cytoplasm promote these movements and act on chromosome segregation. Molecular maturation consists of transcription, storage and processing of maternal mRNA, which is stored in a stable, inactive form until translational recruitment. Polyadenylation is the main mechanism that initiates protein translation and consists of the addition of adenosine residues to the 3' terminal portion of mRNA. Cell cycle regulators, proteins, cytoplasmic maturation markers and components of the enzymatic antioxidant system are mainly transcribed during this stage. Thus, the objective of this review is to focus on the cytoplasmic maturation process by analyzing the modifications in this compartment during the acquisition of meiotic competence for development. (c) 2009 Elsevier Inc. All rights reserved.
C1 [Ferreira, E. M.] Univ Sao Paulo, HCFMRP, Setor Reprod Humana, Fac Med Ribeirao Preto,Dept Gynecol & Obstet, BR-14048900 Ribeirao Preto, Brazil.
   [Adona, P. R.; Meirelles, F. V.] Univ Sao Paulo, Fac Zootechny & Aliments Engn, Dept Basic Sci, BR-13630970 Pirassununga, SP, Brazil.
RP Ferreira, EM (corresponding author), Univ Sao Paulo, HCFMRP, Setor Reprod Humana, Fac Med Ribeirao Preto,Dept Gynecol & Obstet, Av Bandeirantes,3900 Monte Alegre, BR-14048900 Ribeirao Preto, Brazil.
EM elisamferreira@yahoo.com.br
RI Vireque, Alessandra/G-2208-2012; Meirelles, Flavio V/B-5048-2010;
   Navarro, Paula/G-2744-2012; ferriani, rui alberto/G-9974-2012; Ferreira,
   Elisa M/H-6530-2013
OI Meirelles, Flavio V/0000-0003-0372-4920; Ferreira, Elisa
   M/0000-0002-8778-8050; Navarro, Paula Andrea/0000-0003-2368-4188;
   Ferreira, Evandro/0000-0002-1057-5508; Vireque,
   Alessandra/0000-0002-2597-531X
FU Department of Gynecology and Obstetrics of the Faculty of Medicine of
   Ribeirao Preto/USP; University Hospital of the Faculty of Medicine of
   Ribeirao Preto (HC-FMRP/USP); "Fundacao de Amparo Pesquisa do Estado de
   Sio Paulo" (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [05/57952-2]
FX We thank the Department of Gynecology and Obstetrics of the Faculty of
   Medicine of Ribeirao Preto/USP and the University Hospital of the
   Faculty of Medicine of Ribeirao Preto (HC-FMRP/USP) for financial
   support, and "Fundacao de Amparo Pesquisa do Estado de Sio Paulo"
   (FAPESP) for the fellowship granted to Elisa Melo Ferreira (process n
   degrees 05/57952-2).
CR Albarracin JL, 2005, THERIOGENOLOGY, V64, P1740, DOI 10.1016/j.theriogenology.2005.04.018
   ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5
   Alberts B., 2004, MOL BIOL CELL
   Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1
   Brevini TAL, 2007, ANIM REPROD SCI, V98, P23, DOI 10.1016/j.anireprosci.2006.10.018
   Brevini TAL, 2002, MOL REPROD DEV, V63, P510, DOI 10.1002/mrd.10191
   Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7
   Calder MD, 2005, FERTIL STERIL, V83, P1077, DOI 10.1016/j.fertnstert.2004.12.012
   Calder Michele D, 2003, Reprod Biol Endocrinol, V1, P14, DOI 10.1186/1477-7827-1-14
   Cetica PD, 2001, IUBMB LIFE, V51, P57, DOI 10.1080/15216540152035073
   Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0
   Conner S, 1997, MOL REPROD DEV, V48, P106
   Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Cummins JM, 2004, EUR J OBSTET GYN R B, V115, pS23, DOI 10.1016/j.ejogrb.2004.01.011
   CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9
   DAVIDSON EH, 1986, GENE ACTIVITY EARLY, P1
   de Matos DG, 2000, THERIOGENOLOGY, V53, P761, DOI 10.1016/S0093-691X(99)00278-2
   Eckert J, 1998, REPROD FERT DEVELOP, V10, P327, DOI 10.1071/R98077
   Fair T, 2001, BIOL REPROD, V64, P1516, DOI 10.1095/biolreprod64.5.1516
   Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830
   FitzHarris G, 2007, DEV BIOL, V305, P133, DOI 10.1016/j.ydbio.2007.02.006
   Fulka J, 1998, MOL HUM REPROD, V4, P41, DOI 10.1093/molehr/4.1.41
   Furnus CC, 2008, ANIM REPROD SCI, V109, P88, DOI 10.1016/j.anireprosci.2007.12.003
   Gandolfi TALB, 2001, THERIOGENOLOGY, V55, P1255, DOI 10.1016/S0093-691X(01)00481-2
   Gavin AC, 1997, MOL REPROD DEV, V46, P383, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;383::AID-MRD18&gt;3.0.CO;2-#
   Haley SA, 2004, MOL BIOL CELL, V15, P2084, DOI 10.1091/mbc.E03-11-0843
   Herrick JR, 2003, ANIM REPROD SCI, V78, P123, DOI 10.1016/S0378-4320(03)00081-2
   Hosoe M, 1997, ZYGOTE, V5, P371, DOI 10.1017/S0967199400003956
   Hyttel P, 1997, THERIOGENOLOGY, V47, P23, DOI 10.1016/S0093-691X(96)00336-6
   Hyttel P, 2001, REPRODUCTION, V122, P21, DOI 10.1530/rep.0.1220021
   HYTTEL P, 1986, J REPROD FERTIL, V78, P615, DOI 10.1530/jrf.0.0780615
   JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7
   Jones KT, 2004, MOL HUM REPROD, V10, P1, DOI 10.1093/molehr/gah009
   JONES KT, 1995, DEVELOPMENT, V121, P3259
   Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4
   Kim NH, 2000, ZYGOTE, V8, P25, DOI 10.1017/S0967199400000794
   Kline D, 2000, CURR TOP DEV BIOL, V50, P125, DOI 10.1016/S0070-2153(00)50007-6
   KLINE JT, 1994, BIOL REPROD, V50, P193, DOI 10.1095/biolreprod50.1.193
   Krischek C, 2002, ANIM REPROD SCI, V73, P129, DOI 10.1016/S0378-4320(02)00131-8
   Krisher RL, 1998, THERIOGENOLOGY, V49, P103, DOI 10.1016/S0093-691X(97)00405-6
   KRUIP TAM, 1983, GAMETE RES, V8, P29, DOI 10.1002/mrd.1120080105
   Lechniak D, 2008, REPROD BIOLOGY, V8, P23, DOI 10.1016/S1642-431X(12)60002-3
   Levesque JT, 1996, BIOL REPROD, V55, P1427, DOI 10.1095/biolreprod55.6.1427
   Li GP, 2005, MOL REPROD DEV, V71, P220, DOI 10.1002/mrd.20255
   Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557
   Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745
   Lonergan P, 2000, MOL REPROD DEV, V57, P146, DOI 10.1002/1098-2795(200010)57:2&lt;146::AID-MRD5&gt;3.0.CO;2-2
   Luciano AM, 2005, MOL REPROD DEV, V71, P389, DOI 10.1002/mrd.20304
   Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194
   Meirelles FV, 2004, ANIM REPROD SCI, V82-3, P13, DOI 10.1016/j.anireprosci.2004.05.012
   Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081
   Meric F, 1996, J BIOL CHEM, V271, P30804, DOI 10.1074/jbc.271.48.30804
   MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497
   Modina S, 2001, MARC MALPIG SYMP SER, V8, P241
   Moreno RD, 2002, BIOL REPROD, V66, P1259, DOI 10.1095/biolreprod66.5.1259
   Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002
   Payne C, 2003, DEV BIOL, V264, P50, DOI 10.1016/j.ydbio.2003.08.004
   Rodriguez KF, 2004, REPROD FERT DEVELOP, V16, P55, DOI 10.1071/RD03078
   Sasayama T, 2005, GENES CELLS, V10, P627, DOI 10.1111/j.1365-2443.2005.00870.x
   Shim C, 1997, MOL REPROD DEV, V48, P185, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;185::AID-MRD6&gt;3.0.CO;2-O
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Sirard MA, 2001, THERIOGENOLOGY, V55, P1241, DOI 10.1016/S0093-691X(01)00480-0
   StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x
   Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077
   Steuerwald N, 2000, MOL HUM REPROD, V6, P448, DOI 10.1093/molehr/6.5.448
   Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904
   Stricker SA, 2006, SEMIN CELL DEV BIOL, V17, P303, DOI 10.1016/j.semcdb.2006.02.002
   Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847
   Sun QY, 2003, MICROSC RES TECHNIQ, V61, P342, DOI 10.1002/jemt.10347
   Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x
   TERASAKI M, 1994, J CELL SCI, V107, P1797
   THACH RE, 1992, CELL, V68, P177, DOI 10.1016/0092-8674(92)90461-K
   THIBAULT C, 1987, REPROD NUTR DEV, V27, P865, DOI 10.1051/rnd:19870701
   Tomek W, 2002, REPROD DOMEST ANIM, V37, P86, DOI 10.1046/j.1439-0531.2002.00336.x
   Tremblay K, 2005, BIOL REPROD, V72, P1037, DOI 10.1095/biolreprod.104.034793
   Trimarchi JR, 2000, BIOL REPROD, V62, P1866, DOI 10.1095/biolreprod62.6.1866
   Uzbekova S, 2008, BIOL REPROD, V78, P218, DOI 10.1095/biolreprod.107.061036
   Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314
   Van Blerkom J, 2000, HUM REPROD, V15, P2621, DOI 10.1093/humrep/15.12.2621
   Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393
   Van Blerkom J, 2008, REPROD BIOMED ONLINE, V16, P553, DOI 10.1016/S1472-6483(10)60463-4
   Van Blerkom J, 2006, REPROD BIOMED ONLINE, V13, P246, DOI 10.1016/S1472-6483(10)60622-0
   Wessel GM, 2001, INT REV CYTOL, V209, P117
   Wessel GM, 2002, DEVELOPMENT, V129, P4315
   Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155
   ZENG HT, 2008, FERTIL STERIL   0303
NR 87
TC 166
Z9 176
U1 0
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0093-691X
EI 1879-3231
J9 THERIOGENOLOGY
JI Theriogenology
PD MAR 15
PY 2009
VL 71
IS 5
BP 836
EP 848
DI 10.1016/j.theriogenology.2008.10.023
PG 13
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 413QY
UT WOS:000263808800015
PM 19121865
DA 2020-12-17
ER

PT J
AU Navarro, PA
   de Araujo, MM
   de Araujo, CM
   Rocha, M
   dos Reis, R
   Martins, W
AF Navarro, Paula Andrea
   de Araujo, Maria Medeiros
   de Araujo, Carlos Medeiros
   Rocha, Marcelo
   dos Reis, Rosana
   Martins, Wellington
TI Relationship between first polar body morphology before intracytoplasmic
   sperm injection and fertilization rate, cleavage rate, and embryo
   quality
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Assisted reproduction outcome; Embryo quality; Fertilization rate; First
   polar body; Intracytoplasmic sperm injection; Oocyte quality
ID OOCYTE MORPHOLOGY; ICSI PATIENTS; IMPLANTATION; PREGNANCY; PATIENT
AB Objectives: To evaluate the influence of the morphology of the first polar body (PB) on intracytoplasmic sperm injection (ICSI) outcomes. Methods: The morphology of the first PB was assessed in 3177 metaphase 11 oocytes and classified as: intact and normal size, fragmented, or enlarged size. The rates of fertilization, cleavage, and embryo quality were evaluated on day 2. Results: The rates of fertilization, cleavage, and formation of good quality embryos resulting from the insemination of oocytes with an enlarged first PB (20.7%, 18.7%, and 5.0%, respectively) were significantly lower than those for oocytes with an intact first PB of normal size (70.8%, 62.5%, and 19%, respectively) or a fragmented first PB (69.7%, 60.5%, and 17.1%, respectively). Rates did not differ significantly between oocytes with an intact first PB of normal size and oocytes with a fragmented first PB (P>0.05). Conclusions: The presence of an enlarged PB is related to poorer rates of fertilization, cleavage, and top quality embryos. However, identification of first PB fragmentation does not seem to interfere with ICSI outcomes. (C) 2008 International Federation ofGynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Navarro, Paula Andrea; de Araujo, Maria Medeiros; de Araujo, Carlos Medeiros; Rocha, Marcelo; dos Reis, Rosana; Martins, Wellington] Univ Sao Paulo, Dept Obstet & Gynecol, Ribeirao Preto Med Sch, BR-14049900 Sao Paulo, Brazil.
RP Navarro, PA (corresponding author), Univ Sao Paulo, Dept Obstet & Gynecol, Ribeirao Preto Med Sch, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM pnavarro@fmrp.usp.br
RI Navarro, Paula/G-2744-2012; Martins, Wellington/B-1284-2008
OI Martins, Wellington/0000-0002-7593-5607; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Balaban B, 1998, HUM REPROD, V13, P3431, DOI 10.1093/humrep/13.12.3431
   Balaban B, 2006, REPROD BIOMED ONLINE, V12, P608, DOI 10.1016/S1472-6483(10)61187-X
   Ciotti PM, 2004, HUM REPROD, V19, P2334, DOI 10.1093/humrep/deh433
   De Santis L, 2005, REPROD BIOMED ONLINE, V11, P36, DOI 10.1016/S1472-6483(10)61296-5
   DeSutter P, 1996, HUM REPROD, V11, P595
   Ebner T, 2000, HUM REPROD, V15, P427, DOI 10.1093/humrep/15.2.427
   Ebner T, 1999, FERTIL STERIL, V72, P599, DOI 10.1016/S0015-0282(99)00315-5
   Ebner T, 2006, REPROD BIOMED ONLINE, V12, P507, DOI 10.1016/S1472-6483(10)62006-8
   Ebner T, 2005, FERTIL STERIL, V83, P1635, DOI 10.1016/j.fertnstert.2005.02.009
   Ebner T, 2002, HUM REPROD, V17, P2415, DOI 10.1093/humrep/17.9.2415
   EICHENLAUBRITTER U, 1995, HUM REPROD, V10, P2343
   Fancsovits P, 2006, ACTA BIOL HUNG, V57, P331, DOI 10.1556/ABiol.57.2006.3.7
   Kahraman S, 2000, HUM REPROD, V15, P2390, DOI 10.1093/humrep/15.11.2390
   Martini E, 1997, HUM REPROD, V12, P2011, DOI 10.1093/humrep/12.9.2011
   Meriano JS, 2001, HUM REPROD, V16, P2118, DOI 10.1093/humrep/16.10.2118
   PICKERING SJ, 1988, HUM REPROD, V3, P978, DOI 10.1093/oxfordjournals.humrep.a136828
   Rienzi L, 2008, FERTIL STERIL, V90, P1692, DOI 10.1016/j.fertnstert.2007.09.024
   Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9
   Ubaldi F, 2008, PLACENTA, V29, pS115, DOI 10.1016/j.placenta.2008.08.009
   VANSTEIRTEGHEM AC, 1993, HUM REPROD, V8, P1061, DOI 10.1093/oxfordjournals.humrep.a138192
   Verlinsky Yury, 2003, Reprod Biomed Online, V7, P336
   Xia P, 1997, HUM REPROD, V12, P1750, DOI 10.1093/humrep/12.8.1750
NR 22
TC 18
Z9 21
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0020-7292
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAR
PY 2009
VL 104
IS 3
BP 226
EP 229
DI 10.1016/j.ijgo.2008.11.008
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 419YM
UT WOS:000264255600014
PM 19105998
DA 2020-12-17
ER

PT J
AU Vireque, AA
   Camargo, LSA
   Serapido, RV
   Silva, AAMR
   Watanabe, YF
   Ferreira, EM
   Navarro, PAAS
   Martins, WP
   Ferriani, RA
AF Vireque, A. A.
   Camargo, L. S. A.
   Serapido, R. V.
   Rosa e Silva, A. A. M.
   Watanabe, Y. F.
   Ferreira, E. M.
   Navarro, P. A. A. S.
   Martins, W. P.
   Ferriani, R. A.
TI Preimplantation development and expression of Hsp-70 and Bax genes in
   bovine blastocysts derived from oocytes matured in alpha-MEM
   supplemented with growth factors and synthetic macromolecules
SO THERIOGENOLOGY
LA English
DT Article
DE Bovine oocytes; In vitro maturation; Chemically defined medium;
   Embryogenesis; Hsp-70 and Bax genes
ID IN-VITRO MATURATION; FOLLICLE-STIMULATING-HORMONE; MESSENGER-RNA
   EXPRESSION; CUMULUS CELLS; MAMMALIAN DEVELOPMENT; RELATIVE ABUNDANCE;
   EMBRYO CULTURE; AMINO-ACIDS; IGF-I; SERUM
AB In vitro culture conditions affect both the maternal and embryonic expression of genes and is likely to alter both oocyte and embryo developmental competence. The search for better and less variable culture conditions simulating those in vivo has led to the development of defined culture media, with lower impact on the molecular reprogramming of oocytes and embryos. We evaluated embryo development and relative abundance (RA) of Hsp-70 and Bax transcripts in bovine blastocysts produced from oocytes matured in a chemically defined IVM system with synthetic polymers. Immature cumulus oocyte complexes (COCs) were matured for 22-24 h in alpha-MEM supplemented with IGF-1, insulin, 0.1% polyvinyl alcohol (PVA), or 0.1% polyvinylpyrrolidone (PVP), but without FSH or LH. The control group consisted of COCs matured it, TCM plus FSH and 10% estrous cow serum. After fertilization. presumptive zygotes were co-cultured with cumulus cells until 224 h post-insemination. Total RNA was isolated from embryo pools, reverse transcribed into cDNA, and subjected to transcript analysis by real-time PCR. Cleavage rate was higher (P < 0.05) for the control group (68.3%) than for the PVA (54.4%) and PVP-40 (58.3%) groups. Nevertheless. there was no difference among the PVA, PVP-40 and control groups in blastocyst or hatching rates. similarly, no difference in relative abundance of Hsp-70 and Bax transcripts was detected in comparison to the control group. We inferred that bovine oocytes can be matured in serum- and gonadotrophin-free medium supplemented with PVA or PVP, enriched with IGF-I and insulin, without altering post-cleavage development and relative abundance of some genes associated with stress and apoptosis. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Vireque, A. A.; Ferreira, E. M.; Navarro, P. A. A. S.; Martins, W. P.; Ferriani, R. A.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Obstet & Gynecol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Camargo, L. S. A.; Serapido, R. V.] Embrapa Dairy Cattle, Juiz De Fora, MG, Brazil.
   [Rosa e Silva, A. A. M.] Univ Brasilia, Dept Physiol Sci, Brasilia, DF, Brazil.
   [Watanabe, Y. F.] Vitrogen Anim Reprod, Cravinhos, SP, Brazil.
RP Vireque, AA (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Obstet & Gynecol, Bandeirantes Ave 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM alessandra_vireque@yahoo.com.br
RI Martins, Wellington/B-1284-2008; Camargo, Luiz Sergio/G-3511-2012;
   Navarro, Paula/G-2744-2012; Ferreira, Elisa M/H-6530-2013; Saude da
   mulher, Inct/J-9403-2013; Vireque, Alessandra/G-2208-2012; ferriani, rui
   alberto/G-9974-2012
OI Martins, Wellington/0000-0002-7593-5607; Camargo, Luiz
   Sergio/0000-0001-9974-711X; Ferreira, Elisa M/0000-0002-8778-8050;
   Ferreira, Evandro/0000-0002-1057-5508; Navarro, Paula
   Andrea/0000-0003-2368-4188; Vireque, Alessandra/0000-0002-2597-531X
FU Fundacao de Amparo it Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX This research was supported by the Fundacao de Amparo it Pesquisa do
   Estado de Sao Paulo (FAPESP). The authors thank CNPq/FAP-DF, FUNPE,
   FINATEC, FAEPA/HCFMRP/USP, Vitrooen Animal Reproduction for laboratory
   assistance, the Barra Mansa Meat Plant Sertaozinho, SP, for supplying
   bovine ovaries, the Animal Reproduction Laboratory-Dairy Cattle-CNPGL
   for supplying estrous cow serum, and Agrogenetica for permitting the use
   of their real-time PCR apparatus.
CR Ali A, 2002, BIOL REPROD, V66, P901, DOI 10.1095/biolreprod66.4.901
   ALI A, 2005, MOL REPROD DEV, V71, P358, DOI DOI 10.1002/MRD.20281
   Anderiesz C, 2000, HUM REPROD, V15, P1140, DOI 10.1093/humrep/15.5.1140
   Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099
   Bavister BD, 1995, HUM REPROD UPDATE, V1, P91, DOI 10.1093/humupd/1.2.91
   Beker-van Woudenberg AR, 2006, ANIM REPROD SCI, V92, P231, DOI 10.1016/j.anireprosci.2005.05.026
   BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F
   Chen T., 1994, INTEGR FERROELECTR, V5, P1
   Choi YH, 2001, THERIOGENOLOGY, V56, P661, DOI 10.1016/S0093-691X(01)00597-0
   Chung JT, 2007, REPROD BIOMED ONLINE, V15, P198, DOI 10.1016/S1472-6483(10)60709-2
   Corcoran D, 2005, REPROD BIOMED ONLINE, V11, P340, DOI 10.1016/S1472-6483(10)60842-5
   Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698
   Denley A, 2007, MOL CELL BIOL, V27, P3569, DOI 10.1128/MCB.01447-06
   Dode MAN, 2002, THERIOGENOLOGY, V57, P811, DOI 10.1016/S0093-691X(01)00700-2
   DOWNS SM, 1991, J EXP ZOOL, V258, P373, DOI 10.1002/jez.1402580313
   Edwards JL, 2001, THERIOGENOLOGY, V55, P209, DOI 10.1016/S0093-691X(00)00455-6
   Russell D, 2006, MOL REPROD DEV, V73, P1255, DOI 10.1002/mrd.20553
   GARDNER DK, 1994, CELL BIOL INT, V18, P1163, DOI 10.1006/cbir.1994.1043
   Gliedt DW, 1996, J DAIRY SCI, V79, P536, DOI 10.3168/jds.S0022-0302(96)76397-X
   GORDON I, 1994, LAB PRODUCTION CATTL
   Goud PT, 1998, HUM REPROD, V13, P1638, DOI 10.1093/humrep/13.6.1638
   GRIGORESCU F, 1994, HORM RES, V42, P55, DOI 10.1159/000184146
   Guler A, 2000, THERIOGENOLOGY, V54, P209, DOI 10.1016/S0093-691X(00)00342-3
   Hirao Y, 2004, BIOL REPROD, V70, P83, DOI 10.1095/biolreprod.103.021238
   Jacobsen H, 2000, THERIOGENOLOGY, V53, P1761, DOI 10.1016/S0093-691X(00)00312-5
   Keskintepe L, 1996, BIOL REPROD, V55, P333, DOI 10.1095/biolreprod55.2.333
   Kiapekou Erasmia, 2005, Hormones (Athens), V4, P155
   Kito S, 1997, BIOL REPROD, V56, P1281, DOI 10.1095/biolreprod56.5.1281
   Knijn HM, 2002, REPRODUCTION, V124, P365, DOI 10.1530/rep.0.1240365
   LANE MGD, 2004, LAB GUIDE MAMMALIAN, P394
   LONERGAN P, 1992, P 8 C EUR EMBR TRANS, P178
   Makarevich AV, 2002, BIOL REPROD, V66, P386, DOI 10.1095/biolreprod66.2.386
   Matsudo T, 2003, BIOMACROMOLECULES, V4, P1794, DOI 10.1021/bm0341935
   Mizushima S, 2001, THERIOGENOLOGY, V55, P1431, DOI 10.1016/S0093-691X(01)00492-7
   MONAGHAN PCC, 1993, THERIOGENOLOGY, V39, P370
   Nagyova E, 1999, BIOL REPROD, V61, P569, DOI 10.1095/biolreprod61.3.569
   OLSON S E, 1991, Theriogenology, V35, P250, DOI 10.1016/0093-691X(91)90226-4
   Oyamada T, 2004, ZYGOTE, V12, P143, DOI 10.1017/S0967199404002710
   PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171
   PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736
   Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589
   ROSENKRANS CF, 1994, J ANIM SCI, V72, P434, DOI 10.2527/1994.722434x
   Rozen S, 2000, Methods Mol Biol, V132, P365
   SAEKI K, 1991, BIOL REPROD, V44, P256, DOI 10.1095/biolreprod44.2.256
   Sagirkaya H, 2007, ANIM REPROD SCI, V101, P225, DOI 10.1016/j.anireprosci.2006.09.016
   Shimizu T, 2008, ANIM REPROD SCI, V106, P143, DOI 10.1016/j.anireprosci.2007.04.005
   Singh B, 1997, BIOL REPROD, V56, P1370, DOI 10.1095/biolreprod56.6.1370
   SIRARD MA, 1993, THERIOGENOLOGY, V40, P933, DOI 10.1016/0093-691X(93)90361-8
   Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200
   TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113
   TROUNSON A, 1994, THERIOGENOLOGY, V41, P57, DOI 10.1016/S0093-691X(05)80049-4
   Wang HF, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-4
   Wang WH, 1997, J REPROD FERTIL, V111, P101, DOI 10.1530/jrf.0.1110101
   Wang YX, 2004, PHARM RES-DORDR, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Warzych E, 2007, MOL REPROD DEV, V74, P280, DOI 10.1002/mrd.20610
   Watson AJ, 2000, BIOL REPROD, V62, P355, DOI 10.1095/biolreprod62.2.355
   Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893
   Wrenzycki C, 2005, REPROD FERT DEVELOP, V17, P23, DOI 10.1071/RD04109
   Wrenzycki C, 1999, MOL REPROD DEV, V53, P8, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;8::AID-MRD2&gt;3.0.CO;2-K
   YOUNIS AI, 1989, GAMETE RES, V23, P189, DOI 10.1002/mrd.1120230206
NR 60
TC 21
Z9 23
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0093-691X
EI 1879-3231
J9 THERIOGENOLOGY
JI Theriogenology
PD MAR 1
PY 2009
VL 71
IS 4
BP 620
EP 627
DI 10.1016/j.theriogenology.2008.09.028
PG 8
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 406QP
UT WOS:000263310300009
PM 18962879
DA 2020-12-17
ER

PT J
AU Lang, TU
   Navarro, PA
   Weinstein, B
   Fraire, AE
   Garcia-Moliner, M
AF Lang, T. U.
   Navarro, P. A.
   Weinstein, B.
   Fraire, A. E.
   Garcia-Moliner, M.
TI Subtyping of Non-Small Cell Lung Cancer in the Era of Bevacizumab
SO LABORATORY INVESTIGATION
LA English
DT Meeting Abstract
CT 98th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 07-13, 2009
CL Boston, MA
SP US & Canadian Acad Pathol
C1 Tufts Med Ctr, Boston, MA USA.
   Univ Massachusetts, Sch Med, Worcester, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD JAN
PY 2009
VL 89
MA 1611
BP 355A
EP 355A
PG 1
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA 394XK
UT WOS:000262486301610
DA 2020-12-17
ER

PT J
AU Lang, TU
   Navarro, PA
   Weinstein, B
   Fraire, AE
   Garcia-Moliner, M
AF Lang, T. U.
   Navarro, P. A.
   Weinstein, B.
   Fraire, A. E.
   Garcia-Moliner, M.
TI Subtyping of Non-Small Cell Lung Cancer in the Era of Bevacizumab
SO MODERN PATHOLOGY
LA English
DT Meeting Abstract
CT 98th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 07-13, 2009
CL Boston, MA
SP US & Canadian Acad Pathol
C1 Tufts Med Ctr, Boston, MA USA.
   Univ Massachusetts, Sch Med, Worcester, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
J9 MODERN PATHOL
JI Mod. Pathol.
PD JAN
PY 2009
VL 22
MA 1611
BP 355A
EP 355A
PG 1
WC Pathology
SC Pathology
GA 393KF
UT WOS:000262371501609
DA 2020-12-17
ER

PT J
AU Petean, CC
   Ferriani, RA
   dos Reis, RM
   de Moura, MD
   Jordao, AA
   Navarro, PADS
AF Petean, Carla Campos
   Ferriani, Rui Alberto
   dos Reis, Rosana Maria
   de Moura, Marcos Dias
   Jordao, Alceu Afonso
   de Albuquerque Salles Navarro, Paula Andrea
TI Lipid peroxidation and vitamin E in serum and follicular fluid of
   infertile women with peritoneal endometriosis submitted to controlled
   ovarian hyperstimulation: a pilot study
SO FERTILITY AND STERILITY
LA English
DT Article
DE Endometriosis; follicular fluid; lipid peroxidation; malondialdehyde;
   antioxidant status; vitamin E; oxidative stress; infertility
ID IN-VITRO FERTILIZATION; OXIDATIVE STRESS; SPERMATOZOA; QUALITY; DISEASE;
   IVF
AB Objective: To assess the level of lipid peroxidation (LP) and vitamin E in the follicular fluid and serum of infertile patients, with or without endometriosis. who were submitted to ovulation induction for assisted reproduction procedures.
   Design: Prospective study. Setting: Assisted conception unit, university hospital.
   Patient(s): Infertile patients 20 to 38 years of age were selected prospectively and consecutively and were divided into the endometriosis group (17 patients with pelvic endometriosis) and the control group (19 patients with previous tubal ligation or male factor and without endometriosis).
   Intervention(s): Peripheral blood samples were collected on D1 (before the beginning of the use of gonadotropins), D2 (day of hCG administration), and D3 (day of oocyte retrieval). On D3, follicular-fluid samples free from blood contamination also were collected and stored.
   Main Outcome Measure(S): Lipid peroxidation was assessed by malondialdehyde quantification by spectrophotometry, and measurement of vitamin E was performed by HLPC.
   Result(s): On D1, no significant difference in LP was observed between groups. However, vitamin E levels were significantly higher in the control group. On D2, LP levels were significantly higher in the endometriosis group compared with in the control group, and vitamin E levels continued to be significantly higher in the control group. On D3, there was no significant difference in serum and follicular-fluid levels of LP and vitamin E between groups. However, on D3, vitamin E levels were found to be significantly higher in serum than in follicular fluid in both groups, whereas malondialdchyde levels were significantly lower in follicular fluid than in serum only in the control group.
   Conclusion(s): Before the beginning of ovulation induction, a significant decrease in vitamin E was observed in patients with endometriosis, perhaps because antioxidants are consumed during oxidation reactions. After ovulation induction with exogenous gonadotropins, the group of patients with endometriosis not only presented increased lipid peroxidation but also maintained lower vitamin E levels than the control group, a fact that hypothetically could compromise oocyte quality in endometriotic patients. However, on the day of oocyte retrieval, both serum LP potential and vitamin E levels were found to be similar in the two groups. (Fertil Steril(R) 2008; 90:2080-5. (C) 2008 by American Society for Reproductive Medicine.)
C1 [Petean, Carla Campos; Ferriani, Rui Alberto; dos Reis, Rosana Maria; de Moura, Marcos Dias; de Albuquerque Salles Navarro, Paula Andrea] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, BR-14049900 Sao Paulo, Brazil.
   [Jordao, Alceu Afonso] Univ Sao Paulo, Ribeirao Preto Med Sch, Div Nutr, BR-14049900 Sao Paulo, Brazil.
RP Navarro, PADS (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynecol, Ave Bandeirantes,3900 Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
EM paasnavarro@uol.com.br
RI Reis, Rosana M. dos/E-3346-2012; Navarro, Paula/G-2744-2012; Jordao,
   Alceu Afonso/D-7545-2014; ferriani, rui alberto/G-9974-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; Navarro, Paula
   Andrea/0000-0003-2368-4188; /0000-0003-1288-0802
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)-BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX Supported by a scholarship granted by Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)-Brazil (C.C.P.).
CR Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1
   ARNAUD J, 1991, J CHROMATOGR-BIOMED, V572, P103, DOI 10.1016/0378-4347(91)80476-S
   Attaran M, 2000, INT J FERTIL WOMEN M, V45, P314
   Baker MA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-67
   Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6
   Das S, 2006, HUM REPROD, V21, P2403, DOI 10.1093/humrep/del156
   Diplock AT, 1994, FREE RADICAL DAMAGE, P113
   Garrido N, 2002, HUM REPROD UPDATE, V8, P95, DOI 10.1093/humupd/8.1.95
   Halliwell B., 1989, FREE RADICALS BIOL M
   Jozwik M, 1999, MOL HUM REPROD, V5, P409, DOI 10.1093/molehr/5.5.409
   Kaya H, 2004, HORM METAB RES, V36, P693, DOI 10.1055/s-2004-826018
   Kuivasaari P, 2005, HUM REPROD, V20, P3130, DOI 10.1093/humrep/dei176
   Levay PE, 1997, J ASSIST REPROD GEN, V14, P212, DOI 10.1007/BF02766112
   Murphy AA, 1998, FERTIL STERIL, V69, P1092, DOI 10.1016/S0015-0282(98)00087-9
   Murphy AA, 1998, J CLIN ENDOCR METAB, V83, P2110, DOI 10.1210/jc.83.6.2110
   Murphy AA, 1998, SEMIN REPROD ENDOCR, V16, P263, DOI 10.1055/s-2007-1016286
   Nallella Kiran P., 2005, Clinics, V60, P317, DOI 10.1590/S1807-59322005000400010
   Oyawoye O, 2003, HUM REPROD, V18, P2270, DOI 10.1093/humrep/deg450
   Pasqualotto EB, 2004, FERTIL STERIL, V81, P973, DOI 10.1016/j.fertnstert.2003.11.021
   Paszkowski T, 1996, MED SCI RES, V24, P187
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Van Langendonckt A, 2002, FERTIL STERIL, V77, P861, DOI 10.1016/S0015-0282(02)02959-X
   VanBlerkom J, 1997, HUM REPROD, V12, P1047
   Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8
NR 24
TC 33
Z9 35
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD DEC
PY 2008
VL 90
IS 6
BP 2080
EP 2085
DI 10.1016/j.fertnstert.2007.10.072
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 381WO
UT WOS:000261566800006
PM 18249400
DA 2020-12-17
ER

PT J
AU Gomes, FM
   Navarro, PAAS
   de Abreu, LG
   Ferriani, RA
   dos Reis, RM
   de Moura, MD
AF Gomes, Fernando M.
   Navarro, Paula A. A. S.
   de Abreu, Lauriane G.
   Ferriani, Rui Alberto
   dos Reis, Rosana M.
   de Moura, Marcos D.
TI Effect of peritoneal fluid from patients with minimal/mild endometriosis
   on progesterone release by human granulosa-lutein cells obtained from
   infertile patients without endometriosis: A pilot study
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE endometriosis; granulosa-lutein cells; progesterone; peritoneal fluid;
   infertility
ID UNEXPLAINED INFERTILITY; UNRUPTURED FOLLICLE; MILD ENDOMETRIOSIS; WOMEN;
   MACROPHAGES; ENVIRONMENT; ESTRADIOL; INVITRO; STEROIDOGENESIS;
   INTERLEUKIN-6
AB Objective: To evaluate the effect of peritoneal fluid (PF) from women without and with minimal/mild endometriosis on progesterone (P) release by cultured human granulosa-lutein cells obtained from infertile patients without endometriosis submitted to ovarian hyperstimulation for in vitro fertilization (IVF).
   Study design: A pilot study was performed. Human granulosa-lutein cells, obtained from 11 infertile patients without endometriosis (tubal or male factors of infertility) submitted to ovarian hyperstimulation for IVF, were cultured without PF (basal production) and with increasing volumes of steroid-extracted PF samples from 11 patients with endometriosis and 11 patients without endometriosis. Progesterone (P) levels in the media after 72 h culture were measured by chemoluminescence assay. The non-parametric Mann-Whitney-test was used for statistical analysis.
   Results: PF from patients without endometriosis stimulated P release in a dose-dependent manner up to the dose of 100 mu l/ml (10% concentration) when compared with basal production (without adding PF). P release was similar in cultures stimulated with PF from patients with or without endometriosis at 1% (10 mu l/ml) and 5% (50 ml/ml) concentrations. At 10% concentration, there was a non-statistically significant reduction in progesterone release by granulosa cells stimulated with PF from patients with endometriosis. PF from patients with endometriosis significantly reduced P release at 30% concentration (300 mu l/ml).
   Conclusions: PF stimulates P release by human granulosa-lutein cells in a dose-dependent manner. However, higher concentrations of PF from patients with minimal/mild endometriosis reduce P release, suggesting it contains factors that may compromise ovarian steroidogenesis. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
C1 [Gomes, Fernando M.; Navarro, Paula A. A. S.; de Abreu, Lauriane G.; Ferriani, Rui Alberto; dos Reis, Rosana M.; de Moura, Marcos D.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, BR-14049900 Sao Paulo, Brazil.
RP Navarro, PAAS (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Ginecol, Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM paasnavarro@uol.com.br
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012; Reis,
   Rosana M. dos/E-3346-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR ABAE M, 1994, FERTIL STERIL, V61, P1083
   Bedaiwy MA, 2002, HUM REPROD, V17, P426, DOI 10.1093/humrep/17.2.426
   BROSENS IA, 1978, BRIT J OBSTET GYNAEC, V85, P246, DOI 10.1111/j.1471-0528.1978.tb10494.x
   Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041
   Cahill DJ, 1995, HUM REPROD, V10, P3142, DOI 10.1093/oxfordjournals.humrep.a135876
   Canis M, 1997, FERTIL STERIL, V67, P817
   CHEESMAN KL, 1983, FERTIL STERIL, V40, P590
   COMILLIE FJ, 1990, FERTIL STERIL, V53, P978
   Garrido N, 2002, HUM REPROD UPDATE, V8, P95, DOI 10.1093/humupd/8.1.95
   GOROSPE WC, 1992, ENDOCRINOLOGY, V130, P1750, DOI 10.1210/en.130.3.1750
   HALME J, 1983, AM J OBSTET GYNECOL, V145, P333, DOI 10.1016/0002-9378(83)90720-2
   Harlow CR, 1996, J CLIN ENDOCR METAB, V81, P426, DOI 10.1210/jc.81.1.426
   HOLTZ G, 1985, J REPROD MED, V30, P643
   Kaya H, 1999, GYNECOL OBSTET INVES, V48, P123, DOI 10.1159/000010153
   Kondera-Anasz Z, 2005, EUR J OBSTET GYN R B, V123, P198, DOI 10.1016/j.ejogrb.2005.04.019
   MATHUR S, 1982, CLIN EXP IMMUNOL, V50, P259
   MORCOS RN, 1985, FERTIL STERIL, V44, P678
   MORI H, 1992, FERTIL STERIL, V57, P535
   OOSTERLYNCK DJ, 1992, FERTIL STERIL, V58, P290
   Oral E, 1996, HUM REPROD UPDATE, V2, P385, DOI 10.1093/humupd/2.5.385
   Pellicer A, 1998, FERTIL STERIL, V69, P1135, DOI 10.1016/S0015-0282(98)00085-5
   Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516
   POLAN ML, 1989, J CLIN ENDOCR METAB, V69, P1200, DOI 10.1210/jcem-69-6-1200
   RIER SE, 1995, J CLIN ENDOCR METAB, V80, P1431, DOI 10.1210/jc.80.4.1431
   SARACOGLU OF, 1985, FERTIL STERIL, V43, P851
   SHAKIL T, 1994, BIOL REPROD, V50, P1183, DOI 10.1095/biolreprod50.5.1183
   SYROP CH, 1987, FERTIL STERIL, V48, P1
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   TEDESCHI C, 1994, BIOL REPROD, V51, P1058, DOI 10.1095/biolreprod51.5.1058
   van Kaam KJAF, 2007, HUM REPROD, V22, P129, DOI 10.1093/humrep/del325
   WARDLE PG, 1985, LANCET, V2, P236
   WHEELER JM, 1989, J REPROD MED, V34, P41
   Whitehead SA, 1996, FERTIL STERIL, V66, P487, DOI 10.1016/S0015-0282(16)58526-4
NR 33
TC 8
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD MAY
PY 2008
VL 138
IS 1
BP 60
EP 65
DI 10.1016/j.ejogrb.2007.12.008
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 329XQ
UT WOS:000257904300012
PM 18276059
DA 2020-12-17
ER

PT J
AU Navarro, P
   Garcia-Moliner, M
   Safaii, H
   Berrada, Z
   Telford, S
   Alroy, J
AF Navarro, P.
   Garcia-Moliner, M.
   Safaii, H.
   Berrada, Z.
   Telford, S.
   Alroy, J.
TI Histologic, immunohistochemistry, microbiologic and ultrastructural
   characterization of pulmonary tularemia
SO LABORATORY INVESTIGATION
LA English
DT Meeting Abstract
CT 97th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 01-07, 2008
CL Denver, CO
SP US & Canadian Acad Pathol
C1 Tufts Univ, New England Med Ctr, Boston, MA 02111 USA.
   Tufts Univ, Sch Vet, Grafton, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD JAN
PY 2008
VL 88
SU 1
MA 1311
BP 287A
EP 288A
PG 2
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA 248UG
UT WOS:000252181101439
DA 2020-12-17
ER

PT J
AU Navarro, P
   Garcia-Moliner, M
   Safaii, H
   Berrada, Z
   Telford, S
   Alroy, J
AF Navarro, P.
   Garcia-Moliner, M.
   Safaii, H.
   Berrada, Z.
   Telford, S.
   Alroy, J.
TI Histologic, immunohistochemistry, microbiologic and ultrastructural
   characterization of pulmonary tularemia
SO MODERN PATHOLOGY
LA English
DT Meeting Abstract
CT 97th Annual Meeting of the
   United-States-and-Canadian-Academy-of-Pathology
CY MAR 01-07, 2008
CL Denver, CO
SP US & Canadian Acad Pathol
C1 Tufts Univ New England Med Ctr, Boston, MA USA.
   Tufts Vet Sch, Grafton, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
J9 MODERN PATHOL
JI Mod. Pathol.
PD JAN
PY 2008
VL 21
SU 1
MA 1311
BP 287A
EP 288A
PG 2
WC Pathology
SC Pathology
GA 248UA
UT WOS:000252180201440
DA 2020-12-17
ER

PT J
AU Vireque, AA
   Camargo, LSA
   Serapiao, RV
   Ferreira, EM
   Navarro, PAAS
   Silva, AAMRE
   Ferriani, RA
AF Vireque, A. A.
   Camargo, L. S. A.
   Serapiao, R. V.
   Ferreira, E. M.
   Navarro, P. A. A. S.
   Silva, A. A. M. Rosa E.
   Ferriani, R. A.
TI Preimplantation development and expression of Bax and Hsp-70 genes in
   bovine embryos produced from oocytes matured in chemically defined IVM
   medium without gonadotrophins
SO REPRODUCTION FERTILITY AND DEVELOPMENT
LA English
DT Meeting Abstract
C1 [Vireque, A. A.; Ferreira, E. M.; Navarro, P. A. A. S.; Ferriani, R. A.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Camargo, L. S. A.; Serapiao, R. V.] Embrapa Dairy Cattle, Juiz De Fora, Brazil.
   [Silva, A. A. M. Rosa E.] Univ Brasilia, Brasilia, DF, Brazil.
RI Navarro, Paula/G-2744-2012; SERAPIAO, RAQUEL VARELLA/E-8451-2011;
   Vireque, Alessandra/G-2208-2012; ferriani, rui alberto/G-9974-2012
OI SERAPIAO, RAQUEL VARELLA/0000-0002-4198-5753; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CSIRO PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 1031-3613
J9 REPROD FERT DEVELOP
JI Reprod. Fertil. Dev.
PY 2008
VL 20
IS 1
MA 255
BP 207
EP 207
DI 10.1071/RDv20n1Ab255
PG 1
WC Developmental Biology; Reproductive Biology; Zoology
SC Developmental Biology; Reproductive Biology; Zoology
GA 239XB
UT WOS:000251550500267
DA 2020-12-17
ER

PT J
AU Barcelos, ID
   Vieira, RC
   Ferreira, EM
   Abreu, LG
   Ferriani, RA
   Navarro, PA
AF Barcelos, I. D.
   Vieira, R. C.
   Ferreira, E. M.
   Abreu, L. G.
   Ferriani, R. A.
   Navarro, P. A.
TI Evaluation of meiotic spindle and chromosomal configurations of in vitro
   matured oocytes obtained from stimulated cycles of endometriotic
   patients: Preliminary results.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 13-17, 2007
CL Washington, DC
SP Amer Soc Reproduct Med
C1 Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RI Navarro, Paula/G-2744-2012; ferriani, rui alberto/G-9974-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2007
VL 88
SU 1
BP S298
EP S298
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 216PC
UT WOS:000249889800849
DA 2020-12-17
ER

PT J
AU Ferriani, RA
   Ferreira, EM
   Navarro, PAAS
   Silva, AMRE
   Vireque, AA
AF Ferriani, R. A.
   Ferreira, E. M.
   Navarro, P. A. A. S.
   Rosa e Silva, A. M.
   Vireque, A. A.
TI Embryonic developmental competence of bovine oocytes matured in
   chemically defined medium supplemented with synthetic macromolecules.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 13-17, 2007
CL Washington, DC
SP Amer Soc Reproduct Med
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil.
   Univ Brasilia, Brasilia, DF, Brazil.
RI Vireque, Alessandra/G-2208-2012; ferriani, rui alberto/G-9974-2012;
   Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2007
VL 88
SU 1
BP S273
EP S273
DI 10.1016/j.fertnstert.2007.07.927
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 216PC
UT WOS:000249889800778
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Barcelos, ID
   Vieira, RC
   Ferreira, EM
   Reis, RM
   Ferriani, RA
AF Navarro, P. A.
   Barcelos, I. D.
   Vieira, R. C.
   Ferreira, E. M.
   Reis, R. M.
   Ferriani, R. A.
TI Evaluation of meiotic spindle and chromosome configurations of in vitro
   matured human oocytes from PCOS and endometriotic patients submitted to
   ovarian, stimulation: Preliminary results.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 13-17, 2007
CL Washington, DC
SP Amer Soc Reproduct Med
C1 Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RI ferriani, rui alberto/G-9974-2012; Reis, Rosana M. dos/E-3346-2012;
   Navarro, Paula/G-2744-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2007
VL 88
SU 1
BP S297
EP S297
DI 10.1016/j.fertnstert.2007.07.1002
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 216PC
UT WOS:000249889800848
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Vieira, RC
   Barcelos, ID
   Ferreira, EM
   Reis, RM
   Ferriani, RA
AF Navarro, P. A.
   Vieira, R. C.
   Barcelos, I. D.
   Ferreira, E. M.
   Reis, R. M.
   Ferriani, R. A.
TI Analysis of the spindle and chromosome configurations of in vitro
   matured human oocytes from PCOS patients submitted to ovarian
   stimulation: Preliminary results.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 13-17, 2007
CL Washington, DC
SP Amer Soc Reproduct Med
C1 Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; ferriani, rui alberto/G-9974-2012; Reis,
   Rosana M. dos/E-3346-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2007
VL 88
SU 1
BP S296
EP S296
DI 10.1016/j.fertnstert.2007.07.997
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 216PC
UT WOS:000249889800844
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Vireque, AA
   Adona, P
   de Sa, MFS
   Ferriani, RA
   Ferreira, EM
AF Navarro, P. A.
   Vireque, A. A.
   Adona, P.
   Silva de Sa, M. F.
   Ferriani, R. A.
   Ferreira, E. M.
TI Meiotic spindle evaluation of bovine oocytes submitted to in vitro
   maturation after pretreatment with butyrolactone I, an inhibitor of
   premature meiotic resumption.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 13-17, 2007
CL Washington, DC
SP Amer Soc Reproduct Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   Univ Sao Paulo, Dept Basic Sci, Fac Zootech & Aliments Engn, BR-09500900 Sao Paulo, Brazil.
RI ferriani, rui alberto/G-9974-2012; Vireque, Alessandra/G-2208-2012;
   Navarro, Paula/G-2744-2012
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2007
VL 88
SU 1
BP S273
EP S273
DI 10.1016/j.fertnstert.2007.07.929
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 216PC
UT WOS:000249889800780
DA 2020-12-17
ER

PT J
AU Drori, R
   Zeidler, A
   Varadarajan, P
   Navarro, P
   Haywood, JL
   Souibri, K
   Pohost, GM
AF Drori, Rafit
   Zeidler, Adina
   Varadarajan, Padmini
   Navarro, Paula
   Haywood, Julian L.
   Souibri, Karam
   Pohost, Gerald M.
TI Microvascular myocardial disease in type 1 diabetes mellitus of Latin
   American origin
SO DIABETES
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the American-Diabetes-Association
CY JUN 09-13, 2006
CL Washington, DC
SP Amer Diabet Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
J9 DIABETES
JI Diabetes
PD JUN
PY 2006
VL 55
SU 1
BP A155
EP A155
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 049ZE
UT WOS:000238055800650
DA 2020-12-17
ER

PT J
AU Navarro, PAAS
   Liu, L
   Ferriani, RA
   Keefe, DL
AF Navarro, PAAS
   Liu, L
   Ferriani, RA
   Keefe, DL
TI Arsenite induces aberrations in meiosis that can be prevented by
   coadministration of N-acetylcysteine in mice
SO FERTILITY AND STERILITY
LA English
DT Article
DE arsenite; meiosis; oocytes; growth and development; acetylcysteine
ID OXIDATIVE STRESS; DRINKING-WATER; HUMAN OOCYTES; DEVELOPMENTAL
   COMPETENCE; CHROMOSOME ALIGNMENT; SPONTANEOUS-ABORTION; PROTEIN
   OXIDATION; SODIUM ARSENITE; NORTHERN SWEDEN; BOVINE OOCYTES
AB Objective: To evaluate in vitro effects of arsenite and of arsenite plus N-acetylcysteine on mouse oocyte meiosis.
   Design: Morphological study using mouse oocytes Submitted to in vitro maturation (IVM).
   Setting: Laboratory of reproductive biology.
   Animal(s): Six-week-old CD-1 mice superovulated with pregnant mare serum gonadotropin.
   Intervention(S): During IVM, mouse oocytes were exposed to arsenite alone or to arsenite plus N-acetylcysteine.
   Main Outcome Measure(s): Meiotic anomalies were assessed using immunofluorescence microscopy and PolScope (Cambridge Research and Instrumentation, Boston, MA) imaging,
   Result(s): In vitro arsenite administration produced dose-dependent and time-dependent meiotic anomalies. characterized by spindle disruption or chromosome misalignment. After 12-14 hours of IVM. exposure to 2 mu g/mL of arsenite for 12-14 hours or to 8 mu g/mL of arsenite for 2 hours arrested oocyte maturation at the germinal vesicle or germinal-vesicle breakdown stage. Exposure to 4 mu g/mL of arsenite for 2 hours arrested oocyte maturation at metaphase I stage in 95% of exposed oocytes (80% exhibiting abnormalities) after 12-14 hours in IVM. After 12-14 hours in IVM, of the oocytes exposed to 2 mu g/mL of arsenite for 2 hours. only 15% reached the meiosis It stage (5% exhibiting abnormalities). After 15-17 hours in IVM. however. of the oocytes exposed to 2 mu g/mL of arsenite for 2 hours, 65.2% reached the meiosis II stage (43.5% exhibiting abnormalities). Co-administration of N-acetylcysteine prevented the arsenite-induced meiotic abnormalities and the delayed IVM.
   Conclusion(s): In vitro arsenite exposure caused meiotic abnormalities that were prevented by co-administration of N-acetylcysteine, Suggesting that arsenite-induced meiotic aberrations are mediated by reactive oxygen species.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Providence, RI USA.
   Marine Biol Lab, Woods Hole, MA 02543 USA.
RP Navarro, PAAS (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM paasnavarro@uol.com.br
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X
   ALLWORTH AE, 1993, DEV BIOL, V158, P101, DOI 10.1006/dbio.1993.1171
   Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890
   Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9
   Armstrong DT, 2001, THERIOGENOLOGY, V55, P1303, DOI 10.1016/S0093-691X(01)00484-8
   ASCHENGRAU A, 1989, ARCH ENVIRON HEALTH, V44, P283, DOI 10.1080/00039896.1989.9935895
   Battaglia DE, 1996, HUM REPROD, V11, P2217
   BEAUDOIN AR, 1974, TERATOLOGY, V10, P153, DOI 10.1002/tera.1420100211
   Beckman KB, 1998, PHYSIOL REV, V78, P547
   BECKMAN L, 1978, AMBIO, V7, P226
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Borum D, 1994, ENVIRON GEOCHEM HLTH, V16, P21
   BORZSONYI M, 1992, ARCH TOXICOL, V66, P77, DOI 10.1007/BF02307274
   Cantor KP, 1996, EPIDEMIOLOGY, V7, P113
   Chattopadhyay S, 2001, ARCH ENVIRON CON TOX, V41, P83, DOI 10.1007/s002440010223
   DOMINGO JL, 1995, RES COMMUN MOL PATH, V89, P389
   EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77
   FERM VH, 1968, J REPROD FERTIL, V17, P199
   Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7
   Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103
   HOOD RD, 1988, J TOXICOL ENV HEALTH, V25, P423, DOI 10.1080/15287398809531221
   HOOD RD, 1972, B ENVIRON CONTAM TOX, V7, P216, DOI 10.1007/BF01684401
   HOOD RD, 1982, B ENVIRON CONTAM TOX, V29, P671, DOI 10.1007/BF01606106
   *IARC, 1982, IARC MON EV CARC RIS, V4, P50
   Limoli CL, 1998, CANCER RES, V58, P3712
   Liu L, 2000, BIOL REPROD, V63, P251, DOI 10.1095/biolreprod63.1.251
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.98.4.1643
   LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107
   Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586
   Nemec MD, 1998, REPROD TOXICOL, V12, P647, DOI 10.1016/S0890-6238(98)00053-7
   NORDENSON I, 1991, HUM HERED, V41, P71, DOI 10.1159/000153979
   NORDSTROM S, 1979, HEREDITAS, V90, P291, DOI 10.1111/j.1601-5223.1979.tb01316.x
   Oldenbourg R, 1999, METHOD CELL BIOL, V61, P175
   Oldenbourg R, 1996, NATURE, V381, P811, DOI 10.1038/381811a0
   OyaOhta Y, 1996, MUTAT RES-FUND MOL M, V357, P123, DOI 10.1016/0027-5107(96)00092-9
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154
   Wang WH, 2001, HUM REPROD, V16, P1464, DOI 10.1093/humrep/16.7.1464
NR 40
TC 24
Z9 25
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD APR
PY 2006
VL 85
SU 1
BP 1187
EP 1194
DI 10.1016/j.fertnstert.2005.08.060
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 034CM
UT WOS:000236902300015
PM 16616091
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Gomes, FM
   Petean, CC
   Dos Reis, RM
   Ferriani, RA
   De Moura, MD
AF Navarro, PA
   Gomes, FM
   Petean, CC
   Dos Reis, RM
   Ferriani, RA
   De Moura, MD
TI Effect of endometriosis on progesterone secretion by human granulosa
   cells: Role of peritoneal fluid.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Conjoint Annual Meeting of the
   American-Society-for-Reproductive-Medicine/Canadian-Fertility-and-Androl
   ogy-Society
CY OCT 15-19, 2005
CL Montreal, CANADA
SP Amer Soc Reprod Med, Canadian Fertil & Androl Soc
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
RI ferriani, rui a/A-5872-2008; Reis, Rosana M. dos/E-3346-2012; ferriani,
   rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2005
VL 84
SU 1
BP S201
EP S202
DI 10.1016/j.fertnstert.2005.07.508
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 967TR
UT WOS:000232114600505
DA 2020-12-17
ER

PT J
AU Petean, CC
   Navarro, PA
   Gomes, FM
   Dos Reis, RM
   De Moura, MD
   Ferriani, RA
AF Petean, CC
   Navarro, PA
   Gomes, FM
   Dos Reis, RM
   De Moura, MD
   Ferriani, RA
TI Lipid peroxidation and antioxidant capacity in the follicular fluid and
   serum of infertile women with peritoneal endometriosis.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT Conjoint Annual Meeting of the
   American-Society-for-Reproductive-Medicine/Canadian-Fertility-and-Androl
   ogy-Society
CY OCT 15-19, 2005
CL Montreal, CANADA
SP Amer Soc Reprod Med, Canadian Fertil & Androl Soc
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
RI ferriani, rui a/A-5872-2008; Reis, Rosana M. dos/E-3346-2012; Navarro,
   Paula/G-2744-2012; ferriani, rui alberto/G-9974-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2005
VL 84
SU 1
BP S193
EP S193
DI 10.1016/j.fertnstert.2005.07.483
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 967TR
UT WOS:000232114600480
DA 2020-12-17
ER

PT J
AU Navarro, P
   Lluch, J
   Font, E
AF Navarro, P
   Lluch, J
   Font, E
TI The component helminth community in six sympatric species of Ardeidae
SO JOURNAL OF PARASITOLOGY
LA English
DT Article
ID INTESTINAL HELMINTHS; LARVAL HELMINTHS; PATTERNS; HOST; ECOLOGY;
   PARASITOLOGY; ASSOCIATIONS; EVOLUTION; RICHNESS; TERMS
AB We studied the helminth communities in 6 sympatric species of Ardeidae (Ixobrychus minutus (Linnaeus, 1766), Nycticorax nycticorax (Linnaeus, 1758), Bubulcus ibis (Linnaeus, 1758), Egretta garzetta (Linnaeus, 1766), Ardea cinerea (Linnaeus, 1758). and Ardea purpurea (Linnaeus, 1766)) from "La Albufera de Valencia," Spain. The survey revealed 13 species of helminth parasites: 5 digeneans, 2 cestodes, and 6 nematodes. The component helminth communities of the Ardeidae examined are depauperate and conform to the pattern typically found in isolationist communities, probably because of their high trophic dependence on a few prey species. Evenness was positively correlated with richness and abundance, but host body weight was not correlated with the number of helminth species or with the total number of helminths. Ardea cinerea is more heavily infected than E. garzetta by Apharyngostrigea cornu, and B. ibis is more heavily infected than both Ardea cinerea and E. garzetta by Desportesius spinulatus. Apharyngostrigea cornu was positively associated with Desmidocercella numidica and D. spinulatus in A. cinerea.
C1 Univ Valencia, Dept Zool, E-46100 Burjassot, Valencia, Spain.
RP Navarro, P (corresponding author), Univ Valencia, Dept Zool, C Dr Moliner 50, E-46100 Burjassot, Valencia, Spain.
EM pnavarro@uv.es
CR Alexander S, 1997, ONDERSTEPOORT J VET, V64, P161
   Barus V, 1978, HELMINTHS FISH EATIN
   BOHATYREVA OB, 1997, 1 NAT C CONS BIOD 21
   Bush A.O., 1990, PARASITE COMMUNITIES, P321
   Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227
   BUSH AO, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P197
   BUSH AO, 1986, CAN J ZOOL, V64, P132, DOI 10.1139/z86-022
   Campos Francisco, 2001, Avocetta, V25, P283
   CASTILLOREMIRO JA, 1989, REV IBERICA PARASITO, V49, P43
   Correia AM, 2001, J ZOOL, V255, P533
   Cramp S., 1983, HDB BIRDS EUROPE MID, V3
   Dezfuli BS, 2000, INT J PARASITOL, V30, P1143, DOI 10.1016/S0020-7519(00)00093-X
   Dies JI, 2003, WATERBIRDS, V26, P379, DOI 10.1675/1524-4695(2003)026[0379:WBBBNH]2.0.CO;2
   EDWARDS DD, 1989, J PARASITOL, V75, P225, DOI 10.2307/3282771
   Esch G.W., 1990, PARASITE COMMUNITIES
   Fedynich AM, 1996, CAN J ZOOL, V74, P1253, DOI 10.1139/z96-139
   FEDYNICH AM, 1994, CAN J ZOOL, V72, P496, DOI 10.1139/z94-067
   FERNANDEZ M, 1999, 6 C IB PAR 21 24 SEP, P26
   Galindo Javier, 2000, Dugastella, V1, P9
   Gibson D.I., 2002, KEYS TREMATODA, V1
   GIJON-BOTELLA H, 1985, Revista Iberica de Parasitologia, V45, P263
   GOMEZ MA, 2000, ANUARIO ORNITOLOGICO, V7
   Habsburgo-Lorena AS., 1978, FRESHWATER CRAYFISH, V4, P175
   KENNEDY CR, 1989, PARASITOLOGY, V98, P439, DOI 10.1017/S0031182000061527
   KENNEDY CR, 1986, PARASITOLOGY, V93, P205, DOI 10.1017/S0031182000049945
   KEYMER AE, 1991, ACTA OECOL, V12, P105
   KOSTADINOVA A, 1995, CR HEBD ACAD SCI, V48, P89
   Krebs C.H., 1989, ECOLOGICAL METHODOLO
   LUZNOGUESEROLA M, 2002, ANALES BIOL, V24, P139
   MARGOLIS L, 1982, J PARASITOL, V68, P131, DOI 10.2307/3281335
   Morand S, 2000, DEV AN VET, V32, P63
   OTERO AC, 1988, MISCELANEA ZOOLOGICA, V40, P4
   Pielou E. C., 1975, ECOLOGICAL DIVERSITY
   Poulin R, 2004, ECOGRAPHY, V27, P119, DOI 10.1111/j.0906-7590.2004.03695.x
   POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061
   Poulin R, 2001, INT J PARASITOL, V31, P1589, DOI 10.1016/S0020-7519(01)00276-4
   Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341
   Poulin R, 1996, INT J PARASITOL, V26, P181, DOI 10.1016/0020-7519(95)00112-3
   Poulin R, 1998, EVOLUTIONARY ECOLOGY
   Prosper J, 1996, COLON WATERBIRD, V19, P98, DOI 10.2307/1521952
   PROSPER J, 1989, MEDIANTE NATURAL, V1, P61
   Sepulveda MS, 1999, J HELMINTHOL SOC W, V66, P7
   Sokal R., 1995, BIOMETRY
   STOCK TM, 1987, CAN J ZOOL, V65, P669, DOI 10.1139/z87-104
   STUART JJ, 1972, J PARASITOL, V58, P518, DOI 10.2307/3278197
   Yamaguti S, 1971, SYNOPSIS DIGENETIC T
NR 46
TC 10
Z9 10
U1 2
U2 11
PU AMER SOC PARASITOLOGISTS
PI LAWRENCE
PA 810 EAST 10TH STREET, LAWRENCE, KS 66044 USA
SN 0022-3395
J9 J PARASITOL
JI J. Parasitol.
PD AUG
PY 2005
VL 91
IS 4
BP 775
EP 779
DI 10.1645/GE-3342.1
PG 5
WC Parasitology
SC Parasitology
GA 963OS
UT WOS:000231814200008
PM 17089743
DA 2020-12-17
ER

PT J
AU Navarro, PAAS
   Liu, L
   Trimarchi, JR
   Ferriani, RA
   Keefe, DL
AF Navarro, PAAS
   Liu, L
   Trimarchi, JR
   Ferriani, RA
   Keefe, DL
TI Noninvasive imaging of spindle dynamics during mammalian oocyte
   activation
SO FERTILITY AND STERILITY
LA English
DT Article
DE developmental biology; oocyte activation; spindle dynamics; Pol-Scope
   imaging
ID PROTEIN-KINASE-C; INTRACYTOPLASMIC SPERM INJECTION; MATURATION-PROMOTING
   FACTOR; POLARIZED-LIGHT MICROSCOPY; MATURED IN-VITRO; MOUSE OOCYTES;
   PARTHENOGENETIC ACTIVATION; PIVOTAL REGULATOR; MEIOTIC SPINDLE; BOVINE
   EMBRYOS
AB Objective: To develop a method to evaluate spindle dynamics in living oocytes and in karyoplasts during the initial stages of activation and after pharmacological disruption of cytoskeleton.
   Design: Morphological study using a novel microscope.
   Setting: Translational research laboratory at marine biological laboratory.
   Animal(s): Six-week-old CD-1 or B6C3F1 mice superovulated with pregnant mare's serum gonadotropin and human chorionic gonadotropin (hCG).
   Intervention(s): Spindles of living oocytes and karyoplasts were imaged at 5-10 minute intervals using the Pol-Scope during the initial stages of oocyte activation and after pharmacological disruption of cytoskeleton.
   Main Outcome Measure(s): Assessment of spindle dynamics using Pol-Scope imaging.
   Result(s): During oocyte activation, spindle mid-region birefringence increased, followed by spindle rotation and second polar body extrusion in both intact oocytes and karyoplasts. Activation of protein kinase C (PKC) with phorbol 12-myristate 13-acetate failed to induce spindle activation in 60% of living oocytes and caused spindle disruption in some oocytes. Inhibition of PKC by a myristoylated PKC pseudosubstrate inhibited metaphase II release in most oocytes evaluated (86.7%). Cytochalasin D inhibited only spindle rotation and separation. Nocodazole disrupted spindles in less than 5 minutes after administration.
   Conclusion(s): Pol-Scope imaging allows investigation at near real time of spindle dynamics during activation of living oocytes. Spindles also showed evidence of activation even in karyoplasts. The procedure may be useful for detecting functional spindle aberrations in living oocytes. Further studies are needed to determine whether spindle dynamics predict clinical Outcome.
C1 Marine Biol Lab, Woods Hole, MA 02543 USA.
   Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Providence, RI USA.
   Univ Fed Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, Sao Paulo, Brazil.
RP Keefe, DL (corresponding author), Marine Biol Lab, 7 MBL St,Woods Hole, Woods Hole, MA 02543 USA.
EM dkeefe@wihri.org
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR ALBERTS B, 1994, MOL BIOL CELL, P911
   ALLWORTH AE, 1993, DEV BIOL, V158, P101, DOI 10.1006/dbio.1993.1171
   Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256
   DEPENNART H, 1988, BIOL CELL, V64, P375, DOI 10.1016/0248-4900(88)90012-3
   Gallicano GI, 1997, MOL REPROD DEV, V46, P587, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;587::AID-MRD16&gt;3.0.CO;2-T
   Gallicano GI, 1997, BIOESSAYS, V19, P29, DOI 10.1002/bies.950190107
   GALLICANO GI, 1995, DEV BIOL, V167, P482, DOI 10.1006/dbio.1995.1043
   GALLICANO GL, 1993, DEV BIOL, V156, P94, DOI 10.1006/dbio.1993.1061
   GAPCO DG, 2001, INT REV CITOL, V207, P195
   HARAGUCHI Y, 1989, CELL STRUCT FUNCT, V14, P241
   Hatch KR, 2001, MOL REPROD DEV, V58, P69, DOI 10.1002/1098-2795(200101)58:1&lt;69::AID-MRD10&gt;3.0.CO;2-O
   HIRAMOTO Y, 1981, J CELL BIOL, V89, P121, DOI 10.1083/jcb.89.1.121
   INOUE S, 1995, MOL BIOL CELL, V6, P1619
   Johnson J, 1998, DEV BIOL, V204, P464, DOI 10.1006/dbio.1998.9038
   Jones KT, 1996, DEV BIOL, V178, P229, DOI 10.1006/dbio.1996.0214
   Katoh K, 1999, P NATL ACAD SCI USA, V96, P7928, DOI 10.1073/pnas.96.14.7928
   KAUFMAN MH, 1983, EARLY MAMMALIAN DEV, P1
   Keefe D, 1997, HUM REPROD, V12, P1250
   KUBIAK JZ, 1989, DEV BIOL, V136, P537, DOI 10.1016/0012-1606(89)90279-0
   KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x
   LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153
   Lee J, 2000, BIOL REPROD, V62, P1184, DOI 10.1095/biolreprod62.5.1184
   Liu L, 1999, BIOL REPROD, V61, P1162, DOI 10.1095/biolreprod61.4.1162
   Liu L, 2000, BIOL REPROD, V63, P251, DOI 10.1095/biolreprod63.1.251
   Liu L, 1999, BIOL REPROD, V61, P1, DOI 10.1095/biolreprod61.1.1
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678
   Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692
   Liu L, 2001, CELL CALCIUM, V30, P423, DOI 10.1054/ceca.2001.0251
   Liu L, 2002, BIOL REPROD, V66, P204, DOI 10.1095/biolreprod66.1.204
   Liu Z, 1995, HUM REPROD, V10, P2985, DOI 10.1093/oxfordjournals.humrep.a135834
   MARO B, 1984, J EMBRYOL EXP MORPH, V81, P211
   MOOS J, 1995, BIOL REPROD, V53, P692, DOI 10.1095/biolreprod53.3.692
   MOSES RM, 1995, MOL REPROD DEV, V41, P264, DOI 10.1002/mrd.1080410218
   Oldenbourg R, 1999, METHOD CELL BIOL, V61, P175
   Oldenbourg R, 1996, NATURE, V381, P811, DOI 10.1038/381811a0
   PRESICCE GA, 1994, MOL REPROD DEV, V37, P61, DOI 10.1002/mrd.1080370109
   SATO K, 1979, GAMETE RES, V2, P283, DOI 10.1002/mrd.1120020403
   SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152
   SCHULTZ RM, 1995, CURR TOP DEV BIOL, V30, P21, DOI 10.1016/S0070-2153(08)60563-3
   STEINHAR.RA, 1974, NATURE, V252, P41, DOI 10.1038/252041a0
   SUN FZ, 1992, DEVELOPMENT, V115, P947
   Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879
   Swann K, 1997, BIOESSAYS, V19, P371, DOI 10.1002/bies.950190504
   TAWIA SA, 1992, HUM REPROD, V7, P1004, DOI 10.1093/oxfordjournals.humrep.a137759
   TESARIK J, 1995, FERTIL STERIL, V63, P343, DOI 10.1016/s0015-0282(16)57366-x
   VELHAC MH, 1994, DEVELOPMENT, V120, P1017
   Vignon X, 1998, THERIOGENOLOGY, V49, P392, DOI 10.1016/S0093-691X(98)90745-2
   Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615
   Wang WH, 1999, ZYGOTE, V7, P79, DOI 10.1017/S0967199499000428
   Wang WH, 1998, MOL REPROD DEV, V51, P346, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;346::AID-MRD15&gt;3.0.CO;2-0
   Wang WH, 2002, FERTIL STERIL, V78, P1077, DOI 10.1016/S0015-0282(02)04196-1
   Wang WH, 2001, FERTIL STERIL, V75, P348, DOI 10.1016/S0015-0282(00)01692-7
   Wang WH, 2001, HUM REPROD, V16, P1464, DOI 10.1093/humrep/16.7.1464
   WARD NE, 1993, BIOCHEMISTRY-US, V32, P11903, DOI 10.1021/bi00095a020
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Yanagida K, 1999, HUM REPROD, V14, P1307, DOI 10.1093/humrep/14.5.1307
   Zakhartchenko V, 1999, MOL REPROD DEV, V54, P264, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;264::AID-MRD7&gt;3.0.CO;2-Y
   Zakhartchenko V, 1999, J REPROD FERTIL, V115, P325, DOI 10.1530/jrf.0.1150325
NR 59
TC 28
Z9 28
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD APR
PY 2005
VL 83
SU 1
BP 1197
EP 1205
DI 10.1016/j.fertnstert.2004.07.983
PG 9
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 918FB
UT WOS:000228526600016
PM 15831293
DA 2020-12-17
ER

PT J
AU do Amaral, VF
   Bydlowski, SP
   Peranovich, TC
   Navarro, PAAS
   Subbiah, MTR
   Ferriani, RA
AF do Amaral, VF
   Bydlowski, SP
   Peranovich, TC
   Navarro, PAAS
   Subbiah, MTR
   Ferriani, RA
TI Lipid peroxidation in the peritoneal fluid of infertile women with
   peritoneal endometriosis
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE endometriosis; peritoneal fluid; lipid peroxide; infertility
ID TOTAL ANTIOXIDANT STATUS; OXIDATIVE STRESS; FREE-RADICALS; NITRIC-OXIDE;
   DISEASE; PLASMA
AB Objective: To assess the level of lipid peroxidation in the peritoneal fluid of infertile women with peritoneal endometriosis and of fertile disease-free controls.
   Study design: Level of lipid peroxidation (malondialdeyde, malondialdeyde with copper addition, and cholest-3,5-dien-7-one) was measured in the peritoneal fluid obtained from 21 women with endometriosis-related infertility and from 21 fertile women having tubal ligation.
   Results: The level of lipid peroxidation did not differ significantly (P > 0.05) according to the stage of endometriosis. The level of lipid peroxidation (malondialdeyde, malondialdeyde with the addition of copper, and cholest-3,5-dien-7-one) did not differ significantly (P > 0.05) between patients with endometriosis-related infertility (0.07 nmol/ml, 0.34 nmol/ml, 0.24 mu g/ml, respectively) and disease-free controls (0.04 nmol/ml, 0.21 nmol/ml, 0.25 mu g/ml, respectively).
   Conclusion: The level of lipid peroxidation did not differ between women with endometriosis-related infertility and fertile disease-free controls, suggesting that increased reactive oxygen species may not be one of the factors responsible for compromised fertility in patients with endometriosis. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Sao Paulo, Dept Obstet & Ginecol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Lab Hematol Expt, Dept Hematol & Hemoterapia, Fac Med,Superintendencia Pesquisa Pro Sangue, Sao Paulo, Brazil.
   Fdn Pro Sangue Hemoctr Sao Paulo, Div Pesquisa & Biol Mol, Sao Paulo, Brazil.
   Univ Cincinnati, Med Ctr, Dept Internal Med, Cincinnati, OH 45267 USA.
RP Ferriani, RA (corresponding author), Univ Sao Paulo, Dept Obstet & Ginecol, Fac Med Ribeirao Preto, Av Bandeirantes,3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM raferria@fmrp.usp.br
RI Navarro, Paula/G-2744-2012; Bydlowski, Sergio Paulo/D-5171-2013;
   ferriani, rui alberto/G-9974-2012
OI Bydlowski, Sergio Paulo/0000-0002-7582-5942; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR ARSHAD MAQ, 1991, CLIN CHEM, V37, P1756
   ARUMUGAM K, 1995, FERTIL STERIL, V63, P198, DOI 10.1016/S0015-0282(16)57320-8
   Beliard A, 1997, FERTIL STERIL, V67, P266, DOI 10.1016/S0015-0282(97)81909-7
   Cameron IT, 1998, HUM REPROD UPDATE, V4, P565, DOI 10.1093/humupd/4.5.565
   Canis M, 1997, FERTIL STERIL, V67, P817
   CURTIS P, 1993, BRIT J OBSTET GYNAEC, V100, P165, DOI 10.1111/j.1471-0528.1993.tb15215.x
   DELAMIRANDE E, 1995, HUM REPROD S1, V10, P115
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175
   HAHN M, 1995, BBA-LIPID LIPID MET, V1255, P341, DOI 10.1016/0005-2760(95)00004-V
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   HANEY AF, 1993, BAILLIERE CLIN OB GY, V7, P791, DOI 10.1016/S0950-3552(05)80464-X
   Ho HN, 1997, HUM REPROD, V12, P2810, DOI 10.1093/humrep/12.12.2810
   LIU Y, 2001, J TONGJI MED U, V21, P16
   MORCOS RN, 1985, FERTIL STERIL, V44, P678
   Murphy AA, 1998, FERTIL STERIL, V69, P1085, DOI 10.1016/S0015-0282(98)00088-0
   Murphy AA, 1998, SEMIN REPROD ENDOCR, V16, P263, DOI 10.1055/s-2007-1016286
   OAK M K, 1985, Clinical Reproduction and Fertility, V3, P297
   Ota H, 1999, GYNECOL OBSTET INVES, V48, P29, DOI 10.1159/000052866
   Ota H, 2001, FERTIL STERIL, V75, P785, DOI 10.1016/S0015-0282(01)01670-3
   Polak G, 2001, EUR J OBSTET GYN R B, V94, P261, DOI 10.1016/S0301-2115(00)00352-3
   POLAK G, 1999, GINEKOL POL
   Szczepanska M, 2003, FERTIL STERIL, V79, P1288, DOI 10.1016/S0015-0282(03)00266-8
   Van Langendonckt A, 2002, FERTIL STERIL, V77, P861, DOI 10.1016/S0015-0282(02)02959-X
   Wang YJ, 1997, FERTIL STERIL, V68, P826, DOI 10.1016/S0015-0282(97)00343-9
   ZELLER JM, 1987, AM J REPROD IMMUNOL, V13, P78
NR 26
TC 19
Z9 20
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD MAR 1
PY 2005
VL 119
IS 1
BP 72
EP 75
DI 10.1016/j.ejogrb.2004.07.020
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 906HX
UT WOS:000227632800011
PM 15734088
DA 2020-12-17
ER

PT J
AU Navarro, PAAS
   Lin, L
   Keefe, DL
AF Navarro, PAAS
   Lin, L
   Keefe, DL
TI In vivo effects of arsenite on meiosis, preimplantation development, and
   apoptosis in the mouse
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE apoptosis; early development; embryo; environment; meiosis
ID BOVINE OOCYTES; CYTOCHROME-C; SODIUM ARSENATE; MAMMALIAN-CELLS; RISK
   ASSESSMENT; DRINKING-WATER; AMINO-ACIDS; INDUCTION; MITOCHONDRIA;
   FERTILIZATION
AB Inorganic arsenic, an environmental contaminant, produces a variety of stress responses in mammalian cells, including metabolic abnormalities accompanied by growth inhibition and carcinogenesis. Much of the toxicity of arsenic is known to stem from its uncoupling effects on mitochondria. Because previously we had shown that mitochondrial dysfunction can disrupt oocyte and embryo development, we investigated effects of arsenite on meiotic progression and early embryo development in mice. Six-week-old CD-1 mice were treated with 0 (solvent as control), 8 mg/kg (a dose previously established in mice as the maternal no-observed-adverse-effect level), and 16 mg/kg doses of sodium arsenite every 2 days for a total of seven i.p. injections over a period of 14 days. The incidence of meiotic anomalies, characterized by spindle disruption and/or chromosomal misalignment, was significantly increased in arsenite-treated groups (25% after 8 mg/kg and 62.5% after 16 mg/kg), compared to normal metaphase 11 in control oocytes. Further, arsenite treatment significantly decreased cleavage rates of zygotes at 24 h, morula formation at 72 h, and development to blastocysts at 96 h in a dose-dependent manner. The total cell number in developed blastocysts did not differ significantly between the 8 mg/ kg arsenite treatment and control groups, but was significantly reduced in the 16 mg/kg arsenite treatment group. Moreover, the percentage of apoptotic nuclei was significantly increased in blastocysts following 16 mg/kg arsenite treatment. These data suggest that arsenite causes meiotic aberrations, which may contribute to decreased cleavage and preimplantation development, as well as increased apoptosis.
C1 Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Providence, RI 02905 USA.
   Marine Biol Lab, Woods Hole, MA 02543 USA.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, BR-14049000 Ribeirao Preto, SP, Brazil.
   Tufts Univ, New England Med Ctr, Dept Obstet & Gynecol, Boston, MA 02111 USA.
RP Keefe, DL (corresponding author), Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, 101 Dudley St, Providence, RI 02905 USA.
EM dkeefe@wihri.org
RI Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR ALLWORTH AE, 1993, DEV BIOL, V158, P101, DOI 10.1006/dbio.1993.1171
   APPLEGATE LA, 1991, CANCER RES, V51, P974
   Armstrong DT, 2001, THERIOGENOLOGY, V55, P1303, DOI 10.1016/S0093-691X(01)00484-8
   *ATSDR, 1993, TOX PROF ARS, P99
   BEAUDOIN AR, 1974, TERATOLOGY, V10, P153, DOI 10.1002/tera.1420100211
   Borum D, 1994, ENVIRON GEOCHEM HLTH, V16, P21
   Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088
   BURK D, 1977, TERATOLOGY, V16, P247, DOI 10.1002/tera.1420160303
   Cantor KP, 1996, EPIDEMIOLOGY, V7, P113
   CARLSONLYNCH H, 1994, ENVIRON HEALTH PERSP, V102, P354, DOI 10.2307/3431620
   Chappell WR, 1997, ENVIRON HEALTH PERSP, V105, P1060, DOI 10.2307/3433847
   DOMINGO JL, 1995, RES COMMUN MOL PATH, V89, P389
   FERM VH, 1968, J REPROD FERTIL, V17, P199
   FISHBEIN L, 1981, ENVIRON HEALTH PERSP, V40, P43, DOI 10.2307/3429220
   Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552
   Harmon BV, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P327
   Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103
   HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214
   HOOD RD, 1988, J TOXICOL ENV HEALTH, V25, P423, DOI 10.1080/15287398809531221
   HOOD RD, 1972, B ENVIRON CONTAM TOX, V7, P216, DOI 10.1007/BF01684401
   HOOD RD, 1982, B ENVIRON CONTAM TOX, V29, P671, DOI 10.1007/BF01606106
   Hughes K, 1995, REGUL TOXICOL PHARM, V22, P213, DOI 10.1006/rtph.1995.0003
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   LAWITTS JA, 1993, GUIDE TECHNIQUES MOU, P153
   Liu L, 1998, BIOL REPROD, V59, P537, DOI 10.1095/biolreprod59.3.537
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Liu L, 2001, CELL CALCIUM, V30, P423, DOI 10.1054/ceca.2001.0251
   Liu L, 2000, BIOL REPROD, V62, P1828, DOI 10.1095/biolreprod62.6.1828
   Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745
   LIU L, 2003, J BIOL CHEM
   Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.98.4.1643
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Liu Z, 1995, HUM REPROD, V10, P2985, DOI 10.1093/oxfordjournals.humrep.a135834
   LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107
   National Academy of Science, 1999, ARS DRINK WAT
   Nemec MD, 1998, REPROD TOXICOL, V12, P647, DOI 10.1016/S0890-6238(98)00053-7
   NORDENSON I, 1991, HUM HERED, V41, P71, DOI 10.1159/000153979
   Oldenbourg R, 1999, METHOD CELL BIOL, V61, P175
   Oldenbourg R, 1996, NATURE, V381, P811, DOI 10.1038/381811a0
   OyaOhta Y, 1996, MUTAT RES-FUND MOL M, V357, P123, DOI 10.1016/0027-5107(96)00092-9
   PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111
   Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   THORNTON I, 1996, ENVIRON GEOCHEM HLTH, V113, P153
   UTHUS EO, 1994, RISK ASSESSMENT OF ESSENTIAL ELEMENTS, P273
   VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X
   WANG TS, 1994, MUTAGENESIS, V9, P253, DOI 10.1093/mutage/9.3.253
   Warner CM, 1998, J EXP ZOOL, V282, P272, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;272::AID-JEZ29&gt;3.0.CO;2-U
   WARNER ML, 1994, CANCER EPIDEM BIOMAR, V3, P583
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
NR 50
TC 51
Z9 54
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0006-3363
EI 1529-7268
J9 BIOL REPROD
JI Biol. Reprod.
PD APR
PY 2004
VL 70
IS 4
BP 980
EP 985
DI 10.1095/biolreprod.103.020586
PG 6
WC Reproductive Biology
SC Reproductive Biology
GA 806OU
UT WOS:000220444000013
PM 14656726
OA Bronze
DA 2020-12-17
ER

PT J
AU Liu, L
   DiGirolamo, CM
   Navarro, PAAS
   Blasco, MA
   Keefe, DL
AF Liu, L
   DiGirolamo, CM
   Navarro, PAAS
   Blasco, MA
   Keefe, DL
TI Telomerase deficiency impairs differentiation of mesenchymal stem cells
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE mesenchymal stem cells; MSCs; differentiation; telomerase; telomere;
   mice
ID MARROW STROMAL CELLS; BONE-MARROW; REPLICATIVE SENESCENCE; LIFE-SPAN;
   EXPRESSION; GROWTH; TRANSPLANTATION; REGENERATION; ACTIVATION; CULTURE
AB Expression of telomerase activity presumably is involved in maintaining self-replication and the undifferentiated state of stem cells. Adult mouse bone marrow mesenchymal stem cells (mMSCs) are multipotential cells capable of differentiating into a variety of lineage cell types, including adipocytes and chondrocytes. Here we show that the lacking telomerase of mMSC lose multipotency and the capacity to differentiate. Primary cultures of mMSCs were obtained from both telomerase knockout (mTR(-/-)) and wild-type (WT) mice. The MSCs isolated from mTR(-/-) mice failed to differentiate into adipocytes and chondrocytes, even at early passages, whereas WT MSCs were capable of differentiation. Consistent with other cell types, late passages mTR(-/-)MSCs underwent senescence and were accompanied by telomere loss and chromosomal end-to-end fusions. These results suggest that in addition to its known role in cell replication, telomerase is required for differentiation of mMSCs in vitro. This work may be significant for further potentiating adult stem cells for use in tissue engineering and gene therapy and for understanding the significance of telomerase expression in the process of cell differentiation. (C) 2003 Elsevier Inc. All rights reserved.
C1 Brown Univ, Women & Infants Hosp, Sch Med, Dept Obstet & Gynecol, Providence, RI 02905 USA.
   Marine Biol Lab, Lab Reprod Med, Woods Hole, MA 02543 USA.
   Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain.
RP Liu, L (corresponding author), Brown Univ, Women & Infants Hosp, Sch Med, Dept Obstet & Gynecol, 101 Dudley St, Providence, RI 02905 USA.
EM lliu@mbl.edu
RI Navarro, Paula/G-2744-2012; Blasco, Maria A./M-1694-2014
OI Blasco, Maria A./0000-0002-4211-233X; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239
   Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x
   Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933
   Greider CW, 1998, CURR BIOL, V8, pR178, DOI 10.1016/S0960-9822(98)70105-8
   HIYAMA K, 1995, J IMMUNOL, V155, P3711
   Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   Liechty KW, 2000, NAT MED, V6, P1282
   Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580
   OWEN M, 1988, CIBA F SYMP, V136, P42
   Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Phinney DG, 1999, J CELL BIOCHEM, V72, P570
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Ravindranath N, 1997, ENDOCRINOLOGY, V138, P4026, DOI 10.1210/en.138.9.4026
   Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767
   Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078
   Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343
   Shay JW, 2000, NAT BIOTECHNOL, V18, P22, DOI 10.1038/71872
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780
   Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3
   Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
NR 46
TC 92
Z9 99
U1 0
U2 8
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAR 10
PY 2004
VL 294
IS 1
BP 1
EP 8
DI 10.1016/j.yexcr.2003.10.031
PG 8
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 800KX
UT WOS:000220028300001
PM 14980495
DA 2020-12-17
ER

PT J
AU Navarro, PAD
   Kaddouz, D
   De Ziegler, D
   De Sa, MFS
   Ferriani, RA
AF Navarro, PAD
   Kaddouz, D
   De Ziegler, D
   De Sa, MFS
   Ferriani, RA
TI Vaginal administration of allopregnanolone to postmenopausal women
   undergoing estrogen replacement therapy: preliminary results
SO MATURITAS
LA English
DT Article
DE allopregnanolone; hormonal replacement therapy; tolerability;
   endometrium; menopause
ID POST-MENOPAUSAL ENDOMETRIUM; GABA-A RECEPTOR; PREMENSTRUAL-SYNDROME;
   CIRCULATING LEVELS; PROGESTERONE; ESTRADIOL; NEUROSTEROIDS;
   PREGNENOLONE; BIOSYNTHESIS; STEROIDS
AB Objective: To assess the tolerability and endometrial effects of vaginal administration of an allopregnanolone gel to postmenopausal women undergoing estrogen therapy. Methods: Thirteen postmenopausal women included in the study were divided into two groups and submitted to two consecutive cycles of 28 days during which they received 2 mg oral estradiol valerate daily and vaginally administered allopregnanolone gel during the last 10 days of the second cycle (group 1) or during the last 10 days of each cycle (group 2). Systemic adverse effects, vaginal bleeding and endometrial histology were characterized, with group 1 patients being submitted to two endometrial biopsies (days 28 and 56) and group 2 patients to one biopsy (day 56). Results: Five patients did not show any adverse effect. Mastalgia was the most frequently reported adverse effect (four cases), followed by headache and abdominal pain (two cases each). The adverse effects were mild and did not interfere with the adequate use of the medication prescribed. Vaginal bleeding due to deprivation was observed in three of the seven patients submitted to one treatment cycle with allopregnanolone (group 1) and in two of six patients submitted to two treatment cycles (group 2). Endometrial biopsy findings did not suggest any secretory action after exposure to allopregnanolone. Conclusions: Tolerability of vaginal administration of allopregnanolone gel was good. Studies employing a larger series and longer time of follow-up are necessary to determine the endometrial effects of this drug. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Sao Paulo, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
   Columbia Res Labs, Paris, France.
RP Ferriani, RA (corresponding author), Univ Sao Paulo, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012; ferriani,
   rui a/A-5872-2008
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR AKWA Y, 1992, BIOCHEM J, V288, P959, DOI 10.1042/bj2880959
   Baulieu EE, 1996, CELL MOL NEUROBIOL, V16, P143, DOI 10.1007/BF02088173
   BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C
   BICIKOVA M, 1995, STEROIDS, V60, P210
   Bulletti C, 1997, HUM REPROD, V12, P1073
   BURCH DJ, 1995, BRIT J OBSTET GYNAEC, V102, P243, DOI 10.1111/j.1471-0528.1995.tb09102.x
   CLISHAM PR, 1992, OBSTET GYNECOL, V79, P196
   DEZIEGLER D, 1991, FERTIL STERIL, V55, P775
   Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4
   Genazzani AR, 1998, J CLIN ENDOCR METAB, V83, P2099, DOI 10.1210/jc.83.6.2099
   HAHN RG, 1989, AM J OBSTET GYNECOL, V161, P1854, DOI 10.1016/S0002-9378(89)80006-7
   HOLZBAUER M, 1985, J STEROID BIOCHEM, V22, P97, DOI 10.1016/0022-4731(85)90147-5
   JUNGTESTAS I, 1989, ENDOCRINOLOGY, V125, P2083
   LANE G, 1983, BRIT MED J, V287, P1241, DOI 10.1136/bmj.287.6401.1241
   MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A
   MARSH MS, 1993, BAILLIERE CLIN ENDOC, V7, P183, DOI 10.1016/S0950-351X(05)80275-7
   MCDONNELL DP, 1995, TRENDS ENDOCRIN MET, V6, P133, DOI 10.1016/1043-2760(95)00065-P
   MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V
   MELLON SH, 1993, BRAIN RES, V629, P283, DOI 10.1016/0006-8993(93)91332-M
   MOYER DL, 1993, FERTIL STERIL, V59, P992
   NACHTIGALL LE, 1990, OBSTET GYNECOL, V75, P77
   Neulen J, 1996, HUM REPROD, V11, P1533
   NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0
   PAUL SM, 1992, FASEB J, V6, P2311
   ROBEL P, 1994, TRENDS ENDOCRIN MET, V5, P1, DOI 10.1016/1043-2760(94)90114-7
   SCHMIDT PJ, 1994, J CLIN ENDOCR METAB, V79, P1256, DOI 10.1210/jc.79.5.1256
   VOIGT LF, 1991, LANCET, V338, P274, DOI 10.1016/0140-6736(91)90417-N
   Wang MD, 1996, J CLIN ENDOCR METAB, V81, P1076, DOI 10.1210/jc.81.3.1076
   WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356
   WHITEHEAD MI, 1978, MATURITAS, V1, P87, DOI 10.1016/0378-5122(78)90015-4
   WHITEHEAD MI, 1990, OBSTETRICS GYNECOL S, V75, P59
   WOLF JP, 1989, FERTIL STERIL, V52, P1055
   WREN BG, 1991, MATURITAS, V13, P17, DOI 10.1016/0378-5122(91)90281-T
NR 33
TC 2
Z9 3
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0378-5122
J9 MATURITAS
JI Maturitas
PD OCT 20
PY 2003
VL 46
IS 2
BP 147
EP 152
DI 10.1016/S0378-5122(03)00188-9
PG 6
WC Geriatrics & Gerontology; Obstetrics & Gynecology
SC Geriatrics & Gerontology; Obstetrics & Gynecology
GA 736HG
UT WOS:000186164900017
PM 14559386
DA 2020-12-17
ER

PT J
AU Liu, L
   Trimarchi, JR
   Navarro, P
   Blasco, MA
   Keefe, DL
AF Liu, L
   Trimarchi, JR
   Navarro, P
   Blasco, MA
   Keefe, DL
TI Oxidative stress contributes to arsenic-induced telomere attrition,
   chromosome instability, and apoptosis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PERMEABILITY TRANSITION PORE; ACUTE PROMYELOCYTIC LEUKEMIA; CYTOCHROME-C
   RELEASE; HUMAN TUMOR-CELLS; SODIUM ARSENITE; DEFICIENT MICE; CANCER;
   MOUSE; CARCINOGENESIS; MITOCHONDRIA
AB The environmental contaminant arsenic causes cancer, developmental retardation, and other degenerative diseases and, thus, is a serious health concern worldwide. Paradoxically, arsenic also may serve as an antitumor therapy, although the mechanisms of its antineoplastic effects remain unclear. Arsenic exerts its toxicity in part by generating reactive oxygen species. We show that arsenic-induced oxidative stress promotes telomere attrition, chromosome end-to-end fusions, and apoptotic cell death. An antioxidant, N-acetylcysteine, effectively prevents arsenic-induced oxidative stress, telomere erosion, chromosome instability, and apoptosis, suggesting that increasing the intracellular antioxidant level may have preventive or therapeutic effects in arsenic-induced chromosome instability and genotoxicity. Embryos with shortened telomeres from late generation telomerase-deficient mice exhibit increased sensitivity to arsenic-induced oxidative damage, suggesting that telomere attrition mediates arsenic-induced apoptosis. Unexpectedly, arsenite did not cause chromosome end-to-end fusions in telomerase RNA knockout mouse embryos despite progressively damaged telomeres and disrupting embryo viability. Together, these findings may explain why arsenic can initiate oxidative stress and telomere erosion, leading to apoptosis and anti-tumor therapy on the one hand and chromosome instability and carcinogenesis on the other.
C1 Marine Biol Lab, Lab Reprod Med, Woods Hole, MA 02543 USA.
   Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Providence, RI 02905 USA.
   Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain.
RP Keefe, DL (corresponding author), Marine Biol Lab, Lab Reprod Med, Woods Hole, MA 02543 USA.
EM dkeefe@wihri.org
RI Blasco, Maria A./M-1694-2014; Navarro, Paula/G-2744-2012
OI Blasco, Maria A./0000-0002-4211-233X; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR BARRETT JC, 1989, BIOL TRACE ELEM RES, V21, P421, DOI 10.1007/BF02917284
   Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Chappell WR, 1997, ENVIRON HEALTH PERSP, V105, P1060, DOI 10.2307/3433847
   Chattopadhyay S, 2001, ARCH ENVIRON CON TOX, V41, P83, DOI 10.1007/s002440010223
   Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   Chou WC, 2001, J CLIN INVEST, V108, P1541, DOI 10.1172/JCI14064
   Cotgreave I A, 1997, Adv Pharmacol, V38, P205
   Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217
   Goering PL, 1999, TOXICOL SCI, V49, P5, DOI 10.1093/toxsci/49.1.5
   Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552
   Gonsebatt ME, 1997, MUTAT RES-REV MUTAT, V386, P219, DOI 10.1016/S1383-5742(97)00009-4
   Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089
   Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061
   Hahn WC, 1999, NATURE, V400, P464
   Hamadeh HK, 1999, BIOCHEM BIOPH RES CO, V263, P446, DOI 10.1006/bbrc.1999.1395
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172
   Huang SY, 2000, LEUKEMIA LYMPHOMA, V38, P283, DOI 10.3109/10428190009087019
   Kipling D, 1997, HUM MOL GENET, V6, P1999, DOI 10.1093/hmg/6.12.1999
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Larochette N, 1999, EXP CELL RES, V249, P413, DOI 10.1006/excr.1999.4519
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   LEE TC, 1994, ENVIRON HEALTH PERSP, V102, P101, DOI 10.2307/3431770
   LEE TC, 1989, IN VITRO CELL DEV B, V25, P442
   LEONARD A, 1980, MUTAT RES, V75, P49, DOI 10.1016/0165-1110(80)90027-5
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Liu L, 2002, DEV BIOL, V249, P74, DOI 10.1006/dbio.2002.0735
   Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.98.4.1643
   Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045
   MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496
   Mirkes PE, 2000, TOXICOL APPL PHARM, V162, P197, DOI 10.1006/taap.1999.8849
   Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8
   MULLER WU, 1986, ARCH TOXICOL, V59, P172, DOI 10.1007/BF00316328
   NAKAMURO K, 1981, MUTAT RES, V88, P73, DOI 10.1016/0165-1218(81)90091-4
   Oulton R, 2000, CURR OPIN ONCOL, V12, P74, DOI 10.1097/00001622-200001000-00013
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174
   Saretzki G, 1999, ONCOGENE, V18, P5148, DOI 10.1038/sj.onc.1202898
   Tabacova S, 1996, TOXICOL APPL PHARM, V138, P298, DOI 10.1006/taap.1996.0128
   TAYLOR PR, 1989, BRIT J IND MED, V46, P881
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   WANG TS, 1994, MUTAGENESIS, V9, P253, DOI 10.1093/mutage/9.3.253
   Wang XD, 2001, GENE DEV, V15, P2922
   WARNER ML, 1994, CANCER EPIDEM BIOMAR, V3, P583
   Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3
   Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388
   Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887
   Zhu XH, 1999, J NATL CANCER I, V91, P772, DOI 10.1093/jnci/91.9.772
   Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423
NR 57
TC 144
Z9 152
U1 1
U2 13
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 22
PY 2003
VL 278
IS 34
BP 31998
EP 32004
DI 10.1074/jbc.M303553200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 712DP
UT WOS:000184782100069
PM 12767976
OA Bronze
DA 2020-12-17
ER

PT J
AU Navarro, PA
   Liu, L
   Trimarchi, JR
   Ferriani, RA
   Keefe, DL
AF Navarro, PA
   Liu, L
   Trimarchi, JR
   Ferriani, RA
   Keefe, DL
TI Non-invasive imaging of spindle dynamics during physiologic and
   pharmacologic mammalian oocyte activation.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2002
CL SEATTLE, WASHINGTON
SP Amer Soc Reproduct Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   Brown Univ, Women & Infants Hosp, Providence, RI USA.
RI Navarro, Paula/G-2744-2012; ferriani, rui alberto/G-9974-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2002
VL 78
IS 3
SU 1
MA P146
BP S164
EP S165
DI 10.1016/S0015-0282(02)03829-3
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 597UP
UT WOS:000178239400444
DA 2020-12-17
ER

PT J
AU Navarro, PAAS
   Liu, L
   Ferriani, RA
   Keefe, DL
AF Navarro, PAAS
   Liu, L
   Ferriani, RA
   Keefe, DL
TI Arsenite induces aberrations in meiosis that can be rescued by
   co-administration of N-acetylcysteine in mouse.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the American-Society-for-Reproductive-Medicine
CY OCT 12-17, 2002
CL SEATTLE, WASHINGTON
SP Amer Soc Reproduct Med
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   Brown Univ, Women & Infants Hosp, Providence, RI USA.
RI ferriani, rui alberto/G-9974-2012; Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2002
VL 78
IS 3
SU 1
MA P152
BP S166
EP S166
DI 10.1016/S0015-0282(02)03835-9
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 597UP
UT WOS:000178239400450
DA 2020-12-17
ER

PT J
AU Navarro, PAAS
   Liu, L
   Keefe, DL
AF Navarro, PAAS
   Liu, L
   Keefe, DL
TI Efects of arsenite on meiotic progression, preimplantation development,
   and apoptosis.
SO BIOLOGY OF REPRODUCTION
LA English
DT Meeting Abstract
C1 Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Providence, RI USA.
   Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Obstet & Gynecol, BR-14049 Ribeirao Preto, Brazil.
   Biol Marine Lab, Woods Hole, MA USA.
RI Navarro, Paula/G-2744-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC STUDY REPRODUCTION
PI MADISON
PA 1603 MONROE ST, MADISON, WI 53711-2021 USA
SN 0006-3363
J9 BIOL REPROD
JI Biol. Reprod.
PY 2002
VL 66
SU 1
MA 130
BP 150
EP 151
PG 2
WC Reproductive Biology
SC Reproductive Biology
GA 568UD
UT WOS:000176561900190
DA 2020-12-17
ER

PT J
AU Maciel, LMZ
   Rodrigues, SS
   Dibbern, RS
   Navarro, PAA
   Donadi, EA
AF Maciel, LMZ
   Rodrigues, SS
   Dibbern, RS
   Navarro, PAA
   Donadi, EA
TI Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves'
   disease in a population representing the gene contribution from several
   ethnic backgrounds
SO THYROID
LA English
DT Article
ID AUTOIMMUNE THYROID-DISEASE; CAUCASIAN POPULATION; HLA ANTIGENS;
   SUSCEPTIBILITY; RECEPTOR; RESISTANCE; LOCI; DNA
AB Graves' disease (GD) is the most frequent cause of hyperthyroidism. Although the etiology is not completely elucidated, there are several lines of evidence suggesting multifactorial mechanisms. Genetic, constitutional, and environmental factors are involved in its pathogenesis. Major histocompatibility complex (MHC) class II alleles have been associated with CD in several populations of distinct ethnic backgrounds and there is increasing evidence supporting an association between CD and HLA-DRS in Caucasian populations. The MHC class II alleles were evaluated in 75 Brazilian patients presenting with GD and in 166 control individuals from the same geographic area. HLA-DRB, DQB, and DQA alleles were identified using polymerase chain reaction (PCR)-amplified DNA hybridized with sequence-specific probes. The HLA-DRB1*0301 allele was significantly increased in patients (34/75, 45.3%) as compared with controls (37/166, 22.3%, p = 0.009), conferring a relative risk (RR) of 2.8 and an etiologic fraction (EF) of 0.287. The HLA DQA1*0501 allele was also overrepresented in patients (48/71, 67.6%) in relation to controls (24/71, 33.8%; p = 0.004), conferring an RR of 3.74 and an EF of 0.351. The susceptibility conferred by HLA DQA1*0501 was independent of the HLA-DRB1*0301 allele. On the other hand, the HLA-DQB1*0602 allele was significantly decreased in patients (6/75, 8.0%) in relation to controls (53/166, 31.9%, p = 0.0008), conferring an RR of 0.18 and a preventive fraction of 0.267. Although the Brazilian population comprises individuals of several ethnic backgrounds, these results corroborate the participation of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles as susceptibility markers for GD, and emphasize the participation of the HLA-DQB1*0602 allele as conferring protection against the development of the disease.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Div Endocrinol, BR-14048900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Div Clin Immunol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Maciel, LMZ (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, Div Endocrinol, Av Bandirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
EM lmzmacie@fmrp.usp.hr
RI Navarro, Paula/G-2744-2012; donadi, eduardo A/H-7080-2013; Maciel, Lea
   MZ/O-6539-2015
OI donadi, eduardo A/0000-0002-9457-9601; 
CR BADENHOOP K, 1995, J CLIN ENDOCR METAB, V80, P2112, DOI 10.1210/jc.80.7.2112
   BAHN RS, 1994, J CLIN ENDOCR METAB, V78, P256, DOI 10.1210/jc.78.2.256
   Barlow ABT, 1996, CLIN ENDOCRINOL, V44, P73, DOI 10.1046/j.1365-2265.1996.634454.x
   BLAKEMORE AIF, 1995, J CLIN ENDOCR METAB, V80, P111, DOI 10.1210/jc.80.1.111
   Brix TH, 1998, THYROID, V8, P627, DOI 10.1089/thy.1998.8.627
   CAVAN DA, 1994, CLIN ENDOCRINOL, V40, P63, DOI 10.1111/j.1365-2265.1994.tb02444.x
   Chen QY, 2000, J CLIN ENDOCR METAB, V85, P1545, DOI 10.1210/jc.85.4.1545
   Cuddihy RM, 1996, J CLIN ENDOCR METAB, V81, P847, DOI 10.1210/jc.81.2.847
   DAVIES TF, 1992, J CLIN INVEST, V89, P157, DOI 10.1172/JCI115556
   DONG RP, 1992, HUM IMMUNOL, V35, P165, DOI 10.1016/0198-8859(92)90101-R
   DONNER H, 1994, J CLIN ENDOCR METAB, V84, P143
   Heward J, 1997, CLIN SCI, V93, P479, DOI 10.1042/cs0930479
   Heward JM, 1999, CLIN ENDOCRINOL, V51, P115, DOI 10.1046/j.1365-2265.1999.00755.x
   Heward JM, 1999, J CLIN ENDOCR METAB, V84, P2398, DOI 10.1210/jc.84.7.2398
   Kraemer MHS, 1998, IMMUNOL INVEST, V27, P17, DOI 10.3109/08820139809070887
   MACIEL LMZ, 1997, ARQ BRASIL ENDOCRINO, V41, P76
   McIver B, 1998, ENDOCRIN METAB CLIN, V27, P73, DOI 10.1016/S0889-8529(05)70299-1
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MORAES ME, 1993, TISSUE ANTIGENS, V41, P238, DOI 10.1111/j.1399-0039.1993.tb02012.x
   OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x
   OMAR MAK, 1990, CLIN IMMUNOL IMMUNOP, V54, P98, DOI 10.1016/0090-1229(90)90009-F
   Philippou G, 1998, CLIN ENDOCRINOL, V48, P393, DOI 10.1046/j.1365-2265.1998.00453.x
   Sanjeevi CB, 2000, HUM IMMUNOL, V61, P148, DOI 10.1016/S0198-8859(99)00146-9
   SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x
   TAMAI H, 1994, J CLIN ENDOCR METAB, V78, P94, DOI 10.1210/jc.78.1.94
   TANDON N, 1990, CLIN ENDOCRINOL, V33, P21, DOI 10.1111/j.1365-2265.1990.tb00461.x
   Tomer Y, 1999, J CLIN ENDOCR METAB, V84, P4656, DOI 10.1210/jc.84.12.4656
   WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788
   YANAGAWA T, 1994, J CLIN ENDOCR METAB, V79, P227, DOI 10.1210/jc.79.1.227
   YANAGAWA T, 1993, J CLIN ENDOCR METAB, V76, P1569, DOI 10.1210/jcem.76.6.8501164
NR 30
TC 38
Z9 42
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1050-7256
EI 1557-9077
J9 THYROID
JI Thyroid
PD JAN
PY 2001
VL 11
IS 1
BP 31
EP 35
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 400WH
UT WOS:000166894300005
PM 11272094
DA 2020-12-17
ER

PT J
AU Moura, MD
   Navarro, PAAS
   Nogueira, AA
AF Moura, MD
   Navarro, PAAS
   Nogueira, AA
TI Pregnancy and term delivery after neovaginoplasty in a patient with
   vaginal agenesis
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE vaginal agenesis; hematocolpus; neovaginoplasty; pregnancy; Mullerian
   defects
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, BR-14049900 Ribeirao Preto, Brazil.
RP Moura, MD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, BR-14049900 Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012
OI Navarro, Paula Andrea/0000-0003-2368-4188
CR GREEN LK, 1976, OBSTET GYNECOL, V47, P427
   HAMPTON HL, 1990, OBSTET GYNECOL, V76, P900, DOI 10.1097/00006250-199011001-00001
   SALVATORE CA, 1978, ACTA OBSTET GYN SCAN, V57, P89, DOI 10.3109/00016347809154205
NR 3
TC 14
Z9 15
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0020-7292
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD DEC
PY 2000
VL 71
IS 3
BP 215
EP 216
DI 10.1016/S0020-7292(00)00269-1
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 384WJ
UT WOS:000165969200004
PM 11102605
DA 2020-12-17
ER

PT J
AU Moura, MD
   Navarro, PAAS
   de Sa, MFS
   Ferriani, RA
   Unzer, SM
   Reis, RM
AF Moura, MD
   Navarro, PAAS
   de Sa, MFS
   Ferriani, RA
   Unzer, SM
   Reis, RM
TI Hypogonadotropic hypogonadism: retrospective analysis of 19 cases
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE isolated gonadotropin deficiency; amenorrhea; gynecologic malformations;
   hypogonadotropic hypogonadism; Rokitansky syndrome; mullerian defects
ID KALLMANNS-SYNDROME; HORMONE DEFICIENCY; GENE; MOLECULES; ANOMALIES;
   ADHESION; PROTEIN; ANOSMIA; FATHER; SON
AB Objectives: To survey the clinical data of patients with isolated gonadotropin deficiency. Methods: We retrospectively surveyed the medical records of 19 patients with isolated gonadotropin deficiency aged 16-31 years (mean: 20 years). The major complaint was primary amenorrhea in 100% of the patients, with 42.1% of them also reporting absence of secondary sex traits, and 10% reporting anosmia or hyposmia. Seventy-four percent of the patients had been submitted to hormonal replacement therapy. Results: Bone densitometry was determined in 5 patients and revealed lumbar spine osteopenia in 3 patients and femoral osteopenia in 1. An association with urologic malformations was detected in 10.5% of cases and an association with gynecologic malformations was detected in 31.6%. Conclusions: Isolated gonadotropin deficiency can be easily diagnosed but requires early estrogen replacement therapy because of a higher risk of osteopenia and consequently of osteoporosis. Concomitant urogenital malformations are frequent and should be investigated. (C) 2000 International Federation of Gynecology and Obstetrics. All rights reserved.
C1 USP, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, Brazil.
RP Moura, MD (corresponding author), USP, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, Brazil.
RI Navarro, Paula/G-2744-2012; ferriani, rui alberto/G-9974-2012; Reis,
   Rosana M. dos/E-3346-2012
OI Reis, Rosana M. dos/0000-0001-9631-4167; Navarro, Paula
   Andrea/0000-0003-2368-4188
CR Adashi EY, 1999, NEW ENGL J MED, V340, P709, DOI 10.1056/NEJM199903043400907
   Aharoni A, 1989, Obstet Gynecol Surv, V44, P491, DOI 10.1097/00006254-198907000-00001
   BICK D, 1992, NEW ENGL J MED, V326, P1752, DOI 10.1056/NEJM199206253262606
   BRANDENBERGER AW, 1994, FERTIL STERIL, V61, P395
   CROWLEY WF, 1992, ENDOCR REV, V13, P635, DOI 10.1210/er.13.4.635
   DEAN JCS, 1990, CLIN ENDOCRINOL, V32, P341, DOI 10.1111/j.1365-2265.1990.tb00875.x
   FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0
   GARIEPY G, 1974, UNION MED CAN, V103, P1396
   GAUTHIER G, 1960, ACTA NEUROVEG, V21, P345, DOI 10.1007/BF01228269
   GLASS MR, 1981, BRIT J OBSTET GYNAEC, V88, P450, DOI 10.1111/j.1471-0528.1981.tb01012.x
   HERMANUSSEN M, 1985, CLIN GENET, V28, P106
   HUNTER AGW, 1986, AM J MED GENET, V24, P527, DOI 10.1002/ajmg.1320240316
   JONES JR, 1976, OBSTET GYNECOL ANN, V43, P433
   JUAN AMD, 1856, SIGLO MED, V3, P211
   KALLMANN RJ, 1954, AM J MENT DEFIC, V48, P203
   LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3
   LEVY CM, 1993, CLIN GENET, V43, P51, DOI 10.1111/j.1399-0004.1993.tb04451.x
   LIEBLICH JM, 1982, AM J MED, V73, P506, DOI 10.1016/0002-9343(82)90329-1
   MERRIAM GR, 1977, AM J DIS CHILD, V131, P1216, DOI 10.1001/archpedi.1977.02120240034007
   MOORMAN JR, 1984, AM J MED, V77, P369, DOI 10.1016/0002-9343(84)90724-1
   MOURA MD, 1997, REPROD CLIMATOL, V12, P86
   NOWAKOWSKI H, 1961, RECENT PROG HORM RES, V17, P53
   PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954
   SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0
   Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521
   WEGENKE JD, 1975, CLIN GENET, V7, P368
   WHITE BJ, 1983, AM J MED GENET, V15, P417, DOI 10.1002/ajmg.1320150307
   WHITMAN GF, 1991, AM J OBSTET GYNECOL, V165, P1881, DOI 10.1016/0002-9378(91)90050-2
   WORTSMAN J, 1982, FERTIL STERIL, V37, P123
   ZSELI J, 1991, CALCIFIED TISSUE INT, V48, P387, DOI 10.1007/BF02556451
NR 30
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0020-7292
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD NOV
PY 2000
VL 71
IS 2
BP 141
EP 145
DI 10.1016/S0020-7292(00)00267-8
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 378BV
UT WOS:000165562600007
PM 11064011
DA 2020-12-17
ER

PT J
AU Guzman, JEE
   Perez, JL
   Navarro, PAR
   Sequera, FE
   Alvarez, CS
   Rosales, JP
AF Guzman, JEE
   Perez, JL
   Navarro, PAR
   Sequera, FE
   Alvarez, CS
   Rosales, JP
TI Symptomatic splenic hamartoma
SO REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
LA Spanish
DT Letter
DE hamartoma; spleen; comprehensive syndrome
ID SPLEEN
C1 Hosp Infanta Margarita, Serv Cirugia Gen & Aparato Digest, Cabra 14940, Cordoba, Spain.
RP Guzman, JEE (corresponding author), Hosp Infanta Margarita, Serv Cirugia Gen & Digest, Avda Gongora S-N, Cabra 14940, Cordoba, Spain.
CR MORGENSTERN L, 1984, ARCH SURG-CHICAGO, V119, P1291
   ROSS CF, 1971, J PATHOL, V105, P62, DOI 10.1002/path.1711050109
   SALVADOR JM, 1990, CIR ESP, V3, P334
   SILVERMAN ML, 1978, AM J CLIN PATHOL, V70, P224
   SOLBIATI L, 1983, AM J ROENTGENOL, V140, P59, DOI 10.2214/ajr.140.1.59
   ZISSIN R, 1992, CLIN RADIOL, V45, P410, DOI 10.1016/S0009-9260(05)81003-7
NR 6
TC 0
Z9 0
U1 0
U2 0
PU EDITORIAL GARSI
PI MADRID
PA JUAN BRAVO, 46, 28006 MADRID, SPAIN
SN 1130-0108
J9 REV ESP ENFERM DIG
JI Rev. Esp. Enferm. Dig.
PD JAN
PY 2000
VL 92
IS 1
BP 47
EP 48
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 293MK
UT WOS:000085855700008
DA 2020-12-17
ER

PT J
AU San Juan, J
   Monteagudo, C
   Navarro, P
   Terradez, JJ
AF San Juan, J
   Monteagudo, C
   Navarro, P
   Terradez, JJ
TI Basal cell carcinoma with prominent central palisading of epithelial
   cells mimicking schwannoma
SO JOURNAL OF CUTANEOUS PATHOLOGY
LA English
DT Article
AB Basal cell carcinoma (BCC), the most common malignant neoplasm of skin, may show a wide spectrum of histologic appearances. The presence of peripheral palisades is a very characteristic feature of BCC but, to our knowledge, central nuclear palisading has never been described. We report two cases of BCC exhibiting striking central nuclear palisading with Verocaylike bodies, in a pattern reminiscent of schwannoma. Peripheral palisades and clefts were also present in most tumor nodules and lobules, giving the neoplasms the overall configuration of otherwise typical solid BCC. In addition, foci of conventional BCC could be found adjacent, and in transition, to schwannoid areas. The immunohistochemical study showed strong reactivity for keratins (AE1 and AE3) in tumor cells, whereas no immunostaining for S-100 or muscle-specific actin was found. This previously undescribed histological feature of BCC should lead us to include BCC in the List of tumors to be considered in the differential diagnosis of a cutaneous neoplasm with schwannoid features.
C1 Hosp Arnau Vilanova, Serv Anat Patol, Valencia, Spain.
   Hosp Clin Univ, Valencia, Spain.
RP San Juan, J (corresponding author), Hosp Arnau Vilanova, Serv Anat Patol, C San Clemente 26,C46015, Valencia, Spain.
RI , Monteagudo/H-6555-2016
CR ALLEN PW, 1981, TUMORS PROLIFERATION, P20
   GISSER SD, 1977, AM J OBSTET GYNECOL, V129, P389, DOI 10.1016/0002-9378(77)90582-8
   Goldberg LH, 1996, LANCET, V347, P663, DOI 10.1016/S0140-6736(96)91208-8
   Rippey JJ, 1998, HISTOPATHOLOGY, V32, P393
   SCHWOB VS, 1986, J CUTAN PATHOL, V13, P403, DOI 10.1111/j.1600-0560.1986.tb01083.x
   SUSTER S, 1991, AM J DERMATOPATH, V13, P350, DOI 10.1097/00000372-199108000-00005
   Wade T R, 1978, J Dermatol Surg Oncol, V4, P23
   WEISS SW, 1989, AM J SURG PATHOL, V13, P341, DOI 10.1097/00000478-198905000-00001
   Zelger BG, 1997, AM J DERMATOPATH, V19, P242, DOI 10.1097/00000372-199706000-00007
NR 9
TC 11
Z9 11
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6987
J9 J CUTAN PATHOL
JI J. Cutan. Pathol.
PD NOV
PY 1999
VL 26
IS 10
BP 528
EP 532
PG 5
WC Dermatology; Pathology
SC Dermatology; Pathology
GA 260ZM
UT WOS:000083983400010
PM 10599946
DA 2020-12-17
ER

PT J
AU Son, J
   Navarro, P
   Huang, M
   D'Agostin, D
   Han, SJ
   Morquecho, I
   Padilla, X
   Vu, S
   Sharp, SB
AF Son, J
   Navarro, P
   Huang, M
   D'Agostin, D
   Han, SJ
   Morquecho, I
   Padilla, X
   Vu, S
   Sharp, SB
TI Regulation of Rb, p21, ERK-6, mkp-1, MRF-4 and p53 in BC3H1 myogenic
   cells.
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Calif State Univ Los Angeles, Dept Biol & Microbiol, Los Angeles, CA 90032 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 23
PY 1999
VL 13
IS 7
SU S
BP A1450
EP A1450
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 226QX
UT WOS:000082033400737
DA 2020-12-17
ER

PT J
AU Butler, JE
   Sun, J
   Navarro, P
   Weber, P
AF Butler, JE
   Sun, J
   Navarro, P
   Weber, P
TI Colonization of the gastrointestinal tract primarily results in
   diversification of pre-immune VDJ transcripts in mucosal tissues.
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   S Dakota State Univ, Dept Vet Sci, Brookings, SD 57007 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 15
PY 1999
VL 13
IS 5
SU S
BP A991
EP A991
PN 2
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 228JG
UT WOS:000082132901989
DA 2020-12-17
ER

PT J
AU Ferrando, I
   Ferrando, J
   Reig, G
   Navarro, P
   Llombart, A
   Minguez, M
   Mora, F
   Benages, A
AF Ferrando, I
   Ferrando, J
   Reig, G
   Navarro, P
   Llombart, A
   Minguez, M
   Mora, F
   Benages, A
TI Barrett's esophagus, markers to distinguish risk groups
SO REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
LA English
DT Article
DE Barrett; adenocarcinoma; progression to malignancy
ID P53 PROTEIN OVEREXPRESSION; INTESTINAL METAPLASIA; SUPPRESSOR GENE;
   OVERRATED RISK; FLOW-CYTOMETRY; ADENOCARCINOMA; MUTATIONS; CANCER;
   EPITHELIUM; EXPRESSION
AB BACKGROUND: as compared to the general population, patients with Barrett's esophagus (BE) present a 30 to 40 times higher risk of developing cancer. Their prognosis is poor and it will only be changed trying to recognize and detect preneoplastic changes early in order to provide these patients with an effective surgical therapy. Although epithelial dysplasia is still the "gold standard" as a marker of increased risk for malignancy, in view of the inter and intraobserver differences for interpreting it, both as regards its existence and grade, we have investigated other markers which can show this increased cancer risk.
   OBJECTIVE: our aim has been to analyze which parameters, in addition to dysplasia, can distinguish groups with a higher or lower risk of progression to malignancy for a differentiated follow-up, so that the cost-benefit ratio is adequate and a sufficiently early diagnosis can be achieved which allows for a healing surgical therapy in most patients.
   PATIENTS AND METHODS: twenty-seven patients have been studied, 9 with BE wi- thout dysplasia (control group), 9 with Barrett's esophagus with dysplasia, and 9 adenocarcinomas over BE, in all of which the presence of p53, cerb-2, PCNA and CEA was established by histochemistry and the existence of aneuploidy by static cytometry.
   RESULTS: PCNA was positive in the three groups, though it was not at the surface epithelium in 55.5% of the control cases. C-erb-2 was negative in all control cases and positive in 5 cases with dysplasia, and 2 with adenocarcinoma. Protein p53 was positive in one control case, in 2 with dysplasia, and 4 with adenocarcinoma. CEA was positive in 7 control cases and in all cases with dysplasia and adenocarcinoma. Finally, aneuploidy was found by static cytometry in 5 of 9 control cases, in 4 of 9 with dysplasia, and in all adenocarcinomas. From the analysis of the results obtained, it can be concluded that a positive marker, even in the absence of dysplasia, suggests the presence of a "genomic instability" which may lead to progression to malignancy.
   CONCLUSIONS: this study allows us to establish three risk groups (high, low and intermediate) for a differentiated follow-up which allows an early diagnosis, with an adequate cost-benefit ratio.
C1 Univ Valencia, Clin Hosp, Valencia, Spain.
RP Ferrando, J (corresponding author), Avda Baron de Carcer 49, Valencia 46001, Spain.
RI Llombart-Cussac, Antonio/A-6706-2010
OI Minguez, Miguel/0000-0003-0148-5938
CR ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291
   ANDREZET MP, 1993, GASTROENTEROLOGY, V104, pA386
   BARJEK J, 1991, ONCOGENE, V6, P1699
   BENNETT WP, 1992, CANCER RES, V52, P6092
   BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287
   BLOUNT PL, 1991, CANCER RES, V51, P5482
   CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404
   CASSON AG, 1991, CANCER RES, V51, P4495
   FERRANDO J, 1991, REV ESP ENFERM DIG, V80, P83
   FLEJOU JF, 1993, J CLIN PATHOL, V46, P330, DOI 10.1136/jcp.46.4.330
   FLEJOU JF, 1993, GASTROENTEROLOGY, V104, pA400
   FLEJOU JF, 1993, GASTROENTEROLOGY, V104, pA401
   GAREWALL HS, 1991, DIGEST DIS SCI, V36, P48
   GEBOES K, 1994, INT CONGR SER, V1052, P993
   GRAMLICH T, 1993, GASTROENTEROLOGY, V104, pA407
   GRAY M R, 1991, Gastroenterology, V100, pA367
   GRAY MR, 1993, GASTROENTEROLOGY, V104, pA91
   HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3
   HAMELIN R, 1994, GASTROENTEROLOGY, V107, P1012, DOI 10.1016/0016-5085(94)90225-9
   HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0
   JANKOWSKI J, 1994, GASTROEN CLIN BIOL, V18, pD40
   JANKOWSKI J, 1992, GUT, V33, P1033, DOI 10.1136/gut.33.8.1033
   KRISHNADATH KK, 1993, GASTROENTEROLOGY, V104, pA1045
   Kumble S, 1997, GASTROENTEROLOGY, V112, P348, DOI 10.1053/gast.1997.v112.pm9024288
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   LEVINE DS, 1989, LAB INVEST, V60, P418
   MCGUIGAN J, 1993, GASTROENTEROLOGY, V104, pA178
   MELTZER SJ, 1991, P NATL ACAD SCI USA, V88, P4976, DOI 10.1073/pnas.88.11.4976
   MEYER W, 1979, ENDOSCOPY, V11, P121, DOI 10.1055/s-0028-1098335
   MOORE JH, 1994, INT J CANCER, V56, P487, DOI 10.1002/ijc.2910560406
   NESHAT D, 1994, GASTROENTEROL CLIN B, V18, pD71
   NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0
   NISHIMAKI T, 1991, CANCER, V68, P1731, DOI 10.1002/1097-0142(19911015)68:8<1731::AID-CNCR2820680814>3.0.CO;2-0
   PAULL A, 1976, NEW ENGL J MED, V295, P476, DOI 10.1056/NEJM197608262950904
   PELLISH LJ, 1980, GUT, V21, P26, DOI 10.1136/gut.21.1.26
   RAMEL S, 1992, GASTROENTEROLOGY, V102, P1220
   REID B J, 1990, Gastroenterology, V98, pA305
   REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7
   REID BJ, 1987, GASTROENTEROLOGY, V93, P1
   REID BJ, 1991, GASTROENTEROL CLIN N, V20, P817
   REID BJ, 1992, GASTROENTEROLOGY, V102, P212
   Richter JE, 1996, J CLIN GASTROENTEROL, V23, P88, DOI 10.1097/00004836-199609000-00002
   RICHTER JE, 1993, AM J GASTROENTEROL, V88, P630
   RIDELL RH, 1994, ESOPHAGEAL MUCOSA, P1004
   ROSENBERG JC, 1985, CANCER, V55, P1353, DOI 10.1002/1097-0142(19850315)55:6<1353::AID-CNCR2820550632>3.0.CO;2-D
   SCHMIT HG, 1989, J CANCER RES CLIN, V110, P145
   Spechler SJ, 1996, GASTROENTEROLOGY, V110, P614, DOI 10.1053/gast.1996.v110.agast960614
   SPECHLER SJ, 1984, GASTROENTEROLOGY, V87, P927
   SPRUNG DJ, 1984, AM J GASTROENTEROL, V79, pA817
   THOMPSON JJ, 1983, HUM PATHOL, V14, P43
   TOMINAGA O, 1992, Critical Reviews in Oncogenesis, V3, P257
   TYTGAT GNJ, 1992, WORLD J SURG, V16, P308, DOI 10.1007/BF02071538
   vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5
   VANDERVEEN AH, 1989, GUT, V30, P14, DOI 10.1136/gut.30.1.14
   WESDORP ICE, 1981, ACTA ENDOSC, V11, P317
   Weston AP, 1996, AM J GASTROENTEROL, V91, P981
   WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212
   WINTERS C, 1987, GASTROENTEROLOGY, V92, P112
   Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574
   YOUNES M, 1993, GASTROENTEROLOGY, V105, P1637, DOI 10.1016/0016-5085(93)91058-P
NR 62
TC 8
Z9 8
U1 0
U2 1
PU ARAN EDICIONES, S A
PI MADRID
PA CASTELLO, 128, 1O, 28006 MADRID, SPAIN
SN 1130-0108
J9 REV ESP ENFERM DIG
JI Rev. Esp. Enferm. Dig.
PD JUN
PY 1998
VL 90
IS 6
BP 436
EP 440
PG 5
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA ZY559
UT WOS:000074634900006
PM 9708008
DA 2020-12-17
ER

PT J
AU Robello, C
   Navarro, P
   Castanys, S
   Gamarro, F
AF Robello, C
   Navarro, P
   Castanys, S
   Gamarro, F
TI A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers
   resistance to antifolates in Trypanosoma cruzi
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
DE Trypanosoma cruzi; pteridine reductase; stage-specific expression; DNA
   transfection; drug resistance
ID CHAIN DEHYDROGENASE GENE; METHOTREXATE RESISTANCE; H-LOCUS; LEISHMANIA;
   AMPLIFICATION; EXPRESSION; BIOPTERIN; COFACTOR; MEMBER; FAMILY
AB We have isolated the pteridine reductase-1 gene (ptr1), from Trypanosoma cruzi (Y strain), located contiguous to the Trypanosoma cruzi P-glycoprotein-2 (tcpgp2). The gene encodes 3 member of the family of short-chain dehydrogenases, enzymes that are involved in several oxidoreduction reactions. One member of the family, pteridine reductase-1 (PTR1) has been previously described in Leishmania as being involved in antifolate resistance. The ptr1 gene from T. cruzi presents an 828 bp open reading frame, coding for a 276 amino acid protein with a predicted molecular mass of 30 kDa. The deduced amino acid sequence exhibited a remarkable homology with the ptr1 genes of Leishmania major and Leishmania tarentolae. Southern blot analysis using a specific probe indicated that T. cruzi PTR1 is encoded by a single copy gene located in two chromosomes of about 0.9 and 1.2 Mb. Western blot analysis using a polyclonal antiserum against recombinant PTR1 revealed that the protein is only expressed in the epimastigote forms of the parasite; we did not detect the protein either in the amastigote or trypomastigote forms. Purified recombinant PTR1 exhibits a NADPH-dependent pteridine reductase activity comparable with those described in Leishmania. Gene transfection experiments using the pTEX expression vector show that, under the conditions tested, T. cruzi PTR1 is involved in resistance to the methotrexate, aminopterin and trimethoprim antifolates. (C) 1997 Elsevier Science Ireland Ltd.
C1 CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Bioquim & Farmacol Mol, Granada 18001, Spain.
RP Gamarro, F (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Bioquim & Farmacol Mol, C Ventanilla 11, Granada 18001, Spain.
EM gamarro@ipb.csic.es
RI Castanys, Santiago/Y-3981-2019; ROBELLO, CARLOS/M-5609-2019
OI Castanys, Santiago/0000-0002-3460-844X; ROBELLO,
   CARLOS/0000-0001-6985-6171; Gamarro, Francisco/0000-0003-1347-3440
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2
   ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BECK JT, 1991, MOL BIOCHEM PARASIT, V49, P21, DOI 10.1016/0166-6851(91)90126-Q
   BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442
   BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7
   BEVERLEY SM, 1991, ANNU REV MICROBIOL, V45, P417, DOI 10.1146/annurev.mi.45.100191.002221
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427
   CALLAHAN HL, 1992, J BIOL CHEM, V267, P24165
   CHIQUERO MJ, 1994, BBA-MOL BASIS DIS, V1227, P188, DOI 10.1016/0925-4439(94)90094-9
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   CODERRE JA, 1983, P NATL ACAD SCI-BIOL, V80, P2132, DOI 10.1073/pnas.80.8.2132
   Dallagiovanna B, 1996, MOL BIOCHEM PARASIT, V75, P145, DOI 10.1016/0166-6851(95)02519-7
   DELANGE T, 1984, NUCLEIC ACIDS RES, V12, P4431, DOI 10.1093/nar/12.11.4431
   DEVEREUX J, 1984, NUCLEIC ACIDS RES, V8, P5725
   ENSOR CM, 1991, BIOCHEM BIOPH RES CO, V176, P840, DOI 10.1016/S0006-291X(05)80262-1
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   GARVEY EP, 1986, SCIENCE, V233, P533
   GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064
   JIMENEZORTIZ A, 1984, ANN PARASIT HUM COMP, V59, P573, DOI 10.1051/parasite/1984596573
   KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963
   KIDDER GW, 1958, J GEN MICROBIOL, V18, P621, DOI 10.1099/00221287-18-3-621
   KWON NS, 1989, J BIOL CHEM, V264, P20496
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAYDEN RE, 1988, MOL CELL BIOL, V8, P1352, DOI 10.1128/MCB.8.3.1352
   LU HY, 1991, MOL BIOCHEM PARASIT, V44, P109, DOI 10.1016/0166-6851(91)90226-V
   Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883
   OUELLETTE M, 1991, EMBO J, V10, P1009, DOI 10.1002/j.1460-2075.1991.tb08035.x
   PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x
   PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P11980
   PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305
   PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P7310
   PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x
   Pizzi P T., 1952, Boletin Chileno de Parasitologia, V7, P22
   Sambrook J, 1989, MOL CLONING LAB MANU
   Silva L H P, 1953, FOLIA CLIN BIOL, V20, P197
   TAYEH MA, 1989, J BIOL CHEM, V264, P19654
   VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995
   Wang JY, 1997, ARCH BIOCHEM BIOPHYS, V342, P197, DOI 10.1006/abbi.1997.0126
NR 41
TC 46
Z9 48
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD DEC 15
PY 1997
VL 90
IS 2
BP 525
EP 535
DI 10.1016/S0166-6851(97)00207-7
PG 11
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA YU236
UT WOS:000071695900012
PM 9476799
DA 2020-12-17
ER

PT J
AU SUN, J
   NAVARRO, P
   BUTLER, JE
AF SUN, J
   NAVARRO, P
   BUTLER, JE
TI EXPRESSED PORCINE J(H) SEGMENTS ARE DERIVED FROM A SINGLE GERMLINE J(H)
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 UNIV IOWA,IOWA CITY,IA 52242.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR 9
PY 1995
VL 9
IS 3
BP A228
EP A228
PN 1
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA QL987
UT WOS:A1995QL98701350
DA 2020-12-17
ER

PT J
AU CHIQUERO, MJ
   OLMO, A
   NAVARRO, P
   RUIZPEREZ, LM
   CASTANYS, S
   GONZALEZPACANOWSKA, D
   GAMARRO, F
AF CHIQUERO, MJ
   OLMO, A
   NAVARRO, P
   RUIZPEREZ, LM
   CASTANYS, S
   GONZALEZPACANOWSKA, D
   GAMARRO, F
TI AMPLIFICATION OF THE H-LOCUS IN LEISHMANIA-INFANTUM
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE METHOTREXATE; H-REGION; GENE AMPLIFICATION; (LEISHMANIA INFANTUM)
ID METHOTREXATE-RESISTANT LEISHMANIA; P-GLYCOPROTEIN GENE;
   SYNTHETASE-DIHYDROFOLATE REDUCTASE; EXTRACHROMOSOMAL CIRCLES; REGION
   AMPLIFICATION; MULTIDRUG RESISTANCE; DNA AMPLIFICATION; DRUG-RESISTANCE;
   TARENTOLAE; AMPLICONS
AB We have selected for a Leishmania infantum cell line resistant to high levels of methotrexate (MTX). The resulting cells were 1233-fold more resistant than wild-type and contained amplified H-region circles. Homologous genes to the antifolate resistant ltdh gene and to the P-glycoprotein ltpgpA gene of Leishmania tarentolae were observed to be contained within the amplicon. In order to invoke additional mechanisms of resistance, we examined possible variations in MTX accumulation. Resistance was not correlated with a decreased uptake of MTX. On the contrary, the resistant line presented a 3-fold increase in the steady-state accumulation of drug with regard to the wild-type line. Northern blot analysis using gene specific probes, showed that the ltdh probe and the ltpgpA probe recognized single transcripts of 1 kb and 5 kb respectively which were both overexpressed only approx. 5-fold in resistant cells. We propose that amplification of the antifolate resistance gene, homologue to the ltdh gene of L. tarentolae, is apparently the only mechanism involved in resistance to the cytotoxic drug MTX in L. infantum resistant to 1000 mu M of MTX.
C1 CSIC,INST PARASITOL & BIOMED,E-18001 GRANADA,SPAIN.
RI Castanys, Santiago/Y-3981-2019
OI Castanys, Santiago/0000-0002-3460-844X; Gonzalez-Pacanowska,
   Dolores/0000-0002-4303-5209; Ruiz-Perez, Luis M./0000-0001-7681-4471;
   Gamarro, Francisco/0000-0003-1347-3440
CR ARREBOLA R, 1994, IN PRESS J BIOL CHEM
   Beverley S. M., 1988, The biology of parasitism. A molecular and immunological approach., P431
   BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7
   CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427
   CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420
   CODERRE JA, 1983, P NATL ACAD SCI-BIOL, V80, P2132, DOI 10.1073/pnas.80.8.2132
   ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15094
   ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15960
   ELLENBERGER TE, 1987, J BIOL CHEM, V262, P13501
   ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   GARVEY EP, 1986, SCIENCE, V233, P535, DOI 10.1126/science.3726545
   GRONDIN K, 1993, NUCLEIC ACIDS RES, V21, P1895, DOI 10.1093/nar/21.8.1895
   HENDERSON DM, 1992, MOL CELL BIOL, V12, P2855, DOI 10.1128/MCB.12.6.2855
   HIGHTOWER RC, 1988, J BIOL CHEM, V263, P16970
   JACKSON PR, 1986, VET PARASITOL, V20, P195, DOI 10.1016/0304-4017(86)90100-7
   KATAKURA K, 1989, MOL BIOCHEM PARASIT, V34, P189, DOI 10.1016/0166-6851(89)90010-8
   KAUR K, 1988, J BIOL CHEM, V263, P7020
   MANIATIS T, 1982, MOL CLONING
   MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021
   OUELLETTE M, 1991, EMBO J, V10, P1009, DOI 10.1002/j.1460-2075.1991.tb08035.x
   OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x
   PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x
   PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305
   PETRILLOPEIXOTO ML, 1988, MOL CELL BIOL, V8, P5188, DOI 10.1128/MCB.8.12.5188
   READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3
   SAMUELSON J, 1990, MOL BIOCHEM PARASIT, V38, P281, DOI 10.1016/0166-6851(90)90031-G
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   WHITE TC, 1988, J BIOL CHEM, V263, P16977
NR 31
TC 11
Z9 12
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD NOV 29
PY 1994
VL 1227
IS 3
BP 188
EP 194
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA PW806
UT WOS:A1994PW80600011
PM 7986827
DA 2020-12-17
ER

EF